Prince William County
Fire and Rescue System
Patient Care Manual
Effective Date: January 1, 2017
Revision Date: July 6, 2019
i
Preliminary Information
Preliminary Information
Overview ................................................................................................................ I
Acknowledgements .............................................................................................. II
Authorization ....................................................................................................... III
General Principles for Medical Care ................................................................... IV
ALS Intercept Guidelines .................................................................................... VIII
Medical Transport Destination ............................................................................ IX
Patient Care During Transport .............................................................................. X
Medical Control Contact ..................................................................................... XI
Automatic Notification of the Medical Director ................................................ XII
Transfer of Care at Hospitals ............................................................................. XIII
Document Guide for Written Format ................................................................ XIV
Adult Protocols
General Patient Care Protocol – Adult ................................................................. 1
Respiratory Emergencies:
Dyspnea ................................................................................................................. 5
Acute Bronchospasm ............................................................................................. 7
Pulmonary Edema ................................................................................................. 8
Submersion Injury ............................................................................................... 10
Respiratory Failure .............................................................................................. 11
Failed Airway ....................................................................................................... 13
Cardiac Arrest:
General Approach ............................................................................................... 15
Asystole/PEA ....................................................................................................... 17
V‐Fib/Pulseless V‐Tach ........................................................................................ 19
Post Resuscitation Care ....................................................................................... 21
Cardiac Emergencies:
Acute Coronary Syndrome .................................................................................. 22
Bradycardia ......................................................................................................... 24
Regular Narrow Complex Tachycardia (SVT) ..................................................... 25
Irregular Narrow Complex Tachycardia (A‐Fib) ................................................. 26
Wide Complex Tachycardia ................................................................................. 27
Polymorphus V‐Tach (Torsades de Pointes) ...................................................... 29
Environmental Emergencies:
Bites and Envenomation ..................................................................................... 30
Hyperthermia ...................................................................................................... 31
Hypothermia ........................................................................................................ 32
Hazardous Materials Exposure:
General Approach ............................................................................................... 33
Cyanide Toxicity and Smoke Inhalation ............................................................. 35
ii
Nerve Agent WMD .............................................................................................. 37
Medical:
Abdominal Pain ................................................................................................... 39
Allergic Reaction ................................................................................................. 40
Altered Mental Status/Syncope .......................................................................... 42
Behavioral Emergencies/Excited Delirium ......................................................... 43
Diabetic Emergencies .......................................................................................... 45
Seizure ................................................................................................................. 46
Sepsis ................................................................................................................... 47
Stroke Suspected ................................................................................................. 48
OB/GYN:
Childbirth ............................................................................................................. 49
Pre‐Eclampsia/Eclampsia .................................................................................... 52
Vaginal Bleeding ................................................................................................. 53
Overdose and Poisoning:
General Approach ............................................................................................... 54
Antidepressants ................................................................................................... 55
Antipsychotics/Acute Dystonic Reaction ............................................................ 57
Beta Blocker Toxicity ........................................................................................... 58
Calcium Channel Blocker ..................................................................................... 59
Carbon Monoxide ................................................................................................ 60
Cholinergic Organophosphate ........................................................................... 61
Pain Management:
Medical/Trauma ................................................................................................. 62
Trauma:
General Patient Care Protocol – Adult Trauma .................................................. 63
Abdominal Injuries .............................................................................................. 65
Burns .................................................................................................................... 66
Chest Injuries ....................................................................................................... 68
Extremity Injuries ................................................................................................ 70
Eye Injuries .......................................................................................................... 71
Head Injuries........................................................................................................ 72
Sexual Assault ..................................................................................................... 74
Traumatic Amputations ...................................................................................... 75
Pediatric Protocols
General Patient Care Protocol – Pediatric .......................................................... 76
Pediatric Respiratory Emergencies:
Dyspnea ............................................................................................................... 80
Acute Bronchospasm ........................................................................................... 81
Stridor .................................................................................................................. 82
iii
Submersion Injury ............................................................................................... 84
Respiratory Failure .............................................................................................. 85
Pediatric Cardiac Arrest:
General Approach .............................................................................................. 87
Asystole/PEA ....................................................................................................... 89
V‐Fib/Pulseless V‐Tach ........................................................................................ 91
Neonatal Resuscitation ....................................................................................... 92
Post Resuscitation Care ....................................................................................... 95
Pediatric Cardiac Emergencies:
Bradycardia ......................................................................................................... 96
Tachycardia ......................................................................................................... 98
Hazardous Materials Exposure:
Cyanide Toxicity and Smoke Inhalation ........................................................... 100
Pediatric Medical:
Allergic Reaction ............................................................................................... 101
Altered Mental Status/Syncope ........................................................................ 102
Apparent Life‐Threatening Event ..................................................................... 103
Diabetic Emergencies ........................................................................................ 105
Seizure ............................................................................................................... 107
Sepsis ................................................................................................................. 108
Pediatric Overdose and Poisoning:
Pediatric Overdose and Poisoning .................................................................... 110
Pediatric Pain Management:
Medical/Trauma ............................................................................................... 111
Trauma:
General Patient Care Protocol – Pediatric Trauma .......................................... 113
Abdominal Injuries .......................................................................................... 115
Burns .................................................................................................................. 116
Chest Injuries .................................................................................................... 118
Extremity Injuries ............................................................................................. 120
Eye Injuries ........................................................................................................ 121
Head Injuries ..................................................................................................... 122
Sexual Assault .................................................................................................. 124
Traumatic Amputations ................................................................................... 125
Procedures
Administrative Procedures:
Abuse and Neglect ............................................................................................ 126
Americans with Disabilities Act ........................................................................ 129
iv
Burn Center Criteria........................................................................................... 132
Code Sepsis ........................................................................................................ 134
Code STEMI ....................................................................................................... 135
Code Stroke ........................................................................................................ 136
Do Not Resuscitate ............................................................................................ 137
Emergency Department Notification ................................................................ 138
Extraordinary Care ............................................................................................ 139
Lights and Siren Use During Transport ............................................................ 141
Medication Administration Cross Check (MACC) ............................................ 143
Patient Care During Interfacility Transport ..................................................... 145
Physician on Scene ........................................................................................... 146
Police Custody Patient Care Standards ............................................................ 148
Refusal of Medical Care .................................................................................... 150
Refusal of Transport After Treatment .............................................................. 155
Restraints ........................................................................................................... 157
Trauma Triage Criteria ...................................................................................... 158
Withholding Resuscitation ................................................................................ 160
Clinical Procedures (Airway/Respiratory):
Advanced Suctioning ......................................................................................... 162
Basic Suctioning ................................................................................................. 163
Carboxyhemoglobin Monitoring ...................................................................... 164
Chest Decompression ........................................................................................ 167
Confirmation of Placement/Effectiveness of Ventilation ............................... 169
Continuous Positive Airway Pressure (CPAP) ................................................... 170
Cricothyrotomy ................................................................................................. 172
End Tidal CO2 Monitoring .................................................................................. 175
General Airway Management ......................................................................... 176
Laryngeal Tube Airway (KING LTS‐D) ............................................................... 178
Obstructed Airway ............................................................................................ 180
Orotracheal Intubation/Bougie ........................................................................ 182
Pulse Oximetry ................................................................................................. 187
Clinical Procedures (Cardiac):
12‐Lead ECG ....................................................................................................... 188
Cardiopulmonary Resuscitation ........................................................................ 190
Cardioversion ..................................................................................................... 191
Defibrillation Automated .................................................................................. 192
Defibrillation Manual ........................................................................................ 194
External Cardiac Pacing .................................................................................... 195
High Performance CPR ...................................................................................... 197
Implanted Cardiac Device ................................................................................. 204
Posterior ECG ..................................................................................................... 209
Right Sided ECG ................................................................................................. 211
Termination of Resuscitation ............................................................................ 213
Clinical Procedures (Other):
Blood Glucose Analysis ..................................................................................... 216
v
Electronic Control Device (Taser) ...................................................................... 217
Eye Irrigation ..................................................................................................... 218
Medication Administration ............................................................................... 219
Selective Spinal Motion Restriction (SSMR) ..................................................... 223
Splinting ............................................................................................................. 227
Tactical Emergency Casualty Care (TECC) ........................................................ 228
Temperature Measurements ............................................................................ 232
Venous Access Indwelling Catheters ................................................................ 233
Venous Access Intraosseous ............................................................................. 234
Venous Access Peripheral ................................................................................. 237
Wound Care/Hemorrhage Control ................................................................... 239
Pharmacology
Authorized Pharmaceuticals ............................................................................. 242
Adenosine .......................................................................................................... 243
Albuterol Sulfate ............................................................................................... 244
Amiodarone ....................................................................................................... 246
Aspirin ................................................................................................................ 248
Atropine Sulfate (cardiac indications) .............................................................. 249
Atropine Sulfate (antidote for poisoning) ........................................................ 250
Calcium Chloride ................................................................................................ 252
Dextrose ............................................................................................................. 254
Diphenhydramine Hydrochloride ...................................................................... 256
Dopamine Hydrochloride .................................................................................. 258
Epinephrine Hydrochloride (1mg/ml) ............................................................... 260
Epinephrine Hydrochloride (0.1mg/ml) ............................................................ 262
Fentanyl ............................................................................................................. 264
Glucagon ............................................................................................................ 266
Hydroxocobalamin ............................................................................................ 267
Ipratropium Bromide ........................................................................................ 268
Ketamine Hydrochloride ................................................................................... 270
Lidocaine ............................................................................................................ 271
Magnesium Sulfate ........................................................................................... 272
Methylprednisolone .......................................................................................... 274
Metoprolol ......................................................................................................... 275
Morphine Sulfate ............................................................................................... 276
Midazolam ......................................................................................................... 278
Naloxone............................................................................................................ 281
Nitroglycerin ...................................................................................................... 283
Ondansetron Hydrochloride .............................................................................. 285
Promethazine .................................................................................................... 286
Racemic Epinephrine ........................................................................................ 287
Sodium Bicarbonate .......................................................................................... 288
Tranexamic Acid ................................................................................................ 290
vi
Reference Documents
Pediatric Quick Reference ................................................................................. 291
Triage Quick Reference ..................................................................................... 293
SAMPLE Durable Do Not Resuscitate Order (DDNR)
SAMPLE Physician Orders for Scope of Treatment (POST)
Virginia Scope of Practice – Procedures for EMS Personnel
Virginia Scope of Practice – Formulary for EMS Personnel
EMS Field Guide for Ventricular Assist Devices
Medication Administration Cross Check (MACC) Quick Reference
HPCPR Triangles
Airtraq – Video Downloading Instructions
Prince William County Fire and Rescue System
Preliminary Information
Preliminary Information: Overview
Prince William County Fire and Rescue System
Preliminary Information: Overview
The Prince William County Fire and Rescue System (FRS) Patient Care Manual is intended to
provide and ensure uniform treatment for all patients who receive care from agencies
participating in the Prince William County EMS System. The protocols within apply exclusively
to agencies responding to activation of the 911 system within Prince William County. Any other
use must receive prior approval from the Operational Medical Director (OMD) of Prince William
County, Virginia.
While attempts have been made to address all patient care scenarios, unforeseen circumstances
and patient care needs will arise. For these instances, medical personnel should follow the
General Principles for Medical Care and General Patient Care Protocol (or other appropriate
protocol), exercise their own best judgment, and contact Online Medical Control (OLMC) for
additional physician orders as needed. The patient’s best interest should be the final determinant
for all decisions.
I
Preliminary Information: Acknowledgements
Prince William County Fire and Rescue System
Preliminary Information: Acknowledgements
The OMD wishes to thank the following agencies and individuals for their hard work and
commitment during the development of these protocols.
Contributing Agencies and Individuals
Prince William County Department Fire Rescue
Battalion Chief Michael LaSalle
Captain Craig Beavers
Captain Robert Montminy
Captain Brett Hamby
Captain Marcus Saager
Captain Jason Reese
Lieutenant Randy Coggin
Lieutenant Sam Kaye
Lieutenant Ryan Kirk
Lieutenant Robert Moreau
Lieutenant David Seifert
Lieutenant Robert Wiencko
Technician II Yasmin Ahmady
Technician II Amanda Gott
Technician II Werter Willis
William Fritz, ALS Training Specialist
Christine Gallagher, Technical Services Analyst
Other Contributing Agencies and Individuals
EMS Advisory Committee
Debbie Eaton, FRS Administrative Coordinator
Mary Smith, Administrative Support Assistant III
Dynette Rombough, Sentara Emergency Service Nurse Manager
The Honorable Devan Lee Kirk, 31st Judicial District
Tiffany Fischer, Novant/UVA Prince William Emergency Services Nurse Manager
Jessica Silcox, Sentara Stroke Coordinator
II
Preliminary Information: Authorization
Prince William County Fire and Rescue System
Preliminary Information: Authorization
III
In accordance with 12VAC5‐31‐1040, effective 1 January 2017 the following Patient Care Manual
is authorized by the OMD for use in the Prince William County EMS System. Changes to this
manual may only be made with written authorization of the OMD.
Kevin Campbel
Acting Operational Medical Director
Prince William County
Preliminary Information: General Principles for Medical Care
Prince William County Fire and Rescue System
Preliminary Information: General Principles for Medical Care
IV
The following measures shall be applied to help promote prompt and efficient emergency medical
care to the sick, ill, injured, or infirmed. They shall be utilized by EMS personnel in the field, in the
Emergency Department, and when dealing with OLMC Physicians.
1. This document makes references to “provider”. Provider is limited to mean those
individuals who maintain active endorsement by the OMD at either the Basic Life Support
(BLS) or Advanced Life Support (ALS) level.
2. A patient is defined by The Virginia Department of Health Office of EMS as:
“a person who needs immediate medical attention or transport, or both, whose physical or
mental condition is such that he is in danger of loss of life or health impairment, or who
may be incapacitated or helpless as a result of physical or mental condition or a person
who requires medical attention during transport from one medical care facility to
another.”‐12VAC5‐31‐10.
3. A patient care encounter and a provider‐patient relationship is established whenever the
EMS provider has determined that assessment of the individual is necessary to ensure no
illness or injury exists and to ensure the individual’s capacity to decline assessment or care
is not impaired by illness, injury, or intoxication.
4. The safety of EMS personnel is paramount. Each scene must be properly evaluated for
crew safety and hazards upon arrival and throughout patient care. Assess the need for
additional public safety resources as soon as possible after arrival.
5. Proper Personal Protective Equipment (PPE) and Body Substance Isolation (BSI) must be
utilized according to the Exposure Control Plan, Fire Rescue System Policy 4.8.1.
6. All patients in the care of EMS shall be offered transport by ambulance to the nearest
appropriate hospital or protocol‐based destination. In the event a patient for whom EMS
has responded refuses transport to the hospital, a properly executed refusal process must
be completed.
7. The only appropriate destination for EMS patients transported by ambulance is an
Emergency Department. Exceptions and details concerning hospital destination based on
clinical criteria are outlined in specific protocols.
Prince William County Fire and Rescue System V
8. For all 911 calls, upon initial patient contact, be prepared for immediate medical
intervention appropriate for the call level (defibrillation, airway management, drug
therapy, etc.).
9. Upon arrival at a scene where an initial EMS crew is rendering patient care, all subsequent
arriving EMS crews should immediately engage the on‐scene crew. The goal is to
determine the status of the patient assessment and seamlessly assist with, or transfer,
patient care.
10. Prior to the transfer of care between crews, the provider rendering initial care should
directly interface with the provider assuming care, to ensure all pertinent information is
conveyed.
11. Verbal consent prior to treatment should be obtained whenever possible. The patient’s
rights to privacy and dignity must be respected. Courtesy, concern, and common sense will
ensure the patient receives the best possible care.
12. The provider should generally be able to decide within 3 minutes after patient contact if
ALS measures will be needed. If identified, they should be requested and/or instituted
simultaneously with the initial assessment. A secondary, comprehensive exam is
appropriate after the patient has been stabilized.
13. Generally, initial assessment and therapy should be completed within 10 minutes after
patient contact. Except for extensive extrication or atypical situations, trauma patients
should be enroute to the receiving facility within 10 minutes. Medical patients
(excluding cardiac arrests) should be enroute to the receiving facility within 20 minutes.
Additional therapy, if indicated, should be continued during transport.
14. High acuity patients (those with unstable vital signs or who require assistance with airway,
breathing, or circulation) require an initial assessment and intervention by the responding
crew. Prompt patient care shall take priority over obtaining demographic information or
Patient Care Report (PCR) data.
15. For all 911 calls where BLS and ALS providers are in attendance, the ALS provider shall
make the final patient care decisions. If there is a difference of opinion regarding the
appropriate level of care needed, the ALS provider shall assist with transport of the patient
to the hospital. Request an ALS transport unit if it will not delay transport.
16. When both BLS and ALS transport units have made patient contact and the patient is
deemed to not need ALS transport, the ALS provider must perform and document an
assessment and rationale in the PCR.
Preliminary Information: General Principles for Medical Care
Preliminary Information: General Principles for Medical Care
Prince William County Fire and Rescue System VI
18. When caring for pediatric patients, use a weight/length based system to determine
medication dosages and equipment sizes.
19. For cases that do not exactly fit into a treatment protocol, refer to the General Patient Care
Protocol (Adult or Pediatric), and contact OLMC as needed.
20. Following training, OMD authorization, and when authorized by protocol, all providers
in this system are authorized to:
 Administer oxygen.
 Administer oral aspirin.
 Administer oral glucose.
 Administer nebulized albuterol.
 Administer intranasal naloxone.
 Administer ondansetron via oral disintegrating tablet (ODT).
 Administer sublingual nitroglycerin.
 Administer continuous positive airway pressure (CPAP).
 Apply pulse oximetry and capnography monitoring devices.
 Perform blood glucose evaluations.
 Perform laryngeal tube airway (LTA) insertion and ventilation.
 Obtain and transmit 12‐lead ECGs.
21. Perform all procedures as per the Prince William County FRS PCM. If a procedure is not
addressed in this manual and is deemed necessary, contact OLMC or the receiving
hospital physician for orders prior to proceeding.
22. In the setting of concern for immediate loss of life or limb, OLMC may approve orders for a
procedure that is not covered in the Prince William County FRS PCM, but is within the
scope of practice of an endorsed provider. If a provider is trained in the procedure and is
proficient in performing the procedure, they may follow the orders of OLMC (12 VAC 5‐31‐
1070).
23. EMS providers have the right to refuse to perform specific procedures or treatments
ordered by OLMC in the following circumstances (12 VAC 5‐31‐1080):
 If not adequately trained and proficient to perform the procedure;
 If the procedure is not fully understood; or
 If the procedure is judged not to be in the best interests of the patient.
Preliminary Information: General Principles for Medical Care
Preliminary Information: General Principles for Medical Care
17. When possible, prior to administration of any medication, medication allergies must be
assessed. If any questions arise in reference to medication allergies, contact OLMC prior
to administration.
Prince William County Fire and Rescue System VII
25. The Regional Poison Control Center (RPCC) should be contacted when handling calls
involving poisonous/hazardous material exposures, overdoses, or suspected
envenomation. In the event that the RPCC gives recommendations that are not covered in
the Prince William County FRS PCM, but is within the scope of practice of an endorsed
provider and the individual has been trained in the procedure, EMS providers should
confirm with OLMC before carrying out the RPCCs recommendations. The RPCC can be
reached at 1.800.222.1222.
26. All medical equipment used in Prince William County must be authorized by the OMD.
Preliminary Information: General Principles for Medical Care
Preliminary Information: General Principles for Medical Care
27. ALS Engines carry a limited quantity of equipment and medications to provide ALS care for
the first minutes prior to an ALS transport unit’s arrival. All treatments outlined in the
“Advanced Life Support” section of these protocols, shall be followed by ALS providers to
the extent the ALS Engines equipment and medications allow. The ALS Engines
inventory will be determined by the OMD.
24. For all cases where patients require administration of opiates or sedative agents
(midazolam/ketamine/diphenhydramine), endorsed providers shall perform continuous
ECG monitoring, oxygen saturation monitoring (SpO2), and end‐tidal carbon dioxide
monitoring (ETCO2) until formal transfer of care has occurred.
Preliminary Information: ALS Intercept Guidelines
Prince William County Fire and Rescue System
Preliminary Information: ALS Intercept Guidelines
VIII
The following situations define when an ALS unit should be requested to intercept with an
ambulance staffed at the BLS level.
If an ALS intercept has been requested but the estimated time of ALS transport arrival is longer
than the time it would take to transport the patient to the hospital via BLS ambulance, the patient
should be transported without delay. In general, BLS transport units should not wait on scene for
ALS.
Indications for ALS Intercept:
 Cardiac arrest (during transport).
 Unconsciousness.
 Difficulty breathing/compromised airway/respiratory arrest.
 Multi‐system trauma.
 Chest pain – suspected cardiac.
 Diabetic with persistent altered level of consciousness.
 Patients with unstable or deteriorating vital signs.
 First seizure, seizure following head trauma, or active persistent seizures.
 llergic reaction.
 Any other situation, in the opinion of the BLS provider or OLMC, that may benefit
from advanced level care.
Preliminary Information: Medical Transport Destination
Prince William County Fire and Rescue System
Preliminary Information: Medical Transport Destination
IX
All patients should be transported to the nearest appropriate hospital. If several hospitals are
within the same approximate distance/time from the scene, allow the patient, and/or patient’s
family to select the receiving facility of their choice.
All patients whose condition is judged to be unstable will be transported to the closest appropriate
receiving facility.
The duty Battalion Chief should be notified for transports outside of county boundaries.
For transport destination of SEPSIS, STROKE, STEMI, TRAUMA, or BURN patients, refer to the
appropriate protocol.
Preliminary Information: Patient Care During Transport
Prince William County Fire and Rescue System
Preliminary Information: Patient Care During Transport
X
In the following situations more than 1 attendant in the back of a transport unit is required, unless
operationally not feasible:
 Medical or traumatic cardiac arrest or post‐resuscitation care.
 STEMI or unstable cardiac patients.
 Patients with unstable vital signs requiring active intervention or assistance.
 Patient conditions requiring emergent transport to the hospital.
 Patients requiring active airway assistance (CPAP, BVM, LTA, ETT).
 Imminent delivery.
 Provider request.
Preliminary Information: Medical Control Contact
Prince William County Fire and Rescue System
Preliminary Information: Medical Control Contact
XI
Contact OLMC for any additional orders or with questions needed to meet the patient’s needs
during on‐scene care or transport.
Novant/UVA Haymarket Medical Center
 571‐261‐3413
 Radio Channel 59 Charlie
Novant/UVA Prince William Medical Center
 703‐396‐5260
 Radio Channel 59 Bravo
Sentara Northern Virginia Medical Center
 703‐670‐0129
 Radio Channel 59 Alpha
INOVA Fairfax Hospital
 703‐876‐0522
 Radio Channel 59 Delta
INOVA Fair Oaks Hospital
 703‐391‐0767
 Radio Channel 49 Delta
Fauquier Hospital
 540‐316‐4911 or 540‐316‐4900
 Radio Channel 59 Lima
Mary Washington Hospital
 540‐373‐0348 or 540‐741‐2124
 Radio Channel 59 November
Stafford Hospital
 540‐741‐9102
 Radio Channel 59 Mike
Any quality concerns involving OLMC should be forwarded to the Office of the Medical Director for
review as soon as possible.
Preliminary Information: Automatic Notification of the Medical Director
Prince William County Fire and Rescue System
Preliminary Information: Automatic Notification of the Medical Director
XII
As we work together to provide the highest quality patient care, any incident which potentially has
an adverse or negative impact on the patient or the system, shall be immediately reported to EMS
Operations Quality Assurance Lieutenant by phone or email.
Events that require this notification include:
 Cardiac and/or respiratory arrest occurring after administration of ketamine,
midazolam, morphine, or fentanyl.
 Cardiac arrest after administration of an antiarrhythmic agent in a previously stable
patient.
 Any attempt (successful or unsuccessful) at cricothyrotomy.
 Incorrect medication administration with patient complication (wrong dose, etc.).
 Any cardiac and/or respiratory arrest or patient injury related to the use of physical
restraints.
 A provider operating outside of their scope of practice. The scope of practice is
defined by the provider’s state certification and the provider’s level of OMD
endorsement.
 Failure to recognize a misplaced advanced airway device or other complication
related to advanced airway management.
If the provider has other patient care concerns (potential adverse events, follow‐up questions, or
clinical issues) that are not noted above, the provider should contact the Quality Assurance
Lieutenant in EMS Operations during regular business hours.
Preliminary Information: Transfer of Care at Hospitals
Prince William County Fire and Rescue System
Preliminary Information: Transfer of Care at Hospitals
XIII
Once on hospital property, the receiving facility assumes responsibility for all further medical care
delivered to patients transported by EMS. Patient monitoring to include vital signs, SpO2, ETCO2
and cardiac monitoring should continue until patient care has been transferred. EMS personnel
are not authorized to follow pre‐hospital protocols after arrival at an Emergency Department and
OLMC should not be contacted for orders.
Exceptions to this should occur only in the following circumstances:
 Life‐threatening situations (e.g., cardiac arrest, airway emergencies, or imminent
delivery of a newborn).
 Continuation of treatment started prior to arrival (e.g., nebulizers, CPAP, IV fluids).
 When specifically instructed to continue care by the ED physician (document the
physician’s name and the time the verbal order was given).
To ensure all known pertinent information is conveyed to the hospital staff, crews should interface
with nursing staff within 5 minutes of arrival to give a verbal report. Crews should provide the
receiving facility with all known pertinent patient information. In addition, provide the receiving
facility with a copy of pre‐hospital 12‐lead ECGs.
PCRs should be transmitted in accordance with VAOEMS regulations:
“Should EMS personnel be unable to provide the full prehospital patient care report at the
time of patient transfer, EMS personnel shall provide an abbreviated documented report
with the critical EMS findings and actions at the time of patient transfer and the full
prehospital patient care report shall be provided to the accepting facility within 12 hours.”
‐12 VAC5‐31‐1140.
Preliminary Information: Document Guide for Written Format
Prince William County Fire and Rescue System
Preliminary Information: Document Guide for Written Format
XIV
All patients shall be assessed and treated based on the appropriate General Patient Care Protocol.
 General Patient Care Protocol ‐ Adult.
 General Patient Care Protocol ‐ Adult Trauma.
 General Patient Care Protocol ‐ Pediatric.
 General Patient Care Protocol ‐ Pediatric Trauma.
General Patient Care Protocols shall be used in conjunction with other specific protocols and
procedures as indicated.
 Items indicated in Bold Italic Font are references to other protocols or procedures.
 Items indicated in Bold Font indicates a medication administration.
Protocols will be formatted as follows:
All Providers
Medical Control
Advanced Life Support
 Treatments under this section are authorized for all endorsed BLS and ALS providers.
 Treatments under this section are authorized for all endorsed ALS providers.
Paramedic Only
 Treatments under this section are authorized by OLMC.
 Treatments under this section are authorized for all endorsed Paramedics.
Preliminary Information: Document Guide for Written Format
Prince William County Fire and Rescue System
Preliminary Information: Document Guide for Written Format
XV
Abbreviations Found in this Document
ALS
BGL
BLS
BSI
BVM
CHF
CO
CPAP
ECG
ESRD
ETCO2
ETT
FiO2
FRS
GCS
HR
IV
IO
IVP
LOC
LPM
LTA
MAP
MI
NPA
NRB
NS
O2
ODT
OLMC
OMD
OPA
PCR
PEA
PO
PPE
ROSC
SBP
SL
SpO2
TBSA
V‐Fib
V‐Tach
Advanced Life Support
Blood Glucose Level
Basic Life Support
Body Substance Isolation
Bag Valve Mask
Congestive Heart Failure
Carbon Monoxide
Continuous Positive Airway Pressure
Electrocardiogram
End‐Stage Renal Disease
End‐Tidal Carbon Monoxide
Endotracheal Tube
Fraction of Inspired Oxygen
Fire Rescue System
Glasgow Coma Score
Hear Rate
Intravenous
Intraosseous
Intravenous Push
Level Of Consciousness
Litters Per Minute
Laryngeal Tube Airway
Mean Arterial Pressure
Myocardial Infarction
Nasal Pharyngeal Airway
Non‐Rebreather
Normal Saline
Oxygen
Oral Dissolving Tablet
On‐Line Medical Control
Operational Medical Director
Oral Pharyngeal Airway
Patient Care Report
Pulseless Electrical Activity
“Per Os” orally
Personal Protective Equipment
Return Of Spontaneous Circulation
Systolic Blood Pressure
Sublingual
Peripheral Capillary Oxygen Saturation
Total Burn Surface Area
Ventricular Fibrillation
Ventricular Tachycardia
Prince William County Fire and Rescue System
Adult Protocols
General Patient Care Protocol - Adult
Prince William County Fire and Rescue System
The following measures will serve as the “General Patient Care Protocol ‐ Adult” and apply to the
management of all adult patients.
All Providers
General Patient Care Protocol - Adult
 Assess the patient’s mental status and nature of illness.
o For mental status, use the AVPU scale:
 A – The patient is Alert and oriented.
 V – The patient is responsive to Verbal stimulus.
 P – The patient is responsive to Painful stimulus.
 U – The patient is Unresponsive to any stimulus.
 Assess the patient’s circulation for presence of pulse, rate and quality. If no central pulse is
palpable initiate CPR. Refer to Cardiac Arrest: General Approach.
 In cases of cardiac arrest, initiate continuous chest compressions, place an OPA and NRB
mask on the patient at 15 LPM and withhold positive pressure ventilation per protocol until
resources allow.
 If cardiac arrest is not evident, ensure a patent airway utilizing BLS standards.
 Assess the patient’s respiratory status to include lung sounds, respiratory rate and work of
breathing. Utilize pulse oximetry to obtain SpO2.
 Provide supplemental oxygen to maintain SpO2 ≥ 92% or if any respiratory signs or
symptoms present. Use adjuncts as necessary.
Note: False SpO2 readings may occur in the following situations: hypothermia, hypoperfusion
(shock), carbon monoxide poisoning, and peripheral vasoconstriction.
1
 If suspicion of acute allergic reaction:
o Refer to Medical: Allergic Reaction.
 If suspicion of trauma:
o Refer to Clinical Procedure: Selective Spinal Motion Restriction (SSMR).
Oxygen Saturation Range Patient Care Guidelines
92%‐100% Normal If symptomatic, O2 by NC.
90%‐91% Mild Hypoxia O2 by NC as necessary.
86%‐89% Moderate Hypoxia O2 by NRB.
<86% Severe Hypoxia O2 by NRB, consider CPAP/BVM or airway
adjunct as necessary.
General Patient Care Protocol - Adult
Prince William County Fire and Rescue System
General Patient Care Protocol - Adult
 Manage any profuse bleeding and examine for signs of poor perfusion. If evidence of
trauma, refer to General Patient Care Protocol ‐ Adult Trauma.
 Attempt to obtain the patient’s current medical complaint and pertinent medical history.
Utilize SAMPLE history and OPQRST. If necessary, utilize family or bystanders.
 Evaluate pupillary reaction, motor function, sensation and GCS.
 If appropriate, perform and document a complete neurological assessment and Cincinnati
Prehospital Stroke Scale, including time the patient was last seen normal.
 Record and monitor vital signs including level of consciousness, pulse, respiratory rate, skin
(color, condition, and temperature), blood pressure, blood glucose, continuous SpO2, and
ETCO2 (when appropriate).
o Reassess and document every 5 minutes for critical patients or 15 minutes for noncritical
patients.
 Perform a 12‐lead ECG if chest pain/ischemic equivalent symptoms or abdominal pain
above the umbilicus. If ALS is not on scene, the crew should transmit and confirm that the
Emergency Department received the transmission. If ALS is on scene, document the name
of the reviewing provider.
 Record BGL for any patient experiencing weakness, altered mental status, or history of
diabetes per Clinical Procedure: Blood Glucose Analysis.
o Hypoglycemia < 60 mg/dL:
Refer to Medical: Diabetic Emergencies if indicated.
o Hyperglycemia > 250 mg/dL:
Refer to Medical: Diabetic Emergencies if indicated.
 For severe nausea and vomiting:
o Consider Ondansetron 4 mg ODT (contraindicated in the setting of pregnancy or
suspected pregnancy).
 For patients with suspected opiate overdose with respiratory depression:
o Administer Naloxone 2 mg IN.
 Unless authorized by protocol, nothing by mouth.
 Refer to appropriate protocol for specific treatments and interventions.
 Transport patient to nearest appropriate Emergency Department.
 Minimize on‐scene time when possible.
2
When condition warrants (specified as “Full ALS Assessment and Treatment” in individual
protocols).
 Advanced airway/ventilatory management if indicated.
 Perform cardiac monitoring.
 Continuously monitor SpO2 and ETCO2.
Advanced Life Support
General Patient Care Protocol - Adult
Prince William County Fire and Rescue System
 If not already done, perform a 12‐lead ECG if chest pain or abdominal pain is above the
umbilicus or ischemic equivalent symptoms.
o If STEMI criteria present on 12‐Lead ECG, transmit ECG to a Percutaneous Coronary
Intervention (PCI) Emergency Department and expedite transport. Refer to Chest
Pain: Acute Coronary Syndrome.
 Establish IV access NS KVO or IV lock if indicated (severe symptoms or for medication
access).
o Refer to Clinical Procedure: Venous Access Peripheral.
 If patient is unstable and time permits, establish a second IV.
 Administer NS:
o If evidence of dehydration (tachycardia, dry mucous membranes, poor skin turgor)
or hypovolemia, administer NS 250 ml, repeat once if indicated.
o Consider 250 ml IV NS bolus at wide open rate until SBP ≥ 90 mmHg or MAP ≥ 65
(max cumulative dose 2 L).
Contraindicated if evidence of decompensated congestive heart failure (e.g.,
rales).
 If patient exhibits signs of severe cardiopulmonary compromise (poor systemic perfusion,
hypotension, altered consciousness and/or respiratory distress/failure) and IV attempts
unsuccessful:
o Establish IO, refer to Clinical Procedure: Venous Access Intraosseous.
 For patients with severe nausea or vomiting:
o Administer Ondansetron 4 mg ODT/IV/IM/IO (contraindicated in pregnant or
suspected pregnant patients) repeat once in 10 minutes if indicated (max
cumulative dose 8 mg).
o Administer Promethazine 12.5 mg diluted in 100 ml NS IV at a wide open rate in
a patent 20g or larger IV. IV must be located in the antecubital (for use in pregnant
or suspected pregnant patients ONLY).
3
Administration of Promethazine can cause akathisia (restlessness, anxiety and involuntary
movements [dystonia]). If any of these are noted after administration of Promethazine,
refer to Overdose and Poisoning: Antipsychotic/Acute Dystonic Reaction.
 For patients with suspected opioid overdose consider Naloxone 2 mg IN/IM or if
vascular access established consider Naloxone 0.4 mg IV/IO titrated to maintain
adequate respiratory rate (max cumulative dose 4 mg).
 For patients with moderate or severe pain refer to Pain Management: Medical/Trauma.
 Refer to appropriate protocol for specific treatments and interventions.
o Use caution with Naloxone administration in chronically dependent patients (e.g.,
cancer patients) as it may precipitate acute withdrawal.
General Patient Care Protocols - Adult
General Patient Care Protocol - Adult
Prince William County Fire and Rescue System 4
General Patient Care Protocols - Adult
Medical Control
 Contact OLMC for any additional orders or questions.
Respiratory Emergencies: Dyspnea
Prince William County Fire and Rescue System
All Providers
Advanced Life Support
5
Respiratory Emergencies: Dyspnea
 General Patient Care Protocol – Adult.
 Sit patient upright or in position of comfort unless contraindicated.
 Observe for signs of impending respiratory failure, refer to Respiratory Emergencies:
Respiratory Failure if indicated.
o Decreased level of consciousness with hypoxia (SpO2 < 90%) despite 100% O2
therapy, apnea, and/or respiratory rate < 8.
o Poor ventilatory effort (with hypoxia despite 100% O2 therapy).
o Patients requiring active ventilatory assistance.
o Inability to maintain patent airway.
o Symptomatic airway obstruction.
 If symptoms are severe, initiate CPAP per Clinical Procedure: Continuous Positive Airway
Pressure (CPAP).
o Only ALS Providers may titrate CPAP pressures.
o If hypoxia persists while on CPAP, O2 via capnography‐capable NC should be used in
addition to CPAP to increase the amount of O2 delivered. Expect FiO2 to increase
approximately 4% with each additional LPM of O2.
 If wheezing:
o Administer Albuterol 2.5 mg via nebulizer repeat once in 5 minutes if indicated.
o May be used in conjunction with CPAP.
 If suspected cardiac origin:
o Perform 12‐lead ECG.
o Administer Aspirin 324 mg PO.
 Refer to appropriate Respiratory Emergencies protocol:
o Respiratory Emergencies: Acute Bronchospasm.
o Respiratory Emergencies: Acute Pulmonary Edema Suspected.
o Respiratory Emergencies: Submersion Injury.
o Respiratory Emergencies: Failed Airway.
 If concern for foreign body obstruction refer to Clinical Procedure: Obstructed Airway.
 Full ALS Assessment and Treatment.
o Titrate the pressure of CPAP per the Clinical Procedure: Continuous Positive
Airway Presure (CPAP) if indicated.
Respiratory Emergencies: Dyspnea
Prince William County Fire and Rescue System
Medical Control
6
Respiratory Emergencies: Dyspnea
 Contact OLMC for any additional orders or questions.
Respiratory Emergencies: Acute Bronchospasm
Prince William County Fire and Rescue System
All Providers
Medical Control
 General Patient Care Protocol – Adult.
 Refer to Respiratory Emergencies: Dyspnea.
 Refer to Medical: Allergic Reaction.
 If wheezing/dyspnea:
o Administer Albuterol 2.5 mg and Ipratropium Bromide 0.5 mg via nebulizer,
repeat once in 5 minutes if indicated.
Atrovent is only contraindicated in the setting of known allergy to Atrovent or
Atropine.
 If wheezing persists:
o Administer Albuterol 2.5 mg via nebulizer, repeat every 5 minutes if indicated
(max cumulative dose 15 mg).
 If wheezing/dyspnea persists after first nebulizer treatment:
o Administer Methylprednisolone 125 mg IV/IM/IO.
o Consider CPAP if symptoms are moderate to severe.
Refer to Clinical Procedure: Continuous Positive Airway Pressure (CPAP).
 If wheezing/dyspnea is not improving:
o Administer Magnesium Sulfate 2 g diluted in 100 ml NS IV/IO over 10 minutes.
Contraindicated if history of renal failure (e.g., dialysis patient).
Do not use if CHF suspected.
 Severe symptoms (not speaking, little or no air movement or not improving):
o Consider Epinephrine (1mg/ml) 0.3 mg IM*.
Advanced Life Support
 *If age >50, HR >150, or history of Coronary Artery Disease, contact OLMC prior to
administering Epinephrine (1mg/ml) 0.3 mg IM.
 Contact OLMC for any additional orders or questions.
Respiratory Emergencies: Acute Bronchospasm
7
Respiratory Emergencies: Pulmonary Edema
Prince William County Fire and Rescue System
(History of CHF, Peripheral Edema, Elevated SBP, Rales, Decreased Breath Sounds)
All Providers
8
Respiratory Emergencies: Pulmonary Edema
 General Patient Care Protocol ‐ Adult.
 Refer to Respiratory Emergencies: Dyspnea.
o If symptoms are moderate/severe, initiate CPAP per Clinical Procedure:
Continuous Positive Airway Pressure (CPAP).
 Consider Nitroglycerin 0.4 mg SL, repeat in 5 minutes if indicated (max cumulative dose
of 1.2 mg administered by patient or provider).
o Assess blood pressure before each dose.
o Contraindicated if SBP < 100 mmHg or MAP < 65.
o Contraindicated if use of a Phosphodiesterase‐5 (PDE5) inhibitor within last 48
hours.
 Full ALS Assessment and Treatment.
 If not already initiated, initiate CPAP if symptoms are moderate/severe:
o Moderate:
Moderate dyspnea, SpO2 < 92% on oxygen. SBP usually greater than 150.
Unable to speak in full sentences. Normal mental status.
o Severe:
Severe dyspnea, respiratory failure, hypoxia (SpO2 < 90% O2), diaphoresis,
SBP commonly > 180 mmHg. One word sentences, altered level of
consciousness.
o Refer to Clinical Procedure: Continuous Positive Airway Pressure (CPAP).
 For patients with hypertension and severe symptoms:
o Administer Nitroglycerin 0.4 mg SL, reassess blood pressure in 5 minutes.
If patient remains hypertensive with moderate/severe symptoms, administer
Nitroglycerin 0.8 mg SL.
o Continue with Nitroglycerin 0.8 mg SL every 5 minutes. Reassess blood pressure
before each administration. The goal is to achieve a 20% reduction in SBP.
Contraindicated if SBP < 100 mmHg or MAP < 65.
Contraindicated if use of a Phosphodiesterase‐5 (PDE5) inhibitor within last
48 hours.
In the setting of severe pulmonary edema, CPAP is the preferred treatment.
It is not required to give additional nitroglycerin or aspirin.
Advanced Life Support
Respiratory Emergencies: Pulmonary Edema
Prince William County Fire and Rescue System 9
Respiratory Emergencies: Pulmonary Edema
 Administer Aspirin 324 mg PO if not already administered.
 If hypertensive (SBP > 150 mmHg) after CPAP and/or nitrates:
o Consider Morphine Sulfate .05‐0.1 mg/kg IV (max dose 5 mg), repeat every 5
minutes for persistent severe hypertension (max cumulative dose 15 mg).
Use caution and titrate when used in conjunction with CPAP and
nitroglycerin.
 If hypotensive (SBP < 90 mmHg or MAP < 65):
o Consider 250 ml IV NS bolus at a wide open rate until SBP ≥ 90 mmHg or MAP ≥ 65,
repeat once if indicated.
Reassess breath sounds prior to second NS bolus administration. Do not
administer additional fluids if progressive deterioration.
o Consider Dopamine infusion at 5 mcg/kg/min titrated up to 20 mcg/kg/min in
order to maintain SBP ≥ 90 mmHg or MAP ≥ 65.
 For wheezing associated with Acute Pulmonary Edema:
o Administer Albuterol 2.5 mg and Ipratropium Bromide 0.5 mg via nebulizer,
repeat once in 5 minutes if indicated (max cumulative Albuterol dose 15 mg).
Atrovent is only contraindicated in the setting of known allergy to Atrovent or
Atropine
 Refer to Respiratory Emergencies: Respiratory Failure if indicated.
 Contact OLMC for any additional orders or questions.
Medical Control
Respiratory Emergencies: Submersion Injury
Prince William County Fire and Rescue System
All Providers
Medical Control
10
Respiratory Emergencies: Submersion Injury
 General Patient Care Protocol – Adult.
 Refer to Respiratory Emergencies: Dyspnea.
 Protect from heat loss.
 Patients may develop delayed onset respiratory symptoms:
o Encourage transport for evaluation.
o Consider CPAP for patients with significant dyspnea or hypoxia.
Refer to Clinical Procedure: Continuous Positive Airway Pressure (CPAP) if
indicated.
 Contact OLMC for any additional orders or questions.
Respiratory Emergencies: Respiratory Failure
Prince William County Fire and Rescue System
All Providers
Medical Control
Advanced Life Support
11
Respiratory Emergencies: Respiratory Failure
 General Patient Care Protocol – Adult.
 Refer to Respiratory Emergencies: Dyspnea.
 If signs of airway obstruction, refer to Clinical Procedure: Obstructed Airway.
 Refer to Clinical Procedure: Continuous Positive Airway Pressure (CPAP) if indicated.
 Continuously monitor SpO2 and ETCO2.
 Observe for signs of impending respiratory failure:
o Decreased level of consciousness with hypoxia (SpO2 < 90%) despite 100% O2
therapy, apnea, and/or respiratory rate < 8.
o Poor ventilatory effort (with hypoxia despite 100% O2 therapy).
o Patients requiring active ventilatory assistance.
o Inability to maintain patent airway.
o Symptomatic airway obstruction.
 Suction all debris/secretions and remove any visible foreign body from airway.
 Perform basic airway maneuvers:
o Open airway, insert NPA/OPA and use BVM if needed.
Ventilate once every 6 seconds (10 times/minute).
 If patient does not respond to above measures or deteriorates consider ventilations via
LTA.
o Refer to Clinical Procedure Laryngeal Tube Airway (KING LTS‐D).
 Following placement of LTA confirm proper placement.
o Refer to Clinical Procedure: Confirmation of Placement/Effectiveness of
Ventilation.
 As condition allows, obtain 12‐lead ECG.
 Full ALS Assessment and Treatment.
 If LTA already in place, confirm proper placement.
o Refer to Clinical Procedure: Confirmation of Placement and Effectiveness of
Ventilation.
 Follow Airway Emergencies Algorithm on next page if invasive airway intervention is
needed LTA/ETT in the setting of an absent gag reflex.
 Refer to Clinical Procedure: Orotracheal Intubation if indicated.
o Refer to Clinical Procedure: Confirmation of Placement and Effectiveness of
Ventilation.
 Contact OLMC for any additional orders or questions.
Prince William County Fire and Rescue System
All Providers
A Advanced Life Support A
E E
LEGEND
Assess ABCs, RR, effort, and adequacy
Adequate Inadequate
Administer
supplemental 100%
O2.
(+) Gag Reflex?
CPAP/BVM
Open airway and insert NPA/OPA, BVM, with goal to
keep O2 saturations > 92% if possible1.
(–) Gag Reflex?
Laryngeal Tube Airway2
(KING LT‐SD)
Only 2 attempts** for medical.
Only 1 attempt** for trauma.
Endotracheal Intubation
Only 2 attempts** for medical.
Only 1 attempt** for trauma.
Confirm with
ETCO2
and exam
Successful Unsuccessful
Continue
ventilation2 and
monitoring.
Resume BVM1 with
adjuncts as needed4.
As a last resort, if unable to ventilate
by any other means, consider
cricothyrotomy3.
1. At any step of the airway algorithm, effective BVM venitlation is an acceptable level of airway management.
2. Components of effective ventilation include oxygenation, chest rise and fall, adequate lung sounds and the presence of
an alveolar waveform on capnograophy.
3. Attempt cricothyrotomy only after all other ventilation method have failed.
4. If patient condition allows, another ALS provider may attempt a non‐visualized airway prior to performing a surgical
airway.
**Attempt Defined
An attempt is the
introduction of the tip
of the laryngoscope
blade or LTA past the
teeth.
12
Respiratory Emergencies: Respiratory Failure
Respiratory Emergencies: Respiratory Failure
P Paramedic P
E E
E E E E
E E E E
E E E E
E E
E E
E E E E
E E E E
E E
A A
P P
Respiratory Emergencies: Failed Airway
Prince William County Fire and Rescue System
A patient with a failed airway is one who is near death or dying, not stable, or not improving. A failed
airway occurs when a provider begins a course of airway management and identifies that it will not
be successful.
Conditions which define a failed airway:
 Failure to maintain adequate SpO2 after 2 or more failed intubation attempts.
AND
 Inability to successfully oxygenate/ventilate via LTA, in a patient who requires an
advanced airway to prevent death.
AND
 Unable to maintain adequate SpO2 (> 90%) with BVM techniques by most experienced
provider on scene and insufficient time to attempt alternative maneuvers.
Managing airway with BLS techniques:
 Patients who cannot be intubated, or who do not have an SpO2 > 90%, do not
necessarily have a failed airway.
o Patients may be sustained by BVM and/or basic airway adjuncts (e.g., OPA, NPA,
LTA). If effective, it is acceptable to continue with basic airway measures and
continuous monitoring of SpO2 and ETCO2 .
o Based on pathophysiologic condition with otherwise reassuring vital signs, it is
acceptable to continue with basic airway measures.
When in a failed airway scenario, immediate transport to the nearest emergency department and
notification of OLMC is required.
All Providers
13
Respiratory Emergencies: Failed Airway
 General Patient Care Protocol—Adult.
 If ventilation is ineffective with single person BVM, place an OPA and/or NPA and begin
two‐person BVM.
 If ventilation is ineffective with two‐person BVM and patient has no gag reflex, attempt to
place LTA.
o Refer to Clinical Procedure: Laryngeal Tube Airway (KING LTS‐D).
Respiratory Emergencies: Failed Airway
Prince William County Fire and Rescue System
Medical Control
Advanced Life Support
14
Respiratory Emergencies: Failed Airway
 Full ALS Assessment and Treatment.
 Failed Intubation:
o Attempt ventilation with BVM and OPA and/or NPA.
Ventilation acceptable:
Continue with BVM and initiate rapid transport.
Continuously monitor SpO2, ETCO2, and ECG.
Consider securing airway with an LTA.
Refer to Clinical Procedure: Laryngeal Tube Airway (KING
LTS‐D).
 If time permits, contact OLMC for cricothyrotomy.
 Contact OLMC for any additional orders or questions.
Paramedic Only
 Cannot intubate or oxygenate/ventilate by any other means:
o Perform Cricothyrotomy.
Refer to Clinical Procedure: Cricothyrotomy.
If in the paramedics’ judgement, the time necessary to contact OLMC will
compromise the patient’s chance of survival and it is not possible to
ventilate the patient by ANY OTHER MEANS during transport,
cricothyrotomy may be performed without OLMC.
Cardiac Arrest: General Approach
Prince William County Fire and Rescue System
 Successful resuscitation requires planning and clear role definition.
 Good, fast (100‐120), hard and deep (2‐2.4”) compressions with adequate recoil and minimal
interruptions are essential to a successful resuscitation. A metronome shall be utilized to aid
in maintaining a correct compression rate.
 Compressors should be rotated every 2 minutes.
 Apply the AED/Monitor as quickly as possible to defibrillate shockable rhythms.
 All defibrillations will be at 360J.
 In the event a patient suffers cardiac arrest in the presence of EMS (EMS witnessed Cardiac
Arrest), the absolute highest priority is to apply the AED/Defibrillator while compressions are
ongoing and deliver a shock immediately if indicated.
 Management of airway and breathing is important but secondary to compressions and
defibrillation.
 Reassess airway patency frequently and with every patient move.
 DO NOT INTERRUPT CHEST COMPRESSIONS!
 Designate a “Code Manager” to coordinate transitions, defibrillation and pharmacological
interventions. The “Code Manager” should typically not have any procedural tasks. If the
“Code Manager” is needed for a specific task, a new leader must be designated.
 Typically cardiac arrest should be worked in the field until:
o ROSC is obtained.
o Criteria for Termination of Resuscitation are met, refer to Clinical Procedure:
Termination of Resuscitation.
o Exclusion criteria for Termination of Resuscitation are met, refer to Clinical
Procedure: Termination of Resuscitation.
All Providers
15
Cardiac Arrest: General Approach
 General Patient Care Protocol – Adult.
 Refer to Clinical Procedure: High Performance CPR.
 Check responsiveness, breathing, and for a carotid pulse.
 Announce “CPR in progress” to incoming units and communications.
 Consider need for resuscitation:
o Presence of DNR/POST.
o DOA/Withholding Resuscitation criteria.
 If adequate bystander compressions ongoing, have bystander continue compressions until
monitor pads are in place and the monitor is charged. Stop compressions for rhythm
analysis for no more than 10 seconds.
 If compressions are not being performed upon arrival or if compressions are not deemed
adequate, immediately perform compressions at a rate of 100‐120 compressions per
minute while applying defibrillator.
Cardiac Arrest: General Approach
Prince William County Fire and Rescue System 16
Cardiac Arrest: General Approach
Medical Control
Advanced Life Support
 After analysis and (possible) defibrillation, immediately resume chest compressions with a
different compressor. Do not pause for post‐shock rhythm analysis. Stop compressions
only for signs of life (patient movement) or pre‐defibrillation rhythm analysis every 2
minutes. Agonal respirations are a brain stem reflex and NOT an indication to stop
compressions.
 As resources allow maintain adequate airway and ventilations.
o Use BLS adjuncts and suction as necessary.
o In a two responder situation, insert an OPA and administer passive oxygenation via
NRB.
o Once adequate resources are available, initiate 10:1 BVM ventilation.
o Establish advanced airway if indicated.
Do not pause compressions to insert advanced airway.
Do not pause compressions to ventilate.
Continuously monitor SpO2 and ETCO2.
 Full ALS Assessment and Treatment.
 Refer to rhythm appropriate protocol.
 Establish vascular access.
 If patient regains a pulse, reassess vital signs, maintain patient airway, support respirations
and refer to Cardiac Arrest: Post Resuscitation Care.
 Refer to Clinical Procedure: Termination of Resuscitation if indicated.
 Contact OLMC for any additional orders or questions.
Cardiac Arrest: Asystole/PEA
Prince William County Fire and Rescue System 17
Cardiac Arrest: Asystole/PEA
All Providers
Advanced Life Support
 General Patient Care Protocol – Adult.
 Cardiac Arrest: General Approach.
 Clinical Procedure: High Performance CPR.
When Asystole is seen on the cardiac monitor, confirmation of the rhythm shall include a printed
rhythm strip. Low amplitude V‐Fib or PEA may be difficult to distinguish from asystole when using
only the cardiac monitor for interpretation.
 Full ALS Assessment and Treatment.
 Consider and treat possible causes.
 Administer Epinephrine (0.1mg/ml) 1 mg IV/IO every 3‐5 minutes during arrest.
 Do not discontinue compressions unless there is a definitive pulse.
 Suspected hyperkalemia (dialysis patient):
o Administer Calcium Chloride 1 g IV/IO.
Contraindicated in patients on Digoxin/Lanoxin.
o Administer Sodium Bicarbonate 1 mEq/kg IV/IO (max dose 50 mEq), may repeat
once in 10 minutes.
Sodium Bicarbonate and Calcium Chloride shall not be administered in the
same line. If second line unavailable, ensure line is adequately flushed.
Potential Causes of PEA Treatment
Hypovolemia Normal Saline 1‐2 liters IV/IO
Hypoxia Secure airway and ventilate
Hydrogen Ion (acidosis) Sodium Bicarbonate 1 mEq/kg IV/IO
Hyperkalemia (end stage renal disease) Sodium Bicarbonate 1 mEq/kg IV/IO
Calcium Chloride 1 g IV/IO
Hypothermia Active rewarming
Tablets (drug overdose) See below
Tamponade, Cardiac Normal Saline 1‐2 liters IV/IO
Expedite transport
Tension pneumothorax Needle thoracostomy
Cardiac Arrest: Asystole/PEA
Prince William County Fire and Rescue System 18
Cardiac Arrest: Asystole/PEA
Medical Control
 Suspected overdose:
o Beta Blocker OD:
Administer Glucagon 3 mg IV/IO slow push.
o Calcium Channel Blocker OD:
Administer Calcium Chloride 1 g IV/IO.
o Tricyclic antidepressant OD:
Administer Sodium Bicarbonate 1 mEq/kg IV/IO (max dose 50 mEq), may
repeat once in 10 minutes.
 If no response to resuscitative efforts after at least 30 minutes (including at least 3 rounds
of medications) consider discontinuation of efforts per Clinical Procedure: Termination of
Resuscitation.
 Contact OLMC for any additional orders or questions.
Cardiac Arrest: V-Fib/Pulseless V-Tach
Prince William County Fire and Rescue System 19
Cardiac Arrest: V-Fib/Pulseless V-Tach
All Providers
Advanced Life Support
 General Patient Care Protocol – Adult.
 Refer to Cardiac Arrest: General Approach.
 Refer to Administrative Procedure: High Performance CPR.
 Full ALS Assessment and Treatment.
 Apply therapy pads, print strip, and pre‐charge to 360J.
 Confirm the presence of V‐Fib/Pulseless V‐Tach.
 Initiate/continue compressions while defibrillator charges.
 Defibrillate V‐Fib/Pulseless V‐Tach at 360 J.
o Immediately resume CPR after shock (do not stop to check pulse).
 Using the most readily available route:
o Administer (during CPR) Epinephrine (0.1mg/ml) 1 mg IV/IO every 3‐5 minutes
during arrest.
 Analyze rhythm after 2 minutes of high quality CPR:
o If V‐Fib/Pulseless V‐Tach persists defibrillate at 360 J.
Continue compressions while defibrillator charges.
Immediately resume CPR after shock.
 Using the most readily available route:
o Administer (during CPR) Amiodarone 300 mg bolus IV/IO.
For persistent V‐Fib/Pulseless V‐Tach, may repeat once in 3‐5 minutes,
Amiodarone 150 mg IV/IO (max cumulative dose 450 mg) .
o Suspected torsades de pointes or hypomagnesemic state (chronic alcohol use or
diuretic use).
Administer Magnesium Sulfate 2 g IV/IO.
 Analyze rhythm after 2 minutes of high quality CPR:
o If V‐Fib/Pulseless V‐Tach persists defibrillate at 360 J.
Continue compressions while defibrillator charges.
Immediately resume CPR after shock.
 Continue cycle (Defibrillate→ CPR→ Medication→ Analyze every 2 min).
 Hyperkalemia suspected (dialysis patient):
o Administer Calcium Chloride 1 g IV/IO.
Contraindicated in patient on Digoxin/Lanoxin.
o Administer Sodium Bicarbonate 1 mEq/kg IV/IO (max dose 50 mEq), may repeat
once in 10 minutes.
Cardiac Arrest: V-Fib/Pulseless V-Tach
Prince William County Fire and Rescue System 20
Cardiac Arrest: V-Fib/Pulseless V-Tach Medical Control
 Contact OLMC for any additional orders or questions.
Sodium Bicarbonate and Calcium Chloride shall not be administered in the
same line. If second line unavailable, ensure line is adequately flushed.
 Suspected overdose:
o Tricyclic antidepressant OD:
Administer Sodium Bicarbonate 1 mEq/kg IV/IO, (max dose 50 mEq), may
repeat once in 10 minutes.
Cardiac Arrest: Post Resuscitation Care
Prince William County Fire and Rescue System 21
Cardiac Arrest: Post Resuscitation Care
All Providers
Medical Control
 General Patient Care Protocol – Adult.
 Maintain assisted ventilation as needed.
o Monitor ETCO2, goal is 40, DO NOT HYPERVENTILATE!
 Titrate O2 to maintain SpO2 of 92% ‐ 99%.
 Obtain and transmit 12‐lead ECG within 5 minutes of ROSC.
Advanced Life Support
 Full ALS Assessment and Treatment.
 Monitor ETCO2, goal is 40 mmHg, DO NOT HYPERVENTILATE!
 For hypotension (SBP < 90 mmHg or MAP < 65) not improved by fluid boluses, or when
fluid administration is contraindicated:
o Administer Dopamine infusion at 5 mcg/kg/min titrate up to 20 mcg/kg/min in
order to maintain SBP ≥ 90 mmHg or MAP ≥ 65.
 If V‐Fib/V‐Tach occurred during arrest and Amiodarone was administered:
o No additional anti‐arrhythmic is required unless arrhythmia reoccurs.
 If V‐Fib/V‐Tach occurred during arrest and no Amiodarone was administered:
o Administer Amiodarone 150 mg diluted in 100 ml NS IV/IO piggyback over 10
minutes.
 If arrest is thought to be secondary to opiate overdose consider:
o Naloxone 0.4 mg IV/IO titrated to respiratory rate up to 4 mg IV/IO.
 Consider sedation if patient becomes combative:
o Administer Fentanyl 1 mcg/kg IV/IO (max dose 50 mcg), repeat every 5 minutes if
indicated (max cumulative dose 200 mcg).
o Administer Midazolam 2.5 mg IV/IO, repeat in 5 minutes if indicated and monitor
for hypotension (max cumulative dose 5 mg).
 Suspected hyperkalemia (dialysis patient):
o Administer Calcium Chloride 1 g IV/IO.
Contraindicated in patient on Digoxin/Lanoxin.
o Administer Sodium Bicarbonate 1 mEq/kg IV/IO (max dose 50 mEq).
Sodium Bicarbonate and Calcium Chloride shall not be administered in the
same line. If second line unavailable, ensure line is adequately flushed.
o Administer Albuterol 5 mg via Neb.
 Contact OLMC for additional sedation.
 Contact OLMC for any additional orders or questions.
Cardiac Emergencies: Acute Coronary Syndrome
Prince William County Fire and Rescue System 22
Cardiac Emergencies: Acute Coronary Syndrome
All Providers
 General Patient Care Protocol – Adult.
 Obtain and transmit 12‐lead ECG within 5 minutes of arrival at patient.
 The routine use of oxygen is not indicated. Oxygen is indicated if Sp02 is ≤ 92% or if there is
evidence of respiratory distress.
 Administer Aspirin 324 mg PO chewed if patient is able to swallow.
 Consider Nitroglycerin 0.4 mg SL, repeat every 5 minutes for continued chest pain (max
cumulative dose 1.2 mg provided by either patient or provider).
o Assess blood pressure before each dose.
o Contraindicated if SBP < 100 mmHg or MAP < 65 or if a SBP drop ≥ 30 mmHg.
o Contraindicated if use of a Phosphodiesterase‐5 (PDE5) inhibitor within last 48
hours.
Advanced Life Support
Patient Care Goals: 5/5/10/2
At patient to 12‐Lead ECG < 5 minutes
STEMI identification to Emergency Department notification < 5 minutes
STEMI identification to transport < 10 minutes
Providers during transport ‐ 2
 Full ALS Assessment and Treatment.
 Obtain 12‐lead ECG within 5 minutes of arrival at patient.
 Identify the presence of ECG changes suggestive of Acute Myocardial Infarct (AMI).
o Pre‐alert receiving hospital as per Administrative Procedure: Code STEMI.
o Inferior wall MI’s may be associated with right ventricular involvement. Consider
right sided tracing per Clinical Procedure: Right Sided ECG.
o If concern for Posterior MI and patient condition/time permits, consider 15‐lead
ECG prior to transport per Clinical Procedure: 15‐Lead ECG.
 Consider Nitroglycerin 0.4 mg SL repeat every 5 minutes for continued chest pain.
o Assess blood pressure before each dose.
o Contraindicated if SBP < 100 mmHg or MAP < 65.
o Contraindicated if use of a Phosphodiesterase‐5 (PDE5) inhibitor within last 48
hours.
o Use with caution in Acute Inferior Wall MI, or Right Ventricular infarct (ST elevation
in right sided tracing).
IV access is recommended prior to administration of nitroglycerin in inferior
or right ventricular infarcts as the patient is preload dependent.
Cardiac Emergencies: Acute Coronary Syndrome
Prince William County Fire and Rescue System
Cardiac Emergencies: Acute Coronary Syndrome
Medical Control
 Contact OLMC for any additional orders or questions.
23
Use caution with additional administration if significant drop in blood
pressure after administration (≥ 30 mmHg SBP).
If hypotension develops, administer 250 ml IV NS bolus at wide open rate
until until SBP ≥ 90 mmHg or MAP ≥ 65 (max cumulative dose 2 L).
Contraindicated if evidence of decompensated congestive heart failure
(e.g., rales).
 Administer Fentanyl 1 mcg/kg slow IV (max dose 50 mcg), repeat every 5 minutes if
indicated (max cumulative dose 200 mcg).
o If Fentanyl allergy:
Administer Morphine Sulfate 0.1 mg/kg slow IV (max dose 5 mg), repeat
every 5 minutes if indicated (max cumulative dose 15 mg).
Opiates are contraindicated if SBP < 90 mmHg or MAP < 65.
Use with caution in right ventricular or posterior wall MI (ST elevation
in posterior leads with marked depression in V1‐V3).
 Runs of Ventricular Tachycardia (≥ 6 consecutive beats):
o Refer to Cardiac Emergencies: Wide‐Complex Tachycardia.
Cardiac Emergencies: Bradycardia
Prince William County Fire and Rescue System 24
Cardiac Emergencies: Bradycardia
All Providers
Medical Control
 General Patient Care Protocol – Adult.
Advanced Life Support
 Full ALS Assessment and Treatment.
 Do not delay treatment if patient is unstable, by obtaining a 12‐lead ECG, unless diagnosis is
in question.
 Stable with mild symptoms:
o Provide supportive care and expedite transport (Patients can often tolerate HR
much less than the textbook rate of 60 BPM).
 Unstable with severe symptoms and SBP < 90 mmHg or MAP < 65:
o Administer Atropine 0.5 mg IV, repeat every 3‐5 minutes if indicated (max
cumulative dose 3 mg).
Use caution in the setting of second degree Type II/3rd degree blocks.
o If symptoms persist after Atropine or any delay in establishing IV:
Consider sedation if patient condition and time allows.
Administer Fentanyl 1 mcg/kg IV/IO (max dose 50 mcg), repeat
every 5 minutes if indicated (max cumulative dose 200 mcg).
Administer Midazolam 2.5 mg IV/IO, repeat in 5 minutes if indicated
and monitor for hypotension (max cumulative dose 5 mg).
Initiate transcutaneous pacing per Clinical Procedure: External Cardiac
Pacing.
o For hypotension (SBP < 90 mmHg or MAP < 65) not improved by above:
Consider Dopamine infusion at 5 mcg/kg/min titrated to 20 mcg/kg/min
in order to maintain SBP ≥ 90 mmHg, MAP ≥ 65.
o If drug induced, treat for per applicable drug overdose protocol.
Mild Symptoms: Chest Pain, Shortness of Breath, or Lightheadedness.
Severe Symptoms: Acute Altered Mental Status, Hypotension (SBP < 90 mmHg or MAP < 65), Ischemic
Chest Discomfort, Acute Heart Failure, or Other Signs of Shock.
 Contact OLMC for Epinephrine infusion at 2 mcg/min titrated up to 10 mcg/min to
maintain SBP ≥ 90 mmHg or MAP ≥ 65.
o Mix 2 mg (1mg/ml) in 500 ml NS.
 Contact OLMC for any additional orders or questions.
Cardiac Emergencies: Regular Narrow Complex Tachycardia (SVT)
Prince William County Fire and Rescue System
Cardiac Emergencies: Regular Narrow Complex Tachycardia (SVT)
All Providers
Medical Control
 General Patient Care Protocol – Adult.
Advanced Life Support
Mild Symptoms: Chest Pain, Shortness of Breath, or Lightheadedness.
Severe Symptoms: Acute Altered Mental Status, Hypotension (SBP < 90 mmHg or MAP < 65), Ischemic
Chest Discomfort, Acute Heart Failure, or Other Signs of Shock.
 Full ALS Assessment and Treatment.
 Stable with mild symptoms and ventricular rate > 150:
o Vagal maneuvers (e.g., valsalva, cough).
o Administer Adenosine 6 mg rapid IVP over 1‐3 seconds with 20 ml NS flush.
If no response in 2 minutes:
Administer Adenosine 12 mg rapid IVP over 1‐3 seconds with 20 ml
NS flush.
Record the ECG during Adenosine administration and assess underlying rhythm.
o If atrial fibrillation suspected, refer to Cardiac Emergencies: Irregular Narrow
Complex Tachycardia (A‐Fib).
 Unstable with severe symptoms and ventricular rate > 150:
o Consider Adenosine 6 mg rapid IVP (if not already given) over 1‐3 seconds with 20
ml NS flush, while setting up for cardioversion.
o Consider sedation if patient condition and time allows.
Administer Fentanyl 1 mcg/kg IV/IO (max dose 50 mcg), repeat every 5
minutes if indicated (max cumulative dose 200 mcg).
Administer Midazolam 2.5 mg IV/IO, repeat in 5 minutes if indicated and
monitor for hypotension (max cumulative dose 5 mg).
o Refer to Clinical Procedure: Synchronized Cardioversion.
Synchronized Cardioversion Energy Settings
First energy level: 200 Joules
If no response: 300 Joules
If no response: 360 Joules
 Contact OLMC for Amiodarone 150 mg diluted in 100 ml NS IV Piggyback over 10
minutes.
 Contact OLMC for any additional orders or questions.
25
Cardiac Emergencies: Irregular Narrow Complex Tachycardia (A-Fib)
Prince William County Fire and Rescue System 26
Cardiac Emergencies: Irregular Narrow Complex Tachycardia (A-Fib)
All Providers
Medical Control
 General Patient Care Protocol – Adult.
Advanced Life Support
Mild Symptoms: Chest Pain, Shortness of Breath, or Lightheadedness.
Severe Symptoms: Acute Altered Mental Status, Hypotension (SBP < 90mmHg or MAP < 65), Ischemic
Chest Discomfort, Acute Heart Failure, or Other Signs of Shock.
 Full ALS Assessment and Treatment.
 Stable with mild symptoms and no evidence of rapid ventricular rate (typically sustained
HR < 150):
o Provide supportive care and expedite transport.
 Stable with mild symptoms, SBP ≥ 90 mmHg or MAP ≥ 65, and rapid ventricular rate
(typically sustained HR > 150).
o No history of Wolff‐Parkinson‐White (WPW):
Consider Metoprolol 5 mg IV/IO over 1‐2 minutes, repeat every 5 minutes
if indicated (max cumulative dose 15 mg).
o History of WPW:
Beta blockers and Amiodarone are contraindicated. Contact OLMC and
expedite transport.
 Unstable with severe symptoms and SBP < 90 mmHg or MAP < 65:
o Atrial fibrillation or flutter with a rapid ventricular rate (typically sustained HR >
150 beats) and severe symptoms attributed to the tachycardia.
o Consider sedation if patient condition and time allows.
Administer Fentanyl 1 mcg/kg IV/IO (max dose 50 mcg), repeat every 5
minutes if indicated (max cumulative dose 200 mcg).
Administer Midazolam 2.5 mg IV/IO, repeat in 5 minutes if indicated and
monitor for hypotension (max cumulative dose 5 mg).
o Refer to Clinical Procedure: Synchronized Cardioversion.
Synchronized Cardioversion Energy Settings
First energy level: 200 Joules
If no response: 300 Joules
If no response: 360 Joules
 Contact OLMC for any additional orders or questions.
Cardiac Emergencies: Wide Complex Tachycardia
Prince William County Fire and Rescue System 27
Cardiac Emergencies: Wide Complex Tachycardia
All Providers
 General Patient Care Protocol – Adult.
Advanced Life Support
 Full ALS Assessment and Treatment.
 Do not delay treatment if patient is unstable, by obtaining a 12‐lead ECG, unless diagnosis is
in question.
 In general, assume unknown wide complex tachycardia (QRS ≥ 0.12), at rates over 150
represent ventricular tachycardia.
 V‐Tach is defined as 6 consecutive PVC’s.
 Stable with mild symptoms, SBP ≥ 90 mmHg or MAP ≥ 65, and unknown wide complex or
ventricular tachycardia likely (typically sustained HR >150 BPM):
o Administer Amiodarone 150 mg diluted in 100 ml NS IV Piggyback over 10
minutes.
 Unstable with severe symptoms and unknown wide complex or V‐Tach likely (typically
sustained HR >150 BPM):
o Consider sedation if patient condition and time allows.
Administer Fentanyl 1 mcg/kg IV/IO (max dose 50 mcg), repeat every 5
minutes if indicated (max cumulative dose 200 mcg).
Administer Midazolam 2.5 mg IV/IO, repeat in 5 minutes if indicated and
monitor for hypotension (max cumulative dose 5 mg).
o Refer to Clinical Procedure: Synchronized Cardioversion.
Synchronized Cardioversion Energy Settings
First energy level: 200 Joules
If no response: 300 Joules
If no response: 360 Joules
o If delays in synchronization occur and condition is critical, go immediately to
unsynchronized shocks.
o If wide complex tachycardia reoccurs following electrical cardioversion:
Administer Amiodarone 150 mg diluted in 100 ml NS IV Piggyback over
10 minutes, may repeat once.
o Suspected hyperkalemia (dialysis patient):
Administer Calcium Chloride 1 g IV/IO.
Contraindicated in patient on Digoxin/Lanoxin.
Mild Symptoms: Chest Pain, Shortness of Breath, or Lightheadedness.
Severe Symptoms: Acute Altered Mental Status, Hypotension (SBP <90 mmHg or MAP <65), Ischemic
Chest Discomfort, Acute Heart Failure, or Other Signs of Shock.
Cardiac Emergencies: Wide Complex Tachycardia
Prince William County Fire and Rescue System 28
Cardiac Emergencies: Wide Complex Tachycardia
Medical Control
Administer Sodium Bicarbonate 1 mEq/kg IV/IO (max dose 50 mEq).
Sodium Bicarbonate and Calcium Chloride shall not be administered
in the same line. If second line unavailable, ensure line is flushed
adequately.
Administer Albuterol 5 mg via Neb.
 Contact OLMC for any additional orders or questions.
Cardiac Emergencies: Polymorphous V-Tach (Torsades de Pointes)
Prince William County Fire and Rescue System 29
Cardiac Emergencies: Polymorphous V-Tach (Torsades de Pointes)
All Providers
Medical Control
 General Patient Care Protocol – Adult.
Advanced Life Support
 Full ALS Assessment and Treatment.
 Do not delay treatment if patient is unstable, by obtaining a 12‐lead ECG, unless diagnosis is
in question.
 Stable with mild symptoms, SBP ≥ 90 mmHg or MAP ≥ 65, and unknown wide complex or
V‐Tach likely (typically sustained HR >150 BPM):
o Administer Magnesium Sulfate 2 g diluted in 10 ml NS, IV over 2 minutes.
If no response:
Administer Amiodarone 150 mg diluted in 100 ml NS IV Piggyback
over 10 minutes.
 Unstable with severe symptoms and unknown wide complex or V‐Tach likely (typically
sustained HR > 150 BPM):
o Consider sedation if patient condition and time allows.
Administer Fentanyl 1 mcg/kg IV/IO (max dose 50 mcg), repeat every 5
minutes if indicated (max cumulative dose 200 mcg).
Administer Midazolam 2.5 mg IV/IO, repeat in 5 minutes if indicated and
monitor for hypotension (max cumulative dose 5 mg).
o Defibrillate at 360 J.
 Contact OLMC for any additional orders or questions.
Mild Symptoms: Chest Pain, Shortness of Breath, or Lightheadedness.
Severe Symptoms: Acute Altered Mental Status, Hypotension (SBP <90 mmHg or MAP <65), Ischemic
Chest Discomfort, Acute Heart Failure, or Other Signs of Shock.
Environmental Emergencies: Bites and Envenomation
Prince William County Fire and Rescue System 30
Environmental Emergencies: Bites and Envenomation
All Providers
Medical Control
 General Patient Care Protocol – Adult.
 Irrigate/cleanse wound with NS (remove any large debris).
 Remove stinger if appropriate and easily removable.
 Mark edematous area with pen and note time.
 Immobilize affected part and remove distal jewelry.
 Do not incise and suction bite site.
 Do not apply tourniquet.
 Attempt to identify what caused bite and bring to Emergency Department if dead (use
caution when handling dead snakes as envenomation has occurred secondary to reflex
motor movement).
Advanced Life Support
 Contact OLMC for any additional orders or questions.
 Full ALS Assessment and Treatment.
 For hypotension (SBP < 90 mmHg or MAP < 65), thought to be secondary to envenomation
and not improved with fluid boluses up to 2L, NS or when fluid boluses are contraindicated
due to evidence of decompensated congestive heart failure (e.g., rales).
o Administer Dopamine infusion at 5 mcg/kg/min titrated to 20 mcg/kg/min in
order to maintain SBP ≥ 90 mmHg or MAP ≥ 65.
 Refer to Medical: Allergic Reaction if indicated.
 Transport to closest appropriate facility.
Environmental Emergencies: Hyperthermia
Prince William County Fire and Rescue System 31
Environmental Emergencies: Hyperthermia
All Providers
Medical Control
Advanced Life Support
 Contact OLMC for any additional orders or questions.
 General Patient Care Protocol – Adult.
 Move patient to cooler environment.
 Heat Cramps (Painful spasms of the extremities or abdominal muscles, normal mental
status and vital signs):
o Oral fluids if tolerated.
o Spritz with cool water.
 Heat Exhaustion (Dizziness, light‐headedness, headache, irritability, normal or slightly
decreased LOC, normal or decreased blood pressure [hypovolemia], tachycardia, normal or
slightly elevated temperature):
o Remove clothing.
o Spritz with cool water and fan.
 Heat Stroke (Marked alteration in LOC, extremely high temperature [often > 104°F] may be
sweating or have red/hot/dry skin):
o Semi‐reclining with head elevated 15° ‐30° .
o Rapid cooling (prevent shivering as it increases body temperature).
o Cold packs (back of neck, groin, axillary), spritz with cool water, fan.
 If there is concern for heat exhaustion or heat stroke, perform Full ALS Assessment and
Treatment.
 Consider NS:
o If evidence of dehydration (tachycardia, dry mucous membranes, poor skin turgor)
or hypovolemia, administer NS at 250 ml, repeat once if indicated.
Consider 250 ml IV NS bolus at a wide open rate until SBP ≥ 90 mmHg or
MAP ≥ 65 (max cumulative dose 2 L).
Contraindicated if evidence of decompensated congestive heart failure
(e.g., rales).
 Hyperthermia may result in multiple etiologies including cocaine, excited delirium, or
sympathomimetic toxicity.
Environmental Emergencies: Hypothermia
Prince William County Fire and Rescue System 32
Environmental Emergencies: Hypothermia
All Providers
Medical Control
 General Patient Care Protocol – Adult.
 Remove wet clothing.
 Measure temperature. If < 90°F, handle gently.
 Move patient to a warm environment and provide warm blankets.
 Check pulse for 30‐45 seconds to differentiate cardiac arrest from profound bradycardia.
Advanced Life Support
 Contact OLMC for any additional orders or questions.
 Full ALS Assessment and Treatment.
 If available, administer warmed NS.
o Contraindicated if evidence of decompensated congestive heart failure (e.g., rales).
 If cardiac arrest occurs with a temp ≤ 90°F:
o Refer to Cardiac Arrest: General Approach.
o Administer one round of Epinephrine (0.1mg/ml) 1 mg IV/IO.
o If defibrillation is necessary, limit to one shock.
o Continue CPR.
Hazardous Materials Exposures: General Approach
Prince William County Fire and Rescue System 33
Hazardous Materials Exposure: General Approach
All Providers
Advanced Life Support
Consult On‐Duty HAZMAT TECH before attempting to handle any toxic chemical exposure patient.
Contact the Regional Poison Control Center (1‐800‐222‐1222) upon identifying a possible toxic
exposure or overdose. Consider contacting CHEMTREC (1‐800‐424‐9300) for assistance.
 General Patient Care Protocol – Adult.
 Stop the burning process.
 Remove all clothing prior to irrigation.
 If a caustic liquid is involved, flush with copious amounts of water.
 For chemical burns with eye involvement:
o Refer to Trauma: Eye Injuries.
 If a dry chemical is involved, brush it off, then flush with copious amount of water.
 Elemental metals (sodium, potassium, lithium):
o Remove obvious metallic fragments from the skin.
o Cover the burn with mineral oil or cooking oil.
If neither are available, flush the material with copious amounts of water.
 Phenols (carbolic acid, hydroxybenzene, phenyl alcohol) penetrate the skin more readily
when diluted with water.
o If available, dilute with the following (listed in order of efficacy):
Polyethylene glycol (PEG).
Glycerol.
Vegetable Oil.
As a last resort use extremely large amounts of soap and water with
continuous irrigation until all phenols are removed.
 Apply a burn sheet or dry sterile dressing to burn areas.
 For inhaled toxin with acute bronchospasm:
o Administer Albuterol 2.5 mg via nebulizer.
 Full ALS Assessment and Treatment.
 For inhaled toxin with acute bronchospasm:
o Administer Albuterol 2.5 mg and Ipratropium Bromide 0.5 mg ml via nebulizer,
repeat once in 5 minutes if indicated.
Atrovent is only contraindicated in the setting of known allergy to Atrovent or Atropine
Hazardous Materials Exposures: General Approach
Prince William County Fire and Rescue System
Hazardous Materials Exposure: General Approach Medical Control
 For persistent burning sensation of the airways (after Albuterol/Atrovent
administration) in the setting of Chlorine/Chloramine exposure:
o Administer 4.2% Sodium Bicarbonate 5 ml via Nebulizer.
Mix 2.5 ml of 8.4% Sodium Bicarbonate with 2.5 ml of NS.
 Contact OLMC for any additional orders or questions.
o If wheezing persists:
Administer Albuterol 2.5 mg via nebulizer, repeat every 5 minutes if
indicated (max cumulative dose 15 mg).
 Observe for signs of impending respiratory failure. Refer to Respiratory Emergencies:
Respiratory Failure if indicated.
 Refer to Pain Management: Medcial/Trauma Protocol if indicated.
34
Hazardous Materials Exposure: Cyanide Toxicity and Smoke Inhalation
Prince William County Fire and Rescue System 35
Hazardous Materials Exposure: Cyanide Toxicity and Smoke Inhalation
All Providers
 General Patient Care Protocol – Adult.
 Supplemental 100% O2.
 Consider patient decontamination.
Cyanide poisoning may result from inhalation, ingestion or dermal exposure to cyanide containing
compounds, including smoke from closed‐space fires. The presence and extent of the poisoning are
often unknown initially. Treatment decisions must be made on the basis of clinical history and signs
and symptoms of cyanide intoxication.
Not all patients who have suffered smoke inhalation from a closed‐space fire will have cyanide
poisoning. Other conditions such as burns, trauma, or other toxic inhalations (e.g., carbon monoxide)
may be the cause of symptoms. When smoke inhalation is the suspected source of cyanide exposure
assess the patient for the following:
 Exposure to fire or smoke in an enclosed space.
 Presence of soot around the mouth, nose or oropharynx.
 Altered mental status.
Common Signs and Symptoms of Cyanide Toxicity
Advanced Life Support
 Full ALS Assessment and Treatment.
 Evaluate the patient for the clinical suspicion of Cyanide poisoning:
o Known/suspected ingestion, inhalation, or exposure to cyanide product.
OR
o History of being exposed to dense smoke in a confined space or the presence of
oropharyngeal soot or carbonaceous expectorations.
Symptoms Signs
Headache Altered mental status
Confusion Seizures or coma
Shortness of breath Dyspnea/Tachypnea
Chest Pain or tightness Respiratory distress/Apnea
Nausea/Vomiting Hypertension (early)
Hypotension (late)
Cardiovascular collapse/Cardiac arrest
Hazardous Materials Exposure: Cyanide Toxicity and Smoke Inhalation
Prince William County Fire and Rescue System 36
Hazardous Materials Exposure: Cyanide Toxicity and Smoke Inhalation
Medical Control
 Contact OLMC for any additional orders or questions.
 If clinical suspicion of Cyanide poisoning is high AND the patient presents with altered
mental status, seizures, moderate/severe respiratory distress, unexplained hypotension, or
cardiac arrest, administer:
o Hydroxocobalamin (Cyanokit®) 5 g IV/IO over 15 minutes.
Use NS as the diluent for Cyanokit® as per manufacturer instructions.
Requires dedicated venous access as it is incompatible with numerous
medications.
Contraindicated in patients with known anaphylactic reactions to
hydroxocobalamin or cyanocobalamin.
May repeat once if patient is not responsive to treatment.
o Expedite transport and treat other conditions as per appropriate protocol.
o Refer to Respiratory Emergencies: Respiratory Failure if indicated.
Hazardous Materials Exposure: Nerve Agent/WMD
Prince William County Fire and Rescue System 37
Hazardous Materials Exposure: Nerve Agent/WMD
All Providers
 General Patient Care Protocol – Adult.
 Ensure scene safety and proper PPE.
 Consider need for additional resources.
 Obtain history of exposure, observe for toxidromes.
 Initiate triage/decontamination.
Advanced Life Support
REQUEST HAZMAT RESPONSE AND ALERT ONLINE MEDICAL CONTROL
 Full ALS Assessment and Treatment.
 Assess for mild or severe symptoms.
DuoDote™
DuoDote™ Kits carried on response vehicles are primarily for Responders ONLY. The use referenced
below implies that the WMD stockpile has been released and delivered to the scene.
 If patient develops 2 or more mild symptoms, immediately administer 1 DuoDote™ IM.
o If in 15 minutes the patient develops ANY severe symptoms immediately administer
2 additional DuoDote™ IM.
 If patient develops any severe symptoms, immediately administer 3 DuoDote™ IM.
o Consider Atropine 2 mg IV/IM/IO every 5 minutes until symptoms resolve.
o If the patient develops seizures, refer to Medical: Seizure.
Mild Symptoms Severe Symptoms
Blurred vision Strange or confused behavior
Excessive teary eyes/Runny nose Severe difficulty breathing
Increased salivation Copious secretions in the airway
Chest tightness Severe muscle twitching
Difficulty breathing Involuntary urination/Defecation
Muscle tremors Convulsions
Nausea/Vomiting Unconsciousness
Unexplained wheezing/Coughing
Acute onset stomach cramps
Hazardous Materials Exposure: Nerve Agent/WMD
Prince William County Fire and Rescue System 38
Hazardous Materials Exposure: Nerve Agent/WMD
Medical Control
 Contact OLMC for any additional orders or questions.
Medical: Abdominal Pain
Prince William County Fire and Rescue System 39
Medical: Abdominal Pain
All Providers
Medical Control
 General Patient Care Protocol – Adult.
o If pain is above the umbilicus, perform 12‐Lead ECG.
o Refer to Cardiac Emergencies: Acute Coronary Syndrome if indicated.
 Administer nothing by mouth unless indicated by protocol.
 Assess and document presence of distal lower extremity pulses in patients ≥ 50 years of
age.
Advanced Life Support
 Contact OLMC for any additional orders or questions.
 Full ALS Assessment and Treatment.
 Perform continuous cardiac monitoring.
 Consider Pain Management: Medical/Trauma if indicated.
 Suspected kidney stone:
o Administer 250 ml IV NS at a wide open rate.
Medical: Allergic Reaction
Prince William County Fire and Rescue System 40
Medical: Allergic Reaction
All Providers
 General Patient Care Protocol – Adult.
 Assist patient in self‐administration of previously prescribed epinephrine auto‐injector
(e.g., Epi‐Pen).
 If wheezing present:
o Administer Albuterol 2.5 mg via nebulizer, repeat once in 5 minutes if indicated.
Advanced Life Support
Mild Reaction: Itching/Hives.
Moderate Reaction: Dyspnea, Wheezing, Chest Tightness.
Severe Systemic Reaction (Anaphylaxis): SBP < 90 mmHg, MAP < 65, Throat Complaints, Stridor, Severe
Respiratory Distress, Gastrointestinal Symptoms (vomiting and abdominal pain)
 Full ALS Assessment and Treatment.
 Mild Reaction:
o Administer Diphenhydramine 1 mg/kg IV/IM/IO (max dose 50 mg).
 Moderate or Severe Systemic Reaction:
o Administer Epinephrine (1mg/ml) 0.3 mg IM for rapidly progressive worsening
symptoms. Repeat once in 5 minutes if indicated.
o Administer Albuterol 2.5 mg via nebulizer, repeat every 5 minutes if indicated
(max cumulative dose 15 mg).
o Administer Diphenhydramine 1 mg/kg IV/IM/IO (max dose 50 mg).
o Administer Methylprednisolone 125 mg IV/IM/IO.
o Consider 250 ml IV NS bolus at a wide open rate until SBP ≥ 90 mmHg or MAP ≥ 65
(max cumulative dose 2 L).
Contraindicated if evidence of decomensated congestive heart failure (e.g.,
rales).
 Imminent Cardiopulmonary Arrest (e.g., profound bradycardia or hypotension with signs
and symptoms of severe shock with altered mental status):
o Consider Epinephrine (0.1mg/ml) 0.5 mg IV/IO.
o Treat per Moderate or Severe Systemic Reaction.
 Cardiac Arrest:
o Refer to the appropriate cardiac arrest protocol.
o In the setting of cardiac arrest, the following items should be performed in the postresuscitative
phase, if not already completed, when time allows:
Administer Albuterol 2.5 mg via nebulizer, repeat every 5 minutes if
indicated (max cumulative dose 15 mg).
Administer Diphenhydramine 1 mg/kg IV/IM/IO (max dose 50 mg).
Administer Methylprednisolone 125 mg IV/IO.
Medical: Allergic Reaction
Prince William County Fire and Rescue System 41
Medical: Allergic Reaction
Medical Control
 Contact OLMC for additional Epinephrine (1mg/ml) 0.3 mg IM.
 Contact OLMC for Epinephrine infusion 2 mcg/min titrated up to 10 mcg/min to
maintain SBP ≥ 90 mmHg or MAP ≥ 65.
o Mix 2 mg (1mg/ml) in 500 ml NS.
 Contact OLMC for any additional orders or questions.
Medical: Altered Mental Status/Syncope
Prince William County Fire and Rescue System 42
Medical: Altered Mental Status/Syncope
All Providers
Medical Control
 General Patient Care Protocol – Adult.
 Obtain BGL and refer to Medical: Diabetic Emergencies.
 Obtain 12‐Lead ECG.
 If stroke suspected refer to Medical: Stroke Suspected.
 If head injury suspected refer to Trauma: Head Injuries.
 If severely agitated and/or violent refer to Medical: Behavioral Emergencies/Excited
Delirium.
 If sepsis suspected (advanced age, high risk for infection, febrile) refer to Medical: Sepsis.
 If suspected poisoning:
o Refer to Overdose and Poisoning: General Approach.
Advanced Life Support
 Contact OLMC for any additional orders or questions.
 Full ALS Assessment and Treatment.
 If cardiac arrhythmia present, refer to the appropriate cardiac emergencies protocol.
Medical: Behavioral Emergencies/Excited Delirium
Prince William County Fire and Rescue System 43
Medical: Behavioral Emergencies/Excited Delirium
All Providers
 General Patient Care Protocol – Adult.
 If needed, apply physical restraints to ensure patient/crew safety. Refer and adhere to
Administrative Procedure: Restraints when this process is deemed necessary.
 Refer to Medical: Altered Mental Status/Syncope if indicated.
 Refer to Overdose and Poisoning: General Approach if indicated.
 Assess and treat for hyperthermia, refer to Environmental Emergency: Hyperthermia.
Advanced Life Support
NEVER RESTRAIN OR TRANSPORT IN PRONE POSITION
 Full ALS Assessment and Treatment.
 For patients with severe agitation compromising patient/crew safety, or for patients who
continue to struggle against physical restraints:
o Age ≤ 65:
Administer Midazolam 5 mg IV/IM/IN/IO, repeat in 5 minutes if indicated
(max cumulative dose 10 mg).
o Age > 65:
Administer Midazolam 2.5 mg IV/IM/IN/IO, may repeat in 5 minutes if
indicated (max cumulative dose 5 mg).
 If evidence of tachycardia, tachypnea, or hyperthermia:
o Consider 250 ml IV NS bolus at wide open rate (max cumulative dose 2 L).
Contraindicated if evidence of decompensated congested hear failure (e.g.,
rales).
Paramedic Only
 If concerns for Excited Delirium are not controlled with Midazolam after 10 minutes:
Signs and Symptoms of Excited Delirium
Extremely aggressive or violent behavior Hot to touch
Does not respond to police presence Rapid breathing
Naked/Inadequately clothed Profuse sweating
Excessive strength Seemingly insensitive to pain
Does not fatigue
Medical: Behavioral Emergencies/Excited Delirium
Prince William County Fire and Rescue System 44
Medical Control
 Contact OLMC for Sodium Bicarbonate 50 mEq in 1,000 ml NS IV wide open.
 Contact OLMC for all refusals or non‐transports.
 Contact OLMC for any additional orders or questions.
o Consider Ketamine:
Ketamine 3 mg/kg IM.
OR
Ketamine 1 mg/kg IV.
Medical: Behavioral Emergencies/Excited Delirium
Medical: Diabetic Emergencies
Prince William County Fire and Rescue System
Medical: Diabetic Emergencies
All Providers
Medical Control
 General Patient Care Protocol – Adult.
 Hypoglycemia (BGL < 60 mg/dL):
o Consider Oral Glucose Gel 15 g or Glucose containing beverage (e.g., orange juice).
Patient must be alert and able to self‐administer.
Advanced Life Support
 Contact OLMC for any additional orders or questions.
 Full ALS Assessment and Treatment.
 Determine blood glucose and treat:
o Hypoglycemia (BGL < 60 mg/dL):
Administer 100 ml of 10% Dextrose, titrate to improved mental status and
BGL, may repeat every 5 minutes (max cumulative dose 250 ml).
If hypoglycemia persists, repeat blood glucose check with a different
glucometer.
If unable to obtain IV/IO access:
Administer Oral Glucose Gel 15 g or glucose containing beverage
(e.g., orange juice).
Patient must be alert and able to self‐administer.
If unable to administer glucose by mouth:
Administer Glucagon 1 mg IM.
o Hyperglycemia (BGL > 250 mg/dL):
If evidence of dehydration (tachycardia, dry mucous membranes, poor skin
turgor) or hypovolemia, administer NS at 250 ml, repeat once if indicated.
Consider 250 ml IV NS bolus at a wide open rate until SBP ≥ 90 mmHg or
MAP ≥ 65 (max cumulative dose 2 L).
Contraindicated if evidence of decompensated congestive heart failure
(e.g., rales).
 Refer to Administrative Procedure: Refusal of Transport After Treatment if indicated.
45
Medical: Seizure
Prince William County Fire and Rescue System 46
Medical: Seizure
All Providers
Medical Control
 General Patient Care Protocol – Adult.
 Protect patient from injury.
Advanced Life Support
 Contact OLMC for any additional orders or questions.
 Full ALS Assessment and Treatment.
 Refer to Medical: Diabetic Emergencies if indicated.
 For active seizures:
o Age ≤ 65:
Administer Midazolam 5 mg IV/IM/IN/IO, repeat in 5 minutes if indicated
(max cumulative dose 10 mg).
o Age > 65:
Administer Midazolam 2.5 mg IV/IM/IN/IO, repeat in 5 minutes if indicated
(max cumulative dose 5 mg).
 For suspected hypoxic seizures, drug induced seizures, seizures from head trauma, stroke,
or eclampsia suspected:
o Treat as above and refer to appropriate protocol.
Medical: Sepsis
Prince William County Fire and Rescue System 47
Medical: Sepsis
All Providers
Medical Control
 General Patient Care Protocol – Adult.
Advanced Life Support
Sepsis is a rapidly progressing life‐threatening complication of systemic infection. It occurs when an
inflammatory response called Systemic Inflammatory Response Syndrome (SIRS) is triggered in
response to infection. Sepsis must be recognized and treated aggressively to prevent progression to
shock and death. Sepsis can be identified when the following SIRS markers are present in a patient
with suspected infection.
 Fever or hypothermia (> 100.4 F or < 96.8 F).
 Tachypnea (respiratory rate > 20).
 Tachycardia (heart rate > 90).
In addition to physiologic signs of SIRS, severe sepsis may cause hypoxia and inadequate organ
perfusion, resulting in metabolic acidosis marked by elevated serum lactate levels and decreased
ETCO2 (measured by capnography).
 Contact OLMC for any additional orders or questions.
 Full ALS Assessment and Treatment.
 Notify hospital of a “CODE Sepsis” prior to arrival per Administrative Procedure: Code
Sepsis.
 Administer 1 L NS:
o Reassess vital signs and respiratory status after each 500 ml.
o If after 1 L NS, SBP < 90 mmHg or MAP < 65:
Administer 2nd L NS.
Use caution in patients with: CHF and ESRD/Dialysis.
o Total amount of NS shall not exceed 30 ml/kg (max cumulative dose 2 L).
 If SBP < 90 mmHg or MAP < 65 after 2 L NS:
o Consider Dopamine 5 mcg/kg/min titrated up to 20 mcg/kg/min in order to
maintain SBP ≥ 90 mmHg or MAP ≥ 65.
Medical: Stroke Suspected
Prince William County Fire and Rescue System 48
Medical: Stroke Suspected
All Providers
Medical Control
 General Patient Care Protocol – Adult.
 Identify and document time the patient was last seen normal.
o Utilize bystanders and family if available.
 Keep head of stretcher at 30° ‐ 45° elevation (unless clinical condition will not allow).
 If spinal immobilization is indicated; elevate head of backboard 15° ‐ 30°.
 Check BGL per Clinical Procedure: Blood Glucose Analysis.
o Refer to Medical: Diabetic Emergencies if indicated.
 Give nothing by mouth.
 Perform and document the Cincinnati Pre‐Hospital Stroke Score.
Advanced Life Support
Early recognition and transport of stroke is essential to good patient outcomes. Any patient
presenting with a normal blood glucose (> 60 mg/dL), a positive Cincinnati Pre‐Hospital Stroke
Screen, and onset of symptoms (when last seen normal) less than 8 hours should have early
notification of the stroke center (Code Stroke) and rapid transport.
 Contact OLMC for any additional orders or questions.
Patient Care Goals: 5/5/10/2
At patient to stroke assessment < 5 min
Positive stroke assessment to Emergency Department notification < 5 min
Positive stroke assessment to transport < 10 min
Providers during transport ‐ 2
 Full ALS Assessment and Treatment.
 Do not delay transport to obtain IV access.
OB/GYN: Childbirth
Prince William County Fire and Rescue System 49
OB/GYN: Childbirth
All Providers
 General Patient Care Protocol – Adult.
 During assessment, do not place anything inside of the birth canal.
 If presenting part is not the head (e.g., foot, arm, or buttocks), immediately begin transport
while further care continues.
 Non‐Complicated Delivery:
o Slow, controlled delivery of head; apply gentle perineal pressure.
o Observe for meconium staining.
If present, suction oral pharynx and nose as soon as head is delivered.
o Following delivery, refer to Pediatric Cardiac Arrest: Neonatal Resuscitation if
indicated.
o Record delivery time.
o Keep infant at level of perineum until you have double clamped the cord 8‐10 inches
from the newborn’s abdomen.
o Cut cord between clamps.
o Perform APGAR assessment at 1 and 5 minutes post delivery.
APGAR SCORING CHART
Conditions that require immediate transport even in the setting of imminent delivery include:
prolonged rupture of membranes, preeclampsia/eclampsia, breech presentation, cord presentation,
extremity presentation, nuchal cord, and meconium staining.
o Maintain body temperature of the newborn and the mother.
o Allow spontaneous delivery of placenta; do not apply traction to umbilical cord for
placental delivery.
If placental delivery occurs, package in biohazardous waste bag and hand
over to hospital staff upon arrival.
Sign Score 0 Score 1 Score 2
Appearance Pale/Blue Blue extremities Pink
Pulse Absent < 100 per minute >100 per minute
Grimace No response Grimace Cough or Sneeze
Activity Flaccid Some flexion Well flexed
Respiration Absent Weak Good cry
OB/GYN: Childbirth
Prince William County Fire and Rescue System 50
OB/GYN: Childbirth
 Specific Delivery Emergencies:
o Severe Postpartum Hemorrhage:
Control external perineal bleeding by applying direct pressure to any
lacerations.
Perform fundal massage (if placenta has delivered).
Encourage the mother to nurse the newborn (if possible).
o Breech/Limb or Abnormal Presentation:
Transport in knee to chest position, unless delivery imminent.
Encourage mother to refrain from pushing.
Support presenting parts, do not pull.
Insert gloved fingers into vagina, elevate pressure off of cord and to assist in
maintaining airway. Maintain this position.
o Prolapsed Cord:
Elevate mother’s hips and place in the knee to chest position.
Encourage mother not to push.
Evaluate fetal heart rate/cord pulsation.
Cover cord with moist sterile dressing.
Do not attempt to push cord back into vagina.
Emergent transport.
o Shoulder Dystocia:
Place mother in knee‐chest position and reattempt delivery.
If delivery fails, support child’s airway, provide supplemental oxygen.
 Postpartum:
o For neonate, refer to Pediatric Cardiac Arrest: Neonatal Resuscitation if indicated.
o Assess for postpartum hemorrhage.
o After placenta delivers, consider gentle abdominal massage overlying the uterine
fundus until firm.
Advanced Life Support
 Full ALS Assessment and Treatment.
 Consider IV access.
 Consider Pain Management: Medical/Trauma.
 Transport to nearest obstetrics receiving facility.
OB/GYN: Childbirth
Prince William County Fire and Rescue System 51
OB/GYN: Childbirth
Medical Control
 Contact OLMC for any additional orders or questions.
OB/GYN: Pre-Eclampsia/Eclampsia
Prince William County Fire and Rescue System 52
OB/GYN: Pre-Eclampsia/Eclampsia
All Providers
Medical Control
 General Patient Care Protocol – Adult.
Advanced Life Support
Pregnancy‐induced hypertension, pre‐eclampsia, and eclampsia are conditions typically encountered
in late 2nd or 3rd trimester of pregnancy, and may occur up to 6 weeks postpartum. Clinical
manifestations may include elevated blood pressure (SBP > 160 mmHg or Diastolic > 120 mmHg),
headache, confusion, or agitation.
 Contact OLMC for patients < 20 weeks gestation.
 Contact OLMC for any additional orders or questions.
 Full ALS Assessment and Treatment.
 < 20 weeks gestation:
o Do not initiate pharmacological intervention. Contact OLMC.
 ≥ 20 weeks gestation:
o Pre‐Eclampsia (Systolic BP > 160 mmHg or Diastolic > 120 mmHg on two
consecutive readings):
Administer Magnesium Sulfate 4 g diluted in 100 ml NS IV over 10
minutes.
o Eclampsia:
Administer Midazolam 5 mg IV/IM/IN/IO, repeat in 5 minutes if indicated
(max cumulative dose 10 mg).
Administer Magnesium Sulfate 4 g diluted in 100 ml NS IV over 10
minutes.
**DO NOT DELAY MIDAZOLAM ADMINISTRATION TO ESTABLISH IV ACCESS**
Unless IV already established, administer IM/IN and then obtain IV access.
OB/GYN: Vaginal Bleeding
Prince William County Fire and Rescue System 53
OB/GYN: Vaginal Bleedin
All Providers
Medical Control
 General Patient Care Protocol – Adult.
 1st or 2nd trimester bleeding or unknown pregnancy status:
o Place the patient in a position of comfort, consider lateral recumbent position.
 3rd trimester bleeding (> 26 weeks):
o If tolerated, place patient in left lateral recumbent position.
o During assessment, do not place anything inside the birth canal.
Advanced Life Support
 Contact OLMC for any additional orders or questions.
 Full ALS Assessment and Treatment.
 If gestational age known to be < 20 weeks:
o Transport to closest Emergency Department.
 If gestational age known or possibly ≥ 20 weeks:
o Contact Emergency Department for consideration of transport directly to Labor and
Delivery Department.
Whenever possible, transport to patient’s requested obstetric receiving facility
(within county boundaries) if patient not having imminent delivery.
Overdose and Poisoning: General Approach
Prince William County Fire and Rescue System 54
Overdose and Poisoning: General Approach
All Providers
Medical Control
 General Patient Care Protocol – Adult.
 Nothing by mouth, unless advised by Regional Poison Control Center.
 For patients with suspected opiate overdose with respiratory depression:
o Administer Naloxone 2 mg IN.
 Refer to appropriate Overdose and Poisoning protocol:
o Overdose and Poisoning: Antidepressants.
o Overdose and Poisoning: Antipsychotics and Dystonic Reaction.
o Overdose and Poisoning: Beta Blocker Toxicity.
o Overdose and Poisoning: Calcium Channel Blocker.
o Overdose and Poisoning: Carbon Monoxide.
o Overdose and Poisoning: Organophosphate .
Advanced Life Support
For any overdose or poisoning, contact should be made with the Regional Poison Control Center
1‐800‐222‐1222. Whenever possible, determine the agent(s) involved, the time of the ingestion/
exposure, and the amount ingested. Bring empty pill bottles, etc. to the receiving facility.
Treatment for specific toxic exposures is indicated only when patients are clearly symptomatic. In the
absence of significant symptoms, monitor closely and expedite transport.
 Contact OLMC for any additional orders or questions.
 Full ALS Assessment and Treatment.
 For patients with suspected opioid overdose:
o Consider Naloxone 2 mg IN/IM
OR
o Consider Naloxone 0.4 mg IV/IO, titrated to maintain adequate respiratory rate
(max cumulative dose 4 mg).
Overdose and Poisoning: Antidepressants
Prince William County Fire and Rescue System 55
Overdose and Poisoning: Antidepressants
All Providers
 General Patient Care Protocol – Adult.
Advanced Life Support
Common Antidepressants and Overdose Effects
 Full ALS Assessment and Treatment.
 For hypotension (SBP < 90 mmHg or MAP < 65) not improved by fluid boluses, or when
fluid resuscitation is contraindicated:
o Consider Dopamine infusion at 5 mcg/kg/min titrated up to 20 mcg/kg/min in
order to maintain SBP ≥ 90 mmHg or MAP ≥ 65.
Category Drugs Overdose Effects
Tricyclic
Antidepressants
Amitriptyline (Elavil, Endep, Vanatrip,
Levate)
Clomipramine (Anafranil)
Doxepin (Sinequan, Zonalon, Tridapin)
Imipramine (Tofranil, Impril)
Nortryptyline (Aventyl, Pamelor,
Norventyl)
Desipramine (Norpramin)
Protriptyline (Vivactil)
Triimipramine (Surmontil)
Amitriptyline+Chlordiazepoxide
(Limbitrol)
Hypotension
Anti‐cholinergic effects
(tachycardia, seizures,
altered mental status,
mydriasis)
AV conduction blocks
(prolonged QT interval, wide
QRS)
VT and VF
Other Cyclic
Antidepressants
Maprotiline (ludiomil)
Amoxapine (Asendin)
Buproprion (Wellbutrin)
Trazodone (Desyrel, Trazorel)
Similar to tricyclics
Seizures
Seizures
Similar to tricyclics
Selective Serotonin
Reuptake Inhibitors
(SSRIs)
Citalopram (Celexa)
Fluoexitine (Prozac)
Fluvoxamine (Luvox)
Paroxetine (Paxil)
Sertraline (Zoloft)
Hypertension, tachycardia,
agitation, diaphoresis,
shivering, tremor, muscle
rigidity
Malignant Hyperthermia
Overdose and Poisoning: Antidepressants
Prince William County Fire and Rescue System 56
Overdose and Poisoning: Antidepressants
Medical Control
 Contact OLMC for any additional orders or questions.
 If sustained wide QRS complex (≥ 0.12 sec) with tachycardia (> 120 bpm), hypotension, any
arrhythmia, or seizure:
o Administer Sodium Bicarbonate 1 mEq/kg IV/IO (max dose 50 mEq), may repeat
once in 10 minutes if indicated.
 Refer to Cardiac Arrest: V‐Fib/Pulseless V‐Tach if indicated.
 Refer to Medical: Altered Mental Status/Syncope if indicated.
 Refer to Medical: Seizure if indicated.
Overdose and Poisoning: Antipsychotics/Acute Dystonic Reaction
Prince William County Fire and Rescue System 57
Overdose and Poisoning: Antipsychotics/Acute Dystonic Reaction
All Providers
Medical Control
 General Patient Care Protocol – Adult.
Advanced Life Support
Common Antipsychotic Medications
 Contact OLMC for any additional orders or questions.
 Full ALS Assessment and Treatment.
 For Dystonic reactions:
o Consider Diphenhydramine 25 mg IV/IM, repeat once in 10 minutes if indicated.
Medication Medication Effects
Haloperidol
Prolixin
Thorazine
Prochloperazine (Compazine)
Promethazine (Phenergan)
Administration of these agents may cause
akathisia (restlessness, anxiety, and
involuntary movements [dystonia])
Overdose and Poisoning: Beta Blocker Toxicity
Prince William County Fire and Rescue System 58
Overdose and Poisoning: Beta Blocker Toxicity
All Providers
Medical Control
 General Patient Care Protocol – Adult.
Advanced Life Support
Common Beta Blocker Medications
 Contact OLMC for any additional orders or questions.
 Full ALS Assessment and Treatment.
 For all patients with cardiovascular toxicity in the setting of suspected acute Beta Blocker
toxicity, defined by:
o Chest Pain, SBP < 90 mmHg or MAP < 65, acutely altered mental status.
AND
o Heart Rate < 60 or 2nd or 3rd degree heart blocks.
Consider Atropine 0.5 mg IVP, repeat every 3 minutes if indicated (max
cumulative dose 3 mg).
Use caution in the setting of second degree Type II/3rd degree blocks.
 If no response to Atropine:
o Consider Glucagon 3 mg IV/IO, slow push.
 If no response to previous treatments:
o Consider transcutaneous pacing per Clinical Procedure: External Cardiac Pacing.
Single Agent Medication Combination Medication
Propranolol (Inderal)
Atenolol (Tenormin)
Metoprolol (Lopressor, Toprol)
Nadolol (Corgard)
Timolol (Blocadren)
Labetolol (Trandate)
Esmolol (Brevibloc)
Corzide (Nadolol/bendroflumethlazide)
Inderide (Propranolol/HCTZ)
Lopressor HCT (Metoprolol/HCTZ)
Tenoretic (Atenolol/Chlorthalidone)
Timolide (Timolol/HCTZ)
Ziac (Bisoprolol/HCTZ)
Overdose and Poisoning: Calcium Channel Blocker
Prince William County Fire and Rescue System 59
Overdose and Poisoning: Calcium Channel Blocker
All Providers
Medical Control
 General Patient Care Protocol – Adult.
Advanced Life Support
Common Calcium Channel Blocker Medications
 Contact OLMC for any additional orders or questions.
 Full ALS Assessment and Treatment.
 For all patients with cardiovascular toxicity in the setting of suspected acute Calcium
Channel Blocker toxicity, defined by:
o Chest Pain, SBP < 90 mmHg or MAP < 65, acutely altered mental status.
AND
o Heart Rate < 60 or 2nd or 3rd degree heart blocks.
Administer Atropine 0.5 mg IVP, repeat every 3 minutes if indicated (max
cumulative dose 3 mg).
Use caution in the setting of second degree Type II/3rd degree blocks.
 If no response to Atropine:
o Administer Calcium Chloride 1 g IV/IO.
Contraindicated if patient taking Digoxin (Lanoxin).
 If no response to previous treatments:
o Consider Glucagon 3 mg IV/IO slow IVP.
 If no response to previous treatments:
o Consider transcutaneous pacing per Clinical Procedure: External Cardiac Pacing.
Common Medications
Amlodipine (Norvasc)
Felodipine (Plendil, Renedil)
Isradipine (DynaCirc)
Nicardipine (Cardene)
Nifedipine (Procardia, Adalat)
Verapamil (Calan)
Diltiazem (Cardizem)
Overdose and Poisoning: Carbon Monoxide
Prince William County Fire and Rescue System 60
Overdose and Poisoning: Carbon Monoxide
All Providers
Medical Control
 General Patient Care Protocol – Adult.
 Wear appropriate PPE (SCBA) as indicated.
 Remove the patient from the contaminated source.
 Assess Carboxyhemoglobin level utilizing available CO‐oximeter.
 Supplemental 100% O2 via NRB or BVM (if necessary).
o Document time O2 started.
 Refer to Clinical Procedure: Carboxyhemoglobin Monitoring.
Advanced Life Support
 Contact OLMC for any additional orders or questions.
 Full ALS Assessment and Treatment.
 For smoke inhalation patients, also consider Cyanide poisoning.
o Refer to Hazardous Materials Exposure: Cyanide Toxicity and Smoke Inhalation.
Overdose and Poisoning: Cholinergic/Organophosphates
Prince William County Fire and Rescue System 61
Overdose and Poisoning: Cholinergic/Organophosphates
All Providers
Medical Control
 General Patient Care Protocol – Adult.
 Wear protective clothing including at minimum masks, gloves, and eye protection, refer to
department policy regarding PPE.
o Toxicity to providers may result from inhalation or topical/dermal exposure.
 Consider requesting additional resources, including HazMat Response.
o Refer to Hazardous Materials Exposure: Nerve Agent WMD if indicated.
 Decontaminate patient per FRS policy regarding hazardous materials decontamination of
victims.
Advanced Life Support
Consult On‐Duty HAZMAT TECH before attempting to handle any toxic chemical exposure patient.
Contact the Regional Poison Control Center (1‐800‐222‐1222) upon identifying a possible toxic
exposure or overdose. Consider contacting CHEMTREC (1‐800‐424‐9300) for assistance.
 Contact OLMC for any additional orders or questions.
 Full ALS Assessment and Treatment.
 For hypotension (systolic BP < 90 mmHg or MAP < 65) not improved by fluid boluses, or
when fluid resuscitation is contraindicated.
o AdministerDopamine infusion at 5 mcg/kg/min titrated up to 20 mcg/kg/min in
order to maintain SBP ≥ 90 mmHg or MAP ≥ 65.
 If severe signs of toxicity, (severe respiratory distress, bradycardia, heavy respiratory
secretions):
o Administer Atropine 2 mg IV/IO, repeat every 5 minutes.
Titrate dosing by assessing improvement in respiratory effort/bronchial
secretions. Do not rely on pupillary constriction to diagnose or titrate
medications.
 Refer to Medical: Altered Mental Status if indicated.
 Refer to Medical: Seizure if indicated.
Pain Management: Medical/Trauma
Prince William County Fire and Rescue System 62
Pain Management: Medical/Trauma
All Providers
 General Patient Care Protocol – Adult.
 Assess and document baseline pain level (0‐10 scale: 0=no pain; 10=worst pain).
Advanced Life Support
 Full ALS Assessment and Treatment.
 Analgesic agents may be administered under standing orders for patients experiencing
moderate/severe pain (typically ≥ 5/10).
o Common complaints:
Trauma/Isolated extremity injury (e.g., fractures).
Burns (without airway, breathing, or circulation compromise).
Sickle cell crisis.
Acute chest pain, in accordance with the Cardiac Emergencies: Acute
Coronary Syndrome.
Kidney stone highly suspected, in accordance with the Medical: Abdominal
Pain.
 Agents for pain control:
o Administer Fentanyl 1 mcg/kg slow IV/IN/IO (max dose 50 mcg), repeat every 5
minutes if indicated (max cumulative dose 200 mcg).
Contraindicated if SBP < 90 mmHg or MAP < 65.
o If Fentanyl allergy:
Consider Morphine Sulfate 0.1 mg/kg IV/IO (max dose 5 mg), repeat every
5 minutes if indicated (max cumulative dose 15 mg).
Contraindicated if SBP < 90 mmHg or MAP < 65.
 After each drug dosage administration:
o Reassess and document the patient’s pain level (0‐10 scale).
o Note adequacy of ventilation and perfusion.
o Assess vital signs.
 Continuously monitor SpO2 and ETCO2.
Medical Control
 Contact OLMC for any additional orders or questions.
Prince William County Fire and Rescue System
Adult Trauma Protocols
General Patient Care Protocol - Adult Trauma
Prince William County Fire and Rescue System 63
General Patient Care Protocol – Adult Trauma All Providers
 General Patient Care Protocol – Adult.
 Refer to Administrative Procedure: Trauma Triage Criteria.
 Treat life threatening emergencies immediately.
 Perform a rapid trauma assessment and establish initial GCS.
o Reevaluate every 5 minutes.
 Control active bleeding utilizing dressings, direct pressure, hemostatic agents, and
tourniquets as indicated.
o Refer to Clinical Procedure: Wound Care/Hemorrhage Control if indicated.
 Consider Selective Spinal Motion Restriction (SSMR).
o Refer to Clinical Procedure: Selective Spinal Motion Restriction (SSMR) if
indicated.
 Supplemental 100% O2 if evidence of major traumatic injury or respiratory symptoms.
o Refer to appropriate Respiratory Emergencies Protocol as indicated.
 Restrain patient if indicated, refer to Administrative Procedure: Restraints.
Advanced Life Support
Assess all patients for major trauma criteria. Major trauma patients should have transport initiated
within 10 minutes of arrival on scene whenever possible. In the setting of major trauma, DO NOT
prolong scene time to perform procedures unless immediately necessary to stabilize patient (e.g.,
hemorrhage control). Initiate all other procedures enroute to the trauma center.
The following measures will serve as the “General Patient Care Protocol – Adult Trauma” and
apply to the management of all adult trauma patients.
 Full ALS Assessment and Treatment.
 Advanced airway/ventilatory management if indicated.
 Treat life threatening emergencies immediately.
o Assess for tension pneumothorax.
Pleural decompression for tension pneumothorax should only be performed
when all 3 of the following criteria are present or in the setting of
resuscitation in traumatic cardiac arrest.
Severe respiratory distress with hypoxia.
Unilateral decreased or absent lung sounds (may see tracheal
deviation away from collapsed lung field).
Evidence of hemodynamic compromise (e.g., shock, hypotension,
altered mental status).
o If indicated perform pleural decompression, refer to Clinical Procedure: Chest
Decompression.
General Patient Care Protocol - Adult Trauma
Prince William County Fire and Rescue System 64
General Patient Care Protocol – Adult Trauma
Medical Control
 For entanglement/entrapment or crush injuries ≥ 4 hours:
o Consider Albuterol 5 mg via nebulizer.
o Consider Sodium Bicarbonate 1 mEq/kg IV/IO over 5 minutes (max dose 100
mEq).
 Contact OLMC for any additional orders or questions.
 Perform continuous cardiac monitoring.
 Record and monitor SpO2.
 Continuously monitor ETCO2.
 Establish IV NS KVO or IV lock if indicated.
o If patient is unstable and time permits, establish a second IV.
 Administer NS:
o If SBP < 90 mmHg and/or MAP < 65 administer 250 boluses of NS at a wide open IV
rate until SBP ≥ 90 mmHg or MAP ≥ 65 (max cumulative dose 2L).
 Suspected hemorrhage in the setting of trauma (without an isolated head injury):
o SBP ≤ 90 mmHg OR sustained HR > 110.
Administer Tranexamic Acid 1 g diluted into 100 ml IV/IO over 10
minutes.
Must be administered within 3 hours of injury (max benefit in 1st hour).
NOT AUTHORIZED FOR PEDIATRIC PATIENTS.
 Consider Pain Management: Medical/Trauma Protocol if indicated.
Trauma: Abdominal Injuries
Prince William County Fire and Rescue System 65
Trauma: Abdominal Injuries
All Providers
Medical Control
 General Patient Care Protocol ‐ Adult.
 General Patient Care Protocol ‐ Adult Trauma.
 Refer to Administrative Procedure: Trauma Triage Criteria
 For evisceration, apply a moist dressing and cover.
o Do not attempt to place organs back in place.
 For an impaled object, stabilize in place.
o Do not remove the impaled object.
Advanced Life Support
 Contact OLMC for any additional orders or questions.
 Full ALS Assessment and Treatment.
 Refer to Pain Management: Medical/Trauma Protocol if indicated.
Trauma: Burns
Prince William County Fire and Rescue System 66
Trauma: Burns
All Providers
 General Patient Care Protocol – Adult.
 General Patient Care Protocol – Adult Trauma.
 Refer to Hazardous Materials Exposure: Cyanide Toxicity and Smoke Inhalation if
indicated.
 Refer to Clinical Procedure: Selective Spinal Motion Restriction (SSMR) if indicated.
 Refer to Administrative Procedure: Burn Center Criteria.
 Refer to Administrative Procedure: Trauma Triage Criteria.
 Observe for signs of impending respiratory failure, refer to Respiratory Emergencies:
Respiratory Failure if indicated.
o Decreased level of consciousness with hypoxia (SpO2 < 90%) despite 100% O2
therapy, apnea, and/or respiratory rate < 8.
o Poor ventilatory effort (with hypoxia despite 100% O2 therapy).
o Patients requiring active ventilatory assistance.
o Inability to maintain patent airway.
o Symptomatic airway obstruction.
 Stop the burning process, remove or cool heat source if present (e.g., clothing, tar).
 Remove all clothing, contact lenses, and jewelry (especially rings) near the injury site.
 Estimate TBSA (only include 2nd and 3rd degree burns).
o Rule of Nines.
o Alternatively, use the palm of patient’s hand, including fingers, to equal 1% TBSA.
 If < 10% TBSA:
o Cool with moist room temperature sterile dressings.
o NEVER COOL WITH ICE! The goal is to bring the burn to room temperature.
 If ≥ 10% TBSA:
o Cover with dry sterile dressings, plastic wrap, or chux pad.
 Maintain core temperature. Keep patient warm and dry with sheets and blankets.
 If inhalation injury suspected:
o Place patient on 100% O2 – DO NOT DECREASE.
o Continuously monitor SpO2 and ETCO2.
Advanced Life Support
 Full ALS Assessment and Treatment.
 Refer to the appropriate Respiratory Emergencies Protocols if indicated.
Trauma: Burns
Prince William County Fire and Rescue System
Trauma: Burns
Medical Control
 Contact OLMC for any additional orders or questions.
 Place large bore peripheral IV’s in unburned skin if possible.
o If ≥ 20% TBSA:
Administer NS, 500 ml bolus.
Consider 250 ml IV NS bolus at wide open rate until SBP ≥ 90 mmHg or MAP
≥ 65 (max cumulative dose 2L).
o If ≥ 30% TBSA:
Place second large bore peripheral IV.
o Refer to Pain Management: Medical/Trauma Protocol if indicated.
Paramedic Only
 Refer to Pain Management: Medical/Trauma Protocol if indicated.
67
In adults, prehospital endotracheal intubation following acute burns is generally
unnecessary unless signs of respiratory failure are present.
Trauma: Chest Injuries
Prince William County Fire and Rescue System 68
Trauma: Chest Injuries
All Providers
 General Patient Care Protocol – Adult.
 General Patient Care Protocol – Adult Trauma.
 Refer to Clinical Procedure: Selective Spinal Motion Restriction (SSMR) if indicated.
 Observe for signs of impending respiratory failure, refer to Respiratory Emergencies:
Respiratory Failure if indicated.
o Decreased level of consciousness with hypoxia (SpO2 < 90%) despite 100% O2
therapy, apnea, and/or respiratory rate < 8.
o Poor ventilatory effort (with hypoxia despite 100% O2 therapy).
o Patients requiring active ventilatory assistance.
o Inability to maintain patent airway.
o Symptomatic airway obstruction.
 Consider early positive pressure ventilation in the setting of impending respiratory failure
with a flail segment.
 Assess breath sounds frequently.
 Assess for ventilatory compromise and assist with BVM as needed.
 For open ”sucking” chest wounds, apply occlusive dressing sealed on 3 sides or
commercially available chest seal.
o Remove temporarily to vent air if respiratory or mental status worsens.
 For impaled object, stabilize in place.
o Do not remove impaled object.
 Refer to Administrative Procedure: Trauma Triage Criteria.
Advanced Life Support
 Full ALS Assessment and Treatment.
 Treat life threatening emergencies immediately.
o Assess for tension pneumothorax.
Pleural decompression for tension pneumothorax should only be performed
when all 3 of the following criteria are present or in the setting of
resuscitation in Traumatic Cardiac Arrest.
Severe respiratory distress with hypoxia.
Unilateral decreased or absent lung sounds (may see tracheal
deviation away from collapsed lung field).
Evidence of hemodynamic compromise (e.g., shock, hypotension,
altered mental status).
o If indicated perform pleural decompression, refer to Clinical Procedure: Chest
Decompression.
Trauma: Chest Injuries
Prince William County Fire and Rescue System 69
Trauma: Chest Injuries
Medical Control
 Contact OLMC for any additional orders or questions.
 Refer to Pain Management: Medical/Trauma Protocol if indicated.
Trauma: Extremity Injuries
Prince William County Fire and Rescue System 70
Trauma: Extremity Injuries
All Providers
Medical Control
 General Patient Care Protocol – Adult.
 General Patient Care Protocol – Adult Trauma.
 Remove or cut away clothing to expose area of injury.
 Control active bleeding:
o Refer to Clinical Procedure: Wound Care/Hemorrhage Control.
 Refer to Administrative Procedure: Trauma Triage Criteria.
 Suspected fracture/dislocation:
o Assess and document distal pulses, capillary refill, sensation/movement prior to
splinting.
If pulse present:
Splint in position found, if possible.
If pulse absent:
Attempt to realign the injury into anatomical position.
o Open wounds/fractures should be covered with sterile dressings and immobilized in
the presenting position.
o Dislocations should be immobilized to prevent any further movement of the joint.
o Reassess and document distal pulses, capillary refill and sensation after splinting.
Advanced Life Support
 Contact OLMC for any additional orders or questions.
 Full ALS Assessment and Treatment.
 Refer to Pain Management: Medical/Trauma Protocol if indicated.
Trauma: Eye Injuries
Prince William County Fire and Rescue System 71
Trauma: Eye Injuries
All Providers
Medical Control
 General Patient Care Protocol – Adult.
 General Patient Care Protocol – Adult Trauma.
 Assess gross visual acuity.
 If injury is secondary to a chemical exposure:
o Remove patient from source, if safe to do so.
o Remove contact lenses if appropriate; transport with patient.
o Irrigate the eyes with NS for a minimum of 20 minutes.
o Determine chemical involved, bring the Safety Data Sheet (SDS) if available.
 If eye injury is due to trauma:
o Do not irrigate.
o Stabilize any penetrating objects.
o Do not remove any impaled object.
o Prevent patient from bending or standing.
o If blood observed in anterior chamber, transport with head elevated 60°.
 Never apply pressure to the eyeball or globe.
 Bandage both eyes with bulky dressing.
 Do not use chemical cold packs on the face.
 Refer to Administrative Procedure: Trauma Triage Criteria.
Advanced Life Support
 Contact OLMC for any additional orders or questions.
 Full ALS Assessment and Treatment.
 Refer to Pain Management: Medical/Trauma Protocol if indicated.
Trauma: Head Injuries
Prince William County Fire and Rescue System 72
Trauma: Head Injuries
All Providers
 General Patient Care Protocol‐Adult.
 General Patient Care Protocol‐Adult Trauma.
 Restrain patient if indicated, refer to Administrative Procedure: Restraints.
 Refer to Clinical Procedure: Selective Spinal Motion Restriction (SSMR) if indicated.
 Refer to Administrative Procedure: Trauma Triage Criteria.
 If normotensive or hypertensive.
o Elevate head of stretcher 15° – 30°.
 Advanced airway/ventilatory management if indicated.
Airway interventions can be detrimental to patients with head injury by raising intracranial pressure, worsening
hypoxia (and secondary brain injury) and increasing risk of aspiration. Whenever possible these patients should
be managed in the least invasive manner to maintain O2 saturation > 92% (e.g., NRB, BVM with 100% O2).
 Observe for signs of impending respiratory failure, refer to Respiratory Emergencies:
Respiratory Failure if indicated.
o Decreased level of consciousness with hypoxia (SpO2 < 90%) despite 100% O2
therapy, apnea, and/or respiratory rate < 8.
o Poor ventilatory effort (with hypoxia despite 100% O2 therapy).
o Patients requiring active ventilatory assistance.
o Inability to maintain patent airway.
o Symptomatic airway obstruction.
 For patients with assisted ventilation:
o Titrate to target an ETCO2 of 40 mmHg.
o Acute herniation should be suspected when the following signs are present:
Acute unilateral dilated and non‐reactive pupil.
Abrupt deterioration in mental status.
Abrupt onset of motor posturing.
Abrupt increase in blood pressure.
Abrupt decrease in heart rate.
o If signs of herniation develop, increase ventilation rate to 20/minute. Titrate ETCO2
between 30 ‐ 35 mmHg (temporary measure only).
Advanced Life Support
 Full ALS Assessment and Treatment.
Trauma: Head Injuries
Prince William County Fire and Rescue System 73
Trauma: Head Injuries
Medical Control
 Contact OLMC for any additional sedation for combative patients.
 Contact OLMC for any additional orders or questions.
 If severely agitated/combative and unable to de‐escalate by any other means, consider:
o Age < 65:
Consider Midazolam 5 mg IV/IM/IN/IO, repeat in 5 minutes if indicated
(max cumulative dose 10 mg).
o Age > 65:
Consider Midazolam 2.5 mg IV/IM/IN/IO, repeat in 5 minutes if indicated
(max cumulative dose 5 mg).
Trauma: Sexual Assault
Prince William County Fire and Rescue System 74
Trauma: Sexual Assault
All Providers
Medical Control
 General Patient Care Protocol – Adult.
 General Patient Care Protocol – Adult Trauma.
 For victims of sexual assault who meet major trauma criteria:
o Transport to trauma center, refer to Administrative Procedure: Trauma Triage
Criteria.
 For all other cases:
o Transport to nearest appropriate Emergency Department.
 Provide supportive care as indicated by patient’s condition.
 Preserve evidence.
Advanced Life Support
 Contact OLMC for any additional orders or questions.
 Full ALS Assessment and Treatment.
Trauma: Traumatic Amputations
Prince William County Fire and Rescue System 75
Trauma: Traumatic Amputations
All Providers
Medical Control
 General Patient Care Protocol – Adult.
 General Patient Care Protocol – Adult Trauma.
 Control active bleeding.
o Refer to Clinical Procedure: Wound Care/Hemorrhage Control.
 Refer to Administrative Procedure: Trauma Triage Criteria.
 If amputation incomplete:
o Attempt to stabilize with bulky pressure dressing.
o Splint in‐line.
 If amputation complete:
o Cleanse amputated part with sterile saline.
o Wrap in sterile dressing moistened in sterile saline.
o Place in plastic bag if possible.
o Attempt to cool with cold pack during transport. Do not place directly on ice.
Advanced Life Support
 Contact OLMC for any additional orders or questions.
 Full ALS Assessment and Treatment.
 Refer to Pain Management: Medical Trauma Protocol if indicated.
Prince William County Fire and Rescue System
Pediatric Protocols
General Patient Care Protocol - Pediatric
Prince William County Fire and Rescue System
The following measures will serve as the “General Patient Care Protocol – Pediatric” and apply
to the management of all pediatric patients.
 A Neonate shall be defined as:
o Birth to 1 month of age.
 An infant shall be defined as:
o 1 month to 1 year of age.
 A Child shall be defined as:
o 1 year to < 18 years of age.
o If age is unknown,
1 year to puberty (secondary sexual characteristics).
General Patient Care Protocol - Pediatric
All Providers
 Assess the patient’s mental status and nature of illness.
o For mental status, use the AVPU scale:
 A – The patient is Alert and oriented (age appropriate).
 V – The patient is responsive to Verbal stimulus.
 P – The patient is responsive to Painful stimulus.
 U – The patient is Unresponsive to any stimulus.
 Assess the patient’s circulation for presence of pulse, rate, and quality. If no central pulse is
palpable, initiate CPR. Refer to Pediatric Cardiac Arrest: General Approach.
 In cases of cardiac arrest, initiate continuous chest compressions, place an OPA and NRB
mask on the patient at 15 LPM and withhold positive pressure ventilation per protocol until
resources allow.
o Initiate 15:2 rescuer CPR as soon as resources allow.
 If cardiac arrest is not evident, ensure a patent airway utilizing BLS standards with least
invasive means necessary.
 Assess the patient’s respiratory status to include lung sounds, respiratory rate, and work of
breathing. Utilize pulse oximetry to obtain SpO2.
 Provide supplemental O2 to maintain SpO2 ≥ 92%, or if any respiratory signs or symptoms
present. Use adjuncts as necessary.
76
General Patient Care Protocol - Pediatric
Prince William County Fire and Rescue System
General Patient Care Protocol - Pediatric
Note: False SpO2 readings may occur in the following situations: hypothermia, hypoperfusion
(shock), carbon monoxide poisoning, and peripheral vasoconstriction.
 Assess perfusion by measuring HR, an observing skin color, temperature, capillary refill
and the quality of central/peripheral pulses.
 Measure blood pressure in children older than 3 years of age.
 If suspicion of trauma, refer to Clinical Procedure: Selective Spinal Motion Restriction
(SSMR).
 Manage any profuse bleeding and examine for signs of poor perfusion. If evidence of
trauma, refer to General Patient Care Protocol – Pediatric Trauma.
 If a patient’s condition is critical or unstable, initiate transport without delay.
o Perform procedures, history, and detailed physical exam enroute to the hospital.
 Attempt to obtain the patient’s current medical complaint and pertinent medical history.
Utilize SAMPLE history and OPQRST. If necessary, utilize family or bystanders.
 Evaluate mental status including pupillary reaction, motor function, sensation, and GCS.
 If appropriate perform and document a complete neurological assessment and Cincinnati
Prehospital Stroke Scale, including time the patient was last seen normal.
 Record and monitor vital signs including level of consciousness, pulse, respiratory rate, skin
(color, condition, and temperature), blood pressure, blood glucose, continuous SpO2, and
ETCO2 (when appropriate).
o Reassess and document every 5 minutes for critical patients or 15 minutes for noncritical
patients.
 If suspicion of acute allergic reaction with severe symptoms (hypoxia, (SpO2 < 92%), severe
respiratory distress, anaphylactic shock, stridor)”
o Refer to Pediatric Medical: Allergic Reaction.
77
Oxygen Saturation Range Patient Care Guidelines
92%‐100% Normal If symptomatic, oxygen by NC.
90%‐91% Mild Hypoxia O2 by NC as necessary.
86%‐89% Moderate Hypoxia O2 by NRB.
<86% Severe Hypoxia O2 by NRB. Consider BVM or airway
adjunct as necessary.
General Patient Care Protocol - Pediatric
Prince William County Fire and Rescue System
General Patient Care Protocol - Pediatric
Advanced Life Support
When condition warrants (specified as “Full Pediatric ALS Assessment and Treatment” in
individual protocols).
 Advanced airway/ventilatory management if indicated.
 Perform cardiac monitoring.
 Continuously monitor SpO2 and ETCO2.
 Establish IV NS KVO or IV lock if indicated (severe symptoms or for medication access).
 Administer boluses of NS IV/IO.
o If signs of shock, administer boluses of NS at 20 ml/kg until signs of shock resolve or
60 ml/kg total.
 If patient exhibits signs of severe cardiopulmonary compromise (poor systemic perfusion,
hypotension, altered consciousness and/or respiratory distress/failure) and IV attempts
unsuccessful:
o Establish IO refer to Clinical Procedure Venous Access Intraosseous.
 All medication dosages and equipment sizes shall be calculated using a commercially
available length/weight based system.
 For patients with severe nausea or vomiting:
o Administer Ondansetron 2 mg (8 – 15 kg) or 4 mg (> 15 kg) ODT (break in half to
administer 2 mg).
OR
 Record BGL for any patient experiencing weakness, altered mental status, or history of
diabetes per Clinical Procedure: Blood Glucose Analysis.
o Hypoglycemia:
Neonates < 40 mg/dL.
All other patients < 60 mg/dL.
Refer to Pediatric Medical: Diabetic Emergencies if indicated.
o Hyperglyemia > 250 mg/dL:
Refer to Pediatric Medical: Diabetic Emergencies if indicated.
 Unless authorized by protocol, nothing by mouth.
 Refer to appropriate protocol for specific treatments and interventions.
 Transport patient to nearest appropriate Emergency Department.
 Minimize on‐scene time when possible.
78
General Patient Care Protocol - Pediatric
Prince William County Fire and Rescue System
General Patient Care Protocol - Pediatric
Medical Control
 Contact OLMC for any additional orders or questions.
o Administer Ondansetron 0.1 mg/kg IV/IO (max dose 4 mg).
 For patients with moderate or severe pain, refer to Pediatric Pain Management: Medical/
Trauma.
 For patients with suspected opioid overdose with respiratory depression and/or
significantly altered mental status:
o Administer Naloxone 0.1 mg/kg IN/IV/IM/IO (max dose 2 mg), titrated to
maintain adequate respiratory rate (max cumulative dose 2 mg).
 Reassess the patient frequently.
 Ensure the patient is secured appropriately in unit prior to transport.
79
Pediatric Respiratory Emergencies: Dyspnea
Prince William County Fire and Rescue System
Pediatric Respiratory Emergencies: Dyspnea
80
All Providers
 General Patient Care Protocol – Pediatric.
 Sit patient upright or in position of comfort unless contraindicated.
 Observe for signs of impending respiratory failure, refer to Pediatric Respiratory
Emergencies: Respiratory Failure if indicated.
o Decreased level of consciousness with hypoxia (SpO2 < 90%) despite 100% O2
therapy, apnea, and/or respiratory rate < 8.
o Poor ventilatory effort (with hypoxia despite 100% O2 therapy).
o Patients requiring active ventilatory assistance.
o Inability to maintain patent airway.
o Symptomatic airway obstruction.
 If wheezing:
o Administer Albuterol 2.5 mg via nebulizer, repeat once in 5 minutes if indicated.
 Refer to appropriate Respiratory Emergencies protocol/procedure:
o Pediatric Respiratory Emergencies: Acute Bronchospasm.
o Pediatric Respiratory Emergencies: Stridor.
o Pediatric Respiratory Emergencies: Submersion Injury.
o Clinical Procedure: Obstructed Airway.
Advanced Life Support
 Full Pediatric ALS Assessment and Treatment.
Medical Control
 Contact OLMC for additional orders or questions.
Pediatric Respiratory Emergencies: Acute Bronchospasm
Prince William County Fire and Rescue System
Pediatric Respiratory Emergencies: Acute Bronchospasm
81
All Providers
Advanced Life Support
Medical Control
 General Patient Care Protocol – Pediatrics.
 Refer to Pediatric Respiratory Emergencies: Dyspnea.
 Refer to Pediatric Medical: Allergic Reaction.
 Full Pediatric ALS Assessment and Treatment.
 If wheezing/dyspnea:
o Administer Albuterol 2.5 mg and Ipratropium Bromide 0.5 mg via nebulizer,
repeat once in 5 minutes if indicated.
Atrovent is only contraindicated in the setting of known allergy to Atrovent or
Atropine.
 If wheezing persists:
o Administer Albuterol 2.5 mg via nebulizer, repeat every 5 minutes if indicated
(max cumulative dose 15 mg).
 If > 2 years old with history of asthma and wheezing/dyspnea persists after first nebulizer
treatment:
o Administer Methylprednisolone 2 mg/kg IV/IM/IO (max dose 125 mg).
 If wheezing/dyspnea is not improving (refractory to patient/EMS administered albuterol):
o Administer Magnesium Sulfate 50 mg/kg diluted in 100 ml NS IV/IO over 10
minutes (max dose 2 g).
Contraindicated if history of renal failure (e.g., dialysis patient).
 Contact OLMC for patients with severe symptoms (not speaking, little or no air movement
or not improving):
o Administer Epinephrine (1mg/ml) 0.01 mg/kg IM (max dose 0.3 mg).
 Contact OLMC for any additional orders or questions.
Pediatric Respiratory Emergencies: Stridor
Prince William County Fire and Rescue System
Stridor is typically caused by upper airway obstruction/narrowing. Croup is typically a viral
infection that involves the upper airway. It is most prominent in children ages 3 months to 6 years of
age. Care must be taken to attempt differentiation between croup and epiglottitis. Epiglottitis is
more common between 2 years to 8 years of age and is a potentially life threatening bacterial
infection.
Pediatric Respiratory Emergencies: Stridor
82
All Providers
 General Patient Care Protocol – Pediatric.
 Do nothing to upset the child.
 Perform critical assessments only.
 Have parent assist with blow‐by supplemental oxygen.
 Place patient in position of comfort.
 Expedite transport.
Advanced Life Support
 Full Pediatric ALS Assessment and Treatment.
 If partial upper airway obstruction (suspected croup) or stridor at rest with respiratory
distress:
o Administer Racemic Epinephrine 2.25%/0.5 ml mixed with 3 ml NS via
nebulizer.
 Do not attempt vascular access.
Croup Epiglottitis
Age 3 months – 5 years 2 – 6 years
Sex Male more than female Male and Female
Onset Gradual Rapid
Infection Viral Bacterial (H influenza type B)
Fever Low grade High
Breathing Retractions Tripod position
Sounds Barking cough Inspiratory stridor
Voice Hoarseness Muffled voice
Other S/S Drooling, painful swallowing
Treatment Nebulized Racemic Epi,
Steroids
O2, position of comfort, keep calm, prepare for
intubation
Prince William County Fire and Rescue System 83
Medical Control
 Contact OLMC for any additional orders or questions.
 If complete airway obstruction or severe respiratory distress, failure, or arrest:
o Advanced airway/ventilatory management if indicated.
o Refer to Pediatric Respiratory Emergencies: Respiratory Failure if indicated.
Pediatric Respiratory Emergencies: Stridor
Pediatric Respiratory Emergencies: Stridor
Pediatric Respiratory Emergencies: Submersion Injury
Prince William County Fire and Rescue System
Pediatric Respiratory Emergencies: Submersion Injury
84
All Providers
 General Patient Care Protocol – Pediatric.
 Refer to Pediatric Respiratory Emergencies: Dyspnea.
 Protect from heat loss.
 Patients may develop delayed onset respiratory symptoms:
o Encourage transport for evaluation.
o Consider BVM ventilations for patients with significant dyspnea or hypoxia.
Medical Control
 Contact OLMC for any additional orders or questions.
Prince William County Fire and Rescue System
Pediatric Respiratory Emergencies: Respiratory Failure
Prince William County Fire and Rescue System
PEDIATRIC INTUBATION IS NOT INCLUDED IN THE VIRGINIA SCOPE OF PRACTICE
FOR INTERMEDIATES AND THEREFORE IS ONLY AUTHORIZED AT THE PARAMEDIC
LEVEL
Pediatric Respiratory Emergencies: Respiratory Failure
85
All Providers
 General Patient Care Protocol – Pediatric.
 Refer to Pediatric Respiratory Emergencies: Dyspnea.
 If signs of airway obstruction, refer to Clinical Procedure: Obstructed Airway.
 Continuously monitor SpO2 and ETCO2.
 Observe for signs of impending respiratory failure:
o Decreased level of consciousness with hypoxia (SpO2 < 90%) despite 100% O2
therapy, apnea, and/or respiratory rate < 8.
o Poor ventilatory effort (with hypoxia despite 100% O2 therapy).
o Patients requiring active ventilatory assistance.
o Inability to maintain patent airway.
o Symptomatic airway obstruction.
 Suction all debris/secretions and remove any visible foreign body from airway.
 Provide supplemental O2 to maintain SpO2 ≥ 92% or if any respiratory signs or symptoms
present. Use adjuncts as necessary.
 Perform basic airway maneuvers:
o Open airway, insert NPA/OPA and use BVM if needed.
Ventilate once every 3 seconds (20 times/minute) for all ages.
 Ventilate with BVM for at least 2 minutes with 100% O2 to achieve SpO2 > 92%.
 If patient does not respond to above measures or deteriorates consider ventilations via
LTA.
o Refer to Clinical Procedure: Laryngeal Tube Airway (KING LTS‐D).
 Following placement of LTA confirm proper placement.
o Refer to Clinical Procedure: Confirmation of Placement/Effectiveness of
Ventilation.
 Full Pediatric ALS Assessment and Treatment.
 If LTA already in place, confirm proper placement.
o Refer to Clinical Procedure: Confirmation of Placement and Effectiveness of
Ventilation.
Advanced Life Support
Prince William County Fire and Rescue System 86
 Contact OLMC for any additional orders or questions.
 If unable to manage airway by ANY OTHER MEANS, consider ETT (use commercially
available length/weight system to select appropriate equipment):
 Refer to Clinical Procedure: Orotracheal Intubation.
 Following placement of ETT confirm proper placement.
o Refer to Clinical Procedure: Confirmation of Placement and Effectiveness of
Ventilation.
Pediatric Respiratory Emergencies: Respiratory Failure
Pediatric Respiratory Emergencies: Respiratory Failure
Paramedic Only
Medical Control
 If no invasive airway, ventilate with BVM for at least 2 minutes with 100% O2 to achieve
SpO2 > 92%.
 In unable to maintain oxygenation and ventilation, place LTA.
o Refer to Clinical Procedure: Laryngeal Tube Airway (KING LTS‐D).
 Following placement of LTA confirm proper placement.
Refer to Clinical Procedure: Confirmation of Placement/Effectiveness of Ventilation.
Pediatric Cardiac Arrest: General Approach
Prince William County Fire and Rescue System
 Successful resuscitation requires planning and clear role definition.
 Good, fast (100‐120), hard and deep compressions with adequate recoil and minimal
interruptions are essential to a successful resuscitation. A metronome shall be utilized to aid
in maintaining a correct compression rate.
 Compressors should be rotated every 2 minutes.
 Apply the AED/Monitor as quickly as possible to deliver energy to shockable rhythms.
 In the event a patient suffers cardiac arrest in the presence of EMS (EMS witnessed Cardiac
Arrest), the absolute highest priority is to apply the AED/Defibrillator while compressions are
ongoing and deliver a shock immediately if indicated.
 Management of airway and breathing is important but secondary to compressions and
defibrillation.
 If unable to manage airway by any other means, a single attempt at LTA or ETT
(Paramedic Only) placement may be made only if time allows. Do not prolong
transport or scene time to attempt invasive airway interventions.
 Reassess airway frequently and with every patient move.
 DO NOT INTERRUPT CHEST COMPRESSIONS!
 Designate a provider to coordinate transitions, defibrillation and pharmacological
interventions. The provider should typically not have any procedural tasks. If the provider is
needed for a specific task, a new provider must be designated.
 Neonate/Infant/Child Patients do not meet the Criteria for Termination of Resuscitation.
PEDIATRIC INTUBATION IS NOT INCLUDED IN THE VIRGINIA SCOPE OF PRACTICE FOR
INTERMEDIATES AND THEREFORE IS ONLY AUTHORIZED AT THE PARAMEDIC LEVEL.
Pediatric Cardiac Arrest: General Approach
87
All Providers
 General Patient Care Protocol—Pediatric.
 Check responsiveness, breathing, and a pulse.
 Announce “CPR in progress” to incoming units and Communications.
 Apply AED as soon as available.
o From birth to 8 years of age (max 25 kg) use pediatric AED therapy pads if available.
o If pediatric AED therapy pads are unavailable, use adult AED therapy pads.
 If adequate bystander compressions are ongoing, have bystander continue compressions
until monitor pads are in place and the monitor is charged. Stop compressions for rhythm
analysis for no more than 10 seconds.
 If compressions are not being performed upon arrival or if compressions are not deemed
adequate, immediately perform compressions at a rate of 100‐120 compressions per
minute while applying defibrillator.
Pediatric Cardiac Arrest: General Approach
Prince William County Fire and Rescue System
Pediatric Cardiac Arrest: General Approach
88
Advanced Life Support
Medical Control
 After analysis and (possible) defibrillation, immediately resume chest compressions. Do not
pause for post‐shock rhythm analysis. Stop compressions only for signs of life (patient
movement) or pre‐defibrillation rhythm analysis every 2 minutes. Agonal respirations are
a brain stem reflex and NOT an indication to stop compressions.
 As resources allow maintain adequate airway and ventilate.
o Use BLS adjuncts and suction as necessary.
o Establish advanced airway (LTA) if indicated, refer to Clinical Procedure:
Laryngeal Tube Airway (KING LTS‐D).
Do not pause compressions to insert advanced airway.
Do not pause compressions to ventilate.
Continuously monitor SpO2 and ETCO2.
o Following placement of LTA confirm proper placement.
Refer to Clinical Procedure: Confirmation of Placement/Effectiveness of
Ventilation.
 Full Pediatric ALS Assessment and Treatment.
 Refer to rhythm appropriate protocol.
 Establish vascular access.
 Determine blood glucose and treat:
o Neonates < 40 mg/dL.
o All other ages < 60 mg/dL.
o Refer to Pediatric Medical: Diabetic Emergencies if indicated.
 Due to the child’s critical condition, initiate transport within 10 minutes.
 Contact OLMC for any additional orders or questions.
 If unable to manage airway by ANY OTHER MEANS, a single attempt at an ETT may be
made only if time allows. Do not prolong transport or scene time to attempt invasive airway
interventions (use commercially available length/weight system to select appropriate
equipment):
o Following placement of ETT confirm proper placement.
Refer to Clinical Procedure: Confirmation of Placement and Effectiveness
of Ventilation.
Paramedic Only
Pediatric Cardiac Arrest: Asystole/PEA
Pediatric Cardiac Arrest: Asytole/PEA
89
All Providers
Advanced Life Support
 General Patient Care Protocol – Pediatric.
 Pediatric Cardiac Arrest: General Approach.
 Full Pediatric ALS Assessment and Treatment.
 Consider and treat possible causes.
 Minimize any interruptions in compressions.
 Using the most readily available route (during CPR):
o Administer Epinephrine (0.1mg/ml) 0.01 mg/kg IV/IO (max dose 1 mg), repeat
every 3‐5 minutes.
Prince William County Fire and Rescue System
 Hyperkalemia suspected (dialysis patient):
o Administer Calcium Chloride 20 mg/kg IV/IO (max dose 1 g).
o Administer Sodium Bicarbonate 1 mEq/kg IV/IO (max dose 50 mEq).
Sodium Bicarbonate and Calcium Chloride shall not be administered in the
same line. If second line unavailable, ensure line is adequately flushed.
 If toxic ingestion suspected:
o Refer to Pediatric Medical: Overdose and Poisoning.
Potential Causes of PEA Treatment
Hypovolemia Normal Saline 20 ml/kg IV/IO, repeat
twice (max cumulative dose 60 ml/kg).
Hypoxia Secure airway and ventilate.
Hydrogen Ion (acidosis) Sodium Bicarbonate 1 mEq/kg IV/IO.
Hyperkalemia (end stage renal disease) Sodium Bicarbonate 1 mEq/kg IV/IO.
Calcium Chloride 20 mg/kg IV/IO.
Hypothermia Active rewarming.
Tamponade, Cardiac Normal Saline 20 ml/kg IV/IO, repeat
twice (max cumulative dose 60 ml/kg).
Expedite transport.
Tension pneumothorax Needle thoracostomy.
Pediatric Cardiac Arrest: Asystole/PEA
Pediatric Cardiac Arrest: Asytole/PEA
90
Medical Control
 Contact OLMC for any additional orders or questions.
Prince William County Fire and Rescue System
Pediatric Cardiac Arrest: V-Fib/Pulseless V-Tach
Pediatric Cardiac Arrest: V-Fib/Pulseless V-Tach
91
All Providers
Advanced Life Support
 General Patient Care Protocol – Pediatric.
 Pediatric Cardiac Arrest: General Approach.
 Full Pediatric ALS Assessment and Treatment.
 Apply therapy pads, print strip, and pre‐charge to 4 J/kg (max 360J).
 Confirm the presence of V‐Fib/Pulseless V‐Tach.
 Initiate/continue compressions while defibrillator charges.
 Defibrillate V‐Fib/Pulseless V‐Tach at 4 J/kg (max 360J).
o Immediately resume CPR after shock (do not stop to check pulse).
 Using the most readily available route:
o Administer (during CPR) Epinephrine (0.1mg/ml) 0.01 mg/kg IV/IO (max dose 1
mg), repeat every 3‐5 minutes.
 Analyze rhythm after 2 minutes of high quality CPR:
o If V‐Fib/Pulseless V‐Tach persists defibrillate at 4 J/kg (max 360).
Continue compressions while defibrillator charges.
Immediately resume CPR after shock.
 Using the most readily available route:
o Administer (during CPR) Amiodarone 5 mg/kg bolus IV/IO (max dose 300 mg).
For persistent V‐Fib/Pulseless V‐Tach, may repeat every 3‐5 minutes,
Amiodarone 5 mg/kg IV/IO (max cumulative dose 15 mg/kg not to exceed
450mg).
o Suspected polymorphic ventricular tachycardia/torsades de pointes:
Administer Magnesium Sulfate 50 mg/kg IV/IO (max dose 2 g).
 Analyze rhythm after 2 minutes of high quality CPR:
o If V‐Fib/Pulseless V‐Tach persist defibrillate at 4 J/kg (max 360 J).
Continue compressions while defibrillator charges.
Immediately resume CPR after shock.
 Continue cycle (Defibrillate→ CPR→ Medication→ Analyze every 2 min).
Medical Control
 Contact OLMC for any additional orders or questions.
Prince William County Fire and Rescue System
Pediatric Cardiac Arrest: Neonatal Resuscitation
Pediatric Cardiac Arrest: Neonatal Resuscitation
92
All Providers
 General Patient Care Protocol – Pediatric.
 Note gestational age and if twin gestation is known.
 Assess APGAR scores at 1 and 5 minutes after birth. Continue to note scores every 5
minutes until vital signs have stabilized.
 Assess for presence of meconium.
 Provide warmth.
 Spontaneously breathing, well‐appearing neonates do not require suctioning. Provide only
supportive care and keep patient warm.
 For neonates with difficulty breathing, obstructed breathing, or that require BVM
ventilation:
o Open the airway and suction with bulb syringe.
Suction mouth first, then nasopharynx.
Dry, stimulate, and reposition.
Administer supplemental blow‐by oxygen.
Evaluate respirations, heart rate, and color.
 HR < 100, apnea, or gasping respirations:
o Provide positive pressure ventilation (40 – 60 per minute) using BVM initially on
room air only (FiO2 21%).
o Reassess in 20 – 30 seconds.
HR 60 – 100:
Continue to provide ventilatory support via BVM with 100% O2.
Reassess in 20 – 30 seconds.
Prince William County Fire and Rescue System
Sign Score 0 Score 1 Score 2
Appearance Pale/Blue Blue extremities Pink
Pulse Absent < 100 per minute >100 per minute
Grimace No response Grimace Cough or Sneeze
Activity Flaccid Some flexion Well flexed
Respiration Absent Weak Good cry
Pediatric Cardiac Arrest: Neonatal Resuscitation
Prince William County Fire and Rescue System
Pediatric Cardiac Arrest: Neonatal Resuscitation
93
HR remains < 60 after 30 seconds of positive pressure ventilation:
Continue to provide ventilatory support via BVM with 100% O2.
Immediately begin chest compressions.
 Compression to Ventilation Ratio of 3:1.
Advanced Life Support
 Full Pediatric ALS Assessment and Treatment.
 IV NS KVO or lock.
o If no IV access is readily obtainable, proceed directly to IO access.
o Administer a NS 10 cc/kg IV/IO bolus.
 Administer Epinephrine (0.1mg/ml) 0.01 mg/kg IV/IO (max dose 1 mg), repeat every 3‐
5 minutes.
 If respiratory depression is noted in the neonate of a mother who received narcotics within
4 hours of delivery:
o Administer Naloxone 0.1 mg/kg IV/IO.
 Administer 10% Dextrose 2 ml/kg.
o There is no need to check BGL prior to administration.
 Rapid transport.
Paramedic Only
 Meconium Aspirator.
o The tracheal suctioning procedure is not intended for the vigorous newborn with
meconium‐stained fluid that does not develop apnea or respiratory distress.
In the event severe respiratory symptoms develop, proceed with tracheal
suctioning.
o For a non‐vigorous infant (the newborn has absent or depressed respirations
decreased muscle tone, or HR < 100 bpm), with fluid containing meconium, perform
tracheal suctioning (60 – 80 mmHg).
Perform direct laryngoscopy and suction any visible meconium from the
airway.
Pass ETT beyond the cords and withdraw slowly as suction is applied directly
to the ET tube (the tube will act as a suction catheter).
Prince William County Fire and Rescue System
Pediatric Cardiac Arrest: Neonatal Resuscitation
Prince William County Fire and Rescue System
Pediatric Cardiac Arrest: Neonatal Resuscitation
94
Medical Control
 Contact OLMC for any additional orders or questions.
Prince William County Fire and Rescue System
After tube is removed, perform positive pressure ventilation using a BVM and
100% O2.
Do not re‐attempt intubation unless patient exhibits severe respiratory
failure or apnea.
Pediatric Cardiac Arrest: Post Resuscitation Care
Prince William County Fire and Rescue System
Pediatric Cardiac Arrest: Post Resuscitation Care
95
All Providers
Advanced Life Support
 General Patient Care Protocol ‐ Pediatric.
 Maintain assisted ventilation as needed.
o Monitor ETCO2, goal is 40 mmHg, DO NOT HYPERVENTILATE!
o Titrate O2 to maintain SpO2 of 92% ‐ 99%.
 Obtain 12‐lead ECG.
 Full Pediatric ALS Assessment and Treatment.
 Monitor ETCO2, goal is 40 mmHg, DO NOT HYPERVENTILATE!
 For hypotension not improved by fluid boluses, or when fluid administration is
contraindicated:
o Administer Dopamine infusion at 5 mcg/kg/min titrated up to 20 mcg/kg/min in
order to maintain minimum SBP.
Medical Control
 Contact OLMC for any additional orders or questions.
Prince William County Fire and Rescue System
Pediatric Cardiac Arrhythmia: Bradycardia
Prince William County Fire and Rescue System
Pediatric Cardiac Arrhythmia: Bradycardia
96
All Providers
Advanced Life Support
 General Patient Care Protocol – Pediatric.
 Assist ventilation as needed with bag valve mask.
 Look for signs of obstruction.
o Absent breath sounds, tachypnea, intercostal retractions, stridor or drooling,
choking, bradycardia, or cyanosis.
o If a foreign body obstruction is suspected refer to Clinical Procedure: Obstructed
Airway.
o Open airway using head tilt/chin lift if no spinal trauma is suspected. If spinal
trauma is suspected, use modified jaw thrust.
 If signs of severe cardiopulmonary compromise are present in a neonate/infant (< 1 year)
and the HR remains slower than 60 BPM despite oxygenation and ventilation:
o Initiate chest compressions and refer to:
Pediatric Cardiac Arrest: General Approach.
Pediatric Cardiac Arrest: Asystole/PEA.
 Full Pediatric ALS Assessment and Treatment.
 If signs of severe cardiopulmonary compromise persist (use most readily available route):
o Administer Epinephrine (0.1mg/ml) 0.01 mg/kg IV/IO (max dose 1 mg), repeat
every 3‐5 minutes until either the bradycardia or severe cardiopulmonary
compromise resolves.
 Determine BGL and treat:
o Hypoglycemia:
 Neonates < 40 mg/dL.
 All other patients < 60 mg/dL.
 Refer to Pediatric Medical: Diabetic Emergencies if indicated.
 Identify and treat possible causes of bradycardia:
o Hypoxic:
 Secure airway and assist ventilation.
o Hypothermic:
 Active rewarming.
Pediatric Cardiac Arrhythmia: Bradycardia
Prince William County Fire and Rescue System
Pediatric Cardiac Arrhythmia: Bradycardia
97
Medical Control
 Contact OLMC for any additional orders or questions.
o If acutely deteriorating head injury:
Hyperventilate and titrate ETCO2 between 30 – 35 mmHg.
o If toxin ingestion, refer to Pediatric Overdose and Poisoning.
 If signs of severe cardiopulmonary compromise persist despite Epinephrine (Increased
vagal tone, heart blocks) and above measures:
o Administer Atropine 0.02 mg/kg IV/IO (minimum dose 0.1 mg with a max dose
0.5 mg), repeat once in 3‐5 minutes.
 Initiate transcutaneous pacing for high degree (2nd and 3rd degree) heart block, history of
heart block, history of heart transplant, or bradycardia with severe cardiopulmonary
compromise despite Epinephrine/Atropine.
o Refer to Clinical Procedure: External Cardiac Pacing.
Pediatric Cardiac Arrhythmia: Tachycardia
Prince William County Fire and Rescue System
Infants with heart rates < 220 and children with heart rates < 180 typically will respond when the
precipitating cause is treated (e.g., fever, dehydration).
Supraventricular Tachycardia:
 Infants: Rate usually > 220/min.
 Children: Rate usually > 180/min.
Pediatric Cardiac Arrhythmia: Tachycardia
98
All Providers
Advanced Life Support
 General Patient Care Protocol – Pediatric.
 Supplemental 100% O2.
 Full Pediatric ALS Assessment and Treatment.
 Determine BGL and refer to Pediatric Medical: Diabetic Emergency.
 Sinus Tachycardia:
o Identify and treat possible causes (e.g., fever, dehydration).
 Regular Narrow Complex Tachycardia (SVT):
o Attempt vagal maneuvers and contact OLMC.
If able to follow instructions, may attempt Valsalva maneuver.
If unable to follow instructions (age), may attempt cold stimuli to face (ice
pack or towel soaked in ice water).
 Regular Narrow Complex Tachycardia (SVT) with severe cardiopulmonary compromise:
o If time and patient condition permits, contact OLMC.
o If vascular access is available:
Administer Adenosine 0.1 mg/kg rapid IV/IO (max dose 6 mg) over 1‐3
seconds with a 10 ml NS flush.
IV access in the antecubital space is preferred.
Repeat Adenosine 0.2 mg/kg rapid IV/IO (max dose 12 mg) over 1‐3
seconds with a 10 ml NS flush, if indicated.
o If Adenosine is unsuccessful and patient still has severe cardiopulmonary
compromise:
99
Medical Control
 Contact OLMC for Irregular Narrow Complex Tachycardia (A‐Fib).
 Contact OLMC for 2 failed attempts at cardioversion.
 Contact OLMC for any additional orders or questions.
 Perform Synchronized Cardioversion at 1 J/kg (max 360J), refer to Clinical
Procedure: Synchronized Cardioversion.
If time and patient condition allows, consider OLMC consultation prior
to cardioversion.
Sedation if patient condition (e.g., SBP) and time allows.
Administer Fentanyl 1 mcg/kg IV/IO (max dose 50 mcg).
Administer Midazolam 0.1 mg/kg IV/IO (max dose 2 mg).
Repeat synchronized cardioversion at 2 J/kg (max dose 360 J), if indicated.
 Ventricular Tachycardia with a pulse:
o If the patient is stable, monitor and rapid transport.
o If the patient is unstable:
Perform Synchronized Cardioversion at 1 J/kg (max 360 J), refer to Clinical
Procedure: Synchronized Cardioversion.
If time and patient condition allows, consider OLMC consultation prior
to cardioversion.
Sedation if patient condition (e.g., SBP) and time allows.
Administer Fentanyl 1 mcg/kg IV/IO (max dose 50 mcg).
Administer Midazolam 0.1 mg/kg IV/IO (max dose 2 mg).
Repeat synchronized cardioversion at 2 J/kg (max dose 360 J), if indicated.
 If Polymorphic Ventricular Tachycardia/Torsade de Pointes is suspected:
o Administer Magnesium Sulfate 50 mg/kg diluted in 10 ml NS IV/IO over 2
minutes (max dose 2 g).
If vascular access is unavailable or no response to Magnesium Sulfate, and
patient remains unstable:
Defibrillate at 4 J/kg (max dose 360J). Refer to Clinical Procedure:
Defibrillation Manual.
If time and patient condition allows, consider OLMC
consultation prior to defibrillation.
Prince William County Fire and Rescue System
Pediatric Cardiac Arrhythmia: Tachycardia
Pediatric Cardiac Arrhythmia: Tachycardia
Pediatric Hazardous Materials Exposure: Cyanide Toxicity and Smoke Inhalation
Prince William County Fire and Rescue System
Pediatric Hazardous Materials Exposure: Cyanide Toxicity and Smoke Inhalation
100
All Providers
Advanced Life Support
Cyanide poisoning may result from inhalation, ingestion or dermal exposure to cyanide containing
compounds, including smoke from closed‐space fires. The presence and extent of the poisoning are
often unknown initially. Treatment decisions must be made on the basis of clinical history and signs
and symptoms of cyanide intoxication.
Not all patients who have suffered smoke inhalation from a closed‐space fire will have cyanide
poisoning. Other conditions such as burns, trauma or other toxic inhalations (e.g., carbon monoxide)
may be the cause of symptoms. When smoke inhalation is the suspected source of cyanide exposure
assess the patient for the following:
 Exposure to fire or smoke in an enclosed space.
 Presence of soot around the mouth, nose or oropharynx.
 Altered mental status.
Common Signs and Symptoms of Cyanide Toxicity
Symptoms Signs
Headache Altered mental status
Confusion Seizures or coma
Shortness of breath Dyspnea/Tachypnea
Chest Pain or tightness Respiratory distress/Apnea
Nausea/Vomiting Hypertension (early)
Hypotension (late)
Cardiovascular collapse/Cardiac arrest
 General Patient Care Protocol – Pediatrics.
 Supplemental 100% O2.
 Consider patient decontamination.
 Full Pediatric ALS Assessment and Treatment.
 Evaluate the patient for the clinical suspicion of Cyanide poisoning.
o Expedite transport and treat other conditions as per appropriate protocol.
o Refer to Pediatric Respiratory Emergencies: Respiratory Failure if indicated.
Medical Control
 Contact OLMC for any additional orders or questions.
Pediatric Medical: Allergic Reaction
Prince William County Fire and Rescue System
Mild Reaction: Itching/Hives.
Moderate Reaction: Dyspnea, Wheezing, Chest Tightness.
Severe Systemic Reaction (Anaphylaxis): Throat Complaints, Stridor, Severe Respiratory Distress.
Gastrointestinal Symptoms (vomiting and abdominal pain).
Pediatric Medical: Allergic Reaction
101
All Providers
Advanced Life Support
Medical Control
 Contact OLMC for additional Epinephrine (1mg/ml) 0.01 mg/kg IM (max dose 0.3
mg).
 Contact OLMC for Epinephrine infusion 2 mcg/min titrated up based on OLMC
parameters (e.g., acceptable blood pressure or improvement of mental status).
o Mix 2mg (1mg/ml) in 500 ml NS.
 Contact OLMC for any additional orders or questions.
 General Patient Care Protocol – Pediatric.
 Assist patient in self‐administration of previously prescribed epinephrine auto‐injector
(e.g., Epi‐Pen, Epi‐Pen Jr).
 If wheezing is present:
o Administer Albuterol 2.5 mg via nebulizer, repeat once in 5 minutes if indicated.
 Give nothing by mouth.
 Full Pediatric ALS Assessment and Treatment.
 Mild Reaction:
o Administer Diphenhydramine 1 mg/kg IV/IM/IO (max dose 50 mg).
 Moderate Reaction or Severe Systemic Reaction:
o Administer Epinephrine (1mg/ml) 0.01 mg/kg IM (max dose 0.3 mg), repeat once
in 5 minutes if indicated.
o Administer Albuterol 2.5 mg via nebulizer, repeat every 5 minutes if indicated
(max cumulative dose 15 mg).
o Administer Diphenhydramine 1 mg/kg IV/IM/IO (max dose 50 mg).
o Administer Methylprednisolone 2 mg/kg IV/IM/IO (max dose 125 mg).
o If signs of shock, administer boluses of NS at 20 ml/kg until signs of shock resolve or
60 ml/kg total.
Prince William County Fire and Rescue System
102
All Providers
Advanced Life Support
Medical Control
 Contact OLMC for any additional orders or questions.
 Full Pediatric ALS Assessment and Treatment.
 If cardiac arrhythmia present, refer to the appropriate cardiac emergencies protocol.
 General Patient Care Protocol – Pediatric.
 Obtain BGL and refer to Pediatric Medical: Diabetic Emergencies.
 Obtain 12‐Lead ECG.
 If head injury is suspected refer to Pediatric Trauma: Head Injuries.
 If sepsis is suspected (high risk for infection, febrile), refer to Pediatric Medical: Sepsis.
 If suspected poisoning:
o Refer to Pediatric Overdose and Poisoning.
Prince William County Fire and Rescue System
Pediatric Medical: Altered Mental Status/Syncope
Pediatric Medical: Altered Mental Status/Syncope
Pediatric Medical: Apparent Life-Threatening Event (ALTE)
An Apparent Life Threatening Event (ALTE), often referred to as a “near miss SIDS”, is an episode that
is frightening to the observer/caregiver, and involves some combination of the following:
 Apnea (central or obstructive).
 Color change (cyanosis, pallor, erythema, plethora).
 Marked change in muscle tone (e.g., limpness/rigid).
 Choking or gagging.
A Brief Resolved Unexplained Event (BRUE), is similar to an ALTE as it is an observed event in an
infant (<1 years of age) in which a sudden, brief (less than 1 minute) of any of the above signs may be
witnessed as well as any changed level of responsiveness. History of an ALTE or BRUE may represent
serious illness, even if the infant appears entirely well by the time of evaluation. The apparent wellbeing
should not be considered evidence that a potentially life threatening event with successful
resuscitation did not occur if the clinical history indicates otherwise.
Pediatric Medical: Apparent Life-Threatening Event (ALTE)
103
All Providers
 General Patient Care Protocol – Pediatric.
 Assume the history given is accurate and reliable.
 Determine the severity, nature, and duration of the episode.
 Obtain a medical history:
o Known chronic diseases.
o History of preterm delivery.
o Evidence of seizure activity.
o Current or recent infections.
o Gastroesophageal reflux.
o Inappropriate mixture of formula.
o Recent trauma.
 Perform a thorough physical assessment that includes the general appearance, skin color,
level of interaction with environment, evidence of trauma, and blood glucose check.
 Transport to the nearest appropriate receiving facility.
 For patients < 1 years of age:
o In the setting of an ALTE or BRUE, if the parent/guardian is refusing medical care
and/or EMS transport, OLMC must be contacted prior to accepting a refusal.
Prince William County Fire and Rescue System
Pediatric Medical: Apparent Life-Threatening Event (ALTE)
Pediatric Medical: Apparent Life-Threatening Event (ALTE)
104
Medical Control
 Contact OLMC for refusal of medical care/EMS transport in a patient < 1 year of age.
 Contact OLMC for any additional orders or questions.
Prince William County Fire and Rescue System
Pediatric Medical: Diabetic Emergencies
Prince William County Fire and Rescue System
Pediatric Medical: Diabetic Emergencies
105
All Providers
Advanced Life Support
 General Patient Care Protocol – Pediatric.
 Hypoglycemia (BG < 60 mg/dL):
o Consider Oral Glucose Gel 15 g or glucose containing beverage (e.g., orange juice) if
age appropriate.
Patient must be alert and able to self‐administer.
 Full Pediatric ALS Assessment and Treatment.
 Determine blood glucose and treat:
o Neonates < 40 mg/dL:
Administer 10% Dextrose 2 ml/kg IV/IO, titrate to improved mental status
and BGL.
o All other ages < 60 mg/dL:
Administer 10% Dextrose 5 ml/kg IV/IO (max dose 100 ml), titrate to
improved mental status and BGL.
If unable to obtain IV/IO access:
Administer Oral Glucose Gel 15 g or glucose containing beverage
(e.g., orange juice) if age appropriate.
Patient must be alert and able to self‐administer.
 If blood glucose remains < 80 mg/dL (< 60 in a neonate) after treatment or unable to
determine blood glucose and persistent altered mental status:
o Neonates:
Administer 10% Dextrose 2 ml/kg IV/IO, titrate to improved mental status
and BGL.
o All other ages:
Administer 10% Dextrose 5 ml/kg IV/IO (max dose 100 ml), titrate to
improved mental status and BGL.
 If unable to administer glucose by mouth:
o Administer Glucagon 0.1 mg/kg IM (max dose 1 mg).
Pediatric Medical: Diabetic Emergencies
Prince William County Fire and Rescue System
Pediatric Medical: Diabetic Emergencies
106
 Hyperglycemia (BG > 250 mg/dL).
o Administer NS:
If evidence of dehydration (tachycardia, dry mucous membranes, poor skin
turgor) or hypovolemia, administer boluses of NS at 20 ml/kg until signs of
shock resolve (max dose 60 ml/kg).
Medical Control
 Contact OLMC for any additional orders or questions.
Pediatric Medical: Seizure
Prince William County Fire and Rescue System
Pediatric Medical: Seizure
107
All Providers
 General Patient Care Protocol – Pediatric.
 Protect patient from injury.
 Obtain BGL per Clinical Procedure: Blood Glucose Analysis.
 O2 via NC is sufficient if no active seizures and no respiratory signs or symptoms.
Advanced Life Support
Medical Control
 Contact OLMC for additional orders or questions.
 Full Pediatric ALS Assessment and Treatment.
 Refer to Pediatric Medical: Diabetic Emergencies if indicated.
 For active seizures (> 3‐5 minutes):
o Do not delay treatment to obtain IV access:
Administer Midazolam 0.2 mg/kg IN (max individual dose 5 mg), repeat in
5 minutes if indicated (max cumulative dose 10 mg).
OR
Administer Midazolam 0.1 mg/kg IV/IM/IO (max individual dose 2.5 mg),
repeat in 5 minutes if indicated (max cumulative dose 5 mg).
Pediatric Medical: Sepsis
Prince William County Fire and Rescue System
Pediatric Medical: Sepsis
108
Sepsis is a rapidly progressing life‐threatening complication of systemic infection. It occurs when an
inflammatory response called Systemic Inflammatory Response Syndrome (SIRS) is triggered in
response to infection. Sepsis must be recognized and treated aggressively to prevent progression to
shock and death. Sepsis can be identified when the following SIRS markers are present in a patient
with suspected infection.
 Fever or hypothermia (> 101.3 F or < 96.8 F).
 Tachypnea (respiratory rate > 20).
 Tachycardia (heart rate > 90).
In addition to physiologic signs of SIRS, severe sepsis may cause hypoxia and inadequate organ
perfusion, resulting in metabolic acidosis marked by elevated serum lactate levels and decreased
ETCO2 (measured by capnography).
All Providers
 General Patient Care Protocol – Pediatric.
Advanced Life Support
 Full Pediatric ALS Assessment and Treatment.
Age Adjusted Hypotension
Neonate SBP < 60
1 month – 1 year SBP < 70
> 1 year – 10 years SBP < 70 + 2(age in years)
>10 years SBP < 90
Age Specific Vital Signs
Age Heart Rate in BPM Respiratory Rate/Minute
OD – 1 week <100, >180 >50
1 week – 1 month <100, >180 >40
1 month – 1 year <90, >180 >34
2 years – 5 years >140 >22
6 years – 12 years >130 >18
13 years ‐ <18 years >110 >14
Pediatric Medical: Sepsis
Prince William County Fire and Rescue System 109
Medical Control
 Notify hospital of a “CODE Sepsis” prior to arrival per the Administrative Procedure: Code
Sepsis.
 Administer NS:
o Neonate:
Administer 10 ml/kg NS bolus.
o All other pediatric patients:
Administer 20 ml/kg NS bolus.
Repeat if indicated to maintain perfusion (acceptable BP) (max
cumulative dose 60 ml/kg).
Use caution in patients with ESRD/Dialysis.
 Contact OLMC if persistent hypotension after NS Bolus administration.
Contact OLMC for Dopamine infusion at 5 mcg/kg/min titrated up to 20 mcg/kg/min in
order to maintain SBP.
Contact OLMC for any additional orders or questions.
Pediatric Medical: Sepsis
Pediatric Overdose and Poisoning
Prince William County Fire and Rescue System
For any overdose or poisoning, contact should be made with the Regional Poison Control Center,
1‐800‐222‐1222. Whenever possible, determine the agent(s) involved, the time of the ingestion/
exposure, and the amount ingested. Bring empty pill bottles, etc., to the receiving facility.
Treatment for specific toxic exposures is indicated only when patients are clearly symptomatic. In the
absence of significant symptoms, monitor closely and expedite transport.
Pediatric Overdose and Poisoning
110
All Providers
Advanced Life Support
Medical Control
 Consult Regional Poison Control Center prior to treatment for Organophosphates Overdose.
o Symptoms of organophosphate overdose include dyspnea, bronchorrhea,
lacrimation, vomiting/diarrhea, weakness, paralysis, and/or seizures.
o Administer Atropine 0.02 mg/kg IV/IO (minimum dose 0.1 mg with a max dose 2
mg), repeat every 2 minutes if indicated (max 6 mg).
 Contact OLMC for specific treatment for suspected calcium channel blocker or beta
blocker overdose.
 Contact OLMC for any additional orders or questions.
 General Patient Care Protocol – Pediatric.
 Nothing by mouth unless advised by Regional Poison Control Center.
 Full Pediatric ALS Assessment and Treatment.
 If respiratory depression is present and a narcotic overdose is suspected:
o Administer Naloxone 0.1 mg/kg IN/IV/IM/IO (max dose 2 mg), titrated to
maintain adequate respiratory rate (max cumulative dose 2mg).
 Dystonic Reactions (acute uncontrollable muscle contractions):
o Administer Diphenhydramine 1 mg/kg IV/IM (max dose 25 mg).
 Insulin Overdose (Hypoglycemia or unknown blood glucose and altered mental status):
o Refer to Pediatric Medical: Diabetic Emergencies.
 If seizure is present:
o Refer to Pediatric Medical: Seizure.
Prince William County Fire and Rescue System
Pediatric Pain Management: Medical/Trauma
Pediatric Pain Management: Medical/Trauam
111
All Providers
Advanced Life Support
 General Patient Care Protocol ‐ Pediatric
 Full Pediatric ALS Assessment and Treatment.
 Analgesic agents may be administered under standing orders for patients experiencing
moderate/severe pain (≥ 5/10).
o Common complaints:
Isolated extremity injury.
Burns (without airway, breathing, or circulation compromise).
Sickle cell crisis.
 Agents for pain control:
o Administer Fentanyl 1.5 mcg/kg IN with half of the volume administered to each
nare (max dose 100 mcg), repeat half the original dose in 10 minutes if indicated.
OR
o Administer Fentanyl 1 mcg/kg IV/IO (max dose 50 mcg), repeat every 5 minutes if
indicated (max cumulative dose 200 mcg).
o If Fentanyl allergy:
Consider Morphine Sulfate 0.1 mg/kg IV/IO (max dose 5 mg), repeat every
5 minutes if indicated (max cumulative dose 15 mg).
 General Patient Care Protocol – Pediatric.
 Asses baseline pain level (0‐10 scale: 0=no pain; 10=worst pain).
Prince William County Fire and Rescue System
Prince William County Fire and Rescue System 112
Medical Control
 Contact OLMC for additional orders or questions.
Pediatric Pain Management: Medical/Trauma
Pediatric Pain Management: Medical/Trauam
 After each drug dosage administration:
o Reassess the patient’s pain level.
o Note adequacy of ventilation and perfusion.
o Assess and document vital signs.
 Continuously monitor SpO2 and ETCO2.
Prince William County Fire and Rescue System
Pediatric Trauma
Protocols
General Patient Care Protocol – Pediatric Trauma
Prince William County Fire and Rescue System
General Patient Care Protocol – Pediatric Trauma
113
All Providers
 General Patient Care Protocol – Pediatric.
 General Patient Care Protocol – Adult.
 Refer to Trauma Triage Criteria Procedure.
 Treat life threatening emergencies immediately.
 Perform a Rapid Trauma Assessment and establish initial GCS.
o Reevaluate every 5 minutes.
 Control active bleeding utilizing dressings, direct pressure, hemostatic agents, and
tourniquets as indicated.
o Refer to Clinical Procedure: Wound Care/Hemorrhage Control if indicated.
 Consider Spinal Motion Restriction (SMR).
o Refer to Clinical Procedure: Selective Spinal Motion Restriction (SSMR) if
indicated.
 Supplemental 100% O2 if evidence of major traumatic injury or respiratory symptoms.
o Refer to appropriate Pediatric Respiratory Emergencies Protocol as indicated.
 Restrain patient if indicated, refer to Administrative Procedure: Restraints.
Advanced Life Support
Assess all patients for major trauma criteria. Major trauma patients should have transport initiated
within 10 minutes of arrival on scene whenever possible. In the setting of major trauma, DO NOT
prolong scene time to perform procedures unless immediately necessary to stabilize patient (e.g.,
hemorrhage control). Initiate all other procedures enroute to the trauma center.
The following measures will serve as the “General Patient Care Protocol – Pediatric Trauma”
and apply to the management of all pediatric trauma patients.
 Full Pediatric ALS Assessment and Treatment.
 Advanced airway/ventilatory management if indicated.
 Treat life threatening emergencies immediately.
o Assess for tension pneumothorax.
If time and patient condition allows, contact OLMC.
Pleural decompression for tension pneumothorax should only be performed
in the setting of trauma when all 3 of the following criteria are present or in
the setting of resuscitation in Traumatic Cardiac Arrest.
Severe respiratory distress with hypoxia.
Unilateral decreased or absent lung sounds (may see tracheal
deviation away from collapsed lung field).
Evidence of hemodynamic compromise (e.g., shock, hypotension,
altered mental status).
Prince William County Fire and Rescue System 114
Medical Control
o If indicated perform pleural decompression, refer to Clinical Procedure: Chest
Decompression.
 Perform continuous cardiac monitoring.
 Record and monitor SpO2.
 Continuously monitor ETCO2.
 Establish IV NS KVO or IV lock if indicated.
 Administer boluses of NS IV/IO.
o If signs of shock, administer boluses of NS at 20 ml/kg until signs of shock resolve or
60 ml/kg total.
 Consider Pediatric Pain Management: Medical/Trauma Protocol if indicated.
Contact OLMC for any additional orders or questions.
General Patient Care Protocol – Pediatric Trauma
General Patient Care Protocol – Pediatric Trauma
ADMINISTRATION OF TRANEXAMIC ACID IS NOT INDICATED FOR
PATIENTS < 18
Pediatric Trauma: Abdominal Injuries
Prince William County Fire and Rescue System
Pediatric Trauma: Abdominal Injuries
115
All Providers
 General Patient Care Protocol – Pediatric.
 General Patient Care Protocol – Pediatric Trauma.
 Refer to Administrative Procedure: Trauma Triage Criteria
 If concerns for evisceration, apply a moist dressing and cover.
o Do not attempt to place organs back in place.
 If concerns for an impaled object, stabilize in place.
o Do not remove the impaled object.
Advanced Life Support
Medical Control
 Contact OLMC for additional orders or questions.
 Full Pediatric ALS Assessment and Treatment.
 Refer to Pediatric Pain Management: Medical/Trauma Protocol if indicated.
Pediatric Trauma: Burns
Prince William County Fire and Rescue System
Pediatric Trauma: Burns
116
All Providers
 General Patient Care Protocol – Pediatric.
 General Patient Care Protocol – Pediatric Trauma.
 Refer to Pediatric Hazardous Materials Exposure: Cyanide Toxicity and Smoke
Inhalation if indicated.
 Refer to Clinical Procedure: Selective Spinal Motion Restriction (SSMR) if indicated.
 Refer to Administrative Procedure: Burn Center Criteria.
 Refer to Administrative Procedure: Trauma Triage Criteria.
 Observe for signs of impending respiratory failure, refer to Pediatric Respiratory
Emergencies: Respiratory Failure if indicated.
o Decreased level of consciousness with hypoxia (SpO2 < 90%) despite 100% O2
therapy, apnea, and/or respiratory rate < 8.
o Poor ventilatory effort (with hypoxia despite 100% O2 therapy).
o Patients requiring active ventilatory assistance.
o Inability to maintain patent airway.
o Symptomatic airway obstruction.
 Stop the burning process, remove or cool heat source if present (e.g., clothing, tar).
 Remove all clothing, contact lenses, and jewelry (especially rings) near the injury site.
 Estimate TBSA (only include 2nd and 3rd degree burns).
o Rule of Nines.
o Alternatively, use the palm of patient’s hand, including fingers, to equal 1% TBSA.
 If < 10% TBSA:
o Cool with moist room temperature sterile dressings.
o NEVER COOL WITH ICE! The goal is to bring the burn to room temperature.
 If ≥ 10% TBSA:
o Cover with dry sterile dressings, plastic wrap, or chux pad.
 Maintain core temperature. Keep patient warm and dry with sheets and blankets.
 If inhalation injury suspected:
o Place patient on 100% O2 – DO NOT DECREASE.
o Continuously monitor SpO2 and ETCO2.
Advanced Life Support
 Full Pediatric ALS Assessment and Treatment.
 Refer to the appropriate Pediatric Respiratory Emergencies Protocols if indicated.
.
Prince William County Fire and Rescue System 117
Pediatric airways are smaller than adult airways and require thorough and frequent
evaluation for signs of respiratory compromise.
 If ≥ 20% TBSA:
o Administer boluses of NS IV/IO at 20 ml/kg until signs of shock resolve or 60 ml/kg
total.
o After NS bolus is complete, administer NS infusion:
< 5 years, administer NS 125 ml/hour.
6 – 13 years, administer NS 250 ml/hour.
> 13 years, administer NS 500 ml/hour.
o Specific fluid resuscitation based on TBSA will occur at receiving hospital or burn
center.
 Refer to Pediatric Pain Management: Medical/Trauma Protocol if indicated.
Pediatric Trauma: Burns
Pediatric Trauma: Burns
 Contact OLMC for additional orders or questions.
Medical Control
Pediatric Trauma: Chest Injuries
Pediatric Trauma: Chest Injuries
118
All Providers
Advanced Life Support
 General Patient Care Protocol – Pediatric.
 General Patient Care Protocol – Pediatric Trauma.
 Refer to Clinical Procedure: Selective Spinal Motion Restriction (SSMR) if indicated.
 Observe for signs of impending respiratory failure, refer to Pediatric Respiratory
Emergencies: Respiratory Failure if indicated.
o Decreased level of consciousness with hypoxia (SpO2 < 90%) despite 100% O2
therapy, apnea, and/or respiratory rate < 8.
o Poor ventilatory effort (with hypoxia despite 100% O2 therapy).
o Patients requiring active ventilatory assistance.
o Inability to maintain patent airway.
o Symptomatic airway obstruction.
 Consider early positive pressure ventilation in the setting of impending respiratory failure
with a flail segment.
 Assess breath sounds frequently.
 Assess for ventilatory compromise and assist with BVM as needed.
 For open ”sucking” chest wounds, apply occlusive dressing sealed on 3 sides or
commercially available chest seal.
o Remove temporarily to vent air if respiratory or mental status worsens.
 For impaled object, stabilize in place.
o Do not remove impaled object.
 Refer to Administrative Procedure: Trauma Triage Criteria.
 Full Pediatric ALS Assessment and Treatment.
 Assess for tension pneumothorax.
o If time and patient condition allows, contact OLMC.
o Pleural decompression for tension pneumothorax should only be performed in the
setting of trauma when all 3 of the following criteria are present or in the setting of
resuscitation in Traumatic Cardiac Arrest.
Severe respiratory distress with hypoxia.
Unilateral decreased or absent lung sounds (may see tracheal deviation away
from collapsed lung field).
Evidence of hemodynamic compromise (e.g., shock, hypotension, altered
mental status).
o If indicated, perform pleural decompression, refer to Clinical Procedure: Chest
Decompression.
Prince William County Fire and Rescue System
Prince William County Fire and Rescue System 119
Prince William County Fire and Rescue System
Medical Control
 Contact OLMC for additional orders or questions.
Pediatric Trauma: Chest Injuries
Pediatric Trauma: Chest Injuries
 Refer to Pediatric Pain Management: Medical/Trauma if indicated.
Pediatric Trauma: Extremity Injuries
Prince William County Fire and Rescue System
Pediatric Trauma: Extremity Injuries
120
All Providers
Medical Control
 Contact OLMC for additional orders or questions.
 General Patient Care Protocol – Pediatric.
 General Patient Care Protocol – Pediatric Trauma.
 Remove or cut away clothing to expose area of injury.
 Control active bleeding:
o Refer to Clinical Procedure: Wound Care/Hemorrhage Control.
 Refer to Administrative Procedure: Trauma Triage Criteria.
 Suspected fracture/dislocation:
o Assess and document distal pulses, capillary refill, sensation/movement prior to
splinting.
If pulse is present:
Splint in position found, if possible.
If pulse is absent:
Attempt to realign the injury into anatomical position.
o Open wounds/fractures should be covered with sterile dressings and immobilized in
the presenting position.
o Dislocations should be immobilized to prevent any further movement of the joint.
o Reassess and document distal pulses, capillary refill, and sensation after splinting.
Advanced Life Support
 Full Pediatric ALS Assessment and Treatment.
 Refer to Pediatric Pain Management: Medical/Trauma if indicated.
Pediatric Trauma: Eye Injuries
Prince William County Fire and Rescue System
Pediatric Trauma: Eye Injuries
121
All Providers
 General Patient Care Protocol – Pediatric.
 General Patient Care Protocol – Pediatric Trauma.
 Assess gross visual acuity.
 If injury is secondary to a chemical exposure:
o Remove patient from source, if safe to do so.
o Remove contact lenses if appropriate; transport with patient.
o Irrigate the eyes with NS for a minimum of 20 minutes.
o Determine chemical involved, bring Safety Data Sheet (SDS) if available.
 If eye injury is due to trauma:
o Do not irrigate.
o Stabilize any penetrating objects.
o Do not remove any impaled object.
o Prevent patient from bending or standing.
o If blood is observed in anterior chamber, transport with head elevated 60 degrees.
 Never apply pressure to the eyeball or globe.
 Do not use chemical cold packs on the face.
 Refer to Administrative Procedure: Trauma Triage Criteria.
Medical Control
Advanced Life Support
 Contact OLMC for any additional orders or questions.
 Full Pediatric ALS Assessment and Treatment.
 Refer to Pediatric Pain Management: Medical/Trauma Protocol if indicated.
Pediatric Trauma: Head Injuries
Prince William County Fire and Rescue System
Pediatric Trauma: Head Injuries
122
All Providers
 General Patient Care Protocol – Pediatric.
 General Patient Care Protocol – Pediatric Trauma.
 Restrain patient if indicated, refer to Administrative Procedure: Restraints.
 Refer to Clinical Procedure: Selective Spinal Motion Restriction (SSMR) if indicated.
 Refer to Administrative Procedure: Trauma Triage Criteria.
 If normotensive or hypertensive:
o Elevate head of stretcher 15° – 30°.
 Advanced airway/ventilatory management if indicated.
Airway interventions can be detrimental to patients with head injury by raising intracranial pressure, worsening
hypoxia (and secondary brain injury), and increasing risk of aspiration. Whenever possible, these patients should
be managed in the least invasive manner to maintain O2 saturation > 92% (e.g., NRB, BVM with 100% O2).
 Observe for signs of impending respiratory failure, refer to Pediatric Respiratory
Emergencies: Respiratory Failure protocol if indicated.
o Decreased level of consciousness with hypoxia (SpO2 < 90%) despite 100% O2
therapy, apnea, and/or respiratory rate < 8.
o Poor ventilatory effort (with hypoxia despite 100% O2 therapy).
o Patients requiring active ventilatory assistance.
o Inability to maintain patent airway.
o Symptomatic airway obstruction.
 For patients with assisted ventilation:
o Titrate to target an ETCO2 of 40 mmHg.
o Acute herniation should be suspected when the following signs are present:
Acute unilateral dilated and non‐reactive pupil.
Abrupt deterioration in mental status.
Abrupt onset of motor posturing.
Abrupt increase in blood pressure.
Abrupt decrease in heart rate.
o Hyperventilation is a temporary measure which is only indicated in the event of
acute herniation.
If signs of herniation develop, increase ventilation rate as indicated. Titrate
ETCO2 between 30 – 35 mmHg.
< 1 year of age, ventilate at rate of 35.
≥ 1 year of age, ventilate at rate of 25.
Prince William County Fire and Rescue System 123
Medical Control
Contact OLMC for any additional orders or questions.
Pediatric Trauma: Head Injuries
Pediatric Trauma: Head Injuries
 Full Pediatric ALS Assessment and Treatment.
 Advanced airway/ventilatory management if indicated.
 If severely agitated/combative:
o Do not delay treatment to obtain IV access:
Administer Midazolam 0.2 mg/kg IN (max dose 5 mg).
OR
 Administer Midazolam 0.1 mg/kg IM/IV/IO (max dose 5 mg).
Monitor for respiratory depression.
Advanced Life Support
Pediatric Trauma: Sexual Assault
Prince William County Fire and Rescue System
Pediatric Trauma: Sexual Assault
124
All Providers
Medical Control
 General Patient Care Protocol – Pediatric.
 General Patient Care Protocol – Pediatric Trauma.
 For victims of sexual assault who meet major trauma criteria:
o Transport to Pediatric Capable Trauma Center, refer to Administrative Procedure:
Trauma Triage Criteria.
 For all other cases:
o Transport to nearest appropriate Emergency Department.
 Provide supportive care as indicated by patient’s condition.
 Preserve evidence.
 Refer to Administrative Procedure: Abuse/Neglect.
Advanced Life Support
 Contact OLMC for any additional orders or questions.
 Full Pediatric ALS Assessment and Treatment.
Pediatric Trauma: Traumatic Amputations
Prince William County Fire and Rescue System
Pediatric Trauma: Traumatic Amputations
125
All Providers
Medical Control
 General Patient Care Protocol – Pediatric.
 General Patient Care Protocol – Pediatric Trauma.
 Control active bleeding.
o Refer to Clinical Procedure: Wound Care/Hemorrhage Control.
 Refer to Administrative Procedure: Trauma Triage Criteria.
 If amputation is incomplete:
o Attempt to stabilize with bulky pressure dressing.
o Splint in‐line.
 If amputation is complete:
o Cleanse amputated part with sterile saline.
o Wrap in sterile dressing moistened in sterile saline.
o Place in plastic bag if possible.
o Attempt to cool with cold pack during transport. Do not place directly on ice.
Advanced Life Support
 Contact OLMC for any additional orders or questions.
 Full Pediatric ALS Assessment and Treatment.
 Refer to Pediatric Pain Management: Medical/Trauma if indicated.
Prince William County Fire and Rescue System
Administrative/Clinical
Procedures
Administrative Procedure: Abuse and Neglect
Prince William County Fire and Rescue System
Administrative Procedure: Abuse and Neglect
I. Authorized Personnel
A. Active ALS and BLS providers.
II. Definitions
A. Child:
1. For the purpose of this directive, a child is defined as any person < 18 years
of age.
B. Adult:
1. For the purpose of this directive, an adult is defined as any person ≥ 18 years
of age.
C. Incapacitated Adult:
1. For the purpose of this directive, an incapacitated adult means any person ≥
18 years of age who is impaired by reason of mental illness, mental
impairment, physical illness, or disability, advanced age or other causes to
the extent that the adult lacks sufficient understanding or capacity to make,
communicate, or carry out responsible decisions concerning his or her wellbeing.
D. Physical and Mental Abuse:
1. When a caretaker or other person creates or inflicts, threatens to create or
inflict, or allows to be created or inflicted upon such a physical or mental
injury by other than accidental means, or creates a substantial risk of death,
disfigurement or impairment of bodily or mental functions upon the patient.
2. When a caretaker or other person commits or allows to be committed, any
act of sexual exploitation or any sexual act upon the patient.
3. When a caretaker or other person creates a substantial risk of physical or
mental injury by knowingly leaving a child alone in the same dwelling,
including an apartment, with a person to whom the child is not related by
blood or marriage and with whom the parent, or other responsible person,
knows has been convicted of an offense against a minor for which
registration is required as a violent sexual offender.
E. Financial Exploitation:
1. The illegal use of an adult or incapacitated adult or their resources for
another's profit or advantage.
126
Administrative Procedure: Abuse and Neglect
Prince William County Fire and Rescue System
Administrative Procedure: Abuse and Neglect
F. Neglect:
1. Child neglect occurs when there is a failure to provide food, clothing, shelter,
or supervision for a child to the extent that the child’s health or safety is
endangered. This also includes abandonment and situations where the
parent or caretaker’s own incapacitating behavior or absence prevents or
severely limits the performing of child caring tasks.
2. Adult neglect occurs when an adult is living under such circumstances that
he/she is not able to provide for himself/herself or is not being provided
services necessary to maintain his/her physical and mental health and this
failure to receive such necessary services impairs or threatens to impair his/
her well‐being.
G. Required Reporter:
1. All active EMS providers are required reporters and are mandated to report
any suspected abuse or neglect.
III. Indications
A. For use when confronted with suspected situations defined in this directive.
IV. Procedure
A. Patient Care Considerations.
1. Do not delay appropriate treatment and/or transport of patient(s) due to
reporting requirements associated with these cases. Reporting requirements
may be fulfilled following patient care.
2. Handle deceased patient(s) in accordance with the Clinical Procedure:
Termination of Resuscitation and follow the notification procedures below.
B. When adult/child abuse, neglect, and/or exploitation are suspected at the scene of
an emergency, the following reporting criteria should be employed immediately
upon discovery.
1. Advise Communications of need for the police department, if not already
dispatched.
a. If the scene is safe, assess and treat the patient. Initiate transport as
soon as practical.
127
Administrative Procedure: Abuse and Neglect
Prince William County Fire and Rescue System
Administrative Procedure: Abuse and Neglect
b. When police arrive, either at the scene or at the hospital, advise
the officer(s) of the suspected abuse or neglect and any scene
observations you had.
2. Notify Prince William County Department of Social Services.
a. If during normal business hours (Monday through Friday 0800‐1700),
contact (703)792‐4200.
b. If outside of normal business hours, request Communications to page
the on‐call Social Services representative.
c. For adult victims, contact the 24‐hour Virginia DSS Adult Protective
Services hotline at 1‐888‐832‐3858.
d. For pediatric victims, contact the 24‐hour Virginia Child Protective
Services at 1‐800‐552‐7096.
3. Additional Notifications.
a. Transported patients: notify the receiving nurse and physician of
your suspicions, include detailed observations and actions.
b. For victims who are patients/residents in a hospital, nursing facility,
or similar institution: notify the individual in charge of the institution
or his/her designee, include detailed observation and actions.
C. Documentation.
1. Document scene observations and patient information on the PCR. The
PCR will only be released to outside agencies in accordance with the
provider’s departmental guidelines.
2. The police department and/or social service caseworker may request your
observations and basis for suspicion in writing.
D. Guidelines for suspected sexual assault cases.
1. Advise the patient not to bath, void, douche, brush teeth, drink, change
their clothes, etc.
2. Preserve the crime scene. Nothing should be touched or moved in the area of
the suspected assault.
3. Advise patient that they can contact the A.C.T.S. Helpline at (703) 368‐4141.
The A.C.T.S. Helpline will contact the rape crisis counselor on duty for
assistance and support at home, during medical examinations at
the hospital, and during law enforcement interviews through to court
proceedings and appearances.
128
Administrative Procedure: Americans With Disabilities Act
Prince William County Fire and Rescue System
Administrative Procedure: Americans with Disabilities Act
I. Authorized Personnel
A. Active ALS and BLS providers.
B. Any member who is of “active status” and approved by their respective agency to
ride on emergency response equipment.
II. Definitions
A. Service Animal:
1. Any animal individually trained to do work or perform tasks for the benefit of
a person with a disability. A service animal is not considered a pet but rather
an animal trained to provide assistance to a person because of a disability.
B. Direct Threat
1. A significant risk to the health or safety of others that cannot be mitigated or
eliminated by modifying policies, practices, or procedures.
III. Indications
A. Situations where a patient is accompanied by a service animal.
IV. Contraindications
A. A public entity may ask an individual with a disability to remove a service animal
from the premises if:
1. The animal is out of control and the animal's handler does not take
effective action to control it.
OR
2. The animal is not housebroken.
V. Requirements of Providers and Members
A. General.
1. Generally, a public entity shall modify its policies, practices, or procedures to
permit the use of a service animal by an individual with a disability.
B. If an animal is properly excluded (meets contraindications).
1. If a public entity properly excludes a service animal for reasons noted in
Section IV, it shall give the individual with a disability the opportunity to
participate in the service, program, or activity without having the service
animal on the premises.
129
Prince William County Fire and Rescue System
C. Care or supervision.
1. A public entity is not responsible for the care or supervision of a service
animal.
D. Inquiries
1. A public entity shall not ask about the nature or extent of a person's
disability, but may make two inquiries to determine whether an animal
qualifies as a service animal. A public entity may ask:
a. if the animal is required because of a disability.
AND
b. What work or task the animal has been trained to perform.
2. A public entity shall not require documentation, such as proof that the
animal has been certified, trained, or licensed as a service animal.
Generally, a public entity may not make these inquiries about a service
animal when it is readily apparent that an animal is trained to do work or
perform tasks for an individual with a disability (e.g., the dog is observed
guiding an individual who is blind or has low vision, pulling a person's
wheelchair, or providing assistance with stability or balance to an
individual with an observable mobility disability).
E. Access to areas of a public entity.
1. Individuals with disabilities shall be permitted to be accompanied by their
service animals in all areas of a public entity's facilities where members of
the public, participants in services, programs or activities, or invitees, as
relevant, are allowed to go.
VI. Procedure
A. EMS providers and members must be prepared to safely transport service animals
alongside their handlers.
B. Often, EMS providers and members will come across service animals in the form of
canines. There are no regulations to specify where a service canine should be placed
during transport. The following are general recommendations for the safe transport
of canines.
1. A service canine may be placed alongside a center frame stretcher, remaining
clear of the provider.
2. Ensure the canine is secure to a stationary device (e.g., stretcher, seatbelt that
has a retractor that has been pre‐crashed locked).
Administrative Procedure: Americans With Disabilities Act
Administrative Procedure: Americans with Disabilities Act
130
Prince William County Fire and Rescue System
3. Secure the stretcher prior to placing the canine in the patient compartment.
Remove the canine prior to removing the stretcher.
4. If possible, place the leash on the appropriate collar ring to prevent injury or
asphyxiation when securing the dog.
C. When a patient’s condition requires life‐saving interventions or if space prohibits
transport of the canine in the patient compartment, the cab of the vehicle may be
considered as a secondary location to secure the canine.
VII. Special Considerations
A. In the event a service animal cannot be transported with the patient due to the
critical nature of the patient (e.g., cardiopulmonary arrest, illness or injury requiring
transport to facility by helicopter), providers shall arrange transportation of the
service animal to the transport destination of the patient. Care of the animal can also
be taken by a family member or friend at the request of the patient.
B. Miniature horses.
1. Reasonable modifications.
a. A public entity shall make reasonable modifications in policies, practices,
or procedures to permit the use of a miniature horse by an individual with
a disability if the miniature horse has been individually trained to do work
or perform tasks for the benefit of the individual with a disability.
2. Assessment factors.
a. In determining whether reasonable modifications in policies, practices, or
procedures can be made to allow a miniature horse into a specific facility,
a public entity shall consider:
1) The type, size, and weight of the miniature horse and whether the
facility can accommodate these features;
2) Whether the handler has sufficient control of the miniature horse;
3) Whether the miniature horse is housebroken; and
4) Whether the miniature horse's presence in a specific facility
compromises legitimate safety requirements that are necessary for
safe operation.
3. Other requirements
a. Sections V, “If an animal is properly excluded” to sections V, “Care
or supervision” shall also apply to miniature horses.
Administrative Procedure: Americans With Disabilities Act
Administrative Procedure: Americans with Disabilities Act
131
Administrative Procedure: Burn Center Criteria
Prince William County Fire and Rescue System
Administrative Procedure: Burn Center Criteria
I. Authorized Personnel
A. Active ALS and BLS providers.
II. Indications
A. The following shall be transported to a burn center.
1. 3rd degree burns (full thickness).
2. 2nd degree burns (partial thickness) > 10% TBSA.
a. 2nd degree burns on the face, neck, hands, feet, major joints, genitalia,
or perineum.
3. Circumferential burns.
4. Burns with associated trauma.
a. Consider patient transport to a facility that manages burns and
trauma (e.g., MedStar for adults, Children's for pediatrics).
5. Burns in patients with significant pre‐existing medical illness.
6. Burns in the setting of suspected inhalation injury of toxic smoke.
7. Electrical burns, including lightning, or contact with high voltage
(greater than 120V).
a. Spinal immobilization required if high voltage electrical injury.
8. Chemical burns (must be decontaminated).
a. Remove clothing.
b. If dry powder is present, brush away before irrigating.
c. Flush with copious amounts of water on scene and continue irrigation
enroute to hospital.
d. Chemical injuries to eyes are an EMERGENCY. Remove contacts and
irrigate continuously with normal saline for at least 30 minutes.
e. Avoid hypothermia.
III. Procedure
A. Ground Transport.
1. Consider situational awareness (e.g., inclement weather, patients requiring
decontamination) and relative travel time by ground to appropriate
treatment facility (trauma center, burn center, pediatric burn center).
132
Administrative Procedure: Burn Center Criteria
Prince William County Fire and Rescue System
Administrative Procedure: Burn Center Critereia
B. Medevac Transport.
1. Unit officers or incident command will request a Medevac through
Communications in accordance with operational policy.
C. Unstable Patients or Airway Compromise.
1. Transport patient to the nearest emergency department and notify OLMC.
D. Transport Destination.
1. If the provider has any question regarding appropriate transportation
destination, OLMC should be contacted.
133
Administrative Procedure: Code Sepsis
Prince William County Fire and Rescue System
Administrative Procedure: Code Sepsis
I. Authorized Personnel
A. Active ALS and BLS providers.
II. Definitions
A. Code Sepsis:
1. Terminology used to provide pre‐arrival Emergency Department notification
in order to facilitate rapid assessment and treatment of a suspected severe
sepsis patient.
III. Indications
A. Patients who meet the parameters as defined in this procedure.
IV. Procedure
A. Adult Criteria.
1. The receiving Emergency Department should be notified of a “Code Sepsis”
when an adult patient meets the following 3 criteria.
a. Suspected infection.
b. ETCO2 ≤ 25 mmHg.
c. Two or more of the following:
1) Fever or hypothermia (>100.4 F or <96.8 F).
2) Tachypnea (respiratory > 20).
3) Tachycardia (heart rate > 90).
B. Pediatric Criteria.
1. The receiving Emergency Department should be notified of a “Code Sepsis”
when a pediatric patient meets the following 3 criteria.
1) Fever or hypothermia (>101.3 F or <96.8 F).
2) Tachypnea (respiratory rate > 20).
3) Tachycardia (heart rate > 90).
134
Administrative Procedure: Code STEMI
Prince William County Fire and Rescue System
Administrative Procedure: Code STEMI
I. Authorized Personnel
A. Active ALS and BLS providers.
II. Definitions
A. Code STEMI:
1. Terminology used to provide pre‐arrival Emergency Department notification
in order to facilitate rapid assessment and treatment of a suspected STEMI
(ST Segment Elevation Myocardia Infarction) patient.
III. Indications
A. Patients who meet the parameters as defined in this procedure.
IV. Procedure
A. The receiving Emergency Department should be notified of a “Code STEMI” when a
patient who is having chest pain or ischemic equivalent symptoms for < 24 hours
with any of the following:
1. ST segment elevation ≥ 1mm in two or more contiguous leads.
2. Computer interpretation of “**ACUTE MI**” on 12‐lead ECG.
3. New Left Bundle Branch Block (confirmed by comparing to prior ECG).
B. Immediate notification and ECG transmission to the receiving facility is imperative.
Transmission and notification from the scene is preferred.
C. Patients meeting “Code STEMI” criteria should be transported to a Percutaneous
Coronary Intervention (PCI) capable hospital.
1. PCI Capable hospitals in Prince William County:
a. Novant/UVA Prince William Medical Center.
b. Sentara Northern Virginia Medical Center.
D. When operationally feasible, patient’s preference should be taken into account when
determining transport destination.
135
Administrative Procedure: Code Stroke
Prince William County Fire and Rescue System
Administrative Procedure: Code Stroke
I. Authorized Personnel
A. Active ALS and BLS providers.
II. Definitions
A. Code Stroke:
1. Terminology used to provide pre‐arrival Emergency Department notification
in order to facilitate rapid assessment and treatment of a suspected stroke
patient.
III. Indications
A. Patients who meet the parameter as defined in this procedure.
IV. Procedure
A. The Cincinnati Pre‐Hospital Stroke Scale should be completed for all suspected
stroke patients. If one of the following exam components is “positive,” then the
patient stroke screening is positive. All of the exam components must be performed.
1. Look for facial droop by asking the patient to smile.
2. Have patient, while sitting upright or standing, extend both arms parallel to
floor, close eyes, and turn their palms upward.
a. Assess for unilateral drift of an arm.
3. Have the person say, “You can’t teach an old dog new tricks.”
a. Assess for slurring of words, wrong words, or inability to speak.
B. Establish the “time last normal” for the patient. This will be the presumed time of
onset. If possible obtain independent verification of this time from family, friends,
co‐workers, etc.
C. If the “time last normal” is ≤ 8 hours, blood glucose is greater than 60 mg/dL, and at
least one of the stroke screening is positive, alert the receiving hospital of a “Code
Stroke” as early as possible.
D. Assess and treat suspected stroke patients per appropriate Medical: Stroke
Suspected Protocol.
E. The completed Cincinnati Pre‐Hospital Stroke screening should be documented in
the PCR.
136
Administrative Procedure: Do Not Resuscitate Order
Prince William County Fire and Rescue System
Administrative Procedure: Do Not Resuscitate Order
I. Information and Responsibilities
A. Virginia Certified Emergency Medical Service (EMS) Providers:
1. EMS Providers DO NOT need to see an original Durable DNR or Other DNR
Order. As of July 21, 2011, legible copies of a DDNR order may be accepted by
qualified health care providers.
2. What types of DDNR forms or orders can be honored by EMS providers?
a. The VDH/OEMS “State” DDNR form (old or new) can be honored at
any time;
b. A DDNR that was executed in accordance with the laws of another
state;
c. Authorized “Alternate DDNR Jewelry” can be honored at any time, but
it must contain equivalent information to the State form;
d. A verbal order from a physician can be honored by a certified EMS
provider. The verbal order must be from a physician who is physically
present and willing to assume responsibility or from online medical
control.
e. Virginia Physician Orders for Scope of Treatment (POST) form is
acceptable as a DDNR order.
f. “Other” DNR Orders: this is the term used to define a physician’s
written DNR order when it is in a format other than the State form.
“Other” DNR Orders should be honored by EMS providers’ when the
patient is within a license health care facility, being transported
between health care facilities, or receiving hospice or health care
services at home. Examples of “Other” DNR orders include facility
developed DNR forms or other documents that contain the equivalent
information as the State form.
137
Administrative Procedure: Emergency Department Notification
Prince William County Fire and Rescue System
Administrative Procedure: Emergency Department Notification
I. Authorized Personnel
A. Active ALS and BLS providers.
II. Definitions
III. Procedure
A. Begin each transmission with the following:
1. Unit Identifier.
2. Triage Category (e.g., Trauma, Medical, Code STEMI, etc.).
3. Estimated time of arrival (ETA).
B. After the receiving facility acknowledges the initial information, give a concise
report which includes the following:
1. Age and gender of patient.
2. Chief complaint or problem.
3. Vital Signs.
4. Level of consciousness (including GCS if altered or suspected stroke).
5. Nature of illness/mechanism of injury (if trauma).
6. Description of injury (if trauma).
7. Treatment provided and patient response.
8. Any anticipated delay in transport (e.g., extrication, distance).
9. Repeat ETA.
Triage Categories Definitions
Trauma Indicates patient is a trauma patient.
Medical Indicates patient is a medical patient.
Code STEMI Patient meets STEMI criteria per Code STEMI Procedure.
Code Stroke Patient meets Stroke criteria per Code Stroke Procedure.
Code Sepsis Patient meets Sepsis criteria per Code Sepsis Procedure.
Pediatric Indicates Patient is less than 18 years of age.
CPR Cardiopulmonary Arrest
138
Administrative Procedure: Extraordinary Care
Prince William County Fire and Rescue System
Administrative Procedure: Extraordinary Care
I. Authorized Personnel
A. Active ALS and BLS providers.
II. Scope of Practice
A. In Virginia, EMS providers may only provide emergency medical care while acting
under the authority of the Operational Medical Director (via written protocols or
Physician OLMC) and within the scope of the EMS agency license (e.g. ALS and/or
BLS)(12VAC5‐31‐1040). In Prince William County, the scope of practice for all
providers is defined by endorsement level and these protocols. That is, providers
shall exercise good clinical judgment based on training and experience and apply
appropriate FRS protocols to specific patient encounters. It is recognized that
written protocols cannot provide guidance for every possible situation providers
may encounter. Protocols are meant to guide providers in achieving consistently
excellent prehospital care, not to replace judgment or initiative. In routine cases
when written protocols do not address the unique patient care or disposition
needs, physician OLMC is always available and appropriate for such circumstances.
III. Extraordinary Care
A. In rare cases, when there is an immediate threat to life or limb not addressed by
protocol, treatments or interventions outside routine protocol may be required.
Under such circumstances this extraordinary care must be authorized by Physicain
OLMC (in accordance with 12VAC5‐31‐1070). Cases requiring such extraordinary
care will be exceedingly rare. Most providers will never encounter such a case
throughout their career. Nothing in this protocol should be interpreted as
empowering providers to circumvent existent protocol or practice beyond their
scope. In all situations, both the EMS providers and the Physician OLMC are
accountable for their actions and decisions.
IV. Procedure
A. Procedure for Authorization (extraordinary care cannot occur without OLMC):
1. Both the OLMC physician and the provider must acknowledge and agree that:
139
Administrative Procedure: Extraordinary Care
Prince William County Fire and Rescue System
Administrative Procedure: Extraordinary Care
a. The patient’s condition and/or the required/requested extraordinary
care are not addressed elsewhere in the protocols.
AND
b. The order is necessary to maintain the life/limb of the patient.
2. The provider must feel capable of correctly performing the care directed by
the physician, based on available equipment, prior training, experience, and/
or the instructions given by the OLMC physician.
3. The provider must verbally confirm the order and agree to proceed.
B. Inability to Carry Out Physician OLMC Orders.
1. In rare circumstances, providers may receive orders from OLMC that they are
unable to carry out. Providers may refuse to perform specific procedures or
treatments (in accordance with 12VAC5‐31‐1080):
a. If not adequately trained and proficient to perform the procedure.
b. If the procedure is not fully understood.
c. If the procedure is judged to be not in the best interests of the patient.
d. Nothing precludes the provider and physician from reaching
agreement on another order if within the scope of this document.
2. If the provider cannot carry out an order, Physician OLMC must be
immediately notified and given the reason the order could not be carried out.
C. Procedure for documentation.
1. The provider must inform the receiving physician (if not OLMC) of the affects
of treatment or situation surrounding the inability to carry out OLMC orders
as soon as possible.
2. The provider must also notify the EMS Operations and the OMD as soon as
possible.
3. The provider shall fully document the call on the PCR, detailing all specifics of
the matter in the narrative.
4. All such instances shall automatically be reviewed by the OMD.
D. Inability to Contact Physician OLMC.
1. In the rare event providers are unable to contact Physician OLMC, the
provider should:
a. Use good clinical judgment and do what is reasonable and within their
scope of practice and training.
b. Document the events, assessment, and interventions.
c. Make notifications to the Battalion Chief, EMS Operations, and the
OMD as soon as it is reasonable to do so.
Nothing contained herein implicitly or explicitly authorizes the provision of care
exceeding training or scope of practice.
140
Administrative Procedure: Lights and Siren Use During Transport
Prince William County Fire and Rescue System
Administrative Procedure: Lights and Siren Use During Transport
Research has shown that the routine use of emergency lights and siren during patient transport
increases the risk of accidental injury to patients, providers, and the community. The purpose of this
procedure is to provide guidelines for the appropriate usage of emergency warning lights and siren
when transporting a patient from the scene to the hospital.
Outlined below are some of the criteria that would justify the usage of lights and sirens that the
emergency medical providers should consider when determining the need to respond to the hospital.
This list is not inclusive, and it is imperative that the EMS providers weigh the risks versus benefits
before making a decision regarding emergency response to a receiving facility.
I. Authorized Personnel
A. Active ALS and BLS providers who are EVOC certified and have completed all
applicable turn‐over processes as required by their respective agency.
II. Indications
A. At the discretion of the transporting crew, driving with lights and siren may be
considered when the following clinical conditions or circumstances exist:
1. Difficulty in maintaining the patient’s ABCs (airway, breathing circulation)
including (but not limited to):
a. Inability to establish/maintain an adequate airway or provide
adequate ventilations.
b. Severe respiratory distress or injury not responsive to available field
treatment.
2. Acute coronary syndrome with one or more of the following:
a. STEMI.
b. Acute congestive heart failure.
c. Hypotension.
d. Bradycardia.
e. Wide Complex Tachycardia.
f. Signs of impending deterioration.
3. Anaphylaxis with evidence of shock.
4. Cardiac dysrhythmia accompanied by signs of impending or actual instability
which is unresponsive to available field therapy such as:
a. Hypotension.
b. Acute CHF.
c. Altered level of consciousness.
141
Prince William County Fire and Rescue System
d. Syncope.
e. Post cardiac arrest.
5. Severe uncontrolled hemorrhage.
6. Shock, unresponsive to available treatment.
7. Severe trauma including (but not limited to):
a. Penetrating wounds to head, neck, torso.
b. Two or more proximal long bone fractures with hypotension.
c. Major Amputations (proximal to wrist or ankle).
d. Neurovascular compromise of an extremity.
8. Severe neurological conditions including (but not limited to):
a. Status epileptic.
b. Substantial or rapidly deteriorating level of consciousness.
c. Acute stroke‐like symptoms when last seen normal ≤ 8 hours prior.
9. Obstetrical emergencies including (but not limited to):
a. Labor complications that threaten survival of the mother or fetus, such as:
Prolapsed cord.
Breech presentation.
Arrested delivery.
Suspected ruptured ectopic pregnancy.
10. Crew discretion based on patient condition.
11. For any transport where reducing time to definitive care is clinically indicated,
consider use of a Medevac.
Administrative Procedure: Lights and Siren Use During Transport
Administrative Procedure: Lights and Siren Use During Transport
142
Administrative Procedure: Medication Administration Cross Check
Prince William County Fire and Rescue System
Administrative Procedure: Medication Administration Cross Check
I. Authorized Personnel
A. Active ALS and BLS providers.
II. Indications
A. A Medication Administration Cross Check (MACC) shall be performed by endorsed
EMS providers prior to the administration of any medication.
B. The MACC shall be performed in its entirety and prior to repeat doses of
medications.
III. Procedure
A. Provider 1 initiates the procedure by stating “Medication Cross Check.”
B. Provider 2 responds “Ready.”
1. It is important to avoid using ambiguous statements such as “okay” as they
may be interpreted many different ways and they do not effectively reflect
Provider 2's actual state of readiness.
2. It is critical that Provider 2 is actively engaged in the MACC.
C. Provider 1 states “I am going to give” and provides the following information: Dose,
Medication Name, Route, Rate, and Reason for Administration.
1. If and only if there is concurrence on Provider 2's behalf, does the MACC
procedure continue.
D. If Provider 2 agrees, they should respond with the question “Contraindications?”
E. Provider 1 shall check the expiration date, verify that the patient’s vital signs are
appropriate, and check for patient allergies. Provider 1 shall respond with “No
Contraindications” or “Contraindications Present.”
F. If Provider 2 concurs, they should respond with the questions “Volume?” or
“Quantity?”
G. Provider 1 should state the drug concentration, the volume they intend to deliver,
and show the vitals to Provider 2.
H. If provider 2 agrees and makes a positive visual verification, they should respond
with “I agree.”
1. It is important to avoid using ambiguous statements such as “okay” as they
may be interpreted many different ways and they do not effectively reflect
Provider 2's actual state of readiness.
143
Administrative Procedure: Medication Administration Cross Check
Prince William County Fire and Rescue System
Administrative Procedure: Medication Administration Cross Check
IV. Special Considerations
A. It is best practice to have a second endorsed EMS provider visually confirm and
complete the MACC procedure prior to administering medication to a patient.
There may be an instance when the second provider cannot visually confirm the
medication. An example of this would be during the transport of a patient where the
second provider is operating the ambulance. In this situation, a verbal verification
should be conducted between Providers 1 and 2. Safety of the crew is paramount
and the operator of the vehicle should not be distracted from their responsibilities
of driving.
1) In the event a verbal verification can not be conducted with a second
provider, a lone provider must still process through the MACC procedure.
This is the least preferred method and presents the greatest chance for
medication errors to occur.
B. BLS Provider Verification
1) When ALS providers are performing a MACC for an ALS medication, it is
preferred that the Provider 2 also be an endorsed ALS provider. In the event
a second endorsed ALS provider is not present, an endorsed BLS provider
may perform the MACC. The endorsed BLS provider may not be able to verify
dose of medication but can confirm the medication name, concentration, and
date.
2) When BLS providers are performing a MACC for a BLS medication, Provider 2
must be at a minimum an endorsed BLS provider.
144
Administrative Procedure: Patient Care During Interfacility Transport
Prince William County Fire and Rescue System
Administrative Procedure: Patient Care During Interfacility Transport
Although primary responsibility is not for inter‐facility transports, situations may arise necessitating
such transport. They require unique skills and capabilities, both in clinical and operations
coordination.
I. Authorized Personnel
A. Active ALS and BLS providers.
II. Procedure
A. Inter‐facility transport decisions (including but not limited to, transport staffing,
equipment, and transport destination) should be based on the patient’s medical
needs.
1. EMS providers should ensure the transport is emergent. Any concerns
regarding the emergent need for transport should be discussed with the
sending physician.
2. Contact the on duty Battalion Chief with any concerns.
B. Match provider skills and equipment with patient care needs.
C. Coordination between hospitals and inter‐facility transporters is essential before
transport is initiated to ensure that patient care is provided at the appropriate level
and does not exceed the capabilities of the inter‐facility transport provider.
D. If devices/medications are not listed in these protocols and must be continued
during transport, an adequately trained licensed/care provider from the
transferring facility whose credentials are acceptable to the transporting agency
must accompany the patient during transport.
E. All patients should be transported to the receiving facility’s Emergency Department.
F. The sending facility should call 911 to request transport. This is critical for
the following reasons:
1. A new incident is created by Communications.
2. A new incident is created in SafetyPad.
3. Billing related issues are simplified.
G. Ensure on duty Battalion Chief is aware and notify them of any concerns.
145
Administrative Procedure: Physician on Scene
Prince William County Fire and Rescue System
Administrative Procedure: Physician on Scene
I. Authorized Personnel
A. Active ALS and BLS providers.
II. Indications
A. For use when a medical physician at the scene wishes to direct or assume patient
care.
III. Procedure
A. The physician desiring to assume care of the patient must:
1. Provide documentation of his/her status as a physician (MD or DO) to include
a current copy of his/her license to practice medicine in the Commonwealth
of Virginia.
2. Assume care of the patient and allow documentation of his/her assumption
of care on the PCR.
3. Agree to accompany the patient during transport to the hospital.
4. Agree to assume responsibility for outcomes related to his/her oversight of
patient care.
B. Contact with OLMC must be established as soon as possible. The OLMC physician
must agree and relinquish the responsibility of patient care to the physician on
scene in order for care to be transferred.
C. Orders provided by the physician assuming responsibility for the patient should be
followed as long as they do not, in the judgment of the EMS provider, endanger
patient well‐being. The provider may request the physician to physically provide
patient care during transport if the suggested treatment varies significantly from
standing orders.
D. If the physician’s care is judged by the EMS provider to be potentially harmful to the
patient, the EMS provider should:
1. Politely voice his/her objection.
2. Immediately place the on‐scene physician in contact with the OLMC
physician.
E. When conflicts arise between the physician on scene and the OLMC Physician, the
EMS provider should:
1. Follow the directives of the OLMC physician.
2. Offer no assistance in carrying out the order in question; offer no
resistance to the physician performing this care.
146
Prince William County Fire and Rescue System
3. If the physician on scene continues to carry out the order in question,
offer no resistance and enlist the aid of law enforcement.
F. All interactions with physicians on the scene must be completely documented
in the PCR, including the name and license number of the on‐scene physician.
Administrative Procedure: Physician on Scene
Administrative Procedure: Physician on Scene
147
Administrative Procedure: Police Custody Patient Care Standards
Prince William County Fire and Rescue System
Administrative Procedure: Police Custody Patient Care Standards
I. Authorized Personnel
A. Active ALS and BLS providers.
II. Indications
A. Treatment of patients who are in the custody of a law enforcement officer (LEO).
III. Procedure
A. When called to a scene to assess a person in police custody, perform all assessment
and treatment consistent with the standards set for the typical, non‐detained
patient. EMS providers are not equipped to perform formal medical clearance for
patients in police custody prior to jail transport.
B. After assessing the patient and treating any obvious conditions, transport to the
emergency department should be offered in a manner consistent with the Prince
William County EMS Protocols.
C. If the detained patient refuses transport, execute a standard patient care refusal as
outlined in the Administrative Procedure: Refusal of Medical Care.
1. Advise the LEO of the patient’s decision, and if all criteria are met, release the
patient to the LEO.
D. If the patient does not meet refusal criteria, advise the LEO that transport is
indicated and coordinate a safe transport of the detained patient in accordance with
the following:
1. If the patient remains in LEO custody, a LEO must ride with the patient, in the
back of the transporting EMS unit, to the hospital.
2. Do not hog tie or restrain the patient in a manner that inhibits one’s ability to
breathe.
3. If the patient remains restrained by a LEO, ensure the restraints do not
inhibit the patient’s ability to breathe.
4. When restraints need to be moved to facilitate patient care, enlist the
assistance of the LEO.
E. If the LEO requires EMS transport of the patient when the patient has
refused EMS care and/or transport to the Emergency Department:
1. Comply with the LEO’s request and transport the patient to the nearest
appropriate ED.
148
Prince William County Fire and Rescue System
F. In scenarios where a LEO is unwilling to allow transport of a detained patient after
EMS providers have determined transport is indicated (e.g., requested transport, is
not a candidate for refusal, or obvious medical necessity) adhere to the following:
1. Assure that the LEO understands transport is indicated and that medical
clearance prior to incarceration is not a procedure performed by EMS.
2. Request that the LEO have a supervisor dispatched to the incident.
3. Contact OLMC for further input and assistance if indicated.
4. If these actions fail to resolve the issue, defer to the officer’s legal authority to
retain custody of the patient.
5. Document the interaction well, including the law enforcement agency and
officer involved.
Administrative Procedure: Police Custody Patient Care Standards
Administrative Procedure: Police Custody Patient Care Standards
149
Administrative Procedure: Refusal of Medical Care
Prince William County Fire and Rescue System
Administrative Procedure: Refusal of Medical Care
I. Authorized Personnel
A. Active ALS and BLS providers.
II. Definitions
A. Patient:
1. A patient is defined by the Virginia Department of Health Office of EMS as:
“a person who needs immediate medical attention or transport, or both, whose
physical or mental condition is such that he is in danger of loss of life or health
impairment, or who may be incapacitated or helpless as a result of physical or
mental condition or a person who requires medical attention during transport
from one medical care facility to another.”‐12VAC5‐31‐10
B. Court Appointed or Durable Power of Attorney:
1. Adult patients with impaired decision‐making capacity may have courtappointed
representatives or a representative with durable power of
attorney (DPA) who make decisions on the patient’s behalf. Under such
circumstances, the name of the patient’s decision‐making representative
should be documented on the PCR. Note that patients do not forfeit
their rights completely to a DPA; if the patient is lucid and demonstrating
intact decision‐making capacity, the patient’s wishes should be respected.
The DPA only comes into play when the patient is impaired.
C. Impaired decision‐making capacity:
1. Patients demonstrate impaired decision‐making capacity if they are unable to
understand their condition or our recommendations or if they have
unreasonable excuses for refusing treatment or transport. For example, if it
appears that a patient understands our recommendations but does not wish
to go to the ED because he is delusional, his decision‐making capacity is
impaired. Delusional reasoning and/or inability to understand their
condition and our recommendation may render patients unable to make
medical decisions, to include informed consent and refusal.
D. Impaired decision‐making capacity due to physical illness/injury:
1. If the EMS provider has reason to believe that a patient’s decision‐making
ability is impaired due to illness or injury, Physician OLMC may be able to
obtain a Medical Emergency Custody Order (ECO) through a Magistrate.
This Medical ECO can be picked up and delivered to the scene by a law
150
Prince William County Fire and Rescue System
enforcement officer, on whose authority and in whose custody the patient is
involuntarily transported for further evaluation and management.
E. Impaired decision‐making capacity due to psychiatric illness:
1. If the EMS provider has reason to believe that a patient has an illness or
injury and the patient’s decision‐making capacity is impaired by psychiatric
illness, the police should be requested immediately to evaluate the patient.
On arrival, officers will determine if the patient represents a threat to self,
others, or public safety using their own criteria and judgment. If the patient is
deemed a threat, the officers may take the patient into custody on their own
authority for eight hours “8 hour rule” during which providers and officers
may coordinate transport to hospital or other facility. Note that the police do
not make medical decisions or take our medical assessment results into
consideration. They have a formal process they follow with respect to mental
capacity. An alternative to using the police directly is to petition the
Magistrate for an ECO. Any responsible person may do this, and it is possible
that the Magistrate may grant an Order where the police will not intervene of
their own accord.
F. Intact decision‐making capacity:
1. Patients’ decision‐making capacity is dependent upon their ability to
understand their condition, the recommended treatment, and the risks,
benefits, and alternatives to our treatment. A useful technique for assessing
decision‐making capacity is to have patients restate their condition, provider
recommendations, and the risks, benefits, and alternatives associated with
refusal, and then ask their reasons for refusal. A language barrier may make
informed consent and assessment of decision‐making capacity difficult.
Therefore, an approved translator via the language line should be used
if clinical condition allows and call circumstances require it. It should be
apparent that illness, injury, or intoxication may impair a patient’s decision
making capacity.
III. Procedure
A. A patient care encounter and a provider‐patient relationship is established
whenever the EMS provider has determined that assessment of the individual is
necessary to ensure no illness or injury exists and to ensure the individual’s capacity
to decline assessment or care is not impaired by illness, injury, or intoxication.
Administrative Procedure: Refusal of Medical Care
Administrative Procedure: Refusal of Medical Care
151
Prince William County Fire and Rescue System
B. All patients shall be assessed and offered transport by ambulance to the nearest
appropriate emergency department, regardless of the nature of the complaint.
C. In the event a patient, or his/her guardian, refuses transport to the hospital, a
properly executed refusal process must be completed.
D. Pediatric Refusals.
1. OLMC consultation is required prior to completing the refusal process for any
pediatric patient where significant vital sign or physical exam abnormalities
are present.
2. In the event the parent/guardian refuses medical care for a minor when
there is reasonable concern that the refusal will pose a threat to the wellbeing
of the minor:
a. Request PD for patient and crew safety.
b. If an immediate life threatening condition exists,
transport the patient to the nearest appropriate ED.
E. Three step refusal process for EMS providers to complete when accepting a refusal
of care:
Step 1 Determine if the patient/guardian is legally recognized as an informed
decision maker. If not, no refusal will be accepted. The patient should
be one of the following:
a. A person ≥ 14 years of age.
1) If patient is of the age of 14 and under 18 and a parent/legal
guardian are present, they are the legal decision maker for
determination of medical care.
2) If no parent/legal guardian is available, the patient must be
able to produce picture identification to verify age. If
verification is unavailable, treat as if the patient is less than 14
years of age.
3) If identification is present and the refusal is acceptable,
document the incident on the PCR and attempt to advise the
parent/legal guardian of the situation.
b. A court‐emancipated minor.
c. A legally married person of any age.
d. A minor pregnant female only when the medical concern relates to her
pregnancy.
e. A female under the age of 18 who is a parent will be treated as an
adult.
Administrative Procedure: Refusal of Medical Care
Administrative Procedure: Refusal of Medical Care
152
Prince William County Fire and Rescue System
f. A parent (of any age)/ or legal guardian on behalf of their child when
the refusal of care does not place the child at risk.
g. Involve OLMC/law enforcement for any refusal involving a minor
(<14) when the parent/legal guardian cannot be contacted.
Step 2 Determine if the patient’s decision‐making capacity appears to
be intact. To undergo the informed refusal of medical care process, the
patient/legal guardian’s decision‐making process cannot be impaired by
medical or psychiatric conditions. The patient must exhibit all of the
following:
1. Awake, alert and oriented to person, place, time, and situation.
2. Normal gait and coordination.
3. Normal speech pattern.
4. Apparently normal thought process
a. No suicidal ideation.
b. No homicidal ideation.
c. No hallucinations or delusions.
5. Apparently intact insight and judgment.
Step 3 Document the interaction well. The following items should be documented
for every refusal:
1. A mental status examination as detailed in Step 2.
2. A physical assessment (including vital signs).
a. Perform blood glucose level and oxygen saturation when
appropriate.
IF THE PATIENT DOES NOT MEET REFUSAL CRITERIA AS DESCRIBED IN STEPS 1 AND
2, THEN THEY ARE NOT A CANDIDATE FOR REFUSAL. ENLIST THE ASSISTANCE OF
OLMC AND/OR LAW ENFORCMENT FOR CONSIDERATIONS OF EMERGENCY CUSTODY
ORDER. DOCUMENT THESE INTERATIONS IN DETAIL.
F. Refusal of transport after care has been initiated.
1. Contact OLMC for situations that arise that are not addressed in this
manual.
Administrative Procedure: Refusal of Medical Care
Administrative Procedure: Refusal of Medical Care
153
Prince William County Fire and Rescue System
IV. S pecial Considerations/Options for Involuntary Transport
A. Emergency Custody Order Medical process:
1. Contact OLMC to discuss and request justification for the ECO.
2. Obtain the ECO through the Magistrate.
3. Delivery of ECO by law enforcement to the hospital for the OLMC signature.
4. Delivery of ECO by law enforcement to the incident scene.
5. Involuntary patient transport of patient by EMS to ED.
B. Emergency Custody Order Psychiatric Illness process:
1. Notify law enforcement.
2. Contact OLMC to discuss and request justification for the ECO.
3. OLMC petitions the magistrate for an ECO.
4. Delivery of ECO by law enforcement to the incident scene.
5. Involuntary patient transport of patient by EMS to ED.
Administrative Procedure: Refusal of Medical Care
Administrative Procedure: Refusal of Medical Care
154
Administrative Procedure: Refusal of Transport After Treatment
Prince William County Fire and Rescue System
Administrative Procedure: Refusal of Transport After Treatment
I. Authorized Personnel
A. Active ALS and BLS providers.
II. Procedure
A. Refusal of transport: Bronchospasm resolved after nebulizer treatment.
1. After treatment of bronchospasm, and return to an asymptomatic
state, some patients will refuse transport to the hospital. The
following items should be accounted for and included in the
assessment and documentation:
a. The initial presentation is consistent with a mild bronchospasm.
b. No severe dyspnea at onset.
c. No pain, change in sputum, fever, or hemoptysis.
d. Not clinically hypoxic (SpO2 < 92%).
e. Significant improvement after a single nebulizer treatment.
f. Vital signs within normal limits after treatment (BP, pulse,
respiratory rate and SpO2).
2. Additional patient safety measures that should be considered:
a. A family member or caregiver should be available to stay with
the patient and assist if a relapse occurs.
b. Assure the patient understands transport has been offered and
subsequently refused.
c. Inform the patient to follow‐up with their physician as soon as
possible and/or to re‐contact 911 if symptoms reoccur.
3. If the above are accounted for, a properly executed refusal of medical care
can be accepted by an ALS provider, from the patient/ legal guardian,
without contacting OLMC.
a. If the above are not accounted for, OLMC must be contacted prior to
obtaining a patient refusal.
1) Advise OLMC of the patient’s present illness, treatments
provided, patient’s response to treatments, and current vitals.
2) Provide patient with the OLMC’s recommendations for care
and/or transport. Document OLMC’s name and interaction in
PCR.
155
Prince William County Fire and Rescue System
B. Refusal of transport: Insulin dependent diabetic patients after the resolution
of insulin‐induced hypoglycemia by the administration of intravenous glucose.
1. This procedure cannot be used if the patient takes any oral diabetes
medications.
2. After treatment of insulin‐induced hypoglycemia, and return to an
asymptomatic state, some patients will refuse transport to the hospital. The
following items should be accounted for and included in the assessment and
documentation.
a. The patient is on Insulin only (does not take any oral diabetes
medications‐metformin, glipizide, Januvia).
b. The presentation is consistent with hypoglycemia.
c. Rapid improvement and complete resolution of symptoms after
glucose.
d. Vital signs within normal limits after glucose given (BP, pulse,
respiratory rate, oxygenation and blood sugar > 60).
e. There is no indication of an intentional overdose or dosing error.
3. Additional patient safety measures that should be considered:
a. Patient must be evaluated by an ALS provider.
b. A family member or caregiver should be available to stay with the
patient and assist if a relapse occurs.
c. Assure the patient understands transport has been offered and
subsequently refused.
d. Inform the patient to follow‐up with their physician as soon as
possible and/or to re‐contact 911 if symptoms reoccur.
4. If the above are accounted for, a properly executed refusal of medical care
can be accepted by an ALS provider, from the patient/legal guardian, without
contacting OLMC.
a. If the above are not accounted for, OLMC must be contacted prior to
obtaining a patient refusal.
1) Advise OLMC of the patient’s present illness, treatments
provided, patient’s response to treatments, and current vitals.
2) Provide patient with the OLMC’s recommendations for care
and/or transport. Document OLMC’s name and interaction in
PCR.
Administrative Procedure: Refusal of Transport After Treatment
Administrative Procedure: Refusal of Transport After Treatment
156
Administrative Procedure: Restraints
Prince William County Fire and Rescue System
Administrative Procedure: Restraints
I. Authorized Personnel
A. Active ALS and BLS providers.
II. Indications
A. Any patient who is deemed a threat to themselves or others may be gently
restrained to prevent injury to the patient or crew. This restraint must be in a
humane manner and used only as a last resort. Other means to prevent injury to the
patient or crew must be attempted first. These efforts could include reality
orientation, distraction techniques, or other less restrictive therapeutic means.
Physical or chemical restraint should be used as a last resort.
III. Contraindications
A. A patient who meets refusal criteria for refusal of medical care and/or transport.
IV. Procedure
A. Attempt less restrictive means of managing the patient.
B. Ensure that there are sufficient personnel available to physically restrain the patient
safely.
C. Restrain the patient in a lateral or supine position. No devices such as backboards,
splints, or other devices will be on top of the patient.
D. The patient will never be restrained in the prone position.
E. The patient must be under constant observation by the EMS crew at all times. This
includes direct visualization of the patient as well as cardiac, SpO2, and ETCO2
monitoring. Ensure restraints are secured to a non‐moveable part of the stretcher.
F. The extremities that are restrained will have a circulation check at least every 15
minutes. The first of these checks should occur as soon after placement of the
restraints as possible. This MUST be documented on the PCR.
G. If the above actions are unsuccessful or if the patient is resisting the restraints,
consider chemical restraint per Adult Medical: Behavioral Emergencies/Excited
Delirium.
H. If a patient is restrained by law enforcement personnel with handcuffs, or other
devices EMS providers cannot remove, a LEO must accompany the patient to the
hospital in the transporting EMS vehicle.
157
Administrative Procedure: Trauma Triage Criteria
Prince William County Fire and Rescue System
Administrative Procedure: Trauma Triage Criteria
I. Authorized Personnel
A. Active ALS and BLS providers.
II. Procedure
A. Assess trauma patients and determine transport destination per Trauma Triage
Algorithm on the following page.
1. The Trauma Triage Algorithm was adapted from the CDC Guidelines for
Field Triage of Injured Patients, Virginia State Trauma Triage Plan, and
Northern Virginia EMS Council Regional Trauma Plan.
Intentionally Left Blank
158
Prince William County Fire and Rescue System
Step 1: Measure Vitals and LOC
 GCS < 14
 Systolic BP < 90
 Respiratory Rate < 10 or > 29
(<20 in infant < 1 year of age)
Step 2: Assess Anatomy of Injury
 Penetrating injury to head, neck, torso, and
extremities (proximal to knee/elbow)
 Flail Chest
 Two or more long bone fractures
 Crushed, degloved, or mangled extremity
 Amputation proximal to wrist or ankle
 Pelvic Fracture
 Open or Depressed Skull Fracture
 Paralysis
Step 3: Assess Mechanism of Injury and
Evidence of High Energy Impact
Falls
 Older Adults: > 20 Feet (one story = 10 feet)
 Children: > 10 Feet (or 2-3 times the height of the
child)
High Risk Auto Crash
 Intrusion > 12 in. occupant side; > 18 in. any site
 Ejection (partial or complete) from automobile
 Death in the same passenger compartment
 Vehicle automatic crash notification data consistant
with high risk injury
Auto vs. Pedestrian/Bicyclist Thrown, Run Over, or with
Significant Impact (>20 mph)
Motorcycle Crash > 20mph
T T
Transport to Trauma Center
Transport to a Trauma Center may be
achieved by either Medevac or Ground
Transport.
 Inova Fairfax Regional Trauma
Center (FFX) is the primary Level 1
Trauma Center.
 HCA Reston Hospital is a Regional
adult Level II Trauma Center.
 Mary Washington Hospital is a
Regional adultLevel II Trauma
Center.
 Washington Hospital Center/
MEDSTAR is the regional adult Burn
Center and a Level I Trauma Center.
 Children’s National Medical Center is
the regional pediatric Burn Center
and a Pediatric Level 1 Trauma
Center.
 Other Facilities may be considered
on a case-by-case basis.
Step 4: Assess Special Patient or
System Considerations
Age
 Older Adults: Risk of injury death increase after age
55
 Children: Should be triaged preferentially to a
pediatric-capable trauma center
Anticoagulation or bleeding disorders
Burns
 Without other Trauma Mechanism:
o Triage to burn facility
 With Trauma Mechanism:
o Triage to Trauma Center
Time Sensitive Extremity Injury
End-Stage Renal Disease Required Diaylsis
EMS Provider Judgement
T T
Transport to closest appropriate hospital (may be
local facility or Trauma Center) capable of timely
and thorough initial evaluation and management
of potentially serious injuries. Consider
consultation with OLMC if transporting to local
facility.
YES
YES
YES
YES
Transport according to normal
operational procedures.
Administrative Procedure: Trauma Triage Criteria
Administrative Procedure: Trauma Triage Criteria
NO
NO
NO
NO
159
Prince William County Fire and Rescue System
I. Authorized Personnel
A. Active ALS and BLS providers.
II. Indications
A. Fire and/or EMS personnel have not initiated cardiopulmonary resuscitation.
B. The patient has not been exposed to an environment likely to promote hypothermia.
AND
C. The patient is experiencing one of the following.
1. Obvious signs of death.
a. Decapitation.
b. Rigor mortis (postmortem stiffing of the body’s muscles. It may or
may not involve some degree of actual shortening of the muscles. In
most cases, rigor mortis begins within 1‐2 hours after death; it begins
to pass after 24 hours).
c. Decomposition of body tissue.
d. Dependent lividity (purple‐red coloration that appears on dependent
portions of the body other than areas exposed to pressure after the
heart ceases to beat. It results from the settling of the blood under the
force of gravity).
c. Injuries incompatible with life (e.g., incineration, decapitation,
hemicorporectomy).
2. Blunt or penetrating trauma (all criteria must be met).
a. Pulseless, apneic, and no other signs of life present.
b. Lack of pupillary reflex or spontaneous movement.
c. Asystole or agonal rhythm <20 on cardiac monitor (if ALS present).
3. Valid DNR, DDNR, or POST form is present.
a. Refer to Administrative Procedure: Do Not Resuscitate Order for
more information on acceptable forms.
III. Contraindications.
A. Cardiopulmonary resuscitation had been initiated by Fire and/or EMS personnel.
B. Mechanism of injury is inconsistent with a traumatic arrest.
C. The patient has been moved to a transporting EMS unit or transport has been
initiated.
Administrative Procedure: Withholding Resuscitation
Administrative Procedure: Withholding Resuscitation
160
Administrative Procedure: Withholding Resuscitation
Prince William County Fire and Rescue System
Administrative Procedure: Withholding Resuscitation
IV. Procedure
A. If the patient meets the indications for withholding resuscitation (e.g., medical/
traumatic in nature or valid DNR, DDNR, POST), the following should be performed
and documented on the PCR.
1. Heart tones shall be auscultated for at least 30 seconds.
2. Notify communications of the confirmed DOA and request LEO, if not already
present.
3. Preserve the scene and await arrival of LEO. In order to preserve trace
evidence, avoid covering the body when it is prudent and reasonable to do so.
When a patient is deceased at a residence or other private area, partition off
or otherwise restrict access to the area where the body is. LEO on the scene
should be involved in the decision on how to best respect the patient’s
dignity without compromising investigative needs. There is no strict
contraindication to covering the deceased, especially when crews are trying
to protect the dignity of the deceased or the mental state of the family.
4. Provide comfort measures to family members.
5. Be prepared to provide LEO with the following, if applicable:
a. Initial findings.
b. Time of death.
c. Name of provider that determined resuscitation is not indicated.
d. Patient’s medical history.
e. Patient’s medications.
f. Patient’s primary physician.
6. Transportation of deceased bodies will be handled by private funeral homes.
Arrangement questions should be directed to LEO.
IV. Special Consideration
A. Initiate cardiopulmonary resuscitation and contact OLMC in the following situations.
1. Lighting or high voltage electrical injuries.
2. Drowning.
3. Suspected hypothermia.
B. If CPR has been initiated by other (bystanders, law enforcement) prior to EMS
arrival, resuscitative efforts may be terminated provided the patient meets the
indications.
C. If CPR has been initiated by EMS/Fire, OLMC must be contacted for authorization to
terminate resuscitative efforts prior to terminating resuscitation.
161
Clinical Procedure: Advanced Suctioning
Prince William County Fire and Rescue System
Clinical Procedure: Advanced Suctioning
I. Authorized Personnel
A. Active ALS and BLS providers.
II. Indications
A. Obstruction of the airway (secondary to secretions, blood, or any other substance)
in a patient currently being assisted with an airway adjunct such as an endotracheal
tube, tracheostomy tube, or a cricothyrotomy tube.
III. Contraindications
A. None.
IV. Procedure
A. Ensure suction device is in proper working order.
B. Pre‐oxygenate the patient.
C. Attach suction catheter to suction device, keeping sterile plastic covering over
catheter.
E. The suction catheter should not be advanced past the end of the airway. For all
devices, use the suprasternal notch as the end of the airway. Measure the depth
desired for the catheter (judgment must be used regarding the depth of suctioning
with cricothyrotomy and tracheostomy tubes).
F. If applicable, remove ventilation devices (e.g., bag‐valve mask) from the airway.
G. With the thumb port of the catheter uncovered, insert the catheter through the
airway device.
H. Once the desired depth (measured in “E” above) has been reached, occlude the
thumb port and remove the suction catheter slowly.
I. Small volume (< 10 ml) of normal saline lavage may be used as indicated.
J. Reattach ventilation device (e.g., bag‐valve‐mask) and ventilate the patient.
K. Document time and result in the PCR.
162
Clinical Procedure: Basic Suctioning
Prince William County Fire and Rescue System
Clinical Procedure: Basic Suctioning
I. Authorized Personnel
A. Active ALS and BLS providers.
II. Indications
A. Obstruction of the airway (secondary to secretions, blood, or any other substance)
in a patient who cannot maintain or keep the airway clear.
III. Contraindications
A. None.
IV. Procedure
A. Ensure suction device is in proper working order with suction tip in place.
B. Set mechanical suction device to appropriate setting (Adult: 120‐150mmHg OR
Pediatric: 80‐100mmHg).
C. Measure suction tip from corner of mouth to ear lobe and mark maximum insertion
depth; OR ensure tip of catheter is always in sight during use.
D. Pre‐oxygenate the patient.
E. Explain the procedure to the patient if they are coherent.
F. Examine the oropharynx and remove any potential foreign bodies or material that
may occlude the airway.
G. If applicable, remove ventilation devices (e.g., bag‐valve mask) from the airway.
H. Use the suction device to remove any secretions, blood, or other substance.
I. Maximum suction time:
a. Adult ‐ 15 seconds
b. Pediatric ‐ 10 seconds
c. Infant ‐ 5 seconds
J. Reattach ventilation device (e.g., bag‐valve mask) and ventilate or assist the patient.
K. Record the time and result of the suctioning in the PCR.
163
Clinical Procedure: Carboxyhemoglobin Monitoring
Prince William County Fire and Rescue System
Clinical Procedure: Carboxyhemoglobin Monitoring
I. Authorized Personnel
A. Active ALS and BLS providers.
II. Indications
A. Smoke inhalation.
B. Suspected CO poisoning.
C. Firefighter rehabilitation.
D. Patients exhibiting symptoms such as:
1. Headache.
2. Flu‐like symptoms.
3. Weakness or fatigue.
4. Nausea and/or vomiting.
5. Altered LOC.
6. Multiple patients displaying similar symptoms.
III. Contraindications
A. None.
IV. Equipment
A. Physio Control Lifepak 15 with SpCO monitoring and rainbow sensor.
OR
B. RAD‐57 with SPCO monitoring and rainbow sensor.
V. Procedure
A. Perform initial assessment.
B. Obtain Carboxyhemaglobin (SPCO) readings; confirm abnormal readings by taking
measurements in two additional fingers and averaging results.
C. Complete the Carboxyhemaglobin Worksheet and deliver along with the patient to
the receiving facility, if transported.
D. If readings on Lifepak 15 or RAD 57 are positive for possible CO poisoning, the
patient must be moved to a safe environment. Provider safety is paramount.
164
Prince William County Fire and Rescue System
Due to the potential for patients to be located in an IDLH atmosphere, it may be
necessary to utilize SCBA and obtain atmospheric samples prior to accessing
patients. Utilization of additional resources may be necessary to facilitate patient
access or extrication.
E. Treatment and transport recommendations.
1. Refer to appropriate medical protocol based on patients’ signs and
symptoms.
2. SPO2 readings will be unreliable in patients with abnormal SPCO levels.
F. Atmospheric monitoring shall be performed anytime CO poisoning is suspected or
the patient exhibits abnormal CO levels. Request additional resources to perform
atmospheric monitoring when indicated.
G. If abnormal SPCO levels are present and atmospheric readings are within normal
limits (< 35 PPM), attempt to identify alternate source of poisoning and request
assistance through Communications to check remote source locations.
Clinical Procedure: Carboxyhemoglobin Monitoring
Clinical Procedure: Carboxyhemoglobin Monitoring
165
Carbon Monoxide Readings
0‐5% Normal for non‐smokers Treat signs and symptoms
5‐10% Normal for smokers Treat signs and symptoms
5‐10% Abnormal for non‐smokers High flow O2 and transport
10‐15% Abnormal for any patient High flow 02 and transport
>15% Significantly abnormal ALS indicated, High flow 02 and transport
Clinical Procedure: Carboxyhemoglobin Monitoring
Prince William County Fire and Rescue System
Clinical Procedure: Carboxyhemoglobin Monitoring
166
Clinical Procedure: Chest Decompression
Prince William County Fire and Rescue System
Clinical Procedure: Chest Decompresssion
I. Authorized Personnel
A. Active ALS providers.
II. Indications
A. Pleural decompression for tension pneumothorax should be performed when all 3 of
the following criteria are present OR in the setting of a traumatic cardiac arrest in an
adult patient.
1. Severe respiratory distress with hypoxia.
2. Unilateral decreased or absent lung sounds (may see tracheal deviation away
from collapsed lung field).
3. Evidence of hemodynamic compromise (e.g., shock, hypotension, altered
mental status).
III. Equipment
A. 14 gauge 3.25 inch over‐the‐needle‐catheter (Adult).
B. 18 gauge 1.25 inch over‐the‐needle‐catheter (Pediatric).
C. Tape.
D. Sterile gauze pads and roller gauze.
E. Alcohol swabs.
IV. Procedures
A. Locate decompression site.
1. Identify the 2nd intercostal space in the mid‐clavicular line on the same side
as the suspected pneumothorax.
B. Prepare the site with an alcohol swab and allow to air dry.
1. Firmly introduce catheter immediately above distal rib of selected site
perpendicular to chest wall.
C. Insert the catheter into the thorax, and listen for air to exit (may not always be
audible).
D. Advance catheter and remove needle.
E. Secure the catheter taking care not to allow it to kink.
167
Clinical Procedure: Chest Decompression
Prince William County Fire and Rescue System
Clinical Procedure: Chest Decompresssion
F. Reassess lung sounds, patient condition, vital signs, and respiratory status.
G. Monitor for reoccurrence of tension pneumothorax. If signs or symptoms reoccur,
repeat the procedure leaving the initial catheter in place.
168
Clinical Procedure: Confirmation of Placement/Effectiveness of Ventilation
Prince William County Fire and Rescue System
Clinical Procedure: Confirmation of Placement/Effectiveness of Ventilation
I. Authorized Personnel
A. Active ALS and BLS providers.
II. Procedure
A. Capnography/ETCO2 Monitoring.
1. Digital capnography (waveform) is the system standard for ETCO2
monitoring.
2. In the event digital capnography is not available or due to on‐scene
equipment failure, continuous colorimetric monitoring of ETCO2 is an
acceptable alternative.
3. With the exception of on‐scene equipment failure, patients should not be
routinely switched from digital capnography (monitor) to a colorimetric
device for monitoring end‐tidal CO2.
4. Continuous ETCO2 monitoring is a MANDATORY component of invasive
airway management.
a. If ETCO2 monitoring cannot be accomplished by either of the above
methods, the invasive device MUST be REMOVED, and the airway
managed non‐invasively.
b. If an alveolar waveform is not present within the first 3‐6
breaths (e.g., flat line) or disappears after a waveform was present,
briefly check the filter line coupling to assure it is securely in place
then remove the ETT or LTA and manage the airway by alternate
means.
5. Additional confirmation measures:
a. Assess for absence of epigastric sounds, presence of breath sounds,
and chest rise and fall.
6. Record tube depth and secure in place using a commercial holder if
applicable.
7. Utilize head restraint devices (i.e. “head‐blocks”) or rigid cervical collar and
long spine board as indicated to help secure airway device in place.
169
Clinical Procedure: Continuous Positive Airway Pressure (CPAP)
Prince William County Fire and Rescue System
Clinical Procedure: Continuous Positive Airway Pressure (CPAP)
I. Authorized Personnel
A. Active ALS and BLS providers.
II. Indications
A. For adult patients with Acute Bronchospastic Disorders (acute or chronic bronchitis,
emphysema, or asthma) or Acute Pulmonary Edema, who have hypoxemia and/or
respiratory distress that does not quickly improve with pharmaceutical treatment.
B. Consider CPAP if 2 or more present:
1. Retraction of intercostal or accessory muscles.
2. Wheezing or signs bronchospasm.
3. Rales.
4. Respiratory rate > 25 per minute.
5. Oxygen saturation <92% on high flow oxygen.
III. Contraindications
A. Respiratory arrest.
B. Agonal respirations.
C. Unconscious or obtunded.
D. Shock associated with cardiac insufficiency.
E. Trauma.
F. Persistent nausea and vomiting.
G. Facial anomalies.
H. Current tracheostomy.
I. Inability to cooperate with the procedure.
J. Pediatric patients (<18 years of age)
K. Resent gastric, laryngeal, tracheal, or esophageal surgery.
IV. Equipment
A. O2 MAX BiTrac ED Mask, w/Nebulizer, Adult Medium Mask, w/3‐Set (5,7.5,10) PEEP
Valve and Ohmeda Quick Connector.
B. Spare Masks
1. Small
2. Medium
3. Large
170
Prince William County Fire and Rescue System
V. Procedure
A. Perform primary and secondary surveys.
B. Attach cardiac monitor, capnography, and SpO2.
1. Continuous ETCO2 monitoring is mandatory (Advanced Life Support).
C. Verbally instruct patient (this is a critical item).
1. Patients will sometimes require verbal assurance when using this device.
2. Setup CPAP device as per manufacturer’s instructions.
3. Instruct patient to slowly breathe in through the nose and exhale through the
mouth (exhalation phase should be about 4 seconds).
D. For pulmonary edema use an initial CPAP setting of 5 cm H20, titrate up to 10 cm
H20 based on clinical response (decreased work of breathing, improved
oxygenation/ ventilation).
1. Titration of CPAP pressure can only be performed by an endorsed ALS
Provider.
E. For Asthma/COPD use an initial CPAP setting of 5cm H20.
F. Typically, treatment should be continued throughout transport to the ED.
G. If hypoxia persists while on CPAP, O2 via capnography‐nasal cannula should be used
in addition to CPAP to increase the amount of oxygen delivered. Expect FiO2 to
increase approximately 4% with each additional litter of O2 flow.
H. Brief interruptions to administer medications is acceptable.
I. Record and monitor vital signs, ETCO2, and O2 saturation as indicated/available.
J. In the event of progressive respiratory failure:
1. Offer reassurance.
2. Stop treatment if necessary.
3. Institute BLS and ALS care per appropriate protocols.
4. Document adverse reactions and reasons why CPAP was discontinued in
PCR.
K. The following items should also be documented:
1. CPAP setting used (PEEP).
2. FiO2 level used.
Clinical Procedure: Continuous Positive Airway Pressure (CPAP)
Clinical Procedure: Continuous Positive Airway Pressure (CPAP)
171
Clinical Procedure: Cricothyrotomy
Prince William County Fire and Rescue System
Clinical Procedure: Cricothyrotomy
CONTACT MEDICAL CONTROL PRIOR TO PERFORMING CRICOTHYROTOMY
IF TIME PERMITS
I. Authorized Personnel
A. Active ALS providers.
II. Indications
A. When all airway management measures have failed and the patient needs an
advanced airway immediately, consider performing cricothyrotomy.
B. If in the paramedic’s judgement, the time necessary to contact medical control will
compromise the patient's chance of survival AND it is not possible to ventilate the
patient with a bag‐valve‐mask during transport, cricothyrotomy may be performed
without Medical Control.
III. Contraindications
A. Ability to ventilate patient with an oral‐pharyngeal/nasal‐pharyngeal airway, bagvalve‐
mask, LTA, or endotracheal tube.
IV. Equipment
A. Quicktrach II.
B. Adult BVM.
C. In‐line capnography.
D. 10 ml syringe for pilot balloon.
E. 10 ml syringe filled with 5 ml NS.
V. Procedure
A. Fill a 10 ml syringe with 5 ml NS.
B. Remove Quicktrach II from the package and assemble per manufacturer’s
instructions:
1. Remove valve opener, attach syringe, test, and evacuate air from the cuff.
C. Hyperextend the head of the patient when possible. Cleanse anterior neck.
D. Identify and mark cricothyroid membrane as the depression between the thyroid
cricoid cartilage.
172
Prince William County Fire and Rescue System
E. Stabilize the larynx with the index finger and thumb.
F. Puncture the skin and cricothyroid membrane with the Quicktrach II, perpendicular
(90 degree angle) to the skin while gently aspirating with the saline filled syringe.
1. Due to the sharp conical needle, a prior incision is not necessary. The
opening of the trachea is obtained by dilation.
G. Insert the Quicktrach II at a 45 degree angle further towards the trachea. Advance
until the stopper contacts the skin (the stopper helps to prevent the needle from
being inserted too deep).
H. Aspirate air with the saline filled syringe to help determine the position of the
cannula.
1. Tracheal placement is confirmed by air aspiration, evidenced by bubbles
into the syringe.
2. The syringe should aspirate easily confirming tracheal air space.
a. If aspiration is not possible because of an obese neck, remove the
stopper and carefully advance the cannula with the metal needle until
air aspiration is possible.
b. If aspiration is still not possible, reassess landmarks and consider an
additional attempt.
I. Remove the stopper from the cannula.
J. Advance the plastic cannula forward with the thumb until the safety clip audibly
clicks into position. This indicates that the tip of the metal needle is covered by the
plastic cannula to prevent trauma.
K. Further insert the Quicktrach II until the flange rests on the neck. The metal needle
may now be removed.
L. Inflate the cuff with the Tru‐cuff, ensure pressure is in the “Green Zone.” Use up to
10 mL of AIR ONLY. Check for proper inflation by palpation of the pilot balloon.
M. Secure the plastic cannula with the foam neck tape.
N. Attach ETCO2 and BVM.
1. Ventilate the patient directly via the 15mm standard connector or via the
included flexible tubing.
O. Confirm placement with gentle ventilation via bag‐valve‐mask, continuous
capnography and physical means.
1. Be sure air movement is fluid with bilateral symmetric chest rise and that no
visible neck soft‐tissue distortion is noted.
Clinical Procedure: Cricothyrotomy
Clinical Procedure: Cricothyrotomy
173
Prince William County Fire and Rescue System
P. Consider sedation if patient becomes combative:
o Administer Fentanyl 1 mcg/kg/ IV/IO (max dose 50 mcg), repeat every 5
minutes if indicated (max cumulative dose 200 mcg).
o Administer Midazolam 2.5 mg IV/IO, repeat in 5 minutes if indicated and
monitor for hypotension (max cumulative dose 5 mg).
Q. If not previously done, immediately notify medical control physician.
R. At completion of the call, EMS OPS and OMD notification is mandatory.
Clinical Procedure: Cricothyrotomy
Clinical Procedure: Cricothyrotomy
174
Clinical Procedure: End Tidal CO2 Monitoring
Prince William County Fire and Rescue System
Clinical Procedure: End Tidal CO2 Monitoring
I. Authorized Personnel
A. Active ALS and BLS providers.
II. Equipment
A. Adult/Pediatric nasal capnography cannula.
B. In‐line capnography device.
III. Indications
A. Assessment and monitoring of non‐intubated patients experiencing
respiratory distress via Adult/Pediatric nasal capnography cannula.
B. Assessment and monitoring of medical and trauma patients without
respiratory distress where ETCO2 readings will provide additional information into
the patient’s condition and affect treatment performed by providers (e.g., suspected
sepsis, isolated head injuries, stroke, cardiopulmonary arrest).
C. To confirm placement of advanced airways via in‐line capnography device.
IV. Procedure
A. Nasal Cannula ETCO2.
1. Attach capnography tubing to monitoring device (LP‐15).
2. Attach tubing to patient (may supplement with NRB mask if needed).
3. Document readings initially and throughout treatment as with other vital
signs.
B. In‐line capnography device.
1. Attach capnography sensor to BVM or advanced airway.
2. Document readings initially and throughout treatment as with other vital
signs.
3. Any loss of ETCO2 detection of waveform indicates an airway problem.
a. Recheck tube placement and remove if appropriate.
4. ETCO2 goal is 40mmHg.
a.. Above 45mmHg, increase ventilation rate.
b. Below 35mmHg, slow down ventilation rate.
5. Document the procedure and results on the PCR.
175
Clinical Procedure: General Airway Management
Prince William County Fire and Rescue System
Clinical Procedure: General Airway Management
I. Authorized Personnel
A. Active ALS and BLS providers.
II. Indications
A. Inadequate oxygenation or ventilation.
B. Unable to remove/relieve obstructing foreign body.
III. Contraindications
A. See specific technique for contraindications to specific procedures.
IV. Equipment
A. BVM (appropriate bag and mask for patient size).
B. Oxygen source.
C. Suction device with yankuer.
D. OPAs and NPAs.
E. King LT airway.
F. Endotracheal tube (prepare estimated correct size and one size smaller as backup).
G. Stylet for endotracheal tube (if not pre‐loaded).
H. SpO2 monitor.
I. ETC02 detection device.
J. Capnography (waveform).
K. Colorimetric device (back‐up device).
V. Procedure
A. Select and ready equipment, tube sizes, ETC02, suction, non‐visualized devices
(LTA).
B. If suspicion of trauma, maintain c‐spine immobilization.
C. Have assistant apply cricoid pressure.
D. Suction all debris and secretions from airway.
176
Clinical Procedure: General Airway Management
Prince William County Fire and Rescue System
Clinical Procedure: General Airway Management
E. BVM or spontaneous ventilations for 2‐5 minutes with 100% oxygen attempting to
keep the oxygen saturation > 92%.
F. Insert ETT taking no more than 30 seconds per attempt.
1. Refer to Clinical Procedure: Orotracheal Intubation.
G. If unsuccessful or patient’s SpO2 drops 92%, bag mask ventilate for additional 2
minutes so that SpO2 maintains > 95%.
H. If unsuccessful, insert laryngeal tube airway (LTA) following practice parameters.
I. If unable to insert LTA and cannot otherwise ventilate using any of above techniques
(including BVM) and unable to maintain SpO2 by any other means (BVM, OPA, NPA)
at 90% consider cricothyrotomy.
1. Refer to Clinical Procedure: Cricothyrotomy.
177
Clinical Procedure: Laryngeal Tube Airway (KING LTS-D)
Prince William County Fire and Rescue System
Clinical Procedure: Laryngeal Tube Airway (KING LTS-D)
I. Authorized Personnel
A. Active ALS and BLS providers.
II. Indications
A. When an alternative airway device is needed in the management of respiratory
failure, airway control or cardiac arrest in patients 4 feet tall or greater.
III. Contraindications
A. Intact gag reflex.
B. Patients with known esophageal disease.
C. Patients who have ingested caustic substances.
D. Patients with known tracheal obstruction.
E. Patients with a tracheostomy or laryengectomy.
F. Patients less than 4 feet tall.
IV. Equipment
A. Correctly sized LTA (see chart below).
B. BVM.
C. Suction device.
D. Bite block and/or endotracheal tube holder (if available).
E. Appropriately sized syringes for expanding cuff.
F. ETCO2 detection device (capnography preferred).
G. SpO2 monitor.
178
King LTS‐D Airway Sizes
Airway
Size
Connector
Color
Patient
Height
Outer Diameter/
Inner Diameter
Cuff
Volume
Gastric
Tube
3 Yellow 4‐5 feet 18/10 mm 50‐60 ml Up to 18 Fr.
4 Red 5‐6 feet 18/10 mm 70‐80 ml Up to 18 Fr.
5 Purple >6 feet 18/10 mm 80‐90 ml Up to 18 Fr.
Prince William County Fire and Rescue System
V. Procedure
A. Pre‐oxygenate patient with 100% 02 via BVM to achieve SpO2 of > 95% if possible.
B. Check the integrity of the cuff inflation system and pilot balloon.
C. Tightly deflate the cuff with the syringe.
D. Lubricate the posterior distal tip of the LTA with a water soluble lubricant.
E. Place patient in neutral sniffing position (if no C‐spine/spinal injury suspected):
1. For patients with suspected C‐spine injury, perform two‐person insertion
technique.
a. One person maintains manual in‐line cervical spine stabilization while
the other person proceeds with the procedure.
F. Pull mandible down to open mouth.
G. Insert uninflated LTA into oral cavity with a lateral technique. The tube should be
rotated latterly 45 to 90 degrees such as the blue orientation line is touching the
corner of the mouth.
H. Advance the tip behind the base of the tongue while rotating tube back to midline so
that the blue orientation line faces the chin of the patient.
I. Without exerting excessive force, advance tube until base of the colored connector is
aligned with teeth or gums.
J. Inflate the LTA with the appropriate volume:
1. If uninflated King Airway insertion is difficult, perform a jaw thrust, pulling
the tongue forward.
K. Attach the BVM and ETCO2 to the LTA.
L. While bagging the patient, gently withdraw the tube until ventilation becomes easy
and free flowing (large tidal volume with minimal airway pressure).
M. Adjust cuff inflation if necessary to obtain a seal of the airway at the peak ventilatory
pressure employed.
N. Obtain ETCO2, (capnography preferred), listen for breath sounds bilaterally, look for
chest excursion, and check oxygen saturation.
O. Secure in the midline to help maintain a good seal over the larynx.
P. Place bite block, oral airway, or endotracheal tube holder (if available) between
teeth to prevent biting tube.
Q. If applicable, ensure c‐spine motion remains restricted.
R. If an additional attempt is necessary, oxygenate with 100% O2 for 2 minutes
between attempts. Each attempt should last less than 30 seconds. Medical patients
are limited to 2 attempts, trauma patients are limited to 1 attempt.
Clinical Procedure: Laryngeal Tube Airway (KING LTS-D)
Clinical Procedure: Laryngeal Tube Airway (KING LTS-D)
179
Clinical Procedure: Obstructed Airway
Prince William County Fire and Rescue System
Clinical Procedure: Obstructed Airway
I. Authorized Personnel
A. Active ALS and BLS providers.
II. Procedure
A. Foreign Body Airway Obstruction – Birth to 1 year of age and conscious.
1. If coughing, wheezing and exchanging air, do not interfere with the victim’s
efforts to expel the foreign body.
2. If unable to cry or speak, weak or absent cough, or no air exchange:
a. Support the victim in the head down position with your non‐dominant
hand and forearm.
b. Perform 5 back blows with the heel of your dominant hand between
the should blades.
c. Perform 5 chest thrusts with two fingers in the center of the chest.
d. Repeat the steps above until the object is expelled or the victim
becomes unresponsive.
B. Foreign Body Airway Obstruction – > 1 year of age and conscious.
1. If coughing, wheezing and exchanging air, do not interfere with the patient’s
efforts to expel the foreign body.
2. If unable to speak, weak or absent cough OR no air exchange, perform
abdominal thrusts (Heimlich Maneuver).
C. Foreign Body Airway Obstruction – all ages, unconscious.
1. If patient was responsive and then became unresponsive:
a. Lower the victim to the ground and begin CPR, starting with
compressions (do not check for a pulse).
b. Every time you open the airway to give breaths, open the mouth wide
and look for the object.
c. If you see an object that can easily be removed, remove it with your
finger.
d. If you do not see an object, continue CPR.
2. If a foreign body is visualized but cannot be removed with finger, attempt to
remove it under direct visualization using the Laryngoscope blade and Magill
forceps (ALS ONLY).
a. Assemble laryngoscope and check bulb on blade.
b. Hold laryngoscope in left hand.
180
Prince William County Fire and Rescue System
c. Place patient in sniffing position.
d. Use tongue‐jaw lift or cross‐finger technique to open mouth.
e. Insert laryngoscope blade into right corner of mouth and move to
midline, sweeping tongue out of way.
f. Elevate mandible to visualize obstruction without using teeth or gums
as a fulcrum.
g. Grasp Magill forceps in right hand and remove obstruction under
direct visualization.
h. Provide suction as needed.
i. Resume appropriate CPR and airway management.
j. If the obstruction is not visualized or cannot be retrieved, attempt
endotracheal intubation with appropriate size ETT or 0.5
smaller (Paramedic only for pediatric patient).
k. If the patient is an adult, an ETT cannot be passed, and the patient
is unable to be ventilated by any other means, consider
cricothyrotomy. Refer to Clinical Procedure: Cricothyrotomy
(Paramedic only).
Clinical Procedure: Obstructed Airway
Clinical Procedure: Obstructed Airway
181
Clinical Procedure: Orotracheal Intubation/Bougie
Prince William County Fire and Rescue System
Clinical Procedure: Orotracheal Intubation/Bougie
Authorized Personnel
A. Active ALS providers.
Indications
A. Respiratory or cardiac arrest.
B. Inadequate ventilation with BVM.
C. Impending respiratory failure:
1. Decreased level of consciousness with hypoxia (SpO2 < 90%) despite 100%
O2 therapy, apnea, and/or respiratory rate < 8.
2. Poor ventilatory effort (with hypoxia despite 100% O2 therapy).
3. Inability to maintain patent airway.
4. Symptomatic airway obstruction.
Contraindications
A. Pediatric intubations cannot be performed by intermediate providers.
Equipment
A. Appropriate PPE (Mask, eye protection, gloves).
B. Airtraq SP system with appropriate size blade.
C. Laryngoscope handle with appropriate size blade.
D. Proper size ETT (with Stylet) and back‐up ETT 0.5 – 1.0 mm smaller.
E. Bougie 10 or 15 French Coude tip.
F. For pediatrics, utilize an appropriate length/weight based system to determine
appropriate size.
G. Water‐soluble lubrication gel (lubricate distal end of tube at cuff).
H. Tru‐Cuff syringe.
I. Thomas ET Holder or tape with proper OPA.
J. BVM and O2 source.
182
Clinical Procedure: Orotracheal Intubation/Bougie
Prince William County Fire and Rescue System
Clinical Procedure: Orotracheal Intubation/Bougie
K. Suction device.
L. Stethoscope.
M. Digital waveform capnography.
N. SpO2 monitor.
A. Patient /Equipment Preparation.
1. Maintain cervical alignment and immobilization if indicated.
2. Auscultate for presence of bilateral lung sounds before intubation.
3. Prepare suction for immediate use.
4. Attach proper blade to laryngoscope handle and check light.
5. Place Tru‐Cuff syringe on pilot bulb and check the ETT Cuff.
6. Lubricate distal ETT cuff and bottom ½ of Bougie (if utilized).
7. Properly position the patient to facilitate procedure (i.e., raise the stretcher
so the patient’s nose is at the intubating provider’s xiphoid).
8. Pre‐oxygenate patient with 100% O2 (BVM or NRB) before intubation.
Attempt to achieve O2 saturation > 92% for 5 minutes.
9. Attach patient to cardiac monitor and SpO2 monitor.
10. Ready ETC02 detection device.
11. Specify personnel to assist with:
a. Apply cricoid pressure (if required).
b. Keep neck immobile (if required).
c. Monitor cardiac rhythm and SpO2 saturation.
B. Tube Placement.
1. Intubation utilizing Airtraq SP
a. Select the appropriate size Airtraq SP based on the size of the ETT to
be used. Turn ON the light. (the light stops blinking once the anti‐fog
system is fully activated).
b. Attach the Airtraq camera to the appropriately selected blade.
c. Remove ETT stylet, lubricate the ETT, and place into the lateral
channel of the Airtraq SP without contacting the lens.
d. Align the tip of the ETT with the end of the lateral channel.
e. Insert the Airtraq SP into the midline of the patient’s mouth.
f. Before it reaches the vertical plane, begin looking to identify airway
structures.
g. Continue insertion until the epiglottis is identified. Place the tip of the
Airtraq SP into the vallecula. Alternatively, the tip can be placed under
the epiglottis, lifting it out of the way.
183
Clinical Procedure: Orotracheal Intubation/Bougie
Prince William County Fire and Rescue System
Clinical Procedure: Orotracheal Intubation/Bougie
h. Gently lift up the Airtraq SP to expose the vocal cords.
i. Align the vocal cords in the center of the visual field.
j. Gently advance the ETT in the lateral channel. If needed, rotate the
ETT inside the channel. Check insertion depth.
k. Inflate the ETT cuff with the Tru‐Cuff syringe until pressure is in the
green zone, approximately 20‐25 cm H20, and remove the syringe
from inflation valve. Check for proper positioning.
l. Carefully separate the ETT from the Airtrq SP by pulling it laterally
away from the ETT, while holding the ETT in position.
m. Remove the Airtraq SP from the patient’s airway following the
midline.
2. Intubation utilizing stylet:
a. Remove all foreign objects, (e.g., dentures, OPA, etc.) and suction the
patient's airway if needed.
b. Grasp laryngoscope handle in left hand.
c. Grasp ETT tube in right hand.
d. Insert the blade into the right side of the patient's mouth sweeping the
tongue to the left side.
e. Visualize the vocal cords while avoiding any pressure on the teeth.
f. If needed to improve the view of the glottic opening, apply or direct
another provider to apply laryngeal pressure or Bimanual
Laryngoscopy Technique.
g. Insert the ETT until the cuff passes the vocal cords, typical depth =
tube size (ID) X 3 ( e.g. 24 for an 8.0mm tube).
h. Remove the laryngoscope blade.
i. Remove stylet.
j. Inflate the ETT cuff with the Tru‐Cuff syringe until pressure is in the
green zone, approximately 20‐25 cm H20, and remove the syringe from
inflation valve.
3. Intubation utilizing Bougie.
a. Remove all foreign objects, (e.g., dentures, OPA, etc.) and suction the
patient's airway if needed.
b. Grasp laryngoscope handle in left hand. Alternatively, the AirTraq SP
can be used with a Bougie through the lateral channel.
c. Grasp Bougie in right hand.
d. Insert the blade into the right side of the patient's mouth sweeping the
tongue to the left side.
e. Visualize the vocal cords while avoiding any pressure on the teeth.
f. If needed to improve the view of the glottic opening, apply or direct
another provider to apply laryngeal pressure or Bimanual
Laryngoscopy Technique.
184
Clinical Procedure: Orotracheal Intubation/Bougie
Prince William County Fire and Rescue System
Clinical Procedure: Orotracheal Intubation/Bougie
g. Visualize the vocal cords and insert the Bougie with curved tip
anteriorly and visualize the tip passing the vocal cords or above the
arytenoids if the cords cannot be visualized.
h. Once inserted, gently advance the Bougie. Tactile confirmation of
tracheal clicking should be felt as the distal tip of the introducer
bumps against the tracheal rings. If tracheal clicking cannot be felt,
continue to gently advance the Bougie until you meet resistance or
“hold‐up”. If you do not meet resistance, you have a probable
esophageal intubation. Insertion should be re‐attempted.
i. Withdraw the Bougie ONLY to a depth sufficient enough to allow
loading of the ETT while maintaining proximal control of the
Introducer (a depth of approximately 25 cm typically ensures that the
distal tip lies at least 2 to 3 cm beyond the glottic opening).
j. Without taking eyes off the glottis opening, have the assistant gently
advance the ETT over the proximal tip of the Bougie.
k. Once the ETT tip approaches the glottic opening, rotate the ETT 90°
counter clockwise (1/4 turn to the left) so that the ETT bevel does not
catch on the arytenoid cartilage.
l. Insert the ETT until the cuff passes the vocal cords, typical depth =
tube size (ID) X 3 ( e.g. 24 for an 8.0mm tube).
m. Remove Bougie.
n. Remove the laryngoscope blade.
o. Inflate the ETT cuff with the Tru‐Cuff syringe until pressure is in the
green zone, approximately 20‐25 cm H20, and remove the syringe from
the inflation valve.
C. Placement confirmation.
1. Confirm tube placement with capnography first followed with clinical means.
a. Ventilate with BVM and:
1) Observe immediate (within 6 breaths) ETCO2 waveform and
number with capnography.
2) Watch for chest rise.
2. Listen to abdomen to ensure the ETT is not in the esophagus.
3. If bowel sounds heard with bagging or ETCO2 device does not indicate proper
ETT placement, deflate cuff, remove tube, and ventilate with BVM for 2
minutes.
185
Clinical Procedure: Orotracheal Intubation/Bougie
Prince William County Fire and Rescue System
Clinical Procedure: Orotracheal Intubation/Bougie
4. Listen for bilateral breath sounds.
5. Observe SpO2.
Regardless of the apparent presence of lung sounds, tube misting and chest rise, or
lack of gastric sounds; if ETCO2 does not indicate proper tube location (alveolar waveform),
ETTmust be removed.
6. If unilateral right sided breath sounds are heard consider right main stem
intubation:
a. If present, deflate the cuff and withdraw tube 1‐2 cm.
b. Reassess for breath sounds.
7. If intubation attempt(s) unsuccessful refer to the appropriate Respiratory
Emergencies: Failed Airway protocol.
8. If intubation attempt is successful:
a. Secure with Thomas ET Holder or tape with proper OPA.
b. Document depth of tube at teeth.
c. Reassess lung sounds and patient clinical status.
d. Ensure c‐spine motion is restricted, if indicated.
e. Utilize head restraint devices (head blocks, cervical collar) to minimize
displacement of airway.
f. Continue ventilations.
g. Document ETCO2 waveform and readings continuously and at time of
each patient movement, including waveform and reading at time of
transfer of care at the ED.
VII. Video File Use and Requirements
A. Following the use of the Airtraq, the video file shall be emailed to the OMD and the
Quality Management Lieutenant @ EMSIntubations@pwcgov.org.
1. Refer to the Airtraq Video Downloading Instructions located in the Reference
Documents section.
B. Video files can be reviewed by providers who were involved in patient care or with
providers who have received patient care (i.e., physician).
C. At no time shall the video be downloaded/sent to a non‐county computer or device.
Providers shall ensure all applicable HIPPA laws and associated department
policies and procedures are followed.
186
Clinical Procedure: Pulse Oximetry
Prince William County Fire and Rescue System
Clinical Procedure: Pulse Oximetry
I. Authorized Personnel
A. Active ALS and BLS providers.
II. Indications
A. Patients with suspected hypoxemia, altered level of consciousness, or respiratory
issues.
III.. Procedure
A. Apply probe to patient’s finger or any other digit as recommended by the device
manufacturer.
B. Allow machine to register saturation level.
C. Record time and initial saturation percent on room air if possible.
D. Verify pulse rate on machine with actual manual pulse of the patient.
E. Monitor critical patients continuously until arrival at the hospital. If recording a
one‐time reading, monitor patients for a few minutes as SpO2 can vary.
F. Document percent of oxygen saturation every time vital signs are recorded and in
response to therapy to correct hypoxemia.
G. In general, normal saturation is > 92%.
H. Use the pulse oximetry as an added tool for patient evaluation. Treat the patient, not
the data provided by the device.
I. The pulse oximeter reading should never be used to withhold oxygen from a patient
in respiratory distress or when it is the standard of care to apply oxygen despite
good SpO2 readings.
J. Factors which may reduce the reliability of the pulse oximetry reading include:
1. Poor peripheral circulation (blood volume, hypotension, hypothermia).
2. Excessive pulse oximeter sensor motion.
3. Fingernail polish (may be removed with acetone pad).
4. Carbon monoxide bound to hemoglobin.
5. Cyanide toxicity.
6. Irregular heart rhythms (atrial fibrillation, SVT, etc.).
7. Jaundice.
8. Placement of BP cuff on same extremity as pulse ox probe.
187
Clinical Procedure: 12-Lead ECG
Prince William County Fire and Rescue System
Clinical Procedure: 12-Lead ECG
I. Authorized Personnel
A. Active ALS and BLS providers.
II. Indications
A. Suspected cardiac patient.
B. Suspected overdose.
C. Electrical injuries.
D. Altered Mental Status/Syncope.
E. CHF.
F. Abdominal pain above the umbilicus.
G. Undifferentiated respiratory complaints.
H. Suspected stroke.
III. Procedure
A. Assess patient and monitor cardiac status.
B. If patient is unstable, definitive treatment is the priority. If patient is stable or
stabilized after treatment, perform a 12‐Lead ECG.
C. Prepare ECG monitor and connect patient cable to electrodes.
D. Expose chest and prep as necessary. Modesty of the patient should be respected.
E. Apply chest leads and extremity leads using the following landmarks:
1. RA Right arm.
2. LA Left arm.
3. RL Right leg.
4. LL Left leg.
5. V1 4th intercostal space to the right of the sternum.
6. V2 4th intercostal space to the left of the sternum.
7. V3 Directly between leads V2 and V4.
8. V4 5th intercostal space at midclavicular line.
9. V5 Level with V4 at left axillary line.
10. V6 Level with V5 at left midaxillary line.
F. Minimize artifact (instruct patient to remain still, stop motion of ambulance if
necessary).
G. Acquire the 12‐Lead ECG (complete age and gender questions correctly).
H. Transfer the 12‐lead ECG to the PCR. Place the name of the patient on the paper
copy of the ECG.
188
Prince William County Fire and Rescue System
I. ALS Provider:
1. If STEMI identified, notify STEMI Receiving Center immediately. Report
Code STEMI. Detailed report to follow. If equipped, transmit 12‐lead ECG
as soon as obtained.
J. BLS Provider:
1. If ALS is not on scene, transmit 12‐lead ECG as soon as obtained and confirm
that ED received the transmission.
2. If ALS is on scene, document the name of the reviewing ALS provider and
time reviewed.
K. Document the procedure, time and results on/with the PCR.
L. A BLS Provider may perform a 12‐Lead ECG; an ALS Provider, however, should
review it before implementing any treatment modalities.
Limb Lead Electrode Sites
When acquiring a 12‐Lead ECG, limb lead electrodes are typically placed on the wrists and
ankles as shown below. The limb lead electrodes can be placed anywhere along the limbs.
Chest Lead Electrode Sites
The six chest leads are placed on specific locations as shown below. Proper placement is
important for accurate diagnosis.
Clinical Procedure: 12-Lead ECG
Clinical Procedure: 12-Lead ECG
LEAD LOCATION
V1 Fourth intercostal space to the right of the sternum
V2 Fourth intercostal space to the left of the sternum
V3 Directly between leads V2 and V4
V4 Fifth intercostal space at midclavicular line
V5 Level with V4 at left anterior axillary line
V6 Level with V5 at left midaxillary line
189
Clinical Procedure: Cardiopulmonary Resuscitation
Prince William County Fire and Rescue System
Clinical Procedure: Cardiopulmonary Resuscitation
I. Authorized Personnel
A. Active ALS and BLS providers.
II. Indications
A. Pediatric arrest.
B. Suspected non‐cardiac arrest/respiratory arrest in adult patients (e.g., overdose,
drowning).
III. Procedure
A. Assess the patient’s level of responsiveness (shake and shout).
B. Assess pulse (carotid for adults and pediatrics, brachial for infants) for no more than
10 seconds, while observing for movement or breathing.
C. If no pulse, begin chest compressions/ventilations per current AHA guidelines.
D. Only brief interruptions are allowed for rhythm analysis and defibrillation.
E. Refer to appropriate cardiac arrest protocol.
H. Document the time and procedures in the PCR.
Age Location Depth Rate
Infant Over sternum, between nipples (intermammary
line), 2‐3 fingers
1.5 inches (1/3 the anteriorposterior
chest dimension)
100‐120/minute
Child Over sternum, between nipples, heel of
one or two hands
2 inches (1/3 the anteriorposterior
chest dimension)
100‐120/minute
Adult Over sternum, just above the xyphoid
process, hands with interlocked fingers
At least 2 inches (1/3 the
anterior‐posterior chest
dimension)
100‐120/minute
190
Clinical Procedure: Cardioversion
Prince William County Fire and Rescue System
Clinical Procedure: Cardioversion
I. Authorized Personnel
A. Active ALS providers.
II. Indications
A. Unstable patient with a tachydysrhythmia (rapid atrial fibrillation, supraventricular
tachycardia, ventricular tachycardia).
B. Patient has a palpable pulse.
III. Procedure
A. Attach ECG electrodes and monitor through lead II or lead with the greatest QRS
amplitude.
B. Press “SYNC” button and observer for “sense marker” in middle of each QRS
complex.
C. Adjust ECG size or lead if required.
D. Be prepared for defibrillation if the patient fails synchronized cardioversion and the
condition worsens.
E. Apply hands‐free pads to the patient’s chest in the proper position.
F. Consider analgesia and sedation per protocol.
G. Place therapy pads in the proper position.
H. Set energy selection to the appropriate setting per protocol and charge.
I. Make certain all personnel are clear of patient.
J. Confirm ECG rhythm and available energy.
K. Press and hold the shock button until energy has been delivered. Stay clear of the
patient until you are certain the energy has been delivered. NOTE: It may take the
monitor/defibrillator several cardiac cycles to “synchronize”, so there may be a
delay between activating the cardioversion and the actual delivery of energy.
L. Note patient’s response and perform immediate defibrillation if the patient’s rhythm
has deteriorated into pulseless ventricular tachycardia/ventricular fibrillation.
Follow the Clinical Procedure: Defibrillation Manual.
M. If the patient’s condition is unchanged, repeat steps B to K above, using escalating
energy settings per protocol.
N. Repeat per protocol until maximum setting or until efforts succeed.
O. Note procedure, response, and times in the PCR.
191
Clinical Procedure: Defibrillation Automated
Prince William County Fire and Rescue System
Clinical Procedure: Defibrillation Automated
I. Authorized Personnel
A. Active ALS and BLS providers.
II. Indications
A. Patients in cardiac arrest (pulseless, non‐breathing).
III. Contraindications
A. Pediatric patients whose body habitus is such that the therapy pads cannot be
placed without touching one another.
IV. Procedure
A. If multiple rescuers are available, one rescuer should provide uninterrupted chest
compressions while the AED is being prepared for use.
B. Turn on the AED.
C. Apply therapy pads to the patient, per manufacturer’s recommendations.
1. Use alternate placement when implanted devices (pacemakers, ICDs)
occupy preferred pad positions.
2. Remove any medication patches on the chest and wipe off any residue
medication.
3. Use pediatric therapy pads (if available) if less than 8 years of age and less
than 30 kg.
D. Plug the pads into the AED and follow AED prompts.
E. Stop CPR and clear the patient for rhythm analysis. Keep interruption in CPR as
brief as possible.
F. Defibrillate if appropriate by depressing the “shock” button. Assertively state
“CLEAR” and visualize that no one, including yourself, is in contact with the patient
prior to defibrillation.
G. Begin chest compressions immediately after the delivery of the defibrillation.
H. After 2 minutes of CPR, analyze rhythm and defibrillate if indicated. Repeat this step
every 2 minutes.
I. If “no shock advised” check for a pulse. If no pulse, perform CPR for two minutes and
then reanalyze.
192
Clinical Procedure: Defibrillation Automated
Prince William County Fire and Rescue System
Clinical Procedure: Defibrillation Automated
J. Transport and continue treatment as indicated.
K. Keep interruption of CPR compressions as brief as possible. Adequate CPR is a key
to successful resuscitation.
L. If pulse returns refer to appropriate Post‐Resuscitation protocol.
1. Do not disconnect the AED from the patient.
193
Clinical Procedure: Defibrillation Manual
Prince William County Fire and Rescue System
Clinical Procedure: Defibrillation Manual
I. Authorized Personnel
A. Active ALS providers.
II. Indications
A. Cardiac arrest with ventricular fibrillation or pulseless ventricular tachycardia.
III. Procedure
A. Ensure chest compressions are adequate and interrupted only when necessary.
B. Clinically confirm the diagnosis of cardiac arrest and identify the need for
defibrillation.
C. Apply therapy pads to the patient’s chest in the proper position.
D. Charge the defibrillator to the maximum energy level. Continue chest compressions
while the defibrillator is charging.
1. Adults 360 J.
2. Pediatric 4 J/kg to a maximum of 360 J.
E. Pause compressions, assertively state, “CLEAR”, and visualize that no one, including
yourself, is in contact with the patient.
F. Defibrillate by depressing the shock button.
G. Immediately resume chest compressions and ventilations for 2 minutes. After 2
minutes of CPR, analyze rhythm and check for pulse only if appropriate for rhythm.
H. Repeat the procedure every two minutes as indicated by patient response and ECG
rhythm.
I. Keep interruption of compressions as brief as possible. Adequate compressions are
the key to successful resuscitation.
194
Clinical Procedure: External Cardiac Pacing
Prince William County Fire and Rescue System
Clinical Procedure: External Cardiac Pacing
I. Authorized Personnel
A. Active ALS providers.
II. Indications
A. Monitored heart rate less than 50 BPM with unstable severe symptoms such as:
1. Acute altered mental status.
2. Hypotension (SBP < 90 mmHg or MAP < 65).
3. Ischemic chest discomfort.
4. Acute heart failure.
5. Other signs of shock.
Patients can often tolerate HR much less than the textbook rate of 60 BPM. If
symptoms are mild with no signs of shock, provide supportive care and expedite
transport.
III. Procedure
A. Attach cardiac monitoring leads.
1. Maintain the monitoring leads to allow the pacer to work in demand mode.
B. Print a 6 – second ECG strip to document the rhythm prior to pacing.
C. If the patient’s condition allows, perform a 12‐lead ECG.
D. For conscious patients, explain the procedure and what will occur.
E. Apply defibrillation/pacing pads.
F. Consider analgesia and sedation.
1. Refer to Cardiac Emergencies: Bradycardia.
G. Turn on the pacer by pressing the pacer button. Observe the pacing marker ( )
above each QRS.
H. If necessary, adjust ECG amplitude until pacer senses the QRS complex.
I. Adults: Select a rate of 80 BPM.
1. Consider the starting rate of 60 in the case of an acute MI or post
resuscitation.
J. Pediatrics: Select a rate of 100 BPM.
195
Prince William County Fire and Rescue System
K. Increase current in mA until electrical and mechanical capture is achieved.
1. The dial increases in increments of 5 mA and the current button increases in
10 mA.
L. Electrical capture is evident by a wide QRS and broad T‐wave.
M. Mechanical capture is achieved by observing the following:
1. Palpable femoral pulse.
2. Rise in blood pressure.
3. Improved level of consciousness.
4. Improved skin color and temp.
5. Pleth wave on SpO2.
N. After mechanical capture, increase mA by 10%.
O. If you reach maximum energy (200 mA) without mechanical capture, discontinue
pacing. May reattempt to pace following further medication or other appropriate
ALS therapies are performed. Consult OLMC.
P. Reassess patient for comfort and consider analgesia/sedation.
Q. The patient’s response to pacing could change to include loss of capture. Providers
must provide constant monitoring of the patient to include ETCO2 and SpO2. If loss of
capture occurs, return to step H.
1. SpO2 waveform will give instant feedback on the presence of mechanical
pulse.
2. ETCO2 will give instant feedback on perfusion status.
R. Using the defibrillator will cancel pacing. If pacing is needed following defibrillation,
pacing will need to be initiated. Refer to step G.
S. Transplanted hearts will not respond to Atropine.
T. External cardiac pacing is the preferred treatment in 2nd degree type II and 3rd
degree heart blocks.
U. If a cardiac monitoring lead falls off, the pacer converts to non‐demand pacing.
Reattach the lead to return to demand pacing.
V. Document the dysrhythmia and the response to external pacing with ECG strips in
the PCR.
Clinical Procedure: External Cardiac Pacing
Clinical Procedure: External Cardiac Pacing
196
Clinical Procedure: High Performance CPR
Prince William County Fire and Rescue System
Clinical Procedure: High Performance CPR
I. Authorized Personnel
A. Active ALS, BLS, and CPR trained providers who have completed an OMD approved
HPCPR course.
II. Indications
A. Patients In Cardiac Arrest, >12 years of age (> 40 kg or with signs of puberty if age
unknown).
III. Contraindications
A. Patients under the age of 12.
B. Patients who are DOA and are not candidates for resuscitation due to clinical
findings which are incompatible with life.
IV. Procedure
A. Quickly assess patient’s LOC while checking for a carotid pulse.
B. If patient is unconscious and pulseless, initiate resuscitation.
C. Effective Compressions.
1. Manual chest compressions should be initiated immediately upon
identification of cardiac arrest. Compressors shall be rotated every 2
minutes, during rhythm analysis. Chest compressions will be performed at a
depth of 2” ‐2.4” allowing for complete recoil of the chest after each
compression. Chest compressions should be accomplished with equal time
allowed for compression and recoil (upstroke), while maintaining a rate of
100–120/min. A metronome shall be utilized to aid in maintaining a correct
compression rate.
D. Continuous Compressions.
1. Chest compressions take priority over other all interventions except for
defibrillation. Compressions will be paused every two minutes to analyze the
rhythm and to deliver a shock as indicated. Compressions will be delivered
while the defibrillator charges. Compressions will be immediately resumed
following defibrillation.
197
Prince William County Fire and Rescue System
E. Defibrillation.
1. Defibrillators will be utilized as soon as available. Rhythm analysis will be
performed following every two minutes of CPR.
2. Automatic External Defibrillation.
a. The AED will be powered on as soon as the cardiac arrest is
confirmed. Do not interrupt chest compressions to remove clothing or
place defibrillation pads.
1) Shock Advised – If a shock is advised, the compressor will
Immediately start compressions while the AED is charging.
Once the AED has charged, the AED Operator will call “Clear”
and visually verify it is safe to shock. The compressor will
hover over the chest until the shock is delivered, then
immediately resume compressions once the shock is delivered.
There is no pulse check.
2) No Shock Advised ‐ When there is “No Shock Advised,” a pulse
check will be performed by one provider. If a pulse is not
palpated by this provider within 10 seconds, compressions
shall resume.
3. Manual Cardiac Monitor/Defibrillator (ALS Only) ‐ When the Code Manager
announces “15 seconds”, the defibrillator operator will activate the “Print”
button and charge the defibrillator to the appropriate energy.
At the end of the two‐minute cycle, the patient will be cleared when
announced. An ALS provider will assess the rhythm. If V‐Fib (or pulseless VTach)
is present, the patient will be defibrillated. The compressor will hover
over the chest until the shock is delivered, then immediately resume
compressions. There is no pulse check.
If VF or Pulseless VT are not present, the energy charge will be cancelled by
depressing the “speed dial”.
If Asystole is present on the ECG, immediately resume compressions.
Checking the rhythm in alternate leads is not indicated.
If the patient is in an organized rhythm, check a pulse. If no pulse, begin
compressions. Interruptions in compression will not exceed 10 seconds.
Clinical Procedure: High Performance CPR
Clinical Procedure: High Performance CPR
198
Prince William County Fire and Rescue System
F. Ventilations.
1. Ventilations will be performed without stopping chest compressions. One
ventilation will be given every 10th compression during chest recoil
(upstroke). Once an advanced airway is in place, ventilations will be
asynchronous with compressions (1 ventilation every 6 seconds). Ensure
BVM is attached to 100% oxygen and produces chest rise. Placement of an
advanced airway shall not interfere with compressions.
G. Passive Ventilation.
1. Passive ventilation is recommended until adequate resources are available to
provide ventilations without interfering with chest compressions or
defibrillation. Passive ventilation is performed by inserting an Oropharyngeal
Airway and applying a non‐rebreathing oxygen mask flowing at 15 lpm on
the patient. BVM ventilations in conjunction with a basic airway adjunct
(OPA, NPA) should be initiated as soon as adequate staff is available.
H. Advanced Life Support.
1. ALS providers will address defibrillation, IV/IO access, medication
administration, and advanced airway placement, as indicated within
protocols. High performance, continuous compressions remain a high
priority. Placement of an advanced airway will not interrupt chest
compressions. Digital waveform capnography and pulse oximetry shall be
utilized to evaluate the effectiveness of CPR performance and the occurrence
of ROSC. If an advanced airway is not placed, digital waveform capnography
will be utilized with bag‐valve‐mask (BVM) ventilation.
I. Code Resource Management (CRM).
1. Crews should coordinate their duties keeping the call priorities in mind.
Intervention priorities are (in order of highest to lowest):
Clinical Procedure: High Performance CPR
Clinical Procedure: High Performance CPR
199
Prince William County Fire and Rescue System
J. The number of personnel on a given incident and the qualifications of those
personnel can vary; however, the priorities remain the same. Appropriate crew roles
are outlined below (refer to attachments A‐G).
1. Crew Roles.
a. 2 provider crew:
 Provider 1 – Compressor
 Provider 2 –AED/Monitor Operator, Ventilator, Code Manager
*Providers 1 and 2 rotate every two minutes. Roles remain the
same even if providers are ALS equipped.
b. 3 provider crew:
 Provider 1 – Compressor
 Provider 2 – AED/Monitor Operator, Code Manager
 Provider 3 – Ventilator
*Providers 1 and 3 rotate every two minutes. Roles remain the
same even if providers are ALS equipped
c. 4 provider crew:
 Provider 1 – Compressor
 Provider 2 – AED/Monitor Operator
 Provider 3 – Ventilator
 Provider 4 – Code Manager
*Providers 1, 2, and 3 rotate every two minutes.
d. Greater than 4 providers ‐ Utilize the same initial assignments as the
four provider crew.
1) The fifth provider will liaise with the family, informing the
family of patient status, gathering patient information, and
documenting the medical interventions performed on the call.
2) Any additional personnel shall provide logistical support, such
as assisting with additional patient treatment or patient
movement.
Clinical Procedure: High Performance CPR
Clinical Procedure: High Performance CPR
200
Prince William County Fire and Rescue System
K. Roles and Responsibilities.
1. Code Manager ‐ The Code Manager shall:
a. Call remaining time for each cycle. Announcements of time shall occur
as follows. “One minute”, “30 seconds”, “15 seconds”, “5,4,3,2,1”
b. Ensure rotation of personnel doing compressions every two minutes.
c. Assess quality of CPR and give real time feedback.
d. Assure compressions resume following assessment or defibrillation.
e, Assure that only the compressor or ventilator are in contact with the
patient when an AED or manual defibrillator is being charged.
f. Record interventions performed during the arrest, if a scribe is not
available.
2. Compressor.
a. The compressor will promptly begin chest compressions following
determination of an absent pulse and following any defibrillations.
Compression will be provided at a rate of 100‐120 per minute. A
compression depth of 2” ‐ 2.4” shall be maintained. Full chest recoil
must be allowed following each compression. The compressor will
count the 8th through 10th compressions aloud to coordinate
ventilation (“8, 9, Bag”).
3. AED Operator.
a. The AED Operator will perform the initial assessment and pulse check.
If pulseless, the AED operator will direct the compressor to begin
chest compressions and then start the metronome. The AED Operator
will only attach the AED pads after compressions have begun.
Application of AED pads should not interrupt chest compressions.
Once the pads are placed and plugged in, the AED will begin analysis.
Once prompted by the AED, CPR should be withheld to allow for
rhythm analysis. If a shock is indicated, compressions will be resumed
while the defibrillator charges. The AED Operator will assure the
patient is cleared prior to defibrillation by announcing “clear” and
assuring the compressor and ventilator are clear.
4. Ventilator.
a. The ventilator shall assure the airway is open and clear (suction as
needed). They shall initially place an oropharyngeal (O.P.) airway.
Additional airway adjuncts will be utilized as indicated. The patient
Clinical Procedure: High Performance CPR
Clinical Procedure: High Performance CPR
201
Prince William County Fire and Rescue System
will be ventilated with a BVM and supplemental oxygen, following
every 10th compression during the recoil (upstroke). Ventilations
should result in chest rise only. Excessive ventilation or volumes
should be avoided.
5. Family Liaison.
a. The Family Liaison will interface with the patient’s family or
acquaintances to obtain pertinent medical history and to keep the
family apprised of the situation, throughout the resuscitation.
L. Patient Movement and Transport.
1. Resuscitations will be performed where the patient is found. Immediately
place the patient on the floor and begin compressions. If space is inadequate
(e.g., bathroom), the patient should be rapidly relocated to a nearby open
space. Clearing furnishings to create adequate space may be preferable.
a. Routinely, resuscitations that appear to be cardiac in nature, will be
conducted on the scene.
b. In cases where the arrest is NOT thought to be due to a cardiac
etiology, begin immediate resuscitation. Rapid patient packaging and
transport, with ongoing resuscitation, shall be initiated once adequate
resources are available. Examples include:
1) Traumatic cardiac arrest, with ongoing resuscitation.
2) Systemic Hypothermia.
3) Pediatric patients.
4) Pregnancy, estimated ≥24 weeks gestation.
5) Unrelieved airway obstruction.
c. In cases where on scene resuscitation is not possible due to an
untenable environment, EMS providers should move to the closest
appropriate area to conduct the resuscitation.
d. Cardiac arrest patients will normally receive a minimum of 30
minutes of resuscitative attempts, to include delivery of all
appropriate ALS interventions according to protocol.
e. After 30 minutes of resuscitation, EMS providers will consider;
1) Continued on‐scene resuscitative attempts.
2) Termination of resuscitation per Clinical Procedure:
Termination of Resuscitation.
3) Patient packaging and transport to a receiving facility.
Clinical Procedure: High Performance CPR
Clinical Procedure: High Performance CPR
202
Prince William County Fire and Rescue System
M. ALS Interactions.
1. When an ALS crew is the first to arrive to a patient in cardiac arrest, initiate
HPCPR following the Code Resource Management “Crew Roles”. Do not
initiate ALS care until adequate personnel are available to take over HPCPR.
a. The LP‐15 should be utilized in a manual mode in lieu of an AED and
operated by an ALS Provider. Only endorsed ALS Providers will
assess the printed rhythm strips and determine if a shock is advised.
The LP‐15 will be operated in the paddles mode during cardiac
resuscitations.
b. ALS skills will be performed without interfering with HPCPR and only
if there are at least 4 providers.
c. Attach in‐line capnography. If an advanced airway is not in place,
attach it to the BVM.
d. Attach and monitor Pulse Oximetry waveform.
e. When sufficient personnel are available, the following skills are to be
performed without hindering HPCPR.
1) Vascular access.
2) IV access is preferred over IO. Use of a large peripheral vein
preferred.
3) IO access should be attempted if IV access cannot be readily
established or following 2 unsuccessful IV attempts.
4) Airway.
 Assess the airway adjuncts in place and determine the need
for an advanced airway.
 Intubation shall be performed with ongoing compressions.
5) Medications – All medications should be administered per
protocol.
N. CODE‐STAT.
1. Obtaining prompt and complete data of cardiac arrest cases is an imperative
component of the resuscitation program.
a. LP‐1000: Manual downloading is required; promptly email the EMS
OPS Resuscitation Coordinator for manual download.
b. LP‐15 (used in AED or Manual mode): At the conclusion of the
incident, the incident data with be electronically transmitted to the EPPCR
and CODE‐STAT via the Transmit function.
Clinical Procedure: High Performance CPR
Clinical Procedure: High Performance CPR
203
Clinical Procedure: Implanted Cardiac Device
Prince William County Fire and Rescue System
Clinical Procedure: Implanted Cardiac Device
I. Authorized Personnel
A. Active ALS and BLS providers.
II. Indications
A. Patients with the following implanted cardiac devices.
1. Pacemaker.
2. Implanted Cardiac Defibrillator (ICD).
3. Ventricular Assist Device (VAD).
III. Procedure and Device Information
A. When evaluating and assessing patients with these devices, remember to place
therapy electrodes at least one‐inch away from the implanted device to help prevent
damage.
B. Pacemakers.
1. Internal pacemaker battery packs may be implanted subcutaneously in the
upper chest or abdominal region.
2. When operating in the AED mode, pacemaker pulses may prevent
advisement of an appropriate shock, regardless of the patient’s underlying
rhythm.
C. ICD.
1. Perform CPR as required. If the internal defibrillator discharges while a
provider is touching the patient, they may feel a “light” shock, but it is not
dangerous.
2. Apply therapy electrodes or paddles in the anterior‐lateral position, and treat
patient as any other patient requiring emergency care.
3. If defibrillation is unsuccessful, consider placing therapy electrodes in an
anterior‐posterior placement.
4. Internal battery packs may be implanted subcutaneously in the upper chest
or abdominal region.
D. VAD.
1. A VAD is a mechanical pump that is used to support heart function and blood
flow in people who have weakened hearts. Some common reasons for VAD
implantation are MI, Heart Failure, myocarditis, cardiomyopathy and heart
surgery.
204
Clinical Procedure: Implanted Cardiac Device
Prince William County Fire and Rescue System
Clinical Procedure: Implanted Cardiac Device
2. What types of patients receive a VAD?
a. Bridge to Transplant – The VAD is placed to support the patient’s
circulation until a suitable donor heart is found for transplant.
b. Bridge to Recovery – VAD is placed to support the patient’s circulation
until the native heart recovers sufficiently, at which time the VAD will
be surgically removed.
c. Destination Therapy – VAD is placed to support the patient’s
circulation for the rest of their life.
3. How does a VAD work?
a. The device takes blood from a lower chamber of the heart and helps
pump it to the body and vital organs, just as a healthy heart would.
The VAD is implanted in the abdominal cavity and is attached to the
apex of the left ventricle and upwards to the ascending aorta. The VAD
is pre‐load dependent requiring an adequate amount of volume to
maximize the pump’s capabilities. Place high credibility on your
patient’s clinical status, such as level of consciousness, manual heart
rate, and blood pressure before treating your rhythm.
4. What are the parts of a VAD?
a. The basic parts of a VAD include: a small tube that carries blood out of
your heart into a pump; another tube that carries blood from the
pump to your blood vessels, which delivers blood to your body; and a
power source.
5. What is the power source?
a. The power source is either batteries or AC power. The power source is
connected to a control unit that monitors the VAD functions. The
batteries are carried in a case usually located in a holster in a vest
around the patient’s shoulders.
6. What does the control unit (or controller) do?
a. The control unit gives warnings or alarms if the power is low or if it
senses that the device isn’t functioning properly.
7. VAD Center.
a. If the emergency is directly related to malfunction of the VAD, it is
imperative that the patient gets to the appropriate VAD equipment
and personnel trained in using the equipment as soon as possible,
preferably at the patient’s home VAD center. Consider use of Air‐
Medical Transport.
205
Clinical Procedure: Implanted Cardiac Device
Prince William County Fire and Rescue System
Clinical Procedure: Implanted Cardiac Device
8. VAD Patient Management.
a. Assess the patient’s airway and intervene per the Airway Management
Protocol.
b. Auscultate heart sounds to determine if the device is functioning and
what type of device it is. If it is a continuous flow device, you should
hear a “whirling sound.”
c. Look on the controller located around the patient’s waist or in the
VAD PAK and see what device it is.
d. Assess the device for any alarms.
e. Reference the most current Mid‐Atlantic Regional Pre‐Hospital
Mechanical Circulatory Support – Field Guide.
f. Intervene appropriately based on the type of alarm and patient guide.
g. Start one large bore IV.
h. Assess Vital Signs and use the Mean on the Non‐Invasive BP cuff as a
pressure reading. Contact medical control for pharmacologic
treatment modalities.
j. Transport to the closest VAD Center. Call the number listed on the
device for advice.
k. Bring all of the patient’s equipment and paperwork to the Emergency
Department.
l. Allow the trained caregiver to ride in the patient compartment when
possible. They may be able to serve as an expert on the device if the
patient is unconscious or unable to answer for themselves.
9. VAD Patients‐Specific Issues.
a. Unrelated medical/trauma emergency.
1) Treat as any other patient based upon their clinical status of
LOC, skin color temperature, and signs of hypoperfusion as
outlined in the field guide.
2) Notify medical control at the receiving ER that this is a VAD
patient. Based on the physician’s knowledge of VADs and the
resources to monitor them, he/she may alter your
transportation destination.
3) Ensure the patient has their “emergency bag” with extra
batteries, vent filters, and their hand pump (if equipped), in
206
Clinical Procedure: Implanted Cardiac Device
Prince William County Fire and Rescue System
Clinical Procedure: Implanted Cardiac Device
addition to the VAD trained companion that normally
accompanies them prior to leaving the scene.
b. Hypotension.
1) Hypotensive VAD patients should be treated with volume
before inotropic support. Contact medical control prior to
administration of vasodilators (e.g.,.nitro).
c. Cardiac Arrest (confirmed).
1) Do not initiate chest compressions under any circumstances.
Doing so will damage the device or pull the VAD from the
ventricle. Assess patient: auscultate VAD, assess mental status,
perfusion etc.
2) First identify if the patient has a pulse (VAD patients can be in
V‐Fib with a pulse). If they have a pulse, assess their clinical
status and provide airway and/or circulatory support as
indicated.
3) If the patient does not have a pulse, then identify if the VAD is
working. This is assessed by the presence or absence of noise
from the internal pump.
4) Refer to the VAD Field Guide for specific interventions.
5) Contact OLMC and the VAD Coordinator.
6) Un‐witnessed or greater than four minutes:
o If the patient has been in arrest for greater than four
minutes without hand pump initiation, do not initiate
hand pumping or re‐start the VAD. Fresh blood will clot
within the pump during this time, and initiation of the
hand pump or re‐starting the VAD will release these
clots into central circulation.
7) Witnessed cardiac arrest or arrest periods less than four
minutes:
o Manage the airway as you would for any other patient.
o If applicable, use patient’s hand pump in lieu of chest
compressions if the device has failed.
o Follow the instruction card found with the hand pump
or enlist the assistance of those trained in its use (e.g.,
family).
207
Clinical Procedure: Implanted Cardiac Device
Prince William County Fire and Rescue System
Clinical Procedure: Implanted Cardiac Device
o Be sure and let the bulb fully inflate after each squeeze; this
will maximize the pump’s output.
o Utilize the same rate with the hand pump as you would
with chest compressions.
d. Ventricular Fibrillation/Pulseless Ventricular Tachycardia.
1) VAD patients may end up in v‐fib arrest for two reasons. Initial
treatment may vary from the normal v‐fib arrest patient.
2) If the VAD is working:
o Cause: The potential cause for v‐fib is due to the lack of
forward flow (suck down state). This is due to
inadequate volume for the VAD to provide any cardiac
output, causing a significant ischemic cardiac event.
o Treatment: Provide airway management and a fluid
challenge (ALS only), re‐assess for palpable pulses and
blood pressure/MAP. (Do not initiate hand pumping if
the VAD pump is audibly working.).
o Contact OLMC.
3) If the VAD is not working:
o Place therapy pads on patient.
o Defer to field guide for specific VAD controller
instructions.
o Deliver shock per protocol.
o Initiate hand pumping if so equipped for the device.
o Provide treatment as directed by medical control (ALS
only).
o Rapidly transfer to personnel equipped and trained in
managing this patient’s special needs.
208
Clinical Procedure: Posterior ECG
Prince William County Fire and Rescue System
Clinical Procedure: Posterior ECG
I. Authorized Personnel
A. Active ALS providers.
II. Indications
A. For use when confronted with suspected situations defined in this directive. To
detect posterior STEMI associated with occlusion of the circumflex or dominant
right coronary artery. Indications of a posterior wall infarction may include:
1. Inferior or lateral wall MI (especially if accompanied by ST depression
or prominent R waves in leads V1‐V3).
2. Changes in V1‐V3 on the standard 12‐lead ECG predominantly, which may
include:
a. Horizontal ST depression.
b. A tall, upright T‐wave.
c. A tall, wide R‐wave.
III. Procedure
A. Prepare ECG monitor and connect patient cable to electrodes.
B. Expose chest and prep as necessary. Modesty of the patient should be respected.
C. Place three additional ECG electrodes. Start at V9 (the last electrode) and work
forward.
1. V9 Left spinal border, same horizontal line as V4‐6.
2. V8 Mid‐scapular line, same horizontal line as V7 and V9.
3. V7 Posterior axillary line, same horizontal line as V4‐6.
D. Place ECG lead cables as follows (using standard 12‐Lead).
1. Lead cable V6 connects to electrode V9.
2. Lead cable V5 connects to electrode V8.
3. Lead cable V4 connects to electrode V7.
E. Lead cables V1‐V3 are connected the same way as when obtaining a standard 12‐
lead ECG.
F. Minimize artifact (instruct patient to remain still, stop motion of ambulance if
necessary).
209
Prince William County Fire and Rescue System
G. Acquire the posterior ECG (complete age and gender questions correctly).
H. Provide posterior ECG to hospital staff, transmit when appropriate.
1. Clearly identify as a POSTERIOR ECG.
I. Transfer the 12‐lead ECG to the PCR. Place the name of the patient on the paper
copy of the ECG.
Clinical Procedure: Posterior ECG
Clinical Procedure: Posterior ECG
210
Clinical Procedure: Right Sided ECG
Prince William County Fire and Rescue System
Clinical Procedure: Right Sided ECG
I. Authorized Personnel
A. Active ALS providers.
II. Indications
A. To detect right ventricular STEMI associated with occlusion of the Right Coronary
Artery.
1. Indications of a Right Ventricle Wall infarction may include:
a. ST elevation in the inferior leads, II, III and aVF.
b. ST elevation that is greatest in lead III is especially significant.
c. ST elevation in lead V4R.
d. ST elevation in V1 (the only precordial lead that faces the RV on
standard 12‐lead ECG).
e. Right Bundle Branch Block, 2nd and 3rd Degree AV Blocks, ST
elevation in V2 50% greater than the ST depression in aVF.
III. Procedure
A. Prepare ECG monitor and connect patient cable to electrodes.
B. Expose chest and prep as necessary. Modesty of the patient should be respected.
C. Apply chest leads and extremity leads using the following landmarks:
1. V1R 4th intercostal space, left sternal border.
2. V2R 4th intercostal space, right sternal border.
3. V3R Halfway between V2R and V4R, on a diagonal line.
4. V4R 5th intercostal space, right midclavicular line.
5. V5R Right anterior axillary line, same horizontal line as V4R and V6R.
6. V6R Right mid‐axillary line, same horizontal line as V5R and V6R.
D. Isolated V4R tracing is acceptable alternative to a complete right sided ECG in
patient or time sensitive scenarios.
E. Minimize artifact (instruct patient to remain still, stop motion of ambulance if
necessary).
F. Acquire the ECG (complete age and gender questions correctly).
G. Provide Right Sided ECG to hospital staff, transmit when appropriate.
1. Clearly identify as a RIGHT sided ECG.
H. Document the procedure, time, and results in the electronic PCR.
211
Prince William County Fire and Rescue System
Clinical Procedure: Right Sided ECG
Clinical Procedure: Right Sided ECG
212
Clinical Procedure: Termination of Resuscitation
Prince William County Fire and Rescue System
Clinical Procedure: Termination of Resucitation
I. Authorized Personnel
A. Active ALS and BLS providers.
II. Indications
A. Cardiac arrest patients in which CPR has been initiated by EMS, when it is
contraindicated (BLS or ALS).
B. Presumed medical (non‐traumatic) cardiac arrest patients who have not responded
to ALS resuscitation (ALS ONLY).
III. Contraindications
A. Transportation has been initiated.
B. Systemic Hypothermia.
C. Cold water immersion.
D. Patients < 18 years of age.
E. Pregnancy, estimated ≥ 24 weeks gestation.
F. Unrelieved airway obstruction.
G. ROSC at any point during resuscitation (transient or permanent).
IV. Procedure
A. Termination of resuscitation in patients in which CPR has been initiated by EMS,
when it is contraindicated (BLS or ALS).
1. Patient should present with one or more of the following:
a. Rigor mortis.
b. Decomposition of body tissues.
c. Dependent lividity.
d. Obvious injuries incompatible with life (decapitation, crush injury,
penetrating or blunt injury with evisceration of vital organs).
e. Incineration (100% full thickness burns).
213
Prince William County Fire and Rescue System
B. Termination of Resuscitation (ALS ONLY).
1. Resuscitative efforts may be terminated with medical control consent for
adult patients assumed to be ≥ 18 years of age provided all of the following
criteria are met:
a. Patient has received an appropriate resuscitation based on the clinical
presentation. Normally 30 minutes of resuscitation is considered an
adequate trial. Some situations may dictate a longer or shorter
resuscitation.
b. No ROSC, even briefly.
c. Terminal rhythm is asystole or agonal (with a rate of 20 or less),
confirmed in two leads and documented with a printed ECG.
d. Secure airway placed (ETT/KING) and confirmed by waveform
capnography.
e. Initiation and monitoring of Continuous Capnography and Pulse
Oximetry. (Consistent Quantitative Capnography readings < 10 mmHg
following resuscitation is associated with extremely poor chances of
survival).
f. Patent IV or IO access.
g. Appropriate treatments and medication administration according to
Cardiac Arrest protocols to include at least three doses of
Epinephrine.
C. If the above criteria in procedure “A” or “B” are met, contact On‐Line Medical Control
for authorization to terminate resuscitation. Provide complete report to include
findings, actions, and outcomes to On‐Line Medical Control and request termination.
1. If authorized by On‐Line Medical Control, terminate the resuscitation. Note
the physician’s name on PCR.
2. Document time of death.
3. Following termination, assess and document absence of pulse and heart
tones (assessed by 30 seconds of auscultation). This should be confirmed by
two EMS providers.
D. Following Termination of Resuscitation:
1. Notify Communications of the death. Request PD, if not already present.
2. Preserve the scene and await arrival of PD. Do not cover the patient’s body to
avoid contamination of evidence. Refer to Fire and Rescue System procedure
titled “Preservation of Potential Crime Scenes” for further direction.
Clinical Procedure: Termination of Resuscitation
Clinical Procedure: Termination of Resucitation
214
Prince William County Fire and Rescue System
3. Provide comfort measures to family members. Consider contacting clergy,
friends, family, or FD Chaplains if agreeable to next of kin and law
enforcement.
4. Be prepared to provide law enforcement with initial findings, time of death,
and name of provider that determined the patient’s death, patient’s medical
history, patient’s medications, and patient’s primary physician.
5. Transportation of the deceased will be handled by private funeral homes.
Arrangement questions should be directed to law enforcement.
Clinical Procedure: Termination of Resuscitation
Clinical Procedure: Termination of Resucitation
215
Clinical Procedure: Blood Glucose Analysis
Prince William County Fire and Rescue System
Clinical Procedure: Blood Glucose Analysis
I. Authorized Personnel
A. Active ALS and BLS providers.
II. Indications
A. Patients with suspected hypoglycemia (diabetic emergencies, altered/change in
mental status, bizarre behavior, etc.).
III. Procedure
A. Gather and prepare equipment.
B. Place correct amount of blood on reagent strip or site on glucometer per the
manufacturer’s instructions.
C. Time the analysis as instructed by the manufacturer.
D. Document the glucometer reading and treat the patient as indicated by the analysis
and protocol.
1. Consider error if patient symptoms are discoordinate with readings. Utilize a
different glucometer to reassess.
E. Repeat glucose analysis as indicated for reassessment after treatment and per
protocol.
216
Clinical Procedure: Electronic Control Device (Taser)
Prince William County Fire and Rescue System
Clinical Procedure: Electronic Control Device (Taser)
For patients who have been controlled by law enforcement via an ECD/Taser, follow this protocol in
conjunction with any protocol that applies to underlying conditions (e.g., behavioral emergencies,
cocaine/sympathomimetic toxicity, and agitated delirium).
I. Authorized Personnel
A. Active ALS and BLS providers.
II. Procedure
A. Confirm scene safety with law enforcement.
B. Turn patient supine if found in a prone position.
C. Determine location of electrodes:
1. If removed by an LEO prior to evaluation:
a. Examine site for bleeding, expanding hematoma or distal neurological
deficit.
2. Eye, Face, Neck, Groin, Spinal Column, Axilla:
a. DO NOT REMOVE ELECTRODES, stabilize in place, and transport as
impaled object.
3. Superficial soft tissues EXCLUDING Eye, Face, Neck, Groin, Spinal Column,
Axilla:
a. Use scissors to cut the wire at the base of each probe cylinder to
disconnect probes from the cartridge.
b. Place one hand on the patient in the area where the probe is
embedded and stabilize the skin surrounding the puncture site.
c. Grasp the probe with your other hand/pliers at the base of the probe.
d. In one fluid motion pull the probe straight out from the puncture site.
Repeat procedure with the second probe.
e. Examine site for Bleeding, Expanding Hematoma, or Distal
Neurological Deficit.
D. If non‐transport:
1. Refer to Administrative Procedure: Police Custody Patient Care Standards.
2.. Refer to Administrative Procedure: Refusal of Medical Care.
217
Clinical Procedure: Eye Irrigation
Prince William County Fire and Rescue System
Clinical Procedure: Eye Irrigation
I. Authorized Personnel
A. Active ALS and BLS providers.
II. Indications
A. Concern for ocular chemical exposure by either history or physical exam.
III. Procedure
A. Identify agent that victim was exposed to.
B. Tilt head forward and brush eyelids/lashes if dry chemical present.
C. Remove contact lenses if present.
D. Prime macro drip tubing (10 gtt/cc or 20 gtt/cc) after hanging a 1000 ml bag of NS.
Close tubing clamp.
E. Start irrigation with normal saline and continue for 30 minutes or until arrival at the
the hospital.
218
Clinical Procedure: Medication Administration
Prince William County Fire and Rescue System
Clinical Procedure: Medication Administration
I. Authorized Personnel
A. Active ALS and BLS providers.
II. Indications
A. As indicated by protocol or OLMC.
III. Procedure
A. A Medication Administration Cross Check (MACC) shall be performed by endorsed
EMS providers prior to the administration of any medication.
1. Refer to Administrative Procedure: Medication Administration Cross
Check.
B. Confirmation of OLMC orders are always indicated:
1. Echo the medication order back to OLMC and receive confirmation of
medication name, indication, dose, and route.
2. Document the name of the OLMC physician in the PCR.
3. If providers are unsure as to whether a medication is contraindicated for
their patient, they are to contact OLMC.
a. Obtain and document the OLMC physician’s name and orders that
were received.
C. Monitor patient for adverse effects after administration of all medications.
D. Medication Administration Routes.
1. Auto Injector (All Providers).
a. Obtain the patient’s prescribed auto injector and perform a MACC.
b. Place the tip of the auto injector against the lateral portion of the midthigh.
c. Push the epinephrine auto injector firmly against the thigh and hold in
place for a minimum of 10 seconds.
d. Record time of administration in the PCR and bring the used auto
injector, with the patient, to the receiving facility.
e. ALS transport is preferred unless this delays patient delivery to the
receiving facility.
219
Clinical Procedure: Medication Administration
Prince William County Fire and Rescue System
Clinical Procedure: Medication Administration
2. Intra‐muscular (IM) (Advanced Life Support).
a. Determine appropriate dose of medication per appropriate protocol.
b. Draw medication into syringe (add additional 0.1 ml of medication
due to dead space) and dispose of the sharps into a sharps container.
b. Perform a MACC.
c. Ensure volume of medication to be administered does not exceed the
following maximum volume limits.
1) Adult vastus lateralis muscle = max 2 ml per site.
2) Pediatric vastus lateralis muscle = max 1 ml per site.
3) Adult deltoid muscle = max 1 ml per site.
d. Prepare the site of injection with an alcohol prep.
e. Insert a 1"‐1.25" long 22‐25 g needle at a 90 degree angle into the
vastus lateralis muscle (adult and pediatric) or the deltoid muscle
(adult only).
f. Aspirate to ensure no blood return.
h. Depress the plunger on the syringe to inject the medication.
i. Record time of administration and document in the PCR.
3. Intra‐nasal (IN) (All Providers).
a. IN medication administration is contraindicated in patients with
severe nasal/facial trauma, active nasal bleeding, or nasal discharge.
b. Put protective eyewear on.
c. Determine appropriate dose of medication per appropriate protocol.
d. Draw medication into syringe (add additional 0.1 ml of medication
due to dead space) and dispose of the sharps into a sharps container.
e. Do not administer more than 1 ml per nostril.
f. Perform a MACC.
g. Attach the Mucosal Atomizer Device (MAD) to the syringe.
h. With one hand, control the patient’s head.
i. Gently introduce the MAD into the nostril, stop when resistance is met.
j. Aim slightly upwards and toward the ear on the same side.
k. Briskly compress the syringe to administer the medication.
l. Providers may need to draw up medication in two syringes in order to
not exceed the 1 mL limit per nostril (both nares may be used).
m. Record time of administration and document in the PCR.
220
Clinical Procedure: Medication Administration
Prince William County Fire and Rescue System
Clinical Procedure: Medication Administration
4. Intravenous (IV) and Intraosseous (IO) (Advanced Life Support).
a. Determine appropriate dose of medication per appropriate protocol.
b. If medication is not pre‐filled, draw the medication into syringe (add
additional 0.1 ml of medication due to dead space) and dispose of the
sharps into a sharps container.
c. Perform a MACC.
d. All IV/IO medications shall be flushed with an appropriate NS bolus.
1) Adult = 20 ml.
2) Pediatrics = 10 ml.
3) Neonates = 5 ml.
e. Record time of administration and document in the PCR.
5. Metered Dose Inhaler (All Providers).
a. Meter Dose Inhaler (MDI) administration is contraindicated if the
patient has taken their maximum dosage of medication in the past 4‐6
hours.
b. Obtain the patient’s prescribed MDI and perform a MACC.
c. Shake the inhaler vigorously.
d. Instruct the patient to:
1) Inhale and exhale deeply.
2) Place mouth around the inhaler mouthpiece to create a tight
seal.
3) Inhale deeply as the medication canister is depressed.
4) Hold their breath as long as possible.
5) Repeat the process if the patient’s prescription states multiple
puffs.
e. Record time of the administration and document in the PCR.
f. ALS transport is preferred unless this delays patient delivery to the
receiving facility.
6. Nebulizer (All Providers).
a. Determine appropriate dose of medication per appropriate protocol.
b. Perform a MACC.
c. Place medication into the nebulizer kit.
d. Attach O2 source to the nebulizer kit (enough to promote a visabile
mist, typically 6‐8 lpm).
e. Instruct the patient to breath through their mouth, occasionally taking
in a deep breath and holding it for a few moments.
221
Clinical Procedure: Medication Administration
Prince William County Fire and Rescue System
Clinical Procedure: Medication Administration
f. Record time of administration and document in the PCR.
7. Orally Dissolving (All Providers).
a. Determine appropriate dose of medication per appropriate protocol.
b. Perform a MACC.
c. Ensure the patient has a patent airway prior to medication
administration.
d. Oral glucose should be administered via the buccal route (between the
patient’s gum and cheek.
e. Orally Dissolving Tablets (e.g., Ondansetron) should be placed on the
patient’s tongue.
f. Instruct the patient to allow the medication to dissolve in the mouth
and that they are not to chew or swallow the medication.
g. Record time of administration and document in the PCR.
8. Per os (PO) (All Providers).
a. Determine appropriate dose of medication per appropriate protocol.
b. Perform a MACC.
c. Ensure the patient has a patent airway prior to medication
administration.
d. Instruct the patient to chew and swallow the medication.
e. Record time of administration and document in PCR.
9. Sublingual (All Providers).
a. Determine appropriate dose of medication per appropriate protocol.
b. Perform a MACC.
d. Ensure the patient has a patent airway prior to medication
administration.
e. Instruct patient to allow the medication to dissolve under the tongue
and that they are not to chew or swallow the medication.
f. Record time of administration and document in PCR.
222
Clinical Procedure: Selective Spinal Motion Restriction (SSMR)
Prince William County Fire and Rescue System
Clinical Procedure: Selective Spinal Motion Restriction (SSMR)
Spinal Immobilization of neurologically intact trauma patients has long been hypothesized to be helpful in
preventing secondary spinal injury and stabilize potential fractures. Research has not necessarily demonstrated
this to be true and has demonstrated it to be harmful in other ways. Spinal Immobilization is not without risk. It
may increase pain, increase risk of aspiration, and respiratory compromise.
Selective Spinal Motion Restriction (SSMR) utilizes validated clinical decision rules to identify those patients at risk
for spinal injury, minimize spinal motion, prevent further injury during extrication and transport, and prevent
unnecessary harm from methods used to restrict spinal motion.
I. Authorized Personnel
A. Active ALS and BLS providers.
II. Methods of (SSMR)
A. Full Spinal Motion Restriction.
1. Long backboard with cervical collar.
B. Patient regulated SMR with a cervical collar.
C. Patient regulated SMR without a cervical collar.
III. Procedure
A. Determining the need for spinal immobilization and the method of immobilization
requires a careful assessment of:
1. The mechanism of injury.
2. The patient’s mental status and ability to recognize and communicate the
presence of spinal injury symptoms.
3. Physical complaints and overall condition.
B. In the presence of trauma where there is potential spinal injury, immediately
stabilize the cervical spine and address clinical needs in standard order of priority
(e.g., ABC).
IV. Penetrating Trauma
A. Clinical Indications for full SMR.
1. The patient exhibits evidence of clinical intoxication.
2. The patient cannot be assessed due to an altered mental status/decreased
level of consciousness (GCS < 15).
223
Clinical Procedure: Selective Spinal Motion Restriction (SSMR)
Prince William County Fire and Rescue System
Clinical Procedure: Selective Spinal Motion Restriction (SSMR)
3. The patient has neurological deficits:
a. Paresthesia/Numbness.
b. Focal weakness.
c. Focal Sensory deficit.
B. If the patient also has a blunt trauma injury, refer to the blunt trauma section.
C. If there are no indications as described above, then no SMR is required for
Penetrating Trauma.
V. Blunt Trauma
A. Clinical Indications for full SMR:
1. Altered level of consciousness (GCS<15, severe dementia, evidence of
clinical intoxication (alcohol or other).
2. Focal neurological deficit (paralysis or paresis).
3. Has a painful distracting injury.
4. Patient is unable to communicate due to a language barrier.
5. Patient is unable to appropriately respond to questions (e.g., young child,
speech or hearing impairment).
B. If there are no clinical indications for full SMR, establish manual stabilization
for any patient with a traumatic injury. Position the head in the neutral
position. If realignment causes pain or resistance is encountered, stabilize the
c‐spine in the position found. Then perform an SSMR evaluation.
1. Explain to the patient that you will be evaluating their spine, requesting that
the patient answer your questions verbally and to avoid nodding/shaking
their head yes/no.
2. If any time during the SSMR Evaluation the patient complains of pain,
tenderness, or neurological findings, stop the procedure, maintain manual
stabilization, and place a cervical collar on the patient.
3. Palpate each individual vertebra from the base of the skull to the end of T1.
Evaluate the patient for pain, tenderness, and/or deformity. If none are
found, assess cervical spine range of motion utilizing the NEXUS criteria:
a. All range of motion assessments must be performed by the patient
unassisted.
b. Ask the patient to slowly rotate their neck to one side as if to look over
their shoulder and then slowly return to their head to a neutral
position.
224
Clinical Procedure: Selective Spinal Motion Restriction (SSMR)
Prince William County Fire and Rescue System
Clinical Procedure: Selective Spinal Motion Restriction (SSMR)
c. Request that the patient repeat the process on the opposite side by
looking over the other shoulder.
d. Ask the patient to slowly flex their neck down by touching their chin
to their chest and then to slowly return their head to a neutral
position.
e. Ask the patient to slowly extend their neck and then slowly return
their head to a neutral position.
4. If the patient passes all the assessments then there are no indications
for SMR and cervical spine precautions may be released.
5. Patients that do not meet the criteria for FULL SMR but do not pass the
assessment require c‐collar SMR; maintain manual stabilization of the
cervical spine until c‐collar is applied.
a. Apply a properly sized cervical collar and release manual stabilization.
b. If the c‐collar does not fit appropriately, causes difficulty breathing, or
causes increased pain or agitation, immediately remove the collar and
consider using a towel roll to minimize movement.
c. Patients that are ambulatory, standing, or seated should be allowed to
move to and sit down on the cot by themselves if they can. Provide
stability if the patient requires it.
1) Have the cot as close as possible to the patient before moving.
2) Have the head of bed raised 30 degrees.
3) Have the patient sit on the cot and transport in position of
comfort.
d. Patients found on the ground should be moved to the stretcher via a
long backboard (remove backboard after moving patient to
stretcher).
VI. Special Situations
A. If spinal motion restriction is indicated but refused by the patient:
1. Advise the patient of the indication for SMR and the risks of refusing the
intervention.
2.. Maintain spinal alignment as best as can be achieved during transport.
3. Clearly document refusal of SMR.
225
Clinical Procedure: Selective Spinal Motion Restriction (SSMR)
Prince William County Fire and Rescue System
Clinical Procedure: Selective Spinal Motion Restriction (SSMR)
B. For patients who cannot tolerate supine position due to clinical condition:
1. Apply all elements of SMR that the patient will tolerate.
2. Maintain spinal alignment as best as can be achieved during transport.
3. Clearly document the clinical condition that interfered with SMR.
C. Patients of advanced age or with prior medical conditions that would make them
more susceptible to spinal injury, should have SSMR Evaluation performed if injury
is suspected.
D. Pediatric patients may be immobilized in their undamaged car seats by applying a ccollar
or towel roll, padding void spaces, and securing patients to the car seat.
E. If placed on a back board, pregnant patients > 12 weeks gestation shall be
transported on their left side by tilting and stabilizing the backboard at a 15° angle.
F. Kendrick Extrication Device (KED) ‐ may be beneficial when extricating a seated
patient in a VERTICAL move. Once moved to the stretcher, remove the KED leaving
the cervical collar in place. KED use should be limited.
G. When providing care to athletes with suspected spine injury, generally equipment
should be removed prior to transport (e.g., both helmet and shoulder pads).
H. All non‐football helmets should to be removed prior to immobilization (e.g.,
motorcycle helmet, baseball helmet).
226
Clinical Procedure: Splinting
Prince William County Fire and Rescue System
Clinical Procedure: Splinting
I. Authorized Personnel
A. Active ALS and BLS providers.
II. Indications
A. Immobilization of an extremity for transport, either due to suspected fracture,
sprain, or injury.
B. Immobilization of an extremity for transport to secure medically necessary devices
such as intravenous catheters.
III. Equipment
A. OMD approved splinting devices.
IV. Procedure
A. Assess and document pulse, sensation, and motor function prior to placement of
the splint. If no distal pulse is present and a fracture is suspected, consider
reduction of the fracture prior to placement of the splint.
B. Remove all clothing and jewelry from the extremity.
C. Select a site to secure the splint both proximal and distal to the area of suspected
injury or the area where the medical device will be placed.
D. Do not secure the splint directly over the injury or device.
E. Place the splint and secure with Velcro, straps, or bandage material (e.g., kling,
kerlex, cloth bandage, etc.) depending on the splint manufacture and design.
F. Document pulses, sensation, and motor function after placement of the splint. If
there has been a deterioration in any of these 3 parameters, reposition the splint
and reassess. If no improvement, remove splint.
G. If an isolated femur fracture is suspected and there is no evidence of pelvic fracture
or instability, place traction splint.
H. Consider pain management per protocol.
I. Document the time, type of splint, and the pre and post assessment of pulse,
sensation, and motor function in the PCR.
227
Clinical Procedure: Tactical Emergency Casualty Care (TECC)
Prince William County Fire and Rescue System
Clinical Procedure: Tactical Emergency Casualty Care (TECC)
I. Authorized Personnel
A. Active ALS and BLS providers.
II. Indications
A. For use during the management of casualties in high threat environments.
III. Equipment
A. TECC Bag.
1. (4) H‐Bandages.
2. (4) METT Tourniquets.
3. (4) Rescue Blankets.
4. (4) Compressed Gauze.
5. (4) Hemostatic Gauze.
6. (4) Chest Seals.
7. (4) NP Airways.
8. (4) ACE Wraps.
9. (4) 14g Needles.
10. (4) Rolls of tape.
IV. Procedure
A. Indirect threat care.
1. Indirect threat care is provided in an area that has been cleared of a
particular hazard that would otherwise present a direct threat to responders.
2. Mitigate the hazard and move to a safer position if possible.
a. Initial actions should be to address the immediate life threat (e.g.
shoring, fire suppression, extraction from immediate structural
collapse).
3. Life threatening hemorrhage.
a. Stop life threatening external hemorrhage.
1) Apply tourniquet over the clothing as proximal as possible to
the suspected wound site.
2) Do not place over knee, elbow, or open fracture.
228
Clinical Procedure: Tactical Emergency Casualty Care (TECC)
Prince William County Fire and Rescue System
Clinical Procedure: Tactical Emergency Casualty Care (TECC)
3) Windless should be accessible by both the casualty
and other responders.
4) Apply second tourniquet, proximal to the first, if bleeding is not
controlled.
b. Tighten until the bleeding stops.
c. Instruct casualty to apply direct pressure to the wound if no
tourniquet is available or conditions prevent the application of a
tourniquet.
d. Casualties should be placed into a position that facilitates a patent
airway.
4. Direct the casualty to move to cover and apply self‐aid if capable.
5. Assess for unrecognized life threating hemorrhage and control all sources of
major bleeding.
a. If not already performed, apply tourniquet over the clothing as
proximal to the wound as possible (if able to expose and evaluate the
wound, apply directly to the skin 2 ‐ 3 inches above the wound).
b. For total or partial traumatic amputations, a tourniquet should be
applied regardless of bleeding.
c. For compressible hemorrhage not amenable to tourniquet use, apply
hemostatic agent in accordance with directions for its use and an
appropriate pressure bandage.
d. Reassess all tourniquets that were initially applied.
1) If the casualty’s wound continues to hemorrhage despite the
previous application of a tourniquet, apply a second tourniquet
immediately proximal to the first tourniquet. Tighten the
second tourniquet until the hemorrhage has been controlled.
2) If time and the situation allows, a distal pulse should be
assessed on any limb where a tourniquet is applied. If bleeding
is persistent, consider tightening the tourniquet or applying a
second tourniquet. The goal is to eliminate a distal pulse in the
limb where a tourniquet is applied.
3) Expose and mark all tourniquet sites with the application time
of the tourniquet.
229
Clinical Procedure: Tactical Emergency Casualty Care (TECC)
Prince William County Fire and Rescue System
Clinical Procedure: Tactical Emergency Casualty Care (TECC)
A. Airway Management.
1. If no spontaneous breathing is noted after airway is opened, move on to the
next casualty.
2. If casualty is breathing and they are:
a. Unconscious:
1) Insert a NP airway.
2) Place casualty in a recovery position or a position that best
facilitates the patency of the casualty’s airway.
b. Conscious:
1) Place casualty in a recovery position or a position that best
facilitates a patent airway.
3. Breathing.
a. If patient has an open chest wound, apply a SAM chest seal.
b. (ENDORSED ALS PROVIDERS ONLY) For a suspected tension
pneumothorax, decompress the chest with a 14‐gauge, 3.25 inch
needle. Refer to Clinical Procedure: Chest Decompression.
4. Prevention of Hypothermia.
a. Attempt to minimize environmental exposure to the elements.
b. Remove wet clothing if possible.
c. Place casualty onto an insulated surface if possible.
d. Cover the casualty with a rescue blanket or anything that will retain
heat and keep the casualty dry.
230
Clinical Procedure: Tactical Emergency Casualty Care (TECC)
Prince William County Fire and Rescue System
Clinical Procedure: Tactical Emergency Casualty Care (TECC)
C. Tactical Emergency Casualty Care (TECC) Bag
Tape (4)
METT
Tourniquet (4)
14 ga Needle (4)
Chest Seal (4)
ACE Wrap (4)
Compressed
Gauze (4)
NP Airway (4)
Hemostatic
Gauze (4) H‐Bandage (4) Rescue Blanket (4)
231
Clinical Procedure: Temperature Measurements
Prince William County Fire and Rescue System
Clinical Procedure: Temperature Measurements
I. Authorized Personnel
A. Active ALS and BLS providers.
II. Indications
A. Monitoring body temperature in a patient with suspected infection, hypothermia,
hyperthermia, or to assist in evaluating resuscitation.
III. Procedure
A. If clinically appropriate, allow the patient to reach equilibrium with the surrounding
environment.
B. To obtain an oral temperature, ensure the patient has no oral trauma and place the
device under the tongue.
C. Leave the device in place until there is indication an accurate temperature has been
recorded (per the specific device).
D. Record time, temperature, method (tympanic or oral), and scale (C or F) in PCR.
232
Clinical Procedure: Venous Access Indwelling Catheters
Prince William County Fire and Rescue System
Clinical Procedure: Venous Access Indwelling Catheters
I. Authorized Personnel
A. Active ALS providers.
II. Indications
A. Access of an existing venous catheter (i.e., PICC line) for medication or fluid
administration only in a life threatening situation when no other access is available.
B. Central venous access in a patient in cardiac arrest.
III. Contraindications
A. Non‐externalized ports (subcutaneous or tunneled ports).
IV. Procedures
A. Wear appropriate PPE (i.e., gloves, maks).
B. Clean the port of the catheter with alcohol wipe and allow to dry.
C. Using sterile technique, withdraw 5‐10 cc of blood and place syringe in sharps box.
D. Clean the port of the catheter with alcohol wipe and allow to dry.
E. Using 5cc of normal saline, access the port with sterile technique and gently attempt
to flush the saline.
F. If there is no resistance, no evidence of infiltration (e.g., no subcutaneous, collection
of fluid), and no pain experienced by the patient, then proceed to step G. If there is
resistance, evidence of infiltration, pain experienced by the patient, or any concern
that the catheter may be clotted or dislodged, do not use the catheter.
G. Begin administration of medications or IV fluids slowly. Observe for any signs of
infiltration. If difficulties are encountered, stop the infusion and reassess.
H. Record procedure, any complications, and fluids/medications administered in the
PCR.
233
Prince William County Fire and Rescue System
I. Authorized Personnel
A. Active ALS providers.
II. Indications
A. Critical patients where rapid, regular IV access is unavailable with any of the
following:
1. Cardiac Arrest.
2. Multisystem trauma with severe hypovolemia.
3. Severe burns.
4. Severe dehydration with vascular collapse and/or loss of consciousness.
5. Respiratory failure/Respiratory arrest.
6. Critical medical emergencies requiring immediate access .
7. Patients deemed appropriate by Medical Control.
8. Pediatric patients in cardiac arrest may go directly to IO if no peripheral
venous access sites are readily available.
III. Contraindications
A. Conscious patient with stable vital signs.
B. Peripheral vascular or intra nasal access (when applicable) readily available.
C. Fracture proximal to proposed intraosseous site.
D. Patient with history of known bone disorder.
E. Infection overlying intended intraosseous site.
F. Inability to identify landmarks.
G. Previous intraosseous insertion (within 48 hours) or joint replacement at the
selected site.
H. Deep burns involving bone at the selected site.
IV. Procedure
A. Site selection.
1. Patients < 6 years of age or patients < 40 kg, proximal tibia.
2. Patients > 40 kg, proximal humerous (preferred), proximal tibia.
Clinical Procedure: Venous Access Intraosseous
Clinical Procedure: Venous Access Intraosseous
234
Clinical Procedure: Venous Access Intraosseous
Prince William County Fire and Rescue System
Clinical Procedure: Venous Access Intraosseous
B. Identify the appropriate site.
1. Anterior Tibia.
a. Anteromedial aspect of the proximal tibia (bony prominence below
the kneecap).
b. The insertion location will be 1‐2cm (2 finger widths) below this.
2. Proximal Humerus (Method A).
a. Keeping the elbow flat on the floor and close to the side of the body,
rotate the palm over the umbilicus and palpate the greater tubercle of
the humerus.
b. The insertion location will be 1‐2cm (2 finger widths) above the
surgical neck.
3. Proximal Humerus (Method B).
a. With the arm fully extended and tight to the body, rotate the hand
medially (inward) until the palm is facing out.
b. Palpate the greater tubercle of the humerus approximately 1‐2cm (2
finger widths) above the surgical neck.
c. The insertion location will be 1‐2cm (2 finger widths) above the
surgical neck.
C. Wear personal protective equipment (gloves, eye protection, etc.).
D. Cleanse the site.
E. For manual pediatric devices (Anterior Tibia).
1. Hold the intraosseous needle at a 60 to 90 degree angle, aimed away from the
nearby joint and epiphyseal plate, twist the needle handle with a rotating
grinding motion applying controlled downward force until a “pop” or “give”
is felt indicating loss of resistance. Do not advance the needle any
further.
F. For the EZ‐IO intraosseous device.
1. Proximal Humerous
a. Hold the intraosseous needle at a 45° angle, aimed away from the
nearby joint and epiphyseal plate, power the driver until the hub of
the needle is flush with the skin.
2. Proximal Tibia
a. Hold the intraosseous needle at a 90° angle, aimed away from the
nearby joint and epiphyseal plate, power the driver until a “pop” or
“give” is felt indicating loss of resistance. Do not advance the needle
any further.
235
Prince William County Fire and Rescue System
G. Remove the stylet and place in an approved sharps container.
H. Attach a 10 cc syringe filled with 5 cc NS; aspirate bone marrow to verify correct
placement, then inject 5 cc of NS to clear the lumen of the needle.
I. For infusion related pain, ALS Providers may administer:
1. Adults:
a. Administer 40 mg of 2% Lidocaine over 2 minutes.
1) Allow lidocaine to dwell in IO space for 1 minute.
2) Flush with 10 cc of NS.
2. Pediatric:
a. Administer 0.5 mg/kg of 2% Lidocaine (not to exceed 40 mg) over 2
minutes.
1) Allow lidocaine to dwell in IO space for 1 minute
2) Flush with 5 cc of NS.
J. Attach the IV line. Use a pressure bag.
K. Stabilize and secure the needle with dressings and tape.
L. If the proximal humerus site is used, ensure the patient’s arm is secured in the
position that the IO was established.
M. Following the administration of any IO medications, flush the IO line with 10 cc of IV
fluid to expedite medication absorption.
N. Record the time on the manufacture supplied arm band and place the arm band on
the wrist.
O. Document the procedure, time, and result (success) on/with the PCR.
Clinical Procedure: Venous Access Intraosseous
Clinical Procedure: Venous Access Intraosseous
236
Clinical Procedure: Venous Access Peripheral
Prince William County Fire and Rescue System
Clinical Procedure: Venous Access Peripheral
I. Authorized Personnel
A. Active ALS providers.
II. Indications
A. Patients requiring IV medications or fluids.
B. Patients with any potential for deterioration (e.g. seizures, altered mentation,
trauma, chest pain, difficulty breathing, potential emergent medical condition).
III. Contraindications
A. Child with partial airway obstruction (e.g., suspected epiglottitis)– when agitation
from performing procedure may worsen respiratory difficulty.
IV. Equipment
A. Appropriate tubing or IV lock.
B. # 14 ‐ #24 over the needle catheter.
C. Venous tourniquet.
D. Alcohol swab.
E. Gauze pad or adhesive bandage.
F. Tape or other securing device.
V. Procedure
A. Saline locks may be used as an alternative to IV Tubing and fluid at the discretion of
the ALS provider.
B. ALS providers may use intraosseous access where threat to life exists as provided
for in the Venous Access – Intraosseous procedure.
C. ALS providers may use Indwelling catheters where threat to life exists as provided
for in the Venous Access – Indwelling Catheter procedure.
D. Use the largest catheter bore necessary based upon the patient’s condition and size
of veins.
E. Fluid and setup choice is preferably:
1. Normal Saline with a macro drip (10gtt/cc) for medical/trauma conditions.
237
Clinical Procedure: Venous Access Peripheral
Prince William County Fire and Rescue System
Clinical Procedure: Venous Access Peripheral
2. Normal Saline with a micro drip (60gtt/cc) for medication infusions or for
patients where fluid overload is of concern.
F. Assemble IV solution and tubing:
1. Open IV bag and check for clarity, expiration date, etc.
2. Verify correct solution.
3. Open IV tubing.
4. Assemble IV tubing according to manufacturer’s guidelines.
G. Insertion
1. Explain to the patient that an IV is going to be started.
2. Place the tourniquet proximal to the IV site (unless external jugular site), if
appropriate.
3. Palpate veins for resilience.
4. Clean the skin with the alcohol swab in an increasing sized concentric
circle and allow to air dry.
5. Stabilize the vein distally with the provider's thumb/fingers.
6. Enter the skin with the bevel of the needle facing upward.
7. Enter the vein, obtain a flash, and advance the catheter off of the catheter
over the needle and remove the needle while compressing the proximal tip of
the catheter to minimize blood loss.
8. Remove the tourniquet.
9. Connect IV tubing to the catheter, or secure the IV lock to the catheter and
flush with appropriate solution (NS).
10. Open the IV clamp to assure free flow.
11. Set IV infusion rate.
H. Secure the IV.
1. Secure the IV catheter and tubing.
2. Cover IV site with appropriate dressing.
3. Recheck IV drip rate to make sure it is flowing at appropriate rate.
4. Troubleshooting the IV (if the IV is not working well):
a. Make sure the tourniquet is off.
b. Check the IV insertion site for swelling.
c. Check the IV tubing clamp to make sure it is open.
d. Check the drip chamber to make sure it is half full.
238
Clinical Procedure: Wound Care/Hemorrhage Control
Prince William County Fire and Rescue System
Clinical Procedure: Wound Care/Hemorrhage Control
I. Authorized Personnel
A. Active ALS and BLS providers.
II. Indications
A. Patients with wounds that require bandaging.
B. Patients with controlled bleeding that requires dressing and bandaging.
C. Patients with uncontrolled bleeding that requires dressing and bandaging.
III. Procedure
A. Assess the patient and treat per the following algorithm.
*Direct pressure may be considered impractical when the number of patients exceed
available personnel to deliver care, number of critical interventions precludes sustained
direct pressure by one provider, unable to access site of bleeding, indirect threat to the
providers makes direct pressure at the site of wounding impractical, etc.
Wound amenable to tourniquet placement?
(e.g. Extremity injury)
Apply direct pressure/pressure dressing to
the injury.
Direct pressure effective.
(Bleeding controlled)
Apply tourniquet.
Direct pressure ineffective or impractical*.
(Bleeding not controlled)
Wound not amenable to tourniquet
placement?
(e.g. junctional injury, groin, neck, etc.)
Use wound packing with hemostatic gauze,
followed by direct pressure/pressure
dressing
239
Clinical Procedure: Wound Care/Hemorrhage Control
Prince William County Fire and Rescue System
Clinical Procedure: Wound Care/Hemorrhage Control
B. Equipment and application directions.
1. Celox Rapid Hemostatic Z‐fold Gauze.
a. Attempt to locate the area in which the bleeding is coming from.
b. Use sterile gauze to blot excess blood from the wound to aid in
locating where the bleeding has originated from.
c. Fill the wound with Celox Rapid Gauze. When filling the wound, fill in
the direction of the bleeding orgin.
d. Tightly pack the whole space and compress for one minute.
e. Secure in place and consider transport to a Level 1 Trauma Center.
f. Cover wound with sterile gauze/dressing. Check distal pulses,
sensation, and motor function.
g. Document the time the Celox Rapid Gauze was placed in the PCR.
2. H‐Bandage.
a. Center the absorbent pad over the wound.
b. Ensure the “H” is centered over where you want the most pressure.
c. Take the long end of the elastic bandage and wrap it around the
extremity and secure to the Velcro tab. This will prevent the elastic
bandage from sliding.
d. Loop the elastic bandage around the “H” bar nearest the Velcro tab.
e. Hold the “H” to prevent the bandage from slipping and simultaneously
pull the elastic bandage taught.
f. Wrap the elastic bandage back around the extremity and loop it
around the opposite “H” bar.
g. Hold the “H” to prevent the bandage from slipping and simultaneously
pull the elastic bandage taut.
h. Wrap the remaining elastic bandage back around the extremity and
continue to follow the path until the elastic bandage can be secured
with the three‐inch strip of Velcro.
i. Secure in place and consider transport to a Level 1 Trauma Center.
j. Check distal pulses, sensation, and motor function.
k. Document the time the H‐Bandage was placed in the PCR and if able,
write the time the H‐Bandage was placed on the H‐Bandage that was
applied to the patient.
240
Clinical Procedure: Wound Care/Hemorrhage Control
Prince William County Fire and Rescue System
Clinical Procedure: Wound Care/Hemorrhage Control
3. Tourniquet.
a. Apply tourniquet as proximal to the wound as possible (apply
directly to the skin 2 ‐ 3 inches above the wound).
b. If extremity is not trapped, go to number 2 below.
1) For a trapped extremity, pull constriction band backward
through windlass and tourniquet base. Slide constriction band
back through tourniquet base and through windlass.
2) Pull tab up and away from the tourniquet base, working the
strap in an up and down motion until tourniquet base and
windlass slide snug up against limb.
c. Rotate windlass until bleeding has stopped.
d. Secure windlass by pulling the fixed securing‐loop over the closest
end of the end of windless.
e. Pull securing‐loop with friction buckle over free end of windlass and
tighten. The securing loop with friction buckle must be secured before
moving the patient.
f. Secure in place and consider expedited transport to a Level 1 Trauma
Center.
g. Cover wound with sterile gauze/dressing. Document absence or
presence of distal pulse, sensation, and motor function.
h. Monitor wound and/or dressing throughout transport for bleeding.
i. Document the time the tourniquet was placed in the PCR.
j. If conditions allow, physically write the time on the tourniquet that
was applied to the patient.
241
Prince William County Fire and Rescue System
Pharmacology
The following pages provide supplemental information on pharmaceuticals
approved for use in the Prince William County EMS System. This material is
meant to provide additional information; it does not establish orders for
delivery of medication. Refer to the Physician's Desk Reference (PDR) for
complete drug information.
Medications may only be administered as directed by authorized Prince
William County EMS System Protocols or as directed by OLMC orders.
Authorized Pharmaceuticals
Prince William County Fire and Rescue System
Authorized Pharmaceuticals
242
Generic Name Trade Name Route
Adenosine Adenocard IV/IO
Albuterol Proventil, Ventolin Nebulized
Amiodarone Cordarone IV/IO
Aspirin PO
Atropine IV/IO
Calcium Chloride IV/IO
Dextrose IV/IO
Diphenhydramine Benadryl IV/IO/IM
Dopamine Intropin IV/IO
DuoDote IM
Epinephrine 1mg/ml (1:1,000) Adrenaline IM/Nebulized
Epinephrine 0.1mg/ml (1:10,000) Adrenaline IV/IO
Fentanyl Sublimaze IV/IO/IN
Glucagon GlucaGen IV/IM
Glucose, Oral Glutose PO
Hydroxocobalamin CyanoKit IV/IO
Ipratropium Bromide Atrovent Nebulized
Ketamine Ketalar IV/IM
Lidocaine Xylocaine IO
Magnesium Sulfate IV/IO
Methylprednisolone Solu‐Medrol IV/IO
Metoprolol Lopressor IV/IO
Midazolam Versed IV/IO/IM/IN
Morphine Sulfate IV/IO
Naloxone Narcan IV/IO/IM/IN
Nitroglycerin Nitrostat, Nitrolingual SL
Ondansetron Zofran IV/IO/ODT
Promethazine Phenergan IV
Racemic Epinephrine Nebulized
Sodium Bicarbonate 8.4%, 4.2% IV/IO/Nebulized
Tranexamic Acid IV/IO
Adenosine
Prince William County Fire and Rescue System
Adenosine
Pharmacologic properties
Adenosine is an endogenous purine nucleoside that slows conduction time through the AV node
and interrupts AV reentry pathways which restores normal sinus rhythm in patients with
paroxysmal supraventricular tachycardia (PSVT). The onset of action is 20‐30 seconds and the
duration of action is < 10 seconds.
Indications
 Narrow Complex Tachycardia (SVT).
 Wide‐complex tachycardia (rate > 150), stable and SVT highly likely.
Contraindications
 2nd or 3rd degree AV block.
 Sick sinus syndrome.
 Known hypersensitivity.
Precautions
 Effects of adenosine are antagonized by methylxanthine (theophylline and caffeine).
 Adenosine can provoke bronchospasm and should be used cautiously in patients with
reactive airway disease.
 Tegretol and Persantine may potentiate the effect of Adenosine.
 Adenosine is not effective in converting atrial fibrillation or flutter.
 The half‐life of adenosine is < 5 seconds ‐ the drug should be administered via a large bore
IV in the upper extremity, and at the port closest to the IV hub.
Side effects/adverse reactions
 Cardiovascular‐ transient chest pain, periods of sinus bradycardia, ventricular ectopy or
pause.
 Facial flushing (transient).
 Respiratory‐ transient dyspnea.
 Metallic taste.
Dosage and administration
 Cardiac Emergencies: Regular Narrow Complex Tachycardia (SVT)
o Adult:
6 mg rapid IVP over 1‐3 seconds with 20 mL NS flush.
If no response in 2 minutes, administer 12 mg rapid IVP over 1‐3
seconds with 20 ml NS flush.
o Pediatric:
0.1 mg/kg rapid IV/IO over (max dose 6 mg) 1‐3 seconds with a 10 ml NS
flush.
If inadequate response, administer 0.2 mg/kg (max dose 12 mg) rapid
IV/IO over 1‐3 seconds with a 10 ml NS flush.
243
Albuterol Sulfate
Prince William County Fire and Rescue System
Albuterol Sulfate
Pharmacologic properties
Albuterol is primarily a beta‐2 agonist that produces bronchodilation with limited cardiovascular
side effects due to it’s high specificity for beta‐2 receptors. Onset is within 15 minutes; peak effect
is in 60‐90 minutes. Therapeutic effects may be active up to 5 hours.
Indications
 Acute bronchospasm (wheezing) due to asthma, COPD or allergic reation.
 Known or suspected hyperkalemia (dialysis patient, crush injury)
Contraindications
 Known hypersensitivity.
Precautions
 Use cautiously in patients with coronary artery disease, hypertension, hyperthyroidism,
diabetes.
 Epinephrine should typically not be used at the same time as albuterol, however, either may
be used subsequent to a failure of the other.
Side effects/ adverse reactions
 Nervousness
 Tremor
 Tachycardia
 Hypertension
 Nausea
 Vomiting
Dosage and administration
 Respiratory Emergencies: Dyspnea
o Adult and Pediatrics (All Providers):
Albuterol 2.5 mg via nebulizer, repeat once in 5 minutes if indicated.
 Respiratory Emergencies: Acute Bronchospasm
o Adult and Pediatrics (Advanced Life Support):
Albuterol 2.5 mg and Ipratropium Bromide 0.5 mg via nebulizer, repeat once
in 5 minutes if indicated.
If wheezing persist, administer Albuterol 2.5 mg via nebulizer, repeat every 5
minutes if indicated (max cumulative dose 15 mg.)
 Respiratory Emergencies: Pulmonary Edema:
o Adult (Advanced Life Support):
Albuterol 2.5 mg and Ipratropium Bromide 0.5 mg via nebulizer, repeat once
in 5 minutes if indicated (max cumulative Albuterol dose 15 mg).
244
Prince William County Fire and Rescue System
Dosage and administration
 Cardiac Arrest: Post Resuscitation Care
 Cardiac Emergencies: Wide Complex Tachycardia
o Adult (Advanced Life Support):
Suspected Hyperkalemia, Administer Albuterol 5 mg via nebulizer.
 Hazardous Materials Exposure: General Approach
o Adult (All Providers):
Inhaled toxins with acute bronchospasm, administer Albuterol 2.5 mg via
nebulizer.
o Adult (Advanced Life Support):
Inhaled toxins with acute bronchospasm, administer Albuterol 2.5 mg and
Ipratropium Bromide 0.5 mg via nebulizer, repeat once in 5 minutes if
indicated.
If wheezing persist, administer Albuterol 2.5 mg via nebulizer, repeat every 5
minutes if indicated (max cumulative dose 15 mg).
 Medical: Allergic Reaction
o Adult and Pediatric (All Providers):
Albuterol 2.5 mg via nebulizer, repeat once in 5 minutes if indicated.
o Adult and Pediatric (Advanced Life Support):
Albuterol 2.5 mg via nebulizer, repeat every in 5 minutes if indicated (max
cumulative dose 15 mg).
 General Patient Care Protocol – Adult Trauma
o Adult (Medical Control):
Entanglement/entrapment or crush injuries ≥ 4 hours, consider Albuterol 5
mg via nebulizer.
Albuterol Sulfate
Albuterol Sulfate
245
Amiodarone
Prince William County Fire and Rescue System
Amiodarone
Pharmacologic properties
Amiodarone is considered a class III antiarrhythmic. It possesses electrophysiological
characteristics of sodium, potassium and calcium channel blockade, as well as alpha and beta
adrenergic blocking activity. These properties prolong action potentials and repolarization,
stabilizing myocardial membranes.
Indications
 Ventricular fibrillation/pulseless ventricular tachycardia.
 Ventricular tachycardia without overt signs of shock (SBP > 90).
 Wide complex tachycardia of unknown etiology.
 Pediatric ventricular fibrillation/pulseless ventricular tachycardia.
Contraindications
 Cardiogenic shock
 Marked sinus bradycardia
 Second or third degree AV block
 Known hypersensitivity
Precautions
 Solution is extremely viscous. Do not shake.
 Administer the medication slowly.
 Use large bore filtered needles, or needless filter straws.
Side effects/ adverse reactions
 Hypotension
 Bradycardia
 Adverse effects can be treated by the following:
o Slow the rate of drug infusion
o IV fluid bolus, pressers, chronotropic agents, or temporary pacing
Dosage and administration
 Cardiac Arrest: V‐Fib/Pulseless V‐Tach
o Adult:
Amiodarone 300 mg bolus IV/IO.
For persistent V‐Fib/V‐Tach, may repeat every 3‐5 minutes, Amiodarone 150
mg IV/IO (max cumulative dose 450 mg).
o Pediatric:
Amiodarone 5 mg/kg bolus IV/IO (max single dose 300 mg).
For persistent V‐Fib/V‐Tach, may repeat every 3‐5 minutes, Amiodarone 5
mg/kg IV/IO (max cumulative dose 15 mg/kg not to exceed 450 mg).
246
Amiodarone
Prince William County Fire and Rescue System
Amiodarone
Dosage and administration
 Cardiac Arrest: Post Resuscitation Care
o Adult:
If V‐Fib/V‐Tach occurred during arrest and no Amiodarone was given,
administer Amiodarone 150 mg diluted in 100 ml NS IV/IO piggyback over
10 minutes.
 Cardiac Emergencies: Regular Narrow Complex Tachycardia (SVT)
o Adult (Medical Control):
Consider Amiodarone 150 mg diluted in 100 ml NS IV Piggyback, over 10
minutes.
 Cardiac Emergencies: Wide Complex Tachycardia
o Adult – Stable with mild symptoms:
Administer Amiodarone 150 mg diluted in 100 ml NS IV Piggyback over 10
minutes.
o Adult – Reoccurrence following electrical cardioversion:
Administer Amiodarone 150 mg diluted in 100 ml NS IV Piggyback over 10
minutes, may repeat once.
 Cardiac Emergencies: Polymorphous V‐Tach (Torsades de Pointes)
o Adult – Stable with mild symptoms:
No response to Magnesium Sulfate, administer Amiodarone 150 mg diluted in
100 ml NS, IV Piggyback over 10 minutes.
247
Aspirin
Prince William County Fire and Rescue System
Aspirin
Pharmacologic properties
Aspirin is a salicylate with anti‐platelet activity. It inhibits cyclooxygenase, blocking the synthesis
of prostaglandin to interfere with platelet aggregation. This action has been demonstrated to
reduce mortality in patients suffering from myocardial infarction. Aspirin also has moderate
analgesic and anti‐pyretic effects. The onset of action is 5‐30 minutes, and the duration of action is
3‐6 hours.
Indications
 Chest Pain ‐ suspected myocardial ischemia.
 Respiratory Emergencies‐ Cardiac origin suspected.
Contraindications:
 Known hypersensitivity.
 Active ulcer disease.
 Pregnant (especially third trimester) or a nursing mother.
Adverse Reactions:
 Anaphylaxis (if history of hypersensitivity).
 Abdominal discomfort.
 Gastrointestinal bleeding (if previous condition exists).
Dosage and administration:
 Respiratory Emergencies: Dyspnea
o Adult (All Providers):
If suspected cardiac origin, administer Aspirin 324 mg PO.
 Respiratory Emergencies: Pulmonary Edema
o Adult (Advanced Life Support):
Administer Aspirin 324 mg PO.
 Cardiac Emergencies: Acute Coronary Syndrome
o Adult (All Providers):
Administer Aspirin 324 mg PO.
248
Atropine Sulfate (cardiac indications)
Prince William County Fire and Rescue System
Atropine Sulfate (cardiac indications)
Pharmacologic properties
Atropine is a potent parasympatholytic anticholinergic. It inhibits muscarinic receptor activity in
the parasympathetic sites in smooth muscle, central nervous system, cardiac and secretory tissue.
This reduces vagal tone, increases automaticity of the SA node and increases AV conductions, thus
increasing heart rate. Additional effects include drying secretions and slowing motility in the
gastrointestinal tract.
Indications
 Brady dysrhythmias (rate < 50) accompanied by hemodynamic compromise, i.e.
hypotension (systolic less than 90 mmHg), shock, pulmonary edema, altered level of
consciousness.
 Pediatric Bradycardia (HR < 100 in an infant, HR < 60 in a child) despite adequate
oxygenation, ventilation, chest compressions, and refractory to epinephrine.
Contraindications
 Atropine has no effect in patients with transplanted hearts.
 3rd degree AV block in the setting of an acute anterior wall MI.
Precautions
 If normal dose pushed too slowly, or if too small a dose (<0.5 mg) is given, heart rate may
initially slow down.
 Atropine is potentiated by antihistamines and antidepressants.
 Cautious use in Type II AV block and 3rd degree block with wide QRS complexes.
Adverse reactions
 Restlessness.
 Agitation.
 Confusion.
 Pupil dilation.
 Blurred vision.
 Headache.
Dosage and administration
 Cardiac Emergencies: Bradycardia
o Adult:
Administer Atropine 0.5 mg IVP, repeat every 3‐5 minutes if indicated (max
cumulative dose 3 mg).
o Pediatric:
Administer Atropine 0.02 mg/kg IV/IO (minimum dose 0.1 mg with a max
dose 0.5 mg), repeat once in 3‐5 minutes.
249
Atropine Sulfate (antidote for poisoning)
Prince William County Fire and Rescue System
Atropine Sulfate (antidote for poisoning)
Pharmacologic properties:
Atropine is a potent parasympatholytic anticholinergic. It inhibits muscarinic receptor activity in
the parasympathetic sites on smooth muscle and the central nervous system, as well as cardiac and
secretory tissue. This reduces vagal tone, increases automaticity of the SA node and increases AV
conductions, thus increasing heart rate. Additional effects include drying secretions and slowing
motility in the gastrointestinal tract.
Indications
 Organophosphate Poisoning (i.e. parathion, malathion, rid‐a‐bug) and carbamate
(Baygon, sevin, and many common roach and ant sprays).
 Poisoning Signs.
 “SLUDGE”
o Salivation.
o Lacrimation.
o Urination.
o Defecation.
 GI hypermotility (Emesis, diarrhea).
 Excessive sweating and bronchorrhea.
 Additional signs include: pinpoint pupils and bradycardia.
 None when used in the management of severe organophosphate poisoning.
Precautions
 It is important that the patient be adequately oxygenated and ventilated prior to
using atropine, as atropine may precipitate ventricular fibrillation in a poorly
oxygenated patient.
 Do not rely upon pupil constriction to discontinue or to titrate medications.
Adverse reactions
 Victims of organophosphate poisoning can tolerate large doses (1000 mg) of
atropine.
 Signs of atropinization (flushing, pupil dilation, dry mouth, tachycardia) are likely
to occur.
250
Atropine Sulfate (antidote for poisoning)
Prince William County Fire and Rescue System
Atropine Sulfate (antidote for poisoning)
Dosage and administration
 Hazardous Materials Exposure: Nerve Agent/WMD
o Adult:
Consider Atropine 2 mg IV/IO/IM every 5 minutes until symptoms
resolve.
 Overdose and Poisoning: Beta Blocker Toxicity
o Adult:
Consider Atropine 0.5 mg IVP, repeat every 3 minutes if indicated
(max cumulative dose 3 mg).
 Overdose and Poisoning: Calcium Channel Blocker
o Adult:
Administer Atropine 0.5 mg IVP, repeat every 3 minutes if indicated
(max cumulative dose 3 mg).
 Overdose and Poisoning: Cholinergic/Organophosphates
o Adult:
Administer Atropine 2 mg IV/IO, repeat every 5 minutes until
improvement in respiratory effort/bronchial secretions is noted.
 Pediatric Overdose and Poisoning
o Pediatric (Medical Control):
Administer Atropine 0.02 mg/kg IV/IO (minimum dose 0.1 mg with
a max dose 2 mg), repeat every 2 minutes if indicated (max 6 mg).
251
Calcium Chloride
Prince William County Fire and Rescue System
Calcium Chloride
Pharmacologic properties:
Calcium is a cation that is essential for neurotransmission, bone formation, enzymatic reactions
and muscle (including cardiac) contraction. In the myocardium, it increases the force of
contraction and augments cardiac output. Calcium also has a stabilizing effect on myocardial
membranes when dangerously high potassium levels make the heart at risk for fibrillation.
Indications
 Hyperkalemia with associated ECG disturbances.
 Hypocalcemia (known).
 Calcium channel blocker toxicity with hemodynamic compromise.
 Magnesium (MgS04) toxicity.
Contraindications
 Cardiac arrest not associated with one of the above.
 Digoxin toxicity.
 Hypercalcemia.
Precautions
 Cautious use in patients receiving Digoxin ‐ do not administer to patients with suspected
Digoxin toxicity or overdose.
 Do not mix with sodium bicarbonate ‐ it will precipitate.
Adverse reactions
 Bradycardia (usually caused by rapid administration).
 Arrhythmias ‐ especially in patients on digoxin.
 Sclerosis of veins (if IV infiltrates).
Dosage and administration
 Cardiac Arrest: Asystole PEA
o Adult (suspected hyperkalemia and suspected calcium channel blocker overdose):
Administer Calcium Chloride 1 g IV/IO.
o Pediatric (suspected hyperkalemia):
Administer Calcium Chloride 20 mg/kg IV/IO (max dose 1 g).
 Cardiac Arrest: V‐Fib/Pulseless V‐Tach
o Adult (suspected hyperkalemia):
Administer Calcium Chloride 1 g IV/IO.
 Cardiac Arrest: Post Resuscitation Care
o Adult (suspected hyperkalemia):
Administer Calcium Chloride 1 g IV/IO.
252
Calcium Chloride
Prince William County Fire and Rescue System
Calcium Chloride
 Cardiac Emergencies: Wide Complex Tachycardia
o Adult (suspected hyperkalemia):
Administer Calcium Chloride 1 g IV/IO.
 Overdose and Poisoning: Calcium Channel Blocker
o Adult:
Administer Calcium Chloride 1 g IV/IO.
253
Dextrose
Prince William County Fire and Rescue System
Dextrose
Pharmacologic properties
Dextrose is a simple monosaccharide also known as glucose. It provides calories for metabolic
needs, sparing body proteins and loss of electrolytes. Dextrose is a hypertonic solution that is
readily excreted by the kidneys producing diuresis.
Indications
 Hypoglycemia in an adult (< 60 mg/dL).
 Hypoglycemia in a neonate (< 40 mg/dL).
 Hypoglycemia in a pediatric (<60 mg/dL).
 Coma of unknown origin (altered level of consciousness), and unable to perform glucose
check.
Contraindications
 Stroke or acute brain injury with glucose > 60 mg/dL.
Precautions
 May theoretically precipitate Wernicke‐Korsakoff syndrome if given without thiamine in
chronic alcohol dependence and malnutrition.
Adverse reactions
 Thrombosis, sclerosing if given in a peripheral vein.
 Tissue irritation if infiltrates.
 Hyperglycemia.
 Hypokalemia.
Dosage and administration
 Medical: Diabetic Emergencies
o Adult (BGL < 60 mg/dL):
Administer Oral Glucose Gel 15 g.
Administer 100 ml of 10% Dextrose, titrate to improved mental status and
BGL, may repeat every 5 minutes (max cumulative dose 250 ml).
o Pediatric (Neonate BGL < 40 mg/dL):
Administer 10% Dextrose 2 ml/kg IV/IO, titrate to improved mental status
and BGL.
Repeat 10% Dextrose 2 ml/kg if BGL remains < 60 after first dose.
o Pediatric (All other ages BGL < 60 mg/dL):
Administer Oral Glucose Gel 15 g.
Administer 10% Dextrose 5 ml/kg (max dose 100 ml) titrated to improved
mental status and BGL.
Repeat 10% Dextrose 5 ml/kg (max dose 100 ml) if BGL remains < 80 after
first dose.
254
Dextrose
Prince William County Fire and Rescue System
Dextrose
 Pediatric Cardiac Arrest: Neonatal Resuscitation
o Administer 10% Dextrose 2 ml/kg.
255
Diphenhydramine Hydrochloride
Prince William County Fire and Rescue System
Diphenhydramine Hydrochloride
Pharmacologic properties
Diphenhydramine is a histamine (H1)‐receptor antagonist that prevents the release of histamine
from effector mast cells. Histamine is a vasoactive substance central to allergic reactions that
induces vasodilation, vascular permeability, and bronchoconstriction. Diphenhydramine prevents
histamine‐mediated responses, particularly the effects of histamine on the smooth muscle of the
bronchial airways, skin, gastrointestinal tract, and blood vessels.
Indications
 Acute allergic reactions (mild, moderate, or severe).
 Anaphylaxis.
 Acute dystonic reactions associated with ingestion of phenothiazines and related
drugs (haloperidol, thorazine, compazine, metaclopromide, ziprasidone).
Contraindications
 Benadryl is not to be used in newborn or premature infants or in nursing mothers.
 Known hypersensitivity to diphenhydramine or antihistamines.
Precautions
 In premature babies and infants, diphenhydramine in over‐dosage may cause
convulsions or death.
 May cause significant sedation or paradoxical excitation/akathisia.
 Diphenhydramine has additive effects with alcohol and other CNS depressants.
 Antihistamines may cause dizziness, confusion, delirium, hallucinations, and/or
hypotension in the elderly (60 years or older).
 Diphenhydramine has an atropine‐like action and therefore should be used with
caution in patients with a history of bronchial asthma, increased intraocular pressure,
hyperthyroidism, cardiovascular disease or hyper‐tension.
Adverse reactions
 Drowsiness, sedation
 Confusion
 Vertigo
 Hyperactivity in children
 Palpitations
 Tachycardia
 PVC’s
 Hypotension
 Nausea.
 Vomiting.
 Diarrhea.
 Dry mouth.
 Constipation.
 Urinary retention.
 Thickening of bronchial secretion.
 Wheezing.
256
Diphenhydramine Hydrochloride
Prince William County Fire and Rescue System
Diphenhydramine Hydrochloride
Dosage and administration
 Medical: Allergic Reaction
o Adult (Mild, Moderate, Severe Systemic Reaction, Cardiac Arrest):
Administer Diphenhydramine 1 mg/kg IV/IM/IO (max dose 50 mg).
o Pediatric (Mild, Moderate, Severe Systemic Reaction):
Administer Diphenhydramine 1 mg/kg IV/IM/IO (max dose 50 mg).
 Overdose and Poisoning: Antipsychotics/Acute Dystonic Reaction
o Adult:
Consider Diphenhydramine 25 mg IV/IM, repeat once in 10 minutes if
indicated.
 Pediatric Overdose and Poisoning
o Dystonic Reactions:
Administer Diphenhydramine 1 mg/kg IV/IM.
257
Dopamine Hydrochloride
Prince William County Fire and Rescue System
Dopamine hydrochloride
Pharmacologic properties
Dopamine is an endogenous catecholamine that exerts an inotropic effect on the myocardium
resulting in increased cardiac output. It stimulates dopaminergic, beta‐adrenergic and alphaadrenergic
receptors of the nervous system in a dose‐dependent manner. Low to moderate doses
(2‐10 mcg/kg/min) have predominant beta‐adrenergic receptor stimulating actions that result in
increased cardiac output and heart rate with minimal vasoconstriction. At higher doses (>10 mcg/
kg/min), dopamine has alpha receptor stimulating actions that result in peripheral
vasoconstriction and increased blood pressure.
Indications
 Cardiogenic, neurogenic, septic, or anaphylactic shock.
 Bradycardia with hypotension refractory to Atropine.
 Hemodynamically significant (SBP < 90 mmHg) overdose.
 Hypotension (SBP < 90 mmHg) not secondary to hypovolemia.
Contraindications
 Shock due to hypovolemia.
 Dopamine should not be administered in the presence of uncorrected tachyarrhythmia's or
ventricular fibrillation.
 Dopamine should not be used in patients with pheochromocytoma.
Precautions
 Significant local tissue necrosis can occur with extravasation from peripheral IV.
 Dopamine is inactivated in alkaline solution, do not use any alkaline diluent.
 Patients who have been treated with monoamine oxidase (MAO) inhibitors will require
substantially reduced dosage.
Adverse reactions
 Headache.
 Ectopic beats.
 Tachycardia.
 Angina pain.
 Palpitation.
 Hypotension.
Dosage and administration
 Respiratory Emergencies: Pulmonary Edema
o Adult:
Consider Dopamine infusion at 5 mcg/kg/min titrated up to 20 mcg/kg/min
in order to maintain SBP ≥ 90 mmHg or MAP ≥ 65.
 Nausea
 Vomiting
 Local necrosis with extravasation
 Piloerection
 Dyspnea
258
Dopamine Hydrochloride
Prince William County Fire and Rescue System
Dopamine hydrochloride
 Cardiac Arrest: Post Resuscitation Care
o Adult:
Administer Dopamine infusion at 5 mcg/kg/min titrated up to 20 mcg/kg/
min in order to maintain SBP ≥ 90 mmHg or MAP ≥ 65.
o Pediatric:
Administer Dopamine infusion at 5 mcg/kg/min titrated up to 20 mcg/kg/
min in order to maintain minimum SBP.
 Cardiac Emergencies: Bradycardia
o Adult:
Consider Dopamine infusion at 5 mcg/kg/min titrated up to 20 mcg/kg/min
in order to maintain SBP ≥ 90 mmHg or MAP ≥ 65.
 Environmental Emergencies: Bites and Envenomation
o Adult:
Dopamine infusion at 5 mcg/kg/min titrated up to 20 mcg/kg/min in order
to maintain SBP ≥ 90 mmHg or MAP ≥ 65.
 Medical: Sepsis
o Adult :
Consider Dopamine infusion at 5 mcg/kg/min titrated up to 20 mcg/kg/min
in order to maintain SBP ≥ 90 mmHg or MAP ≥ 65.
o Pediatric (Medical Control):
Administer Dopamine infusion at 5 mcg/kg/min titrated up to 20 mcg/kg/
min in order to maintain minimum SBP.
 Overdose and Poisoning: Antidepressants
 Overdose and Poisoning: Cholinergic/Organophosphates
o Adult:
Dopamine infusion at 5 mcg/kg/min titrated up to 20 mcg/kg/min in order
to maintain SBP ≥ 90 mmHg or MAP ≥ 65.
259
Epinephrine Hydrochloride (1mg/ml)
Prince William County Fire and Rescue System
Epinephrine Hydrochloride (1mg/ml)
Pharmacologic properties
Epinephrine is a sympathomimetic which stimulates both alpha and beta adrenergic receptors. Its
effects are to increase systemic vascular resistance, arterial blood pressure, coronary and cerebral
blood flow, heart rate and contractility. The alpha‐adrenergic effect increases vascular resistance
and coronary blood flow, which may make the fibrillating myocardium more susceptible to
counter‐shock. The beta adrenergic effect increases heart rate and cardiac output, and induces
bronchodilation.
Indications
 Anaphylaxis and acute allergic reactions associated with severe systemic symptoms (BP <
90 mmHg, stridor, severe respiratory distress) in adults and pediatrics.
 Bronchospasm (wheezing) with severe respiratory distress during asthma or COPD
exacerbation.
 Cardiac emergencies‐ Bradycardia.
Contraindications
 Known hypersensitivity.
Precautions
 Presence of hypertension.
 History of heart disease.
 Age over 50 years.
 Epinephrine is inactivated by alkaline solutions and should not be mixed with Sodium
Bicarbonate.
 Epinephrine 1mg/ml cannot be given intravenously in non‐cardiac arrest patients.
Adverse reactions
 Anxiety.
 Headache.
 Cerebral hemorrhage.
 Tachycardia.
Dosage and administration
 Respiratory Emergencies: Acute Bronchospasm
o Adult:
Consider Epinephrine (1mg/ml) 0.3 mg IM.
o Pediatric (Medical Control):
Administer Epinephrine (1mg/ml) 0.01 mg/kg IM (max dose 0.3 mg).
 Cardiac Emergencies: Bradycardia
o Adult (Medical Control):
Consider Epinephrine infusion 2 mcg/min titrated up to 10 mcg/min to
maintain SBP > 90 mmHg or MAP ≥ 65.
Mix 2 mg (1mg/ml) in 500 ml NS.
 Ventricular dysrhythmias
 Hypertension
 Angina
 Nausea and vomiting
260
Epinephrine Hydrochloride (1mg/ml)
Prince William County Fire and Rescue System
Epinephrine Hydrochloride (1mg/ml)
 Medical: Allergic Reaction
o Adult:
Administer Epinephrine (1mg/ml) 0.3 mg IM, repeat once in 5 minutes if
indicated.
o Adult (Medical Control):
Epinephrine (1mg/ml) 0.3 mg IM.
Consider Epinephrine infusion 2mcg/min titrated up to 10 mcg/min to
maintain SBP > 90 mmHg or MAP ≥ 65.
Mix 2 mg (1mg/ml) in 500 ml NS.
o Pediatric:
Administer Epinephrine (1mg/ml) 0.01 mg/kg IM (max dose 0.3 mg), repeat
once in 5 minutes if indicated.
o Pediatric (Medical Control):
Consider Epinephrine (1mg/ml) 0.01 mg/kg IM (max dose 0.3mg).
Consider Epinephrine infusion 2 mcg/min titrated up based on OLMC
parameters.
Mix 2 mg (1mg/ml) in 500 ml NS.
261
Epinephrine Hydrochloride (0.1mg/ml)
Prince William County Fire and Rescue System
Epinephrine Hydrochloride (0.1mg/ml)
Pharmacologic properties
Epinephrine is a sympathomimetic, which stimulates both Alpha and Beta‐adrenergic receptors. Its
effects are to increase systemic vascular resistance, arterial blood pressure, coronary and cerebral
blood flow, heart rate and contractility. The alpha‐adrenergic effect increases vascular resistance
and coronary blood flow, which may make the fibrillating myocardium more susceptible to
counter‐shock. The beta‐adrenergic effect increases heart rate and cardiac output, and induces
bronchodilation.
Indications
 Cardiac arrest V‐Fib or pulseless V‐Tach, Asystole, PEA
 Symptomatic bradycardia.
 Anaphylactic shock.
 Newborn resuscitation/neonatal asystole or bradycardia.
 Pediatric bradycardia and cardiac arrest.
Contraindications
 None in the cardiac arrest situation.
Precautions
 Epinephrine is inactivated by alkaline solutions and should not be mixed with Sodium
Bicarbonate.
 See Epinephrine 1mg/ml for non‐cardiac arrest precautions.
Adverse reactions
 Cerebral hemorrhage.
 Tachycardia.
 Ventricular dysrhythmias.
 Hypertension.
 Angina.
 Nausea and vomiting .
Dosage and administration
 Cardiac Arrest: Asystole/PEA
o Adult:
Administer Epinephrine (0.1mg/ml) 1 mg IV/IO every 3‐5 minutes during
arrest.
o Pediatric:
Administer Epinephrine (0.1mg/ml) 0.01 mg/kg IV/IO (max dose 1 mg),
repeat every 3‐5 minutes.
262
Epinephrine Hydrochloride (0.1mg/ml)
Prince William County Fire and Rescue System
Epinephrine Hydrochloride (0.1mg/ml)
 Cardiac Arrest: V‐Fib/Pulseless V‐Tach
o Adult:
Administer Epinephrine (0.1mg/ml) 1 mg IV/IO every 3‐5 minutes during
arrest.
o Pediatric:
Administer Epinephrine (0.1mg/ml) 0.01 mg/kg IV/IO (max dose 1 mg),
repeat every 3‐5 minutes.
 Medical: Allergic Reaction
o Adult (Imminent Cardiopulmonary Arrest):
Consider Epinephrine (0.1mg/ml) 0.5 mg IV/IO.
 Pediatric Cardiac Arrest: Neonatal Resuscitation
o Pediatric
Administer Epinephrine (0.1mg/ml) 0.01 mg/kg IV/IO (max dose 1 mg),
repeat every 3‐5 minutes.
 Pediatric Cardiac Arrhythmia: Bradycardia
o Pediatric
Administer Epinephrine (0.1mg/ml) 0.01 mg/kg IV/IO (max dose 1 mg),
repeat every 3‐5 minutes until either the bradycardia or severe
cardiopulmonary compromise resolves.
263
Fentanyl
Prince William County Fire and Rescue System
Fentanyl
Pharmacologic properties
Fentanyl is a synthetic opioid analgesic that suppresses pain by agonizing opioid receptors in
the central nervous system. Fentanyl has fewer vasoactive effects than morphine and does not
induce significant histamine release. As a result, the drug does not cause significant
hypotension in proper doses.
Indications
 Chest pain associated with suspected myocardial ischemia.
 Thermal burns.
 Frostbite.
 Isolated extremity injury.
 Pain from suspected kidney stone.
Contraindications
 Hypotension, (SBP <100 mmHg) or volume depletion.
 Head trauma.
 Acute alcohol intoxication.
 Acute respiratory distress.
 Known hypersensitivity.
Precautions
 Use with caution in elderly patients
 Fentanyl is metabolized by the liver, use caution in patients with known liver disease
 Sedative effects are potentiated by alcohol, antihistamines, barbiturates,
benzodiazepines, phenothiazines, and other sedatives.
Adverse reactions
 Euphoria.
 Drowsiness.
 Pupillary constriction.
 Respiratory arrest.
Dosage and administration
 Cardia Arrest: Post Resuscitation Care
o Adult:
Consider Fentanyl 1 mcg/kg IV/IO (max dose 50 mcg), repeat every 5 minutes
if indicated (max cumulative dose 200 mcg).
 Cardiac Emergencies: Acute Coronary Syndrome
o Adult:
Administer Fentanyl 1 mcg/kg slow IV (max dose 50 mcg), repeat every 5
minutes if indicated (max cumulative dose, 200 mcg).
 Decreased gastric motility.
 Nausea and vomiting.
 Bradycardia.
 Chest wall rigidity.
264
Fentanyl
Prince William County Fire and Rescue System
Fentanyl
 Cardiac Emergencies: Bradycardia
 Cardiac Emergencies: Regular Narrow Complex Tachycardia (SVT)
 Cardiac Emergencies: Irregular Narrow Complex Tachycardia (A‐Fib)
 Cardiac Emergencies: Wide Complex Tachycardia
 Cardiac Emergencies: Polymorphous V‐Tach (Torsades de Pointes)
o Adult:
Administer Fentanyl 1 mcg/kg IV/IO (max dose 50 mcg), repeat every 5 minutes if
indicated (max cumulative dose 200 mcg).
 Pain Management: Medical/ Trauma
o Adult:
Administer Fentanyl 1 mcg/kg slow IV/IN/IO (max dose 50 mcg), repeat every 5
minutes if indicated (max cumulative dose 200 mcg).
o Pediatric:
Administer Fentanyl 1.5 mcg/kg IN with half of the volume administered to each
nare (max dose 100 mcg), repeat half the original dose in 10 minutes if indicated.
Administer Fentanyl 1 mcg/kg IV/IO (max dose 50 mcg), repeat every 5 minutes if
indicated (max cumulative dose 200 mcg).
 Pediatric Cardiac Arrhythmia: Tachycardia
o Pediatric:
Administer Fentanyl 1 mcg/kg IV/IO (max dose 50 mcg).
265
Glucagon
Prince William County Fire and Rescue System
Glucagon
Pharmacologic properties
Glucagon is an endogenous hormone that is produced in the pancreas. It acts as an insulin antagonist,
accelerating hepatic glycogenolysis and gluconeogenesis. This has the effect of increasing blood
glucose concentrations. Glucagon also effectively restores force and rate of ventricular contractions
in patients with symptomatic beta‐blocker and calcium channel blocker overdose via stimulation of
intracellular cyclic adenosine monophosphate (cAMP) production.
Indications
 Hypoglycemia (where IV access cannot be obtained).
 Beta‐blocker and calcium channel blocker overdoses.
Contradictions
 Known hypersensitivity.
Precautions
 Glucagon should be administered with caution in patients with a history of insulinoma or
pheochromocytoma.
 Awaken patient following administration to provide oral glucose in order to replete glycogen
stores.
Adverse reactions
 Occasional nausea and vomiting.
Dosage and administration
 Cardiac Arrest: Asystole/PEA
 Overdose and Poisoning: Beta Blocker Toxicity
 Overdose and Poisoning: Calcium Channel Blocker
o Adult:
Administer Glucagon 3 mg IV/IO, slow push.
 Medical: Diabetic Emergencies
o Adult:
Administer Glucagon 1 mg IM.
o Pediatric:
Administer Glucagon 0.1 mg/kg IM (max dose 1 mg).
266
Hydroxocobalamin
Prince William County Fire and Rescue System
Hydroxocobalamin
Pharmacologic properties
Hydroxocobalamin is a precursor element. The action of hydroxocobalamin in the treatment of
cyanide poisoning is based on the ability to bind cyanide ions. Each hydroxocobalamin molecule can
bind one cyanide ion by substituting if for the hydroxo ligand linked to the trivalent cobalt ion to
form cyanocobalamin (Vitamin B12) which is then excreted in the urine.
Indications
 Moderate to severe signs/symptoms of cyanide toxicity in the setting of significant smoke
inhalation or other known cyanide exposure.
Contradictions
 Known hypersensitivity.
Precautions
 May redden or discolor the injection site, skin, and mucus membranes.
 Incompatible with other medications; use dedicated line.
Adverse reactions
 Hypertension.
 Flushing of the skin.
Dosage and administration
 Hazardous Materials Exposure: Cyanide Toxicity and Smoke Inhalation
o Adult:
Administer Hydroxocobalmin (Cyanokit®) 5 g IV/IO over 15 minutes.
267
Ipratropium Bromide
Prince William County Fire and Rescue System
Ipratropium Bromide
Pharmacologic properties
Ipratropium bromide is an anticholinergic bronchodilator classified as a quaternary ammonium
compound. Anticholinergics prevent the binding of acetylcholine with muscarinic receptors on
bronchial smooth muscle, inhibiting bronchoconstriction. The broncho‐dilating effect of ipratropium
is primarily local and site specific. Since it is not well absorbed systemically, there is low potential for
toxicity.
Indications
 Acute bronchospasm (wheezing) associated with asthma or COPD in adult and pediatric
patients.
Contraindications
 Hypersensitivity to ipratropium, atropine or its derivatives.
Precautions
 Use with caution in patients with narrow angle glaucoma, prostatic hypertrophy, or bladderneck
obstruction.
 Contact with eyes can cause irritation and precipitation of narrow angle glaucoma.
Adverse reactions
 Palpitations.
 Nervousness.
 Dizziness.
 Headache.
 Nausea.
 GI distress.
 Dry mouth.
 Cough.
Dosage and administration
 Respiratory Emergencies: Acute Bronchospasm
o Adult:
Administer Albuterol 2.5 mg and Ipratropium Bromide 0.5 mg via nebulizer,
repeat once in 5 minutes if indicated.
o Pediatric:
Administer Albuterol 2.5 mg and Ipratropium Bromide 0.5 mg via nebulizer,
repeat once in 5 minutes if indicated.
 Respiratory Emergencies: Pulmonary Edema
o Adult:
Administer Albuterol 2.5 mg and Ipratropium Bromide 0.5 mg via nebulizer,
repeat once in 5 minutes if indicated.
268
Ipratropium Bromide
Prince William County Fire and Rescue System
Ipratropium Bromide
 Hazardous Materials Exposure: General Approach
o Administer Albuterol 2.5 mg and Ipratropium Bromide 0.5 mg via nebulizer, repeat
once in 5 minutes if indicated.
269
Ketamine Hydrochloride
Prince William County Fire and Rescue System
Ketamine Hydrochloride
Pharmacologic properties
Ketamine is a non barbituate rapid acting dissociative anesthetic. It acts on the central nervous
system primarily as a noncompetitive antagonist at the NDMA receptor. Additionally it has a
weaker interaction with opioid receptors producing analgesia.
Indications
 Delirium requiring immediate behavioral control.
Contraindications
 Severe cardiovascular disease (angina, heart failure, malignant hypertension).
 Psychosis.
 Known hypersensitivity.
Precautions
 May precipitate emergence reactions as effects wane (confusion, delirium, excitement,
hallucinations, irrational behavior, vivid imagery, pleasant dream like state).
 Must give SLOW IV. Rapid IV administration increases the incidence of respiratory
depression.
Side effects/ adverse reactions
 Cardiovascular‐ Tachycardia, hypertension, arrhythmia.
 CNS‐ Hallucinations, delirium, emergence reaction.
 Respiratory‐ respiratory depression, laryngeal spasm (more common with fast
administration).
Dosage and administration
 Medical: Behavioral Emergencies/Excited Delirium
o Adult (Paramedic Only):
Administer Ketamine 3 mg/kg IM
OR
Administer Ketamine 1 mg/kg IV.
270
Lidocaine
Prince William County Fire and Rescue System
Lidocaine
Pharmacologic properties
Lidocaine is an amide local anesthetic. It stabilizes the neuronal membrane by inhibiting
fast‐gated sodium channels of the postsynaptic cell membrane preventing depolarization
and inhibiting the generation and propagation of nerve impulses.
Indications
 Local anesthetic for IO use.
Contraindications
 Known hypersensitivity.
Side effects/ adverse reactions
 Burning sensation at the site.
 Erythema.
Dosage and administration
 Clinical Procedure: Intraosseous Access
o Adult:
Administer 40 mg of 2% Lidocaine over 2 minutes.
Allow lidocaine to dwell in IO space for 1 minute.
Flush with 10 cc of NS
o Pediatrics:
Administer 0.5 mg/kg of 2% Lidocaine (not to exceed 40 mg) over 2 minutes.
Allow lidocaine to dwell in IO space for 1 minute.
Flush with 5 cc of NS.
271
Magnesium Sulfate
Prince William County Fire and Rescue System
Magnesium Sulfate
Pharmacologic properties
Magnesium is a cation that acts as a cofactor of the cellular membrane sodium‐potassium pump, and
plays an integral role in maintaining intracellular potassium levels. Magnesium is essential for
energy transfer and electrical stability, and acts as a powerful antiarrhythmic, particularly in the
setting of Torsades de Pointes. It is also a CNS depressant effective in the management of seizures
associated with toxemia of pregnancy (eclampsia), and a bronchodilator effective for asthma and
COPD.
Indications
 Cardiac Arrest associated with suspected hypomagnesemic state.
 Torsades de Pointes.
 Eclampsia.
 Known hypomagnesemia associated with arrhythmias.
 Bronchospasm (wheezing) unresponsive to albuterol and ipratropium bromide.
Contraindications
 Renal Failure.
Precautions
 Avoid rapid IVP unless unstable.
 May induce respiratory depression or apnea ‐ in this setting, treat with 10% calcium chloride,
5‐10 mL IV bolus.
 Use with extreme caution in patients with myasthenia gravis, neuromuscular disease, or heart
block.
Adverse reactions
 Loss of deep tendon reflexes.
 Respiratory arrest.
 Hypotension.
 Drowsiness.
 Flushing.
Dosage and administration
 Respiratory Emergencies: Acute Bronchospasm
o Adult:
Administer Magnesium Sulfate 2 g diluted in 100 ml NS IV/IO over 10 minutes.
o Pediatric:
Administer Magnesium Sulfate 50 mg/kg diluted in 100 ml NS IV/IO over 10
minutes (max dose 2 g).
272
Magnesium Sulfate
Prince William County Fire and Rescue System
Magnesium Sulfate
 Cardiac Arrest: V‐Fib/Pulseless V‐Tach
o Adult:
Administer Magnesium Sulfate 2 g IV/IO.
o Pediatric:
Administer Magnesium Sulfate 50 mg/kg IV/IO (max dose 2 g).
 Cardiac Emergencies: Polymorphous V‐Tach (Torsades de Pointes)
o Adult:
Administer Magnesium Sulfate 2 g diluted in 10 ml NS IV over 2 minutes.
 OB/GYN: Pre‐Eclampsia/Eclampsia
o Adult:
Administer Magnesium Sulfate 4 g diluted in 100 ml NS IV over 10 minutes.
 Pediatric Cardiac Arrhythmia: Tachycardia
o Pediatric:
Administer Magnesium Sulfate 50 mg/kg diluted in 10 ml NS IV/IO over 2
minutes (max dose 2 g).
273
Methylprednisolone
Prince William County Fire and Rescue System
Methylprednisolone
Pharmacologic properties
Methylprednisolone is a systemic corticosteroid that has many downstream effects on the body.
Therapeutically, it has potent anti‐inflammatory properties. The onset of action is several hours.
Indications
 Acute exacerbation of asthma/COPD.
 Anaphylaxis/ Acute allergic reactions.
Contradictions
 Known hypersensitivity.
Precautions
 Use caution when administering to patients with diabetes mellitus, pregnancy, liver disease,
or signs of systemic infection.
 Do not administer methylprednisolone preserved with benzyl alcohol to pregnant women,
breast feeding women, or neonates. Benzyl alcohol is associated with serious adverse events
in this population.
Adverse reactions
 Adverse effects with single bolus use of Methylprednisolone are uncommon, although
patients on chronic steroids are at risk for a multitude of side effects.
Dosage and administration
 Respiratory Emergencies: Acute Bronchospasm
o Adult:
Administer Methylprednisolone 125 mg IV/IM/IO.
o Pediatric > 2 years of age:
Administer Methylprednisolone 2 mg/kg IV/IM/IO (max dose 125 mg).
 Medical: Allergic Reaction
o Adult:
Administer Methylprednisolone 125 mg IV/IM/IO.
o Adult (Cardiac Arrest):
Administer Methylprednisolone 125 mg IV/IO.
o Pediatric:
Administer Methylprednisolone 2 mg/kg IV/IM/IO (max dose 125 mg).
274
Metoprolol
Prince William County Fire and Rescue System
Metoprolol
Pharmacologic properties
Metoprolol is a lipophilic beta1 selective adrenergic receptor blocker. It causes decreased resting
heart rate, inhibition of exercise‐induced increases in heart rate, decreased myocardial contractility
and decreased cardiac output.
Indications
 Irregular narrow complex tachycardia (A‐Fib).
Contraindications
 Bradycardia.
 2nd or 3rd degree AV block.
 Cardiogenic shock.
 Known hypersensitivity.
Precautions
 Due to the Beta1 selectivity, metoprolol may be used in brochospastic disease. As the dose
increases the Beta 1 selectivity decreases therefore use the lowest dose that is effective.
Side effects/ adverse reactions
 Cardiovascular‐ Hypotension, bradycardia, AV block.
 CNS‐ fatigue, dizziness, headache.
Dosage and administration
 Cardiac Emergencies: Irregular Narrow Complex Tachycardia (A‐Fib)
o Consider Metoprolol 5 mg IV/IO over 1‐2 minutes, repeat every 5 minutes if indicated
(max cumulative dose 15 mg).
275
Morphine Sulfate
Prince William County Fire and Rescue System
Morphine Sulfate
Pharmacologic properties
Morphine is an opioid analgesic that suppresses pain by agonizing opioid receptors (primarily
mu) in the central nervous system. Morphine exerts its principal pharmacological effect on the
central nervous system and gastrointestinal tract. Its primary actions of therapeutic value are
analgesia and sedation. Morphine appears to increase the patient's tolerance for pain and to
decrease discomfort, although the presence of the pain itself may still be recognized. In
addition to analgesia, alterations in mood, euphoria, dysphoria, and drowsiness commonly
occur. Opioids also produce respiratory depression by direct action on brain stem respiratory
centers. Morphine has more vasoactive effects than Fentanyl and may induce significant
histamine release resulting in vasodilation and hypotension.
Indications
 Chest pain associated with suspected myocardial ischemia.
 Pulmonary edema with hypertension.
 Thermal burns.
 Isolated extremity injury.
 Severe pain from suspected kidney stone.
Contraindications
 Hypotension, (SBP <100 mmHg) or volume depletion.
 Head trauma.
 Acute alcohol intoxication.
 Acute respiratory distress.
 Known hypersensitivity.
Precautions
 Use with caution in elderly patients.
 Morphine is metabolized by the liver, use caution in patients with known liver disease.
 Sedative effects are potentiated by alcohol, antihistamines, barbiturates,
benzodiazepines, phenothiazines, and other sedatives.
Adverse reactions
 Euphoria.
 Drowsiness.
 Pupillary constriction.
 Respiratory arrest.
 Nausea and vomiting
Dosage and administration
 Respiratory Emergencies: Pulmonary Edema
o Adult:
Consider Morphine Sulfate .05‐0.1 mg/kg IV (max dose 5 mg), repeat every 5
minutes for persistent severe hypertension (max cumulative dose 15 mg).
276
Morphine Sulfate
Prince William County Fire and Rescue System
Morphine Sulfate
 Cardiac Emergencies: Acute Coronary Syndrome
o Adult:
Administer Morphine Sulfate 0.1 mg/kg slow IV (max dose 5 mg), repeat
every 5 minutes if indicated (max cumulative dose 15 mg).
 Pain Management: Medical/Trauma
o Adult:
Consider Morphine Sulfate 0.1 mg/kg IV/IO (max dose 5 mg), repeat
every 5 minutes if indicated (max cumulative dose 15 mg).
o Pediatric:
Consider Morphine Sulfate 0.1 mg/kg IV/IO (max dose 5 mg), repeat
every 5 minutes if indicated (max cumulative dose 15 mg).
277
Midazolam
Prince William County Fire and Rescue System
Midazolam
Pharmacologic properties
Midazolam is a short‐acting sedative hypnotic of the benzodiazepine family that increases the action
of gamma‐aminobutyric acid (GABA), the major inhibitory neurotransmitter in the central nervous
system. Midazolam depresses the limbic system, thalamus, and hypothalamus resulting in profound
sedation and muscle relaxation. The inhibitory nature of the drug also provides anti‐epileptic activity
that terminates and prevents seizures.
Indications
 Status epilepticus.
 Cocaine (sympathomimetic) toxicity.
 Behavioral emergencies in patients with severe agitation or aggressive behavior resulting in
interference with patient care or patient/crew safety.
 May be adjunctive treatment with antipsychotics.
Contraindications
 Acute alcohol intoxication.
 Do not administer to neonatal patients.
 Respiratory insufficiency.
 Hypotension (SBP < 90 mmHg).
 Known hypersensitivity to benzodiazepines.
Precautions
 Use extreme caution with intravenous administration ‐ rapid IV bolus may cause hypotension
and respiratory depression/arrest.
 Effects are exacerbated in the elderly, and when administered to patients who have already
ingested another CNS depressant (ETOH, barbiturates, GHB).
Adverse reactions
 Confusion.
 Drowsiness.
 Respiratory depression/arrest.
 Hypotension.
 Nausea.
 Vomiting.
Dosage and administration
 Cardiac Arrest: Post Resuscitation Care
o Adult:
Consider Midazolam 2.5 mg IV/IO, repeat in 5 minutes if indicated and monitor
for hypotension (max cumulative dose 5 mg).
278
Midazolam
Prince William County Fire and Rescue System
Midazolam
 Cardiac Emergencies: Bradycardia
 Cardiac Emergencies: Regular Narrow Complex Tachycardia (SVT)
 Cardiac Emergencies: Irregular Narrow Complex Tachycardia (A‐Fib)
 Cardiac Emergencies: Wide Complex Tachycardia
 Cardiac Emergencies: Polymorphous V‐Tach (Torsades de Pointes)
o Adult:
Administer Midazolam 2.5 mg IV/IO, repeat in 5 minutes if indicated and
monitor for hypotension (max cumulative dose 5 mg.)
 Medical: Behavioral Emergencies/Excited Delirium
o Adult (≤ 65):
Administer Midazolam 5 mg IV/IM/IN/IO, repeat in 5 minutes if indicated
(max cumulative dose 10 mg).
o Adult (> 65):
Administer Midazolam 2.5 mg IV/IM/IN/IO, repeat in 5 minutes if indicated
(max cumulative dose 5 mg).
 Medical: Seizure
o Adult (≤ 65):
Administer Midazolam 5 mg IV/IM/IN/IO, repeat in 5 minutes if indicated
(max cumulative dose 10 mg).
o Adult (> 65):
Administer Midazolam 2.5 mg IV/IM/IN/IO, repeat in 5 minutes if indicated
(max cumulative dose 5 mg).
o Pediatric:
Administer Midazolam 0.2 mg/kg IN (max individual dose 5 mg), repeat in 5
minutes if indicated (max cumulative dose 10 mg).
OR
Administer Midazolam 0.1 mg/kg IM/IV/IO (max individual dose 2.5 mg),
repeat in 5 minutes if indicated (max cumulative dose 5 mg).
 OB/GYN: Pre‐Eclampsia/Eclampsia
o Adult:
Administer Midazolam 5 mg IV/IM/IN/IO, repeat in 5 minutes if indicated
(max cumulative dose 10 mg).
 Trauma: Head Injuries
o Adult (≤ 65):
Administer Midazolam 5 mg IV/IM/IN/IO, repeat in 5 minutes if indicated
(max cumulative dose 10 mg).
o Adult (> 65):
Administer Midazolam 2.5 mg IV/IM/IN/IO, repeat in 5 minutes if indicated
(max cumulative dose 5 mg).
279
Midazolam
Prince William County Fire and Rescue System
Midazolam
 Pediatric Cardiac Arrhythmia: Tachycardia
o Pediatric:
Administer Midazolam 0.1 mg/kg IV/IO (max dose 2 mg).
 Pediatric Trauma: Head Injuries
o Pediatric:
Administer Midazolam 0.2 mg/kg IN (max dose 5 mg).
OR
Administer Midazolam 0.1 mg/kg IM/IV/IO (max dose 5 mg).
280
Naloxone
Prince William County Fire and Rescue System
Naloxone
Pharmacologic properties
Naloxone is a competitive mu opioid receptor antagonist. The drug antagonizes the effects of opiates
by competing at the same receptor sites. Onset of action is 1‐2 minutes, the duration of action is 1‐4
hours.
Indications
 Naloxone is indicated for the reversal of narcotic intoxication with respiratory depression.
 Altered mental status (unknown cause).
Contraindications
 Known hypersensitivity.
Precautions
 Use caution during administration as patient may become agitated or violent as level of
consciousness increases.
 Should be administered cautiously to persons who are known or suspected to be physically
dependent on opiates, including newborns of dependent mothers – may precipitate acute
withdrawal.
 Naloxone has a relatively short half‐life compared to many narcotics, monitor closely for the
need to repeat dose.
 Naloxone is not effective against a respiratory depression due to non‐opioid drugs.
 Patients who become responsive secondary to naloxone administration are not authorized to
refuse medical care.
Adverse reactions
 Tremor.
 Agitation.
 Belligerence.
 Pupillary dilation.
 Seizures.
 Sweating.
 Hypertension.
Dosage and administration
 General Patient Care Protocol – Adult
o Adult (All Providers):
Administer Naloxone 2 mg IN.
o Adult (Advanced Life Support):
Administer Naloxone 2 mg IN/IM.
Consider Naloxone 0.4 mg IV/IO titrated to maintain adequate respiratory rate
(max cumulative dose 4 mg).
 Hypotension
 Ventricular tachycardia
 Pulmonary edema
 Ventricular fibrillation
 Nausea
 Vomiting
281
Naloxone
Prince William County Fire and Rescue System
Naloxone
 Cardiac Arrest: Post Resuscitation Care
o Adult (Advanced Life Support):
Naloxone 0.4 mg IV/IO titrated to respiratory rate up to 4 mg IV/IO.
 Overdose and Poisoning: General Approach
o Adult (All Providers):
Administer Naloxone 2 mg IN
o Adult (Advanced Life Support):
Consider Naloxone 2 mg IN/IM.
Consider Naloxone 0.4 mg IV/IO, titrated to maintain adequate respiratory rate
(max cumulative dose 4 mg)
 General Patient Care Protocol – Pediatric
o Pediatric (Advanced Life Support):
Administer Naloxone 0.1 mg/kg IV/IN/IM/IO (max dose 2 mg), titrated to
maintain adequate respiratory rate (max cumulative dose 2 mg).
 Pediatric Cardiac Arrest: Neonatal Resuscitation
o Neonate (Advanced Life Support):
Administer Naloxone 0.1 mg /kg IV/IO.
 Pediatric Overdose and Poisoning
o Pediatric (Advanced Life Support):
Administer Naloxone 0.1 mg/kg IV/IN/IM/IO (max dose 2 mg), titrated to
maintain adequate respiratory rate (max cumulative dose 2 mg).
282
Nitroglycerin
Prince William County Fire and Rescue System
Nitroglycerin
Pharmacologic properties
Nitroglycerin is an organic nitrate which causes systemic vasodilation by entering vascular smooth
muscle, converting to nitric oxide, and activating cGMP. This dose‐dependent acts primarily
on the venous system, although it also produces direct coronary artery vasodilation as well. The
overall result is a decrease in venous return, which decreases the workload on the heart and thus,
decreases myocardial oxygen demand. Nitroglycerin also improves blood flow to the myocardium
and lowers systemic blood pressure.
Indications
 Chest pain with suspected cardiac ischemia.
 Suspected acute myocardial infarct.
 Acute dyspnea with suspected pulmonary edema/congestive heart failure.
Contraindications
 Hypertension associated with acute stroke or severe brain injury.
 Systolic BP < 100 mmHg or MAP < 65 (Pulmonary Edema).
 Systolic BP < 100 mmHg or MAP < 65 or if a SBP drop ≥ 30 mmHg. (Acute Coronary
Syndrome) ‐BLS only. ALS providers use caution.
 Phosphodiesterase‐5 (PDE5) inhibitor use within last 48 hours.
Precautions
 Use with caution in acute inferior wall MI or right ventricular infarct (ST elevation in V4R). Be
prepared to administer 250 mL NS bolus if hypotension develops.
 Patients on chronic nitrate therapy may require larger doses of nitroglycerine during acute
angina episodes.
 Nitro tablets are inactivated by light, air and moisture and must be kept in amber glass
containers with tight‐fitting lids.
 Alcohol will accentuate vasodilation and hypotensive effects.
Adverse reactions
 Headache.
 Hypotension.
 Tachycardia.
 Dizziness
 Flushing.
 Nausea and vomiting.
Dosage and administration
 Respiratory Emergencies: Pulmonary Edema
o Adult (All Providers):
Consider Nitroglycerin 0.4 mg SL, repeat in 5 minutes if indicated (max
cumulative dose of 1.2 mg).
283
Nitroglycerin
Prince William County Fire and Rescue System
Nitroglycerin
 Respiratory Emergencies: Pulmonary Edema
o Adult (Advanced Life Support):
Administer Nitroglycerin 0.4 mg SL. If patient remains hypertensive with
moderate to severe symptoms in 5 minutes.
Administer Nitroglycerin 0.8 mg SL. Repeat Nitroglycerin 0.8 mg SL every 5
minutes with goal of achieving 20% reduction in SBP.
 Cardiac Emergencies: Acute Coronary Syndrome
o Adult (All Providers):
Consider Nitroglycerin 0.4 mg SL, repeat every 5 minutes for continued chest
pain (max cumulative dose 1.2 mg provided by either patient or provider).
o Adult (Advanced Life Support):
Consider Nitroglycerin 0.4 mg SL repeat every 5 minutes for continued chest
pain.
284
Ondansetron Hydrochloride
Prince William County Fire and Rescue System
Ondansetron Hydrochloride
Pharmacologic properties
Ondansetron hydrochloride is an anti‐emetic, which acts as a selective inhibitor of the serotonin 5‐
HT 3‐receptor type. The drug binds to both central nervous system and peripheral receptors in the
gastrointestinal tract to exert its effects. Its onset of action is 30 minutes, and duration of action is 2‐
7 hours.
Indications
 Severe, persistent vomiting.
Contraindications
 Known hypersensitivity.
 Known Long‐QT Syndrome.
 Known pregnancy or suspected pregnancy.
Precautions
 May lengthen QT interval – patients should be placed on a cardiac monitor after
administration.
 The use of ondansetron in patients following abdominal surgery may mask a progressive ileus
and/or gastric distention.
Adverse reactions
 Headache.
 Fatigue.
 Diarrhea.
 Dizziness.
Dosage and administration
 General Patient Care Protocol – Adult
o Adult (All Providers):
Consider Ondansetron 4 mg ODT (contraindicated in pregnancy or suspected
pregnancy).
o Adult (Advanced Life Support):
Administer Ondansetron 4 mg ODT/IV/IM/IO (contraindicated in pregnancy
or suspected pregnancy. Repeat once in 10 minutes if indicated (max
cumulative dose 8 mg).
 General Patient Care Protocol – Pediatric
o Pediatric (Advanced Life Support):
Administer Ondansetron 2 mg (8‐15 kg) or 4 mg (>15 kg) ODT (break in half to
administer 2 mg.)
Administer Ondansetron 0.1 mg/kg IV/IO (max single dose 4 mg).
285
Promethazine
Prince William County Fire and Rescue System
Promethazine
Pharmacologic properties
Promethazine is a phenothiazine derivative with antidopaminergic effects. It works by changing the
actions of dopamine receptors and alpha‐adrenergic receptors in the brain. Its onset of action is 3‐5
minutes, and duration of action is 4‐6 hours.
Indications
 Severe, persistent vomiting in patients with a known or suspected pregnancy.
Contraindications
 Known hypersensitivity.
Precautions
 IV administration can cause severe tissue injury, including burning, thrombophlebitis, and
gangrene.
 May alter cardiac conduction – patients should be placed on a cardiac monitor after
administration.
Adverse reactions
 Sedation
 Confusion
 Blurred Vision
 Tachycardia
Dosage and administration
 General Patient Care Protocol
o Adult (Advanced Life Support)
Administer Promethazine 12.5 mg diluted in 100 ml NS IV at a wide open rate
in a patent 20g or large IV. IV must be located in the antecubital.
286
 Bradycardia
 Dystonias
 Photosensitivity
 Hallucinations
Racemic Epinephrine
Prince William County Fire and Rescue System
Racemic Epinephrine
Pharmacologic properties
Racemic Epinephrine elicits agonistic action on alpha, beta‐2, and beta‐2 receptors resulting in
bronchial smooth muscle relaxation, cardiac stimulation, vasodilation in skeletal muscle, and
stimulation of glycogenosis in the liver.
Indications
 Partial upper airway obstruction (suspected croup) or stridor at rest with respiratory
distress.
Contraindications
 Known hypersensitivity.
 Epiglottitis
Precautions
 Co‐administration with MAOI’s or within 2 weeks after discontinuing MAOI.
 History of heart disease.
 History of hypertension.
 History of thyroid disease.
 History of diabetes.
Adverse reactions
 Tachycardia.
 Arrhythmias
 Headache.
 Nausea
 Pulmonary Edema
Dosage and administration
 Pediatric Respiratory Emergencies: Stridor
o Administer Racemic Epinephrine 2.25%/0.5 ml mixed with 3 ml NS via nebulizer.
287
Sodium Bicarbonate
Prince William County Fire and Rescue System
Sodium Bicarbonate
Pharmacologic properties
Sodium bicarbonate is an endogenous anion that reacts with hydrogen ions to form water
carbon dioxide. It is an alkalizing agent used to buffer acids present in the body during
periods of metabolic acidosis. Its effect is to raise the serum pH. This effect is favorable in the
treatment of pre‐existing metabolic acidosis, hyperkalemia, tricyclic anti‐depressant/salicylate
(aspirin)/or phenobarbital overdose, and after profound hypoxia/prolonged cardiac arrest. Sodium
bicarbonate is effective only when administered with adequate ventilation and oxygenation.
Indications
 Bicarbonate responsive metabolic acidosis precipitating cardiac arrest.
 Wide complex tachycardia.
 Hyperkalemia.
 Tricyclic antidepressant overdose.
 Chlorine/Chloramine expure.
Contraindications
 Congestive heart failure.
 Alkalotic states.
 Hypoxic lactic acidosis.
Precautions
 Excessive bicarbonate therapy inhibits the release of oxygen, induces hyperosmolarity and
hypernatremia, and produces paradoxical acidosis in myocardial and cerebral cells.
 Bicarbonate does not improve the ability to defibrillate.
 May inactivate simultaneously administered catecholamines.
 Will precipitate if mixed with calcium chloride.
Adverse reactions
 Metabolic alkalosis.
 Hypernatremia/Hyperosmolality.
 Cerebral acidosis (paradoxical effect).
 Sodium and fluid retention which can cause pulmonary edema.
Dosage and administration
 Cardiac Arrest: Asystole/PEA
o Adult:
Administer Sodium Bicarbonate 1 mEq/kg IV/IO (max dose 50 mEq), may
repeat once in 10 minutes.
o Pediatrics:
Administer Sodium Bicarbonate 1 mEq/kg IV/IO (max dose 50 mEq).
288
Sodium Bicarbonate
Prince William County Fire and Rescue System
Sodium Bicarbonate
 Cardiac Arrest: V‐Fib/Pulseless V‐Tach
o Adult:
Administer Sodium Bicarbonate 1 mEq/kg IV/IO (max dose 50 mEq), may
repeat once in 10 minutes.
 Cardiac Arrest: Post Resuscitation Care
o Adult:
Administer Sodium Bicarbonate 1 mEq/kg IV/IO (max dose 50 mEq).
 Cardiac Emergencies: Wide Complex Tachycardia
o Adult:
Administer Sodium Bicarbonate 1 mEq/kg IV/IO (max dose 50 mEq).
 Hazardous Materials Exposure: General Approach
o Adult (Medical Control):
Administer 4.2% Sodium Bicarbonate 5 ml via Nebulizer.
Mix 2.5 ml of 8.4% Sodium Bicarbonate with 2.5 ml of NS.
 Medical: Behavioral Emergencies/Excited Delirium
o Adult (Medical Control):
Consider Sodium Bicarbonate 50 mEq in 1,000 ml NS IV wide open.
 Overdose and Poisoning: Antidepressants
o Adult:
Administer Sodium Bicarbonate 1 mEq IV/IO (max dose 50 mEq), may repeat
once in 10 minutes if indicated.
 General Patient Care Protocol – Adult Trauma
o Adult (Medical Control):
Consider Sodium Bicarbonate 1 mEq/kg IV/IO over 5 minutes (max dose 100
mEq).
289
Tranexamic Acid
Prince William County Fire and Rescue System
Tranexamic Acid
Pharmacologic properties
Tranexamic acid is an antifibrinolytic. It is a competitive inhibitor of plasminogen activation and at
higher doses a noncompetitive inhibitor of plasmin. It shifts the natural equilibrium in favor of clot
formation rather than clot breakdown.
Indications
 ADULTS ONLY.
 Severe blunt or penetrating traumatic injury with significant blood loss evident or strongly
suspected (hemorrhagic shock).
Contraindications
 Isolated closed head injury.
 Non hemorrhagic shock.
 Pediatric patients.
 Known hypersensitivity.
Precautions
 Should only be given for suspected hemorrhagic shock with sustained vital sign
abnormalities.
Side effects/ adverse reactions
 Acute gastrointestinal disturbance (Nausea, vomiting, diarrhea).
 Abdominal pain.
Dosage and administration
 General Patient Care Protocol – Adult Trauma
o ADULTS ONLY:
Administer Tranexamic Acid 1 g diluted into 100 ml IV/IO over 10 minutes.
290
Prince William County Fire and Rescue System
Reference
Reference Documents: Pediatric Quick Reference
Prince William County Fire and Rescue System
Reference Documents: Pediatric Quick Reference
Modified GCS for Infants and Children
Child Infant Score
Eye Opening
Spontaneous Spontaneous 4
To Speech To Speech 3
To Pain To Pain 2
None None 1
Best Verbal
Response
Oriented, Appropriate Coos and Babbles 5
Confused Irritable, Cries 4
Inappropriate Words Cries in Response to Pain 3
Incomprehensible Sounds Moans in Response to Pain 2
None None 1
Best Motor
Response
Obeys Commands Moves Spontaneously and Purposely 6
Localizes Painful Stimulus Withdraws in Response to Touch 5
Withdraws in Response to Pain Withdraws in Response to Pain 4
Flexion in Response to Pain Abnormal Flexion Posture to Pain 3
Extension in Response to Pain Abnormal Extension Posture to Pain 2
None None 1
Equipment
GRAY
3‐5kg
PINK
Small infant
6‐7kg
RED
Infant
6‐9kg
PURPLE
Toddler
10‐11kg
YELLOW
Small
Child
12‐14kg
WHITE
Child
15‐18kg
BLUE
Child
19‐23kg
ORANGE
Large Child
24‐29kg
GREEN
Adult
30‐36kg
Resuscit
ation
Bag
Infant Infant/Child Infant/Child Child Child Child Child Child Adult
NRB Pediatric Pediatric Pediatric Pediatric Pediatric Pediatric Pediatric Pediatric Pediatric/Ad
ult
OPA 50mm 50mm 50mm 60mm 60mm 60mm 70mm 80mm 80mm
NPA 14 F 14 F 14 F 18 F 20 F 22 F 24 F 26 F 30 F
Laryngos
cope
Blade
1 Straight 1 Straight 1 Straight 1 Straight 2
Straight
2
Straight
2
Straight/Cur
ved
2
Straight/Cu
rved
3
Straight/Cur
ved
ETT 3.5 UC 3.5 UC 3.5 UC 4.0 UC 4.5 UC 5.0 UC 5.5 UC 6.0 Cuff 6.5 Cuff
Suction
Catheter
8 F 8 F 8 F 10 F 10 F 10 F 10 F 10 F 10 F‐12 F
BP Cuff Neonate/
Infant
Infant/Child Infant/Child Child Child Child Child Child Small Adult
IV
Catheter
24G 22G‐24G 22G‐24G 20G‐24G 18G‐22G 18G‐22G 18G‐20G 18G‐20G 16G‐20G
IO 15mm 15mm or
25mm
15mm or
25mm
15mm or
25mm
15mm
or
25mm
15mm
or
25mm
15mm or
25mm
15mm or
25mm
25mm
291
Reference Documents: Pediatric Quick Reference
Prince William County Fire and Rescue System
Reference Documents: Pediatric Quick Reference
Pediatric Weight
Conversion
lbs kg lbs kg
2 0.9 26 11.8
3 1.4 27 12.2
4 1.8 28 12.7
5 2.3 29 13.2
6 2.7 30 13.6
7 3.2 31 14
8 3.6 32 14.5
9 4.1 33 15
10 4.5 34 15.5
11 5.0 35 15.9
12 5.4 36 16.4
13 5.9 37 16.8
14 6.4 38 17.3
15 6.8 39 17.7
16 7.3 40 18.2
17 7.7 41 18.6
18 8.2 42 19.1
19 8.6 43 19.5
20 9.1 44 20
21 9.5 45 20.5
22 10 46 20.9
23 10.4 47 21.4
24 10.9 48 21.8
25 11.3 49 22.3
50 22.7
292
Vital Signs in Children
Age Heart Rate
(Breaths Per
Minute)
Age Respiratory
Rate (Breaths
Per Minute)
Age Minimum SBP
Children
(1‐8 yrs old)
80‐100 Children
(1‐8 yrs old)
15 – 30 Children
(1‐8yrs old)
>70 + (2 x age in
years)
Infant 100‐120 Infant 25 – 50 Infant >70
Neonate 120‐160 Neonate 40 – 60 Neonate >60
Reference Documents: Triage Quick Reference
Prince William County Fire and Rescue System
Reference Documents: Triage Quick Reference
U.S. Department of Health & Human Services
293
Reference Documents: Triage Quick Reference
Prince William County Fire and Rescue System
Reference Documents: Triage Quick Reference
U.S. Department of Health & Human Services
294
Copy 2 – To be kept in patient’s permanent medical record
Durable Do Not Resuscitate Order
Virginia Department of Health
Patient’s Full Legal Name _______________________________________________ Date _______________
Physician’s Order
I, the undersigned, state that I have a bona fide physician/patient relationship with the patient named above. I have certified in
the patient’s medical record that he/she or a person authorized to consent on the patient’s behalf has directed that life-prolonging
procedures be withheld or withdrawn in the event of cardiac or respiratory arrest.
I further certify (must check 1 or 2):
The patient is CAPABLE of making an informed decision about providing, withholding, or withdrawing a specific
medical treatment or course of medical treatment. (Signature of patient is required)
ecision about providing, withholding, or withdrawing a specific
medical treatment or course of medical treatment because he/she is unable to understand the nature, extent or probable
consequences of the proposed medical decision, or to make a rational evaluation of the risks and benefits of
alternatives to that decision.
If you checked 2 above, check A, B, or C below:
hat
life-prolonging procedures be withheld or withdrawn.
a
“Person Authorized to Consent on the Patient’s Behalf” with authority to direct that life-prolonging procedures be
withheld or withdrawn. (Signature of “Person Authorized to Consent on the Patient’s Behalf is required.)
lth care).
(Signature of “Person Authorized to Consent on the Patient’s Behalf is required)
I hereby direct any and all qualified health care personnel, commencing on the effective date noted above, to withhold
cardiopulmonary resuscitation (cardiac compression, endotracheal intubation and other advanced airway management, artificial
ventilation, defibrillation, and related procedures) from the patient in the event of the patient’s cardiac or respiratory arrest. I
further direct such personnel to provide the patient other medical interventions, such as intravenous fluids, oxygen, or other
therapies deemed necessary to provide comfort care or alleviate pain.
____________________________ ____________________________ ____________________________
Physician’s Printed Name Physician’s Signature Emergency Phone Number
____________________________ __________________________________________________________
Patient’s Signature Signature of Person Authorized to Consent on the Patient’s Behalf
SAMPLE


Virginia Office of Emergency Medical Services
Scope of Practice - Procedures for EMS Personnel
This SOP represents practice maximums .
“Investigational medications and procedures which have been reviewed and approved by an Institutional Review Board (IRB) will be considered to be approved by the Medical Direction Committee solely within the
context of the approved study. Investigators involved in IRB approved research are asked to present their study plans to the MDC for informational purposes so that the committee can maintain an awareness of ongoing
pre-hospital research in the Commonwealth. Those who desire to conduct non-IRB reviewed pilot projects, demonstration projects, or research are asked to present those proposals to the MDC prior to their
implementation for review and approval by the MDC.”
Use of medication not listed which is indicated by medical control and/or the operational medical director due to the use of a weapon of mass destruction is exempt from this list.
Approved: November 6, 2013
Page 1 of 6
PROCEDURE SKILL PROCEDURE SUBTYPE EMR EMT
AEMT -
Enhanced I P
AIRWAY TECHNIQUES
Airway Adjuncts
Oropharyngeal Airway     
Nasopharyngeal Airway     
Airway Maneuvers
Head tilt jaw thrust     
Jaw thrust     
Chin lift     
Cricoid Pressure     
Management of existing Tracheostomy    
Alternate Airway Devices
Non Visualized Airway Devices Supraglottic    
Cricothyrotomy
Needle 
Surgical Includes percutaneous techniques 
Obstructed Airway Clearance
Manual     
Visualize Upper-airway   
Intubation
Nasotracheal 
Orotracheal - Over age 12  
Pharmacological facilitation with paralytic Adult Neuromuscular Blockade 
Confirmation procedures    
Pediatric Orotracheal 
Pediatric paralytics 
Pediatric sedation 
** Endotracheal intubation is prohibited for all levels except Intermediate and Paramedic
Specific tasks in this document shall refer to the Virginia Education Standards.
Virginia Office of Emergency Medical Services
Scope of Practice - Procedures for EMS Personnel
This SOP represents practice maximums .
“Investigational medications and procedures which have been reviewed and approved by an Institutional Review Board (IRB) will be considered to be approved by the Medical Direction Committee solely within the
context of the approved study. Investigators involved in IRB approved research are asked to present their study plans to the MDC for informational purposes so that the committee can maintain an awareness of ongoing
pre-hospital research in the Commonwealth. Those who desire to conduct non-IRB reviewed pilot projects, demonstration projects, or research are asked to present those proposals to the MDC prior to their
implementation for review and approval by the MDC.”
Use of medication not listed which is indicated by medical control and/or the operational medical director due to the use of a weapon of mass destruction is exempt from this list.
Approved: November 6, 2013
Page 2 of 6
PROCEDURE SKILL PROCEDURE SUBTYPE EMR EMT
AEMT -
Enhanced I P
Oxygen Delivery Systems
Nasal Cannula     
Venturi Mask    
Simple Face Mask     
Partial Rebreather Face Mask    
Non-rebreather Face Mask     
Face Tent    
Tracheal Cuff    
Oxygen Hood  
O2 Powered Flow restricted device    
Humidification    
Suction
Manually Operated     
Mechanically Operated     
Pharyngeal     
Bronchial-Tracheal    
Oral Suctioning     
Naso-pharyngeal Suctioning    
Endotracheal Suctioning    
Meconium Aspiration Neonate with ET 
Ventilation – assisted / mechanical Mouth to Mask     
Mouth to Mask with O2     
Bag-Valve-Mask Adult     
Bag-Valve-Mask with supplemental O2 Adult     
Bag-Valve-Mask with supplemental O2 and
reservoir Adult     
Bag-Valve-Mask Pediatric     
Virginia Office of Emergency Medical Services
Scope of Practice - Procedures for EMS Personnel
This SOP represents practice maximums .
“Investigational medications and procedures which have been reviewed and approved by an Institutional Review Board (IRB) will be considered to be approved by the Medical Direction Committee solely within the
context of the approved study. Investigators involved in IRB approved research are asked to present their study plans to the MDC for informational purposes so that the committee can maintain an awareness of ongoing
pre-hospital research in the Commonwealth. Those who desire to conduct non-IRB reviewed pilot projects, demonstration projects, or research are asked to present those proposals to the MDC prior to their
implementation for review and approval by the MDC.”
Use of medication not listed which is indicated by medical control and/or the operational medical director due to the use of a weapon of mass destruction is exempt from this list.
Approved: November 6, 2013
Page 3 of 6
PROCEDURE SKILL PROCEDURE SUBTYPE EMR EMT
AEMT -
Enhanced I P
Bag-Valve-Mask with supplemental O2
Pediatric     
Bag-Valve-Mask with supplemental O2 and
reservoir Pediatric     
Bag-Valve-Mask neonate/infant     
Bag-Valve-Mask with supplemental O2
Neonate/Infant     
Bag-Valve-Mask with supplemental O2 and
reservoir Neonate/Infant     
Noninvasive positive pressure vent. CPAP, fixed pressure    
CPAP, BiPAP, PEEP adjustable  
Jet insuflation 
Mechanical Ventilator (Manual/Automated
Transport Ventilator) Maintain long term/established   
Initiate/Manage ventilator  
Anesthesia ( Local)  
Pain Control & Sedation
Self Administered inhaled analgesics    
Pharmacological (non-inhaled)   
Patient controlled analgesia (PCA) Maintain established   
Epidural catheters (maintain) Maintain established  
Blood and Component Therapy Administration Maintain  
Initiate 
Diagnostic Procedures
Blood chemistry analysis    
Capnography    
Pulmonary function measurement   
Pulse Oximetry    
Ultrasonography 
Genital/Urinary
Bladder catheterization
Foley catheter Place bladder catheter 
Maintain bladder catheter    
Virginia Office of Emergency Medical Services
Scope of Practice - Procedures for EMS Personnel
This SOP represents practice maximums .
“Investigational medications and procedures which have been reviewed and approved by an Institutional Review Board (IRB) will be considered to be approved by the Medical Direction Committee solely within the
context of the approved study. Investigators involved in IRB approved research are asked to present their study plans to the MDC for informational purposes so that the committee can maintain an awareness of ongoing
pre-hospital research in the Commonwealth. Those who desire to conduct non-IRB reviewed pilot projects, demonstration projects, or research are asked to present those proposals to the MDC prior to their
implementation for review and approval by the MDC.”
Use of medication not listed which is indicated by medical control and/or the operational medical director due to the use of a weapon of mass destruction is exempt from this list.
Approved: November 6, 2013
Page 4 of 6
PROCEDURE SKILL PROCEDURE SUBTYPE EMR EMT
AEMT -
Enhanced I P
Head and Neck
ICP Monitor (maintain) 
Control of epistaxis     
Inserted epistaxis control devices   
Tooth replacement     
Hemodynamic Techniques
Arterial catheter maintenance 
Central venous maintenance   
Access indwelling port  
Intraosseous access & infusion   
Peripheral venous access and maintenance   
Umbilical Catheter Insertion/Management 
Monitoring Existing IVs    
Mechanical IV Pumps   
Hemodynamic Monitoring
ECG acquisition     
ECG Interpretation  
Invasive Hemodynamic Monitoring 
Vagal Maneuvers/Carotid Massage  
Obstetrics
Delivery of newborn     
Other Techniques
Vital Signs     
Bleeding control     
Tourniquets     
Foreign body removal Superificial without local anesthesia    
Imbedded with local anesthesia/exploration  
Incision/Drainage 
Intravenous therapy   
Medication administration    
Nasogastric tube    
Orogastric tube    
Virginia Office of Emergency Medical Services
Scope of Practice - Procedures for EMS Personnel
This SOP represents practice maximums .
“Investigational medications and procedures which have been reviewed and approved by an Institutional Review Board (IRB) will be considered to be approved by the Medical Direction Committee solely within the
context of the approved study. Investigators involved in IRB approved research are asked to present their study plans to the MDC for informational purposes so that the committee can maintain an awareness of ongoing
pre-hospital research in the Commonwealth. Those who desire to conduct non-IRB reviewed pilot projects, demonstration projects, or research are asked to present those proposals to the MDC prior to their
implementation for review and approval by the MDC.”
Use of medication not listed which is indicated by medical control and/or the operational medical director due to the use of a weapon of mass destruction is exempt from this list.
Approved: November 6, 2013
Page 5 of 6
PROCEDURE SKILL PROCEDURE SUBTYPE EMR EMT
AEMT -
Enhanced I P
Pericardiocentesis 
Pleural decompression  
Patient restraint physical    
Patient restraint chemical  
Sexual assault victim management    
Trephination of nails 
Wound closure techniques  
Wound management     
Pressure Bag for High altitude 
Treat and Release    
Vagal Maneuvers/Carotid Massage  
Intranasal medication administration Fixed/unit dose medications    
Dose calculation/measurement   
Resuscitation
Cardiopulmonary resuscitation (CPR) (all ages)     
Cardiac pacing  
Defibrillation/Cardioversion AED     
Post resuscitative care    
Skeletal Procedures
Care of the amputated part     
Fracture/Dislocation immobilization techniques     
Fracture/Dislocation reduction techniques Manipulation of angulated/pulseless extremities    
Joint reduction techniques    
Spine immobilization techniques     
Thoracic
Thoracostomy (refer to "Other Techniques") 
Body Substance Isolation / PPE     
Lifting and moving techniques     
Virginia Office of Emergency Medical Services
Scope of Practice - Procedures for EMS Personnel
This SOP represents practice maximums .
“Investigational medications and procedures which have been reviewed and approved by an Institutional Review Board (IRB) will be considered to be approved by the Medical Direction Committee solely within the
context of the approved study. Investigators involved in IRB approved research are asked to present their study plans to the MDC for informational purposes so that the committee can maintain an awareness of ongoing
pre-hospital research in the Commonwealth. Those who desire to conduct non-IRB reviewed pilot projects, demonstration projects, or research are asked to present those proposals to the MDC prior to their
implementation for review and approval by the MDC.”
Use of medication not listed which is indicated by medical control and/or the operational medical director due to the use of a weapon of mass destruction is exempt from this list.
Approved: November 6, 2013
Page 6 of 6
PROCEDURE SKILL PROCEDURE SUBTYPE EMR EMT
AEMT -
Enhanced I P
Gastro-Intestinal Techniques
Management of non-displaced gastrostomy tube 
Ophthalmological
Morgan Lenses    
Corneal Exam with fluorescein  
Ocular irrigation     
Virginia Office of Emergency Medical Services
Scope of Practice - Formulary for EMS Personnel
This SOP represents practice maximums .
“Investigational medications and procedures which have been reviewed and approved by an Institutional Review Board (IRB) will be considered to
be approved by the Medical Direction Committee solely within the context of the approved study. Investigators involved in IRB approved research
are asked to present their study plans to the MDC for informational purposes so that the committee can maintain an awareness of on-going prehospital
research in the Commonwealth. Those who desire to conduct non-IRB reviewed pilot projects, demonstration projects, or research are
asked to present those proposals to the MDC prior to their implementation for review and approval by the MDC.”
Use of medication not listed which is indicated by medical control and/or the operational medical director due to the use of a weapon of
mass destruction is exempt from this list.
Approved November 6, 2013
Page 1 of 4
CATEGORY EMR EMT
AEMT -
Enhanced I P
Analgesics
Acetaminophen    
Nonsteroidal anti-inflammatory    
Opiates and related narcotics   
Dissociative analgesics
Ketamine 0.5 mg/kg or less IV/IN  
Anesthetics
Otic   
General - initiate 
Ketamine greater than 0.5 mg/kg 
General - maintenance  
Ocular   
Inhaled-self administered    
Local   
Anticonvulsants   
Glucose Altering Agents
Glucose Elevating Agents    
Glucose Lowering Agents  
Antidotes
Anticholinergic Antagonists  
Anticholenesterase Antagonists     
Benzodiazepine Antagonists
Narcotic Antagonists    
Nondepolarizing Muscle Relaxant
Antagonist
Beta/Calcium Channel Blocker Antidote  
Tricyclic Antidepressant Overdose  
Cyanide Antidote  
Cholinesterase Reactivator     
Virginia Office of Emergency Medical Services
Scope of Practice - Formulary for EMS Personnel
This SOP represents practice maximums .
“Investigational medications and procedures which have been reviewed and approved by an Institutional Review Board (IRB) will be considered to
be approved by the Medical Direction Committee solely within the context of the approved study. Investigators involved in IRB approved research
are asked to present their study plans to the MDC for informational purposes so that the committee can maintain an awareness of on-going prehospital
research in the Commonwealth. Those who desire to conduct non-IRB reviewed pilot projects, demonstration projects, or research are
asked to present those proposals to the MDC prior to their implementation for review and approval by the MDC.”
Use of medication not listed which is indicated by medical control and/or the operational medical director due to the use of a weapon of
mass destruction is exempt from this list.
Approved November 6, 2013
Page 2 of 4
CATEGORY EMR EMT
AEMT -
Enhanced I P
Antihistamines & Combinations    
Biologicals
Immune Serums  
Antibiotics    
Blood/Blood products
Initiate 
Maintain  
Blood Modifiers
Anticoagulants  
Antiplatelet Agents    
Hemostatic Agents    
Thrombolytics 
Anti-fibrinolytics (eg tranexamic acid)  
Cardiovascular Agents
Alpha Adrenergic Blockers  
Adrenergic Stimulants  
Antiarrhythmics  
Beta Adrenergic Blockers  
Calcium Channel Blockers  
Diuretics  
Inotropic Agents  
Vasodilatory Agents    
Vasopressors  
Epinephrine for allergic reaction     Added per MDC discussion 10-10-13
Virginia Office of Emergency Medical Services
Scope of Practice - Formulary for EMS Personnel
This SOP represents practice maximums .
“Investigational medications and procedures which have been reviewed and approved by an Institutional Review Board (IRB) will be considered to
be approved by the Medical Direction Committee solely within the context of the approved study. Investigators involved in IRB approved research
are asked to present their study plans to the MDC for informational purposes so that the committee can maintain an awareness of on-going prehospital
research in the Commonwealth. Those who desire to conduct non-IRB reviewed pilot projects, demonstration projects, or research are
asked to present those proposals to the MDC prior to their implementation for review and approval by the MDC.”
Use of medication not listed which is indicated by medical control and/or the operational medical director due to the use of a weapon of
mass destruction is exempt from this list.
Approved November 6, 2013
Page 3 of 4
CATEGORY EMR EMT
AEMT -
Enhanced I P
Central Nervous System Antipsychotic  
Sedatives
Benzodizepines   Added per MDC discussion 10-10-13
Dietary Supplements/ElectrolyteVitamins
Minerals - start at a health care facility See section: Intravenous Fluids
Salts - start at a health care facility
Electrolytes Solutions - start at a health care
facility
Hypertonic Saline  
Gas
Oxygen     
Heliox  
Gastrointestinal
Antacids
OTC   
Antidiarrheals    
Antiemetics    
EMT SL/PO route only
H2 Blockers    
Hormones Steroids   
Intravenous Fluids isotonic   
hypotonic   
hypertonic  
M = Maintenance I = Initiate
Crystalloid, +/- Dextrose/Lactate M I/M I/M I/M
with Multi=vitamins M M M M
with Thiamine M M M M
Neuromuscular Blockers 
Respiratory Anticholinergics    
Sympathomimetics
Beta agonists    
Virginia Office of Emergency Medical Services
Scope of Practice - Formulary for EMS Personnel
This SOP represents practice maximums .
“Investigational medications and procedures which have been reviewed and approved by an Institutional Review Board (IRB) will be considered to
be approved by the Medical Direction Committee solely within the context of the approved study. Investigators involved in IRB approved research
are asked to present their study plans to the MDC for informational purposes so that the committee can maintain an awareness of on-going prehospital
research in the Commonwealth. Those who desire to conduct non-IRB reviewed pilot projects, demonstration projects, or research are
asked to present those proposals to the MDC prior to their implementation for review and approval by the MDC.”
Use of medication not listed which is indicated by medical control and/or the operational medical director due to the use of a weapon of
mass destruction is exempt from this list.
Approved November 6, 2013
Page 4 of 4
CATEGORY EMR EMT
AEMT -
Enhanced I P
Epinephrine (nebulized)   clarification - refers to nebulized not systemic epinephrine MDC 10-10-13
Dosage and Concentration Calculation   
M = Maintenance
I = Initiate
Note: EMT's may administer medications
within their scope of practice in addition to
assistance in administration of those
medications. EMT's may access a drug kit
to access those medications. MDC
discussions.
EMS Guide
January 2015
This guide is produce by MCSO –
The Mechanical Circulatory Support Organization
It is produced by VAD Coordinators from some of
the largest and most successful VAD implantation
hospitals in the US. It has been vetted by experts
on VADS in Air Medical Transport and EMS. It
should not replace the operator manual as the
primary source of information.
Reprinted with the permission of Thoratec Corporation
M
C
S
O
ECHANICAL
IRCULATORY
UPPORT
RGANIZATION
What is a Ventricular Assist Device (VAD)?
A ventricular assist device (VAD) is a
mechanical pump that’s used to support heart
function and blood flow in people who have
weakened hearts.
How does a VAD work?
The device takes blood from a lower chamber
of the heart and helps pump it to the body and
vital organs, just as a healthy heart would.
What are the parts of a VAD?
The basic parts of a VAD include: a small
tube that carries blood out of your heart into a
pump; another tube that carries blood from the
pump to your blood vessels, which deliver the
blood to your body; and a power source.
What is the power source?
The power source is either batteries or AC power. The power source is connected to a control
unit that monitors the VAD’s functions. The batteries are carried in a case usually located in a
holster in a vest wrapped around the patients shoulders.
What does the control unit or controller do?
The control unit gives warnings, or alarms, if the power is low or if it senses that the device
isn’t working right. It is a computer.
JANUARY 2015
Questions and Answers
Ventricular Assist Device
The portability of the HeartMate II enables patients to
resume many of their normal daily activities.
MOST patients have a tag located on the controller around their waist that says what
type of device it is, what institution put it in and a number to call. Most importantly is
the color of the tag – it matches this EMS Field Guide and allows you to quickly locate
the device you are caring for.
JANUARY 2015
Color Coding System
JANUARY 2015
Patient Management For VADs
1. Assess the patients airway and intervene per your usual protocol.
2. Auscultate Heart Sounds to determine if the device is functioning and
what type of device it is. If it is continuous flow device, you should hear
a “whirling sound”.
3. Assess the device for any alarms.
4. Look on controller found around the waist of the patient or in the VAD
PAK and to see what color tag and device it is.
5. Match the color on the device tag to the EMS Guide.
6. Intervene appropriately based on the type of alarm, tag (device) and
EMS Guide.
7. Start Large Bore IV.
8. Assess vital signs – Use Mean BP with Doppler – with the first sound you
hear is the Mean Arterial Pressure (MAP).
9. If no Doppler, use the Mean on the non invasive blood pressure machine.
10. Transport to closest VAD center. Call the number on the device to
get advice.
11. Bring all of the patient’s equipment.
12. Allow the trained caregiver to ride in the transport vehicle if possible
to act as a expert on the device in he absence of consciousness
in the patient.
ORANGE ORANGE ORANGE ORANGE
ORANGE ORANGE ORANGE ORANGE
ORANGE ORANGE ORANGE ORANGE ORANGE
ORANGE ORANGE ORANGE ORANGE ORANGE
JANUARY 2015
1. Can I do external CPR?
Only if absolutely necessary
2. If not, is there a “hand pump” or external device to use?
No.
3. If the device slows down (low flow state), what alarms will go off?
A red heart alarm light indicator and steady audio alarm will sound if less
than 2.5 lmp. Can give a bolus of normal saline and transport to an
LVAD center.
4. How can I speed up the rate of the device?
No, it is a fixed speed.
5. Do I need to heparinize the patient if it slows down?
Usually no, but you will need to check with implanting center.
6. Can the patient be defibrillated while connected to the device?
Yes.
7. If the patient can be defibrillated, is there anything I have to
disconnect before defibrillating?
No.
8. Does the patient have a pulse with this device?
May have weak pulse or lack of palpable pulse.
9. What are acceptable vital sign parameters?
MAP 70 - 90 mm Hg with a narrow pulse pressure
10. Can this patient be externally paced?
Yes.
HeartMate II® with Pocket Controllers
Adapted from Sweet, L. and Wolfe, Jr., A. Mechanical Circulatory
Devices in Transport in ASTNA: Patient Transport Principles and
Practice, 4th ed., Mosby, 2010 in press.
FAQs
l May not be able to obtain cuff
pressure (continuos flow pump).
l Pump connected to electric line
exiting patient’s abdominal area and
is attached to computer which runs
the pump.
l Pump does not affect EKG
l All ACLS drugs may be given.
l No hand pump is available.
l A set of black batteries last
approximately 3 hours, gray
batteries last 8-10 hours.
l Any emergency mode of
transportation is ok. These patients
are permitted to fly.
l Be sure to bring ALL of the patient’s
equipment with them.
Trouble Shooting HeartMate II® with Pocket Controllers
When the Pump Has Stopped
l Be sure to bring ALL of the patient’s equipment with them.
l Fix any loose connection(s) to restart the pump.
l If the pump does not restart and the patient is connected to batteries replace the current
batteries with a new, fully-charged pair. (see changing batteries section on next page)
l If pump does not restart, change controllers. (see changing controllers section on next page)
Alarms: Emergency Procedures
Yellow or Red Battery Alarm:
Need to Change Batteries. See
changing batteries section on
next page.
Red Heart Flashing Alarm: This may indicate a Low Flow Hazard. Check
patient--the flow may be too low. If patient is hypovolemic, give volume. If
patient is in right heart failure-- treat per protocol. If the pump has stopped
check connections, batteries and controllers as instructed in the section above.
ORANGE ORANGE ORANGE ORANGE
ORANGE ORANGE ORANGE ORANGE ORANGE
ORANGE ORANGE ORANGE ORANGE ORANGE
This guide does not supersede manufacturer instructions. Copy with permission only. March 2011
ORANGE ORANGE ORANGE ORANGE
Trouble Shooting HeartMate II® with Pocket Controllers
l Place the replacement Controller within easy reach,
along with the batteries/battery clips. The spare
Controller is usually found in the patient’s travel case.
l Make sure patient is sitting or lying down since the
pump will momentarily stop during this procedure.
l Attach the battery clips to the
spare controller by lining up
the half moons and gently
pushing together and attach
the batteries to the spare
controller by aligning the
RED arrows.
l On the back of the replacement controller, rotate
down the perc lock so the red tab is fully visible.
Repeat this step on the original controller until the
red tab is fully visible.
l Disconnect the drive line from the original controller
by pressing down on the red tab and gently pulling
on the metal end. The pump will stop and an alarm
will sound. Note: The alarm will continue until the
original controller is put to sleep. You can silence
the alarm by holding down the silence button.
Getting the replacement controller connected
and pump restarted is the first priority.
l Connect the replacement
Controller by aligning the
BLACK ARROWS on the
driveline and replacement
Controller and gently
pushing the driveline into
the replacement Controller.
The pump should restart, if
not complete the following
steps:
Step 1. Firmly press the Silence Alarm or Test Select
Button to restart the pump.
Step 2. Check the powersource to assure that power is
going to the controller.
Step 3. Assure the perc lead is fully inserted into the
socket by gently tugging on the metal end. DO
NOT pull the lead.
l After the pump restarts, rotate up the perc lock on
the new controller so the red tab is fully covered.
If unable to engage perc lock to a fully locked
position, gently push the driveline into the controller
to assure proper connection. Retry to engage perc
lock.
l Disconnect power from the original Controller. The
original Controller will stop alarming once power is
removed.
l Hold down battery symbol for 5 full seconds for
complete shutdown of old controller.
WARNING: At least one power
lead must be connected to a
power source AT ALL TIMES.
Do not remove both batteries at
the same time or the pump will
stop.
l Obtain two charged batteries
from patient’s accessory bag
or battery charger. The charge
level of each gray battery can be
assessed by pressing the battery
button on the battery. (Figures 1
and 2)
l Remove only ONE battery from
the clip by pressing the button
on the grey clip to unlock the
battery. (Figure 3)
l Controller will start beeping,
flash yellow signals and will
read power disconnect on the
front screen.
l Replace with new battery by
lining up RED arrows on battery
and clip. (Figure 4)
l Slide a new, fully-charged battery
(Figure 2) into the empty battery
clip by aligning the RED arrows.
The battery will click into the clip.
Gently tug at battery to ensure
connection. If battery is properly
secured, the beeping and yellow
flashing will stop.
l Repeat previous steps with the
second battery and battery clip.
Figure 1
Not Charged
Figure 2
Fully Charged
Figure 4
Figure 3
Changing Batteries
Changing Controllers
JANUARY 2015
ORANGE ORANGE ORANGE ORANGE
ORANGE ORANGE ORANGE ORANGE
ORANGE ORANGE ORANGE ORANGE ORANGE
ORANGE ORANGE ORANGE ORANGE ORANGE
JANUARY 2015
1. Can I do external CPR?
Only if absolutely necessary
2. If not, is there a “hand pump” or external device to use?
No.
3. If the device slows down (low flow state), what alarms will go off?
A red heart alarm light indicator and steady audio alarm will sound if less
than 2.5 lmp. Can give a bolus of normal saline and transport to an
LVAD center.
4. How can I speed up the rate of the device?
No, it is a fixed speed.
5. Do I need to heparinize the patient if it slows down?
Usually no, but you will need to check with implanting center.
6. Can the patient be defibrillated while connected to the device?
Yes.
7. If the patient can be defibrillated, is there anything I have to
disconnect before defibrillating?
No.
8. Does the patient have a pulse with this device?
May have weak pulse or lack of palpable pulse.
9. What are acceptable vital sign parameters?
MAP 70 - 90 mm Hg with a narrow pulse pressure
10. Can this patient be externally paced?
Yes.
HeartMate II®
Adapted from Sweet, L. and Wolfe, Jr., A. Mechanical Circulatory
Devices in Transport in ASTNA: Patient Transport Principles and
Practice, 4th ed., Mosby, 2010 in press.
FAQs
l May not be able to obtain cuff
pressure (continuos flow pump).
l Pump connected to electric line
exiting patient’s abdominal area and
is attached to computer which runs
the pump.
l Pump does not affect EKG
l All ACLS drugs may be given.
l No hand pump is available.
l A set of black batteries last
approximately 3 hours, gray
batteries last 8-10 hours.
l Any emergency mode of
transportation is ok. These patients
are permitted to fly.
l Be sure to bring ALL of the patient’s
equipment with them.
Trouble Shooting HeartMate II®
When the Pump Has Stopped
l Be sure to bring ALL of the patient’s equipment with them.
l Fix any loose connection(s) to restart the pump.
l If the pump does not restart and the patient is connected to batteries replace the current
batteries with a new, fully-charged pair. (see changing batteries section on next page)
l If pump does not restart, change controllers. (see changing controllers section on next page)
Alarms: Emergency Procedures
Yellow or Red Battery Alarm: Need to Change
Batteries. See changing batteries section on next page.
Red Heart Flashing Alarm: This may indicate a Low
Flow Hazard. Check patient--the flow may be too low.
If patient is hypovolemic, give volume. If patient is in
right heart failure-- treat per protocol. If the pump has
stopped check connections, batteries and controllers
as instructed in the section above.
ORANGE ORANGE ORANGE ORANGE
ORANGE ORANGE ORANGE ORANGE ORANGE
ORANGE ORANGE ORANGE ORANGE ORANGE
This guide does not supersede manufacturer instructions. Copy with permission only. March 2011
ORANGE ORANGE ORANGE ORANGE
Trouble Shooting HeartMate II®
l Place the replacement Controller within easy reach,
along with the batteries/battery clips. The spare
Controller is usually found in the patient’s travel case.
l Make sure patient is sitting
or lying down since the pump
will momentarily stop during
this procedure.
l Attach the battery clips to the
spare controller by lining up
the half moons and gently
pushing together and attach
the batteries to the spare
controller by aligning the RED arrows. ALARMS
WILL SOUND-THIS IS OK.
l Depress the silence alarm button (upside-down bell
with circle) until the alarm is silenced on the new,
replacement Controller.
l Rotate the perc lock on the replacement controller in
the direction of the “unlocked” icon until the perc lock
clicks into the fully- unlocked position. Repeat this
same step for
the original
Controller
until the perc
lock clicks into
the unlocked
position.
l Disconnect
the perc lead/driveline from the original controller
by pressing the metal release tab on the connector
socket. The pump will stop and an alarm will sound.
Note: The alarm will continue until power is removed
from the original Controller. Getting the replacement
Controller connected and the pump restarted is
the first priority.
l Connect the replacement Controller by aligning the
BLACK LINES on the driveline and replacement
Controller and gently pushing the driveline into the
replacement Controller. The pump should restart, if
not complete the following steps:
Step 1. Firmly press the Silence Alarm or Test Select
Button to restart the pump.
Step 2. Check the powersource to assure that power is
going to the controller.
Step 3. Assure the perc
lead is fully
inserted into
the socket by
gently tugging
on the metal
end. DO NOT
pull the lead.
l After the pump restarts, rotate the perc lock on the
new controller in the direction of the “locked” icon until
the perc lock clicks into the fully-locked position. If
unable to engage perc lock to the locked position,
gently push the driveline into the controller to assure a
proper connection. Retry to engage perc lock.
l Disconnect power from the original Controller. The
original Controller will stop alarming once power is
removed.
WARNING: At least one power lead must be connected to a
power source AT ALL TIMES. Do not remove both batteries at
the same time or the pump will stop.
l Obtain two charged batteries from patient’s accessory bag or
battery charger. The charge level of each gray battery can be
assessed by pressing the battery button on the battery. (Figures 3
and 4)
l Remove only ONE battery from the clip by pressing the button on
the grey clip to unlock the battery. (Figure 1)
l Controller will start beeping and flashing green signals.
l Replace with new battery by lining up RED arrows on battery and
clip. (Figure 2)
l Slide a new, fully-charged battery (Figure 4) into the empty battery
clip by aligning the RED arrows. The battery will click into the clip.
Gently tug at battery to ensure connection. If battery is properly
secured, the beeping and green flashing will stop.
l Repeat previous steps with the second battery and battery clip. Figure 3 Figure 4
Figure 2
Figure 1
Changing Batteries
Changing Controllers
JANUARY 2015
ORANGE ORANGE ORANGE ORANGE
ORANGE ORANGE ORANGE ORANGE ORANGE
ORANGE ORANGE ORANGE ORANGE ORANGE
This guide does not supersede manufacturer instructions. Copy with permission only. March 2011
ORANGE ORANGE ORANGE ORANGE
JANUARY 2015
ORANGE ORANGE ORANGE ORANGE
ORANGE ORANGE ORANGE ORANGE ORANGE
ORANGE ORANGE ORANGE ORANGE ORANGE
This guide does not supersede manufacturer instructions. Copy with permission only. March 2011
ORANGE ORANGE ORANGE ORANGE
JANUARY 2015
DARK BLUE DARK BLUE DARK BLUE DARK BLUE
DARK BLUE DARK BLUE DARK BLUE DARK BLUE
DARK BLUE DARK BLUE DARK BLUE DARK BLUE DARK BLUE
DARK BLUE DARK BLUE DARK BLUE DARK BLUE DARK BLUE
1. Can I do external CPR?
Chest compressions may pose a risk of dislodgment – use
clinical judgment. If chest compressions are administered,
confirm function and positioning of the pump.
2. If not, is there a “hand pump” or external device to use?
No.
3. If the device slows down (low flow state), what alarms will
go off?
The device runs at a fixed speed. If a low flow state occurs,
an alarm will be heard, and the controller display will show a
yellow triangle and “Low Flow – Call” message.
4. How can I speed up the rate of the device?
It is not possible to adjust the pump speed in the prehospital
setting. Okay to give IV fluids.
5. Do I need to heparinize the patient if it slows down?
Call the accepting VAD facility for guidance.
6. Can the patient be defibrillated while connected to the device?
Yes.
7. If the patient can be defibrillated, is there anything I have
to disconnect before defibrillating?
No, defibrillate per protocol.
8. Does the patient have a pulse with this device?
The patient may not have a palpable pulse. Depending on the
patient’s own heart function, you may be able to feel a thready
pulse.
9. What are acceptable vital sign parameters?
Goal Mean Arterial Pressure (MAP) is <85 mmHg. Use a Doppler as
the first option to assess blood pressure. If you are using a Doppler,
place the blood pressure cuff on the patient arm. As you release the
pressure in the blood pressure cuff, the first sound you hear with the
Doppler is the MAP. If that is not available, use a non-invasive BP
(NIBP).
10. Can this patient be externally paced?
Yes
Adapted from Sweet, L. and Wolfe, Jr., A. Mechanical Circulatory Devices in Transport in ASTNA:
Patient Transport Principles and Practice, 4th ed., Mosby, 2010 in press.
FAQs
• May not be able to obtain cuff
pressure (continuous flow pump)
• Pump connected to electric
line (driveline) exiting patient’s
abdominal area and is attached
to computer (controller) which
runs the pump.
• Pump does not affect EKG,
but patient may or may not
be symptomatic even iwth
ventricular arrhythmias.
• All ACLS drugs may be given.
• No hand pump is available.
This is a rotary (continuous
flow) pump with typical speed
ranges of 2400 – 3200 RPMs.
The patient should have back-up
equipment.
• The controller draws power from
one battery at a time. A fully
charged battery will provide 4-6
hours of power. Both the battery
and controller have status lights
to indicate the amount of power
remaining.
• Transport by ground to
implanting facility if possible.
• Be sure to bring ALL of the
patient’s equipment with them.
HeartWare® Ventricular Assist System
JANUARY 2015
DARK BLUE DARK BLUE DARK BLUE DARK BLUE
DARK BLUE DARK BLUE DARK BLUE DARK BLUE
DARK BLUE DARK BLUE DARK BLUE DARK BLUE DARK BLUE
DARK BLUE DARK BLUE DARK BLUE DARK BLUE DARK BLUE
DRIVELINE CONNECTION
To Connect to Controller:
l Align the two red marks and push together. An audible
click will be heard confirming proper connection.
(Figure A)
l The Driveline Cover must completely cover the
Controller’s silver driveline connector to protect against
static discharge. (Figure B)
l NOTE: an audible click should be heard when
connecting the Driveline or Driveline extension to the
controller. Failure to use the Driveline Cover may cause
an Electrical Fault Alarm.
HeartWare® Ventricular Assist System
Emergency Operation
Figure A Figure B
Controller
CONNECTING POWER TO CONTROLLER
To Connect a Charged Battery:
l Grasp the cable of the charged battery at the back end
of the connector (leaving front end of connector free to
rotate)
l Line up the solid white arrow on the connector with the
white dot on the Controller.
l Gently push (but DO NOT twist) the battery cable into the
Controller until it naturally locks into place; you should
hear an audible click.
l Confirm that the battery cable is properly locked on the
controller by gently pulling the cable near the controller
power connector.
l DO NOT force the battery cable
into the controller connector
without correct alignment
as it may result in damaged
connectors .
TO DISCONNECT A DEPLETED BATTERY
l Make sure there is a fully charged battery available to
replace the depleted one.
l Disconnect the depleted battery by turning the connector
sleeve counterclockwise until it stops.
l Pull the connector straight out from the controller.
JANUARY 2015
ALARM ADAPTER
l Used to silence the internal NO POWER ALARM.
l Should only be used on a controller that is NOT connected to a
patient’s pump.
l Must be inserted into the blue connector of the original controller
after a controller exchange BUT before the power sources are
disconnected or the NO Power alarm will sound for up to two hours.
Battery
test
button
Battery
Charge
Indicator
Monitor
Power
Source
#1
Power
Source
#2
Driveline
Battery
Charge
Indicator
CONTROLLER BATTERY
DARK BLUE DARK BLUE DARK BLUE DARK BLUE
DARK BLUE DARK BLUE DARK BLUE DARK BLUE
DARK BLUE DARK BLUE DARK BLUE DARK BLUE DARK BLUE
DARK BLUE DARK BLUE DARK BLUE DARK BLUE DARK BLUE
HeartWare® Ventricular Assist System
Emergency Operation
Step 4
Step 3
Step 6
Step 10
Step 9
STEPS TO EXCHANGE THE CONTROLLER
Step 1: Have the patient sit or lie down.
Step 2: Place the new controller within easy reach.
Step 3: Connect back-up power sources (batteries or AC
Power) to the new controller.
l Confirm that the power cables are properly
locked on the controller by gently pulling on the
cable near the connector.
l A “Power Disconnect” alarm will activate if a
second power source is not connected to the
new controller within 20 seconds of controller
power up
l A “VAD Stopped” alarm will activate if the pump
driveline is not connected to the new controller
within 10 seconds - this alarm will resolve once
the pump driveline is connected
Step 4: Pull back the white driveline cover from the
original controller’s silver connector.
Step 5: Disconnect the driveline from the original
controller by pulling the silver connector away
from the controller. Do not disconnect by pulling
on the driveline cable. A “VAD Stopped”
alarm may activate. Don’t panic. You can silence
the alarm after restarting the pump, which is the
priority.
Step 6: Connect the driveline to the new controller (align
the two red marks and push together). If the “VAD
Stopped” alarm was active on the new controller, it
will now resolve.
Step 7: The pump should restart. Verify the pump is
working (RPM, L/min, Watts).
Step 8: IF THE PUMP DOES NOT RESTART, CALL FOR
MEDICAL ASSISTANCE IMMEDIATELY.
Step 9: Insert the Alarm Adapter into the blue connector
on the original controller.
l Disconnect both power sources from the
original controller.
l The controller will be turned off and all alarms
silenced.
Step 10: Slide the white driveline cover up to cover new
controller’s silver connector.
Step 11: Contact the VAD Center or Implanting hospital
for a new backup controller.
JANUARY 2015
DARK BLUE DARK BLUE DARK BLUE DARK BLUE
DARK BLUE DARK BLUE DARK BLUE DARK BLUE
DARK BLUE DARK BLUE DARK BLUE DARK BLUE DARK BLUE
DARK BLUE DARK BLUE DARK BLUE DARK BLUE DARK BLUE
HeartWare® Ventricular Assist System
Troubleshooting
JANUARY 2015
LAVENDER LAVENDER LAVENDER LAVENDER
LAVENDER LAVENDER LAVENDER LAVENDER
LAVENDER LAVENDER LAVENDER LAVENDER LAVENDER
LAVENDER LAVENDER LAVENDER LAVENDER LAVENDER
Jarvik 2000 with Abdominal exit site.
Blood
Pump
Outflow
Graft
Power
Lead
JANUARY 2015
1. Can I do external CPR?
Yes, only as a last resort.
2. If not, is there a “hand pump” or external device to use?
No.
3. If the device slows down (low flow state), what
alarms will go off?
No alarm for low flow. If pump is off, the red “Pump
Stop” symbol will light with a continuous alarm.
4. How can I speed up the rate of the device?
There is a speed dial on the side of the controller (see
picture on next page). Turning the dial in the direction
of the arrow increases the speed. Each increment
is 1,000 RPM. It is recommended not to change the
speed without consulting the implanting center.
5. Do I need to heparinize the patient if it slows
down?
Typically yes, if the pump is stopped (red “Pump Stop”
alarm). Check with the implanting center.
6. Can the patient be defibrillated while connected to
the device?
Yes.
7. If the patient can be defibrillated, is there anything I
have to disconnect before defibrillating?
No.
8. Does the patient have a pulse with this device?
Most patients have a faint palpable pulse. If the
controller is marked “ILS” (see below), the speed is
automatically reduced every minute for 8 seconds &
the patients pulse may increase during this time.
9. What are acceptable vital sign parameters?
MAP 65 - 80mm Hg.
10. Can this patient be externally paced?
Yes.
Jarvik 2000® VAS
Adapted from Sweet, L. and Wolfe, Jr., A. Mechanical Circulatory Devices in
Transport in ASTNA: Patient Transport Principles and Practice, 4th ed., Mosby,
2010 in press. This guide does not supersede manufacturer instructions. Copy
with permission only. March 2015 Jarvik 2000®
Jarvik 2000 with Post-Auricular
exit site.
LAVENDER LAVENDER LAVENDER LAVENDER
LAVENDER LAVENDER LAVENDER LAVENDER
LAVENDER LAVENDER LAVENDER LAVENDER LAVENDER
LAVENDER LAVENDER LAVENDER LAVENDER LAVENDER
JANUARY 2015
The Jarvik 2000® VAS is
available in two models:
the Jarvik 2000® VAS,
Post-Auricular Cable
(JHI-001) and the Jarvik
2000® VAS, Abdominal
Cable (JHI-002). The main
difference between the two
models is the exit site of
the drive cable. The drive
cable of the Jarvik 2000®
VAS, Abdominal Cable
exits the abdomen and the
drive cable of the Jarvik
2000® VAS, Post-Auricular
Cable exits at a Pedestal
surgically attached to the
skull behind the ear.
Jarvik 2000® VAS
Jarvik 2000® VAS,
Post-Auricular Cable.
External Equipment for Jarvik 2000® VAS, Abdominal Cable.
Jarvik 2000® VAS,
Abdominal Cable.
External Equipment for Jarvik 2000® VAS, Post-Auricular Cable.
NOTE: This Field Guide is NOT intended to replace the Operator Manual and Patient Handbook.
LAVENDER LAVENDER LAVENDER LAVENDER
LAVENDER LAVENDER LAVENDER LAVENDER
LAVENDER LAVENDER LAVENDER LAVENDER LAVENDER
LAVENDER LAVENDER LAVENDER LAVENDER LAVENDER
JANUARY 2015
Li-ion Battery. Reserve Battery/Charger.
Jarvik 2000® VAS
The FlowMaker Controller provides:
1. power to the implanted blood pump,
2. user settable speeds at which the pump runs, and
3. alarms and warnings.
The FlowMaker® Controller does not monitor the actual blood flow
that the Jarvik 2000® Ventricular Assist Device (VAD) is pumping.
In general, the higher the setting number the more blood the Jarvik
2000 VAD will pump. The tabulated flow estimates are based on
research measurements in healthy animals. The actual blood flow
may vary and will depend on several factors including blood pressure
and the condition of the natural heart.
Dial
Setting
Speed
Rpm
Flow
L/min
Power
Watts
1 8,000 1-2 3-4
2 9,000 2-3 4-5
3 10,000 4-5 5-6-7
4 11,000 5-7 7-8-9
5 12,000 7-8.5 8-9-10
FlowMaker® Controller. Diagram of FlowMaker® Controller Top Panel.
LAVENDER LAVENDER LAVENDER LAVENDER
LAVENDER LAVENDER LAVENDER LAVENDER
LAVENDER LAVENDER LAVENDER LAVENDER LAVENDER
LAVENDER LAVENDER LAVENDER LAVENDER LAVENDER
JANUARY 2015
Only one control adjustment to the Jarvik 2000® VAD can be made. The Jarvik 2000® VAD
speed can be selected by turning the knob on the side of the FlowMaker® Controller. The setting
number appears in the window on the top panel. The arrow indicates the direction to turn the knob
to increase the speed.
Power Indicator Lights The numbers indicate the electrical power (Watts) that the VAD is using.
One, two, or three numbers may be lit at any moment, and the lights may change rhythmically
with the heartbeat of the natural heart. A power measure of 13 watts or more indicates
malfunction. The High Power Indicator, number 13, will light yellow. This condition should receive prompt
medical attention.
When the battery powering the Jarvik 2000® VAD is low, the Low Battery Alarm on the
FlowMaker® Controller lights yellow and the alarm sound beeps. Remaining running time
with the portable Li-ion Battery is about 5-10 minutes; with the Reserve Battery/Charger for
approximately 15 minutes
If the Jarvik 2000® VAD stops or if the VAD speed drops to below 5,000 RPM for any reason, a
steady alarm sound is heard and the Pump Stopped Alarm on the FlowMaker® Controller lights
red. The Pump Stopped Alarm will also sound if the intermittent low speed featured on the ILS
FlowMaker® Controller fails to function for any reason. Immediate attention is required. Follow the
Pump Stopped Alarm procedure for the appropriate Jarvik 2000® VAS model (Post-Auricular Cable or
Abdominal Cable) which is included in this Field Guide.
The Underspeed Indicator light will glow yellow when the Flowmaker® Controller detects that
the Jarvik 2000 ® VAD speed is slower than the dial setting selected. The most common reason
is the battery voltage is too low.
In this case, corrective actions are to:
1 Select a lower speed setting on the Flowmaker® Controller and/or 2 Change the battery to a fully charged
Li-ion Battery. If the underspeed indicator light is still lit, then the cause may be a fault in the system. Replace
all external components; and if the underspeed light is still on after replacing all external components, treat the
situation as an emergency and seek immediate medical attention. See Patient Handbook and Operator Manual
for more details.
A non-rechargeable Alarm Battery is used to assure that the FlowMaker Controller has
enough power for the alarms if the main battery fails, if the battery cable fails, or if the main
battery becomes accidentally disconnected.
This Alarm Battery is located in a small housing on the end of the FlowMaker® Controller
between the connectors for the cables. Be sure that the Alarm Battery Cap holding the Alarm Battery in place
on the FlowMaker® Controller is screwed on finger tight whenever the FlowMaker® Controller is used. If the
Alarm Battery Cap is not screwed finger tight in place, the backup power for the alarms will not function. Every
time the Alarm Battery Cap is tightened, the Controller’s back-up Alarm needs to be tested. With a caregiver
present, briefly disconnect the main battery (Li-ion Battery or Reserve Battery/Charger) to be sure the Pump
Stopped Alarm sounds. The disconnection should be brief and the main battery should be reconnected almost
immediately. If the Pump Stopped Alarm does not sound, retighten the Alarm Battery Cap and repeat the test.
Contact the implant center immediately if the alarm does not sound during this test.
Speed Setting, Alarms, and Warnings
Jarvik 2000® VAS
LAVENDER LAVENDER LAVENDER LAVENDER
LAVENDER LAVENDER LAVENDER LAVENDER
LAVENDER LAVENDER LAVENDER LAVENDER LAVENDER
LAVENDER LAVENDER LAVENDER LAVENDER LAVENDER
JANUARY 2015
1. Be sure the alarm is not an intermittent beeping
which only indicates a low battery. If the alarm is
beeping, change the battery as usual.
2. If the Jarvik 2000® VAD is stopped (steady
alarm sounding, red light on):
a. Disconnect the Pedestal Cable from the
Pedestal at the skull, and set aside all the
attached components. Disconnect the Liion
Battery Cable and also partially unscrew
the Alarm Battery Cap on the FlowMaker®
Controller to silence the alarm.
b. Plug in a backup Pedestal Cable into the
Pedestal and into a backup FlowMaker®
Controller. Make sure the FlowMaker®
Controller is set at speed setting 1. Make
sure to tighten the Alarm Battery Cap on the
backup FlowMaker® Controller to activate
the alarm.
c. Using the backup Li-ion Battery Cable,
plug a fully charged Li-ion Battery into the
FlowMaker® Controller.
d. If the Jarvik 2000® VAD now runs, and the
patient is feeling well, red tag the original
components that were set aside in step 2a.
e. Set the FlowMaker® Controller back at the
speed the user was using prior to the alarm.
3. If the Jarvik 2000 VAD (pump) is still
stopped call the medical emergency number
immediately.
4. Red tag all components of the system that
were set aside before changing to the backup
components in step 2a. This should be done
with the assistance of a medical support person
if possible.
5. It is possible that one of the connectors is not
fully plugged in and is not making contact.
Recheck all connectors.
6. If the Jarvik 2000® VAD still has not started, the
patient should lie down and the support person
should double check batteries and connectors.
Try changing batteries again. It is possible
that a discharged battery was removed and
the same discharged battery was accidentally
plugged back into the system. It is possible that
neither battery is charged. If no lights illuminate
on either battery, use a third battery. It is also
possible that one of the connectors is not fully
plugged in and is not making contact. Recheck
all connectors.
7. If all of the above steps have been followed
and all cables and components have been
replaced without successfully restarting the
Jarvik 2000® VAD, disconnect the power to
the Jarvik 2000® VAD by unplugging the
battery. Also partially unscrew the Alarm Battery
Cap on the FlowMaker® Controller. (The alarm
should stop sounding). If the Li-ion Battery or
Reserve Battery/Charger is not disconnected,
the FlowMaker® Controller will apply power to
the Jarvik 2000® VAD which could be harmful.
Disconnecting the battery reduces the chance
of a clot forming inside the Jarvik 2000® VAD by
allowing the rotor to spin as blood flows across it.
Note: Return any failed or suspect
component(s) to your Clinical Center for
evaluation by Jarvik Heart, Inc.
Jarvik 2000® VAS
Procedure to Resolve Pump Stopped Alarm
Jarvik 2000® VAS, Post-Auricular Cable
The most likely reason for the Jarvik® 2000 VAD (pump) to stop is a completely discharged battery or
a disconnected or damaged cable. If the cause of a component failure is clearly identifiable (i.e. low
battery, physical damage, etc.) replace that cable or component first.
If the cause is unknown, follow these step-by-step instructions with the assistance of a support person. The
patient should sit down or lie down. This procedure should be completed quickly. Back-up equipment must
be immediately available.
LAVENDER LAVENDER LAVENDER LAVENDER
LAVENDER LAVENDER LAVENDER LAVENDER
LAVENDER LAVENDER LAVENDER LAVENDER LAVENDER
LAVENDER LAVENDER LAVENDER LAVENDER LAVENDER
JANUARY 2014
1. Be sure the alarm is not an intermittent beeping
which only indicates a low battery. If the alarm is
beeping, change the battery as usual.
2. If the Jarvik 2000® VAD is stopped (steady
alarm sounding, red light on):
a. Disconnect the Extension Cable from the
drive cable at the abdomen, and set aside
all the attached components. Disconnect the
Li-ion Battery Cable and also partially unscrew
the Alarm Battery Cap on the FlowMaker®
Controller to silence the alarm.
b. Plug the drive cable (the cable exiting the
skin at the abdomen) directly into the backup
FlowMaker® Controller (eliminating the
Extension Cable). Make sure the FlowMaker®
Controller is set at speed setting 1. Make sure
to tighten the Alarm Battery Cap on the backup
FlowMaker® Controller to activate the alarm.
c. Using the backup Li-ion Battery Cable, plug a
fully charged Li-ion Battery into the FlowMaker®
Controller.
d. If the Jarvik 2000® VAD now runs and the
patient is feeling well, red tag the original
components that were set aside in step 2a.
e. Set the FlowMaker® Controller back at the
speed the user was using prior to the alarm.
3. If the Jarvik 2000® VAD (pump) is still
stopped call your medical emergency
number immediately.
4. Red tag all components of the system that
were set aside before changing to the backup
components in step 2a.
5. Be sure that all external cables and connectors
have been changed and check to see if the
connector at the end of the drive cable exiting
the skin at the abdomen is broken. If it is broken
and has come apart – try to put it back together
where it is broken. If the Jarvik 2000® VAD
does not run, take the connector apart again –
rotate the parts 90° and put the connector back
together again. Repeat three times. The Jarvik
2000 VAD may start. The connector may then
be held together with tape while the patient is
transported to the hospital for it to be repaired.
6. It is possible that one of the connectors is not
fully plugged in and is not making contact.
Recheck all connectors.
7. If the Jarvik 2000® VAD still has not started, the
patient should lie down and the support person
should double check batteries and connectors.
Try changing batteries again. It is possible
that a discharged battery was removed and
the same discharged battery was accidentally
plugged back into the system. It is possible that
neither battery is charged. If no lights illuminate
on either battery, use a third battery. It is also
possible that one of the connectors is not fully
plugged in and is not making contact. Recheck
all connectors.
8. If all of the above steps have been followed
and all cables and components have been
replaced without successfully restarting the
Jarvik 2000® VAD, disconnect the power
to the Jarvik 2000 VAD by unplugging the
battery. Also partially unscrew the Alarm Battery
Cap on the FlowMaker® Controller. (The alarm
should stop sounding). If the Li-ion Battery or
Reserve Battery/Charger is not disconnected,
the FlowMaker® Controller will apply power to
the Jarvik 2000® VAD which could be harmful.
Disconnecting the battery reduces the chance
of a clot forming inside the Jarvik 2000® VAD by
allowing the rotor to spin as blood flows across it.
Note: Return any failed or suspect
component(s) to your Clinical Center for
evaluation by Jarvik Heart, Inc.
Jarvik 2000® VAS
Procedure to Resolve Pump Stopped Alarm
Jarvik 2000® VAS, Abdominal Cable
The most likely reason for the Jarvik 2000® VAD (pump) to stop is a completely discharged battery or
a disconnected or damaged cable. If the cause of a component failure is clearly identifiable (i.e. low
battery, physical damage, etc.) replace that cable or component first.
If the cause is unknown, follow these step-by-step instructions with the assistance of a support person. The
patient should sit down or lie down. This procedure should be completed quickly. Back-up equipment must
be immediately available.
LAVENDER LAVENDER LAVENDER LAVENDER
LAVENDER LAVENDER LAVENDER LAVENDER
LAVENDER LAVENDER LAVENDER LAVENDER LAVENDER
LAVENDER LAVENDER LAVENDER LAVENDER LAVENDER
JANUARY 2015
Jarvik® 2000
Adapted from Sweet, L. and Wolfe, Jr., A. Mechanical Circulatory Devices in Transport in ASTNA: Patient Transport Principles and Practice,
4th ed., Mosby, 2010 in press. This guide does not supersede manufacturer instructions. Copy with permission only. March 2015 Jarvik 2000®
LIGHT BLUE LIGHT BLUE LIGHT BLUE LIGHT BLUE
LIGHT BLUE LIGHT BLUE LIGHT BLUE LIGHT BLUE
LIGHT BLUE LIGHT BLUE LIGHT BLUE LIGHT BLUE LIGHT BLUE
LIGHT BLUE LIGHT BLUE LIGHT BLUE LIGHT BLUE LIGHT BLUE
biVAD
January 2015
1. Can I do external CPR?
No.
2. If not, is there a “hand pump” or external device to use?
Yes, find the blue or red hand bulbs.
3. If the device slows down (low flow state), what alarms will go off?
Low flow alarms: Loss of fill alarm will occur
4. How can I speed up the rate of the device?
Give volume of IV fluids.
5. Do I need to heparinize the patient if it slows down?
Only if it stops. Patient will be anti coagulated on Coumadin.
Only heparinize if the pump stops.
6. Can the patient be defibrillated while connected to the device?
Yes. Nothing needs to be disconnected. Patient should be placed
on battery power BEFORE defibrillation.
7. If the patient can be defibrillated, is there anything I have to
disconnect before defibrillating?
No. If the defibrillation is unsuccessful, disconnect pump and
continue to defibrillate.
8. Does the patient have a pulse with this device?
Yes.
9. What are acceptable vital sign parameters?
Normal blood pressure parameters.
10. Can this patient be externally paced?
Usually in BiVAD configuration, if yes the ECG not important to treat.
Because both sides of the heart are supported, there is little need
to pace regardless of the rhythm seen on ECG.
Thoratec PVAD™ w/TLC II Driver
IVAD is implanted inside the abd cavity
and is attached to the same TLC II
driver on the outside.
Adapted from Sweet, L. and Wolfe, Jr., A. Mechanical Circulatory
Devices in Transport in ASTNA: Patient Transport Principles and
Practice, 4th ed., Mosby, 2010 in press.
l These patients have biventricular support
through 2 pumps: right and left.
l EKG will NOT correlate with the patient’s pulse.
l Patient may be in any arrhythmia, but because
they have biventricular support — DO NOT
TREAT arrhythmias. Only RVAD or LVAD
patients should be treated for arrhythmias.
l Bring all extra batteries & electrical adaptor
along during transport. This system is electrically
driven.
l The pumps are driven by a compressor called
the TLC II driver. The pneumatic hoses and
cables plug into the top of the TLC II driver.
l If the Driver loses power, malfunctions, or stops,
use the hand pump(s). (hand pump instructions
on back of this page)
l Continue hand pumping and then, as soon as
possible, replace the TLC II Driver with the
backup Driver.
l Backup Driver accompanies the patient at all times. (Driver replacement
instructions on back of this page)
l WARNING: If the pump has stopped and blood is stagnant in the device for more
than a few minutes (depending on the coagulation status of the patient), there
is a risk of stroke or thromboembolism. BEFORE the device is restarted or hand
pumping is initiated, contact the implanting center for anticoagulation direction.
AC Power adapter –
plug into yellow port
on driver
Battery Charger
Batteries loaded into
battery slots on TLC-II
Driver
TCL-II Driver
LIGHT BLUE LIGHT BLUE LIGHT BLUE LIGHT BLUE
LIGHT BLUE LIGHT BLUE LIGHT BLUE LIGHT BLUE
LIGHT BLUE LIGHT BLUE LIGHT BLUE LIGHT BLUE LIGHT BLUE
LIGHT BLUE LIGHT BLUE LIGHT BLUE LIGHT BLUE LIGHT BLUE
PVAD/IVAD
Type of Device: pulsatile
IVAD is implanted inside the abd cavity and is
attached to the same TLC II driver on the outside.
Questions:
1. CPR: NO
2. Hand pump: yes called hand bulbs
3. low flow alarms: Loss of Fill alarm
4. speed up device: fluids
5. heparin: only if it stops. Patient has to be on
Coumadin
6. defib: yes
7. disconnect for defib: no
8. pulse: yes
9. Vital signs: Normal BP parameters
10. externally pace: Usually in Bi VAD configuration
if yes the ECG not important to treat
What is an LVAD?
Left Ventricular Assist Devices are pumps surgically attached to patients’ hearts to pump blood for the ventricle. There are
three basic parts to all VAD systems. The pump, a computer with lamps and alarms, and a power source.
Why do patients get VADs?
Patient who have been treated for heart failure but in spite of optimal care continue to suffer from life limiting heart failure.
Patients may be on the heart transplant list but the transplant team is worried the patient may die before a suitable donor
is found, bridge to transplant. Pts who are not candidates for transplant but suffer from end stage heart failure may also
be implanted as destination therapy.
How do VADs work?
Most vads implanted nationally create continuous flow. Blood comes from patients own ventricle into the pump then a
turbine like spinning fan pushes the blood out into the aorta then the body. A cable connects the pump inside with the
computer/controller and batteries outside the body. The pump needs a constant power supply.
Do’s
1. Page the On Call Perfusionist. Call the Tower OR at 3316
to ask for the beeper number.
2. Give whatever medications you want. (no medication
contraindication)
3. Defibrillate if indicated
4. Hand pump only if the devise has stopped pumping, left
faster than right.
Don’ts
1. NO CHEST COMPRESSIONS.
2. NO MRI.
3. Don’t panic if the ECG is at one rate. The LVAD rate is at
another, and the RVAD rate is a third.
biVAD
JANUARY 2015
LIGHT BLUE LIGHT BLUE LIGHT BLUE LIGHT BLUE
LIGHT BLUE LIGHT BLUE LIGHT BLUE LIGHT BLUE
LIGHT BLUE LIGHT BLUE LIGHT BLUE LIGHT BLUE LIGHT BLUE
LIGHT BLUE LIGHT BLUE LIGHT BLUE LIGHT BLUE LIGHT BLUE
Hand Pumping Instructions
Switching to Backup TLC-II Driver
JANUARY 2015
Step 1: Obtain hand pump(s)
from carrying case. Note: One (1)
hand pump is needed for each
VAD.
Step 3: Connect the hand pump(s) to
the pneumatic lead(s).
Step 4: Squeeze hand pump(s) once per second.
Use your foot if necessary.
Note: For 2 VADs (BiVADs), squeeze each hand
pump at the same rate. Never hand pump the
right VAD (RVAD) faster than the left VAD (LVAD),
as this may cause pulmonary edema.
Step 2: Depress metal clip(s) to disconnect the
pneumatic lead(s) from the TLC II Driver.
Step 1: Insert a fully-charged battery (stored in carrying
case) into each battery slot of backup TLC-II driver.
Step 2: Turn on key switch
Step 3: Depress metal clip(s) to remove white occluder
from pneumatic port(s) :
l LVAD port is RED.
l RVAD port is BLUE.
l Note: for BiVADS, switch LVAD first. Do NOT remove
occluder caps from both ports at the same time (or
from unused port during single VAD support), or
system will depressurize.
Step 4: Disconnect pneumatic lead(s) from primary Driver
(or hand pump) and connect to backup Driver.
Step 5: Disconnect electric lead(s) from primary Driver and
connect to backup Driver.
Step 6: Place Driver in AUTO mode, if necessary.
Note: Backup Drivers are preprogrammed with a patient’s
unique settings.
Step 7: Verify full signal(s) is/are ejecting completely.
Step 8: Remove key and place in carrying case pocket.
Step 9: Connect to external power, if available by using the
AC power adapter cord.
All modes of emergency transport are acceptable for VAD patients.
Aviation electronics will NOT interfere with VAD operation (and vice versa).
Air Transport Consideration: In rotor wing and fixed wing aircraft flying at heights lower than
10,000 feet-when using the hand pump for external CPR, you must re-purge the bulb every 2000
feet in ascent and 1000 feet in descent. This will assure you have consistent cardiac output.
PURPLE PURPLE PURPLE PURPLE
PURPLE PURPLE PURPLE PURPLE
PURPLE PURPLE PURPLE PURPLE PURPLE
PURPLE PURPLE PURPLE PURPLE PURPLE
JANUARY 2015
DuraHeart™ System®
1. Can I do external CPR?
• Only if necessary; treat per physician discretion.
• Closed chest CPR is contraindicated
• May be performed as needed at the discretion of the attending physician
• External chest compressions may cause the dislocation/damage of pump Inflow/Outflow
conduits
• External defibrillation any be performed on a patient with the DuraHeart™ System® without
disconnecting any of the system components
2. If not, is there a “hand pump” or external device to use?
No.
3. If the device slows down (low flow state), what alarms will go off?
An emergency alarm will sound and the emergency alarm indicator (RED LIGHT) will light up.
4. How can I speed up the rate of the device?
The rate of the device can only be modified in a hospital setting. For low flow rates, check for
hypovolemia or RHF and treat accordingly.
5. Do I need to heparinize the patient if it slows down?
Call the accepting VAD facility for guidance.
6. Can the patient be defibrillated while connected to the device?
Yes.
7. If the patient can be defibrillated, is there anything I have to disconnect before
defibrillating?
No, defibrillate per protocol.
8. Does the patient have a pulse with this device?
If the patient’s own heart has some residual function, you may be able to feel a pulse.
9. What are acceptable vital sign parameters?
Mean Arterial Pressure (MAP) 80-90 mm Hg.
10. Can this patient be externally paced?
Yes, as needed.
PURPLE PURPLE PURPLE PURPLE
PURPLE PURPLE PURPLE PURPLE PURPLE
PURPLE PURPLE PURPLE PURPLE PURPLE PURPLE PURPLE PURPLE PURPLE
The DuraHeart™ LVAS is the
latest-generation rotary blood pump
designed for long-term patient
support. The system incorporates a
centrifugal flow rotary pump with an
active magnetically levitated impeller
featuring three position sensors
and magnetic coils that optimize
blood flow. The impeller’s magnetic
levitation is designed to eliminate
friction by allowing a wide gap
between blood contacting surface
areas, enabling blood to flow through
the pump unimpeded in a smooth
non-turbulent fashion.
JANUARY 2015
DuraHeart™ System®
The DuraHeart™ System consists
of an implantable Pump and several
components that support the function
of the Pump. The system is made
up of seven main components (see
photo below) which include:
External Batteries
Li-ion batteries
provide power
tot the pum
for untethered
operation for up
to 3-1/2 hours
per battery. Each
battery can be
recharged up to
200 times.
“Sweet, L. and Wolfe, Jr.,
A. Mechanical Circulatory
Devices in Transport
.ASTNA: Patient Transport
Principles and Practice, 4th
ed., Mosby, 2010
PURPLE PURPLE PURPLE PURPLE
PURPLE PURPLE PURPLE PURPLE
PURPLE PURPLE PURPLE PURPLE PURPLE
PURPLE PURPLE PURPLE PURPLE PURPLE
Controller and Batteries
JANUARY 2015
l Communicates with console for system set up,
monitoring and troubleshooting
l Controls and monitors pump function, stores system data
l Interfaces with external power sources (Console,
Batteries, Charger , Emergency Backup Battery)
l Displays system status – Pump Flow Rate
– Pump Rate
– Motor Current
– System alarms and Alerts
– Power Supply Status
DuraHeart™ System®
Patients will be on Coumadin with this deviceTarget INR range should be between 2.0 to 3.0
Combination antiplatelet therapy of ASA 81mg daily and Persantine 25-75 mg TID
Silencing Alarms
Controller
ALARM MESSAGE PROBLEM
Replace Controller The Pump may not be rotating
Connect Pump cable/Pump disconnected The Pump cable is disconnected
Controller Error Possible serious problem with the controller
Pump Failure Pump motor may have serious problem
Mag-Failure
The impeller may not be levitated
Emergency Alarms
Emergency Alarms
• Mute button silences audible alarm for
2 minutes
• Audible alarm returns after 2 minutes
Caution Alerts
• Mute button silences audible alarm for 5
ANTICOAGULATION
l Emergency Alarms
l High Priority.
l Flashing RED light and
continuous Emergency
Alarm tone.
l Requires immediate care
by medical specialist and
controller exchange.
“Sweet, L. and Wolfe, Jr., A. Mechanical Circulatory Devices in Transport .ASTNA: Patient Transport Principles and Practice, 4th ed., Mosby, 2010”
CALL
HOSPITAL
Emergency Alarm
Indicator (RED)
Caution Alarm
Indicator (YELLOW)
Display MUTE Button
MENU Button
and Power Light
Emergency Alarm
Indicator (RED)
MENU Button
and Power Light
Emergency Alarm
Messages
BATTERIES
CONTROLLER
GREEN GREEN GREEN GREEN
GREEN GREEN GREEN GREEN
GREEN GREEN GREEN GREEN GREEN
GREEN GREEN GREEN GREEN GREEN
SEPTEMBER 2016
1. Can I do external CPR?
Only if absolutely necessary
2. If not, is there a “hand pump” or external device to use?
No.
3. If the device slows down (low flow state), what alarms will go off?
A red heart alarm light indicator and steady audio alarm will sound if less than
2.5 lpm. Can give a bolus of normal saline and transport to an LVAD center.
4. How can I speed up the rate of the device?
No, it is a fixed speed.
5. Do I need to heparinize the patient if it slows down?
Usually no, but you will need to check with implanting center.
6. Can the patient be defibrillated while connected to the device?
Yes.
7. If the patient can be defibrillated, is there anything I have to
disconnect before defibrillating?
No.
8. Does the patient have a pulse with this device?
Likely they will not because it is a continuous flow device, however some
patients may have a pulse as this pump was designed with an “artificial
pulse.”
9. What are acceptable vital sign parameters?
MAP 70 - 90 mm Hg with a narrow pulse pressure.
10. Can this patient be externally paced?
Yes.
HeartMate III® with Pocket Controllers
FAQs
l Pump has “artificial pulse”
created by speeding up &
slowing down of pump. This
can be heard when auscultating
the heart and differs from other
continuous flow devices.
l May not be able to obtain cuff
pressure (continuous flow
pump).
l Pump connected to electric line
exiting patient’s abdominal area
and is attached to computer
which runs the pump.
l Pump does not affect EKG.
l All ACLS drugs may be given.
l A set of batteries last 14 – 16
hours
l Any emergency mode of
transportation is ok. These
patients are permitted to fly.
l Be sure to bring ALL of the
patient’s equipment with them.
Trouble Shooting HeartMate III® with Pocket Controllers
When the Pump Has Stopped
l Be sure to bring ALL of the patient’s equipment with them.
l Fix any loose connection(s) to restart the pump.
l If the pump does not restart and the patient is connected to batteries replace the current
batteries with a new, fully-charged pair. (see Changing Batteries section on next page)
l If pump does not restart, change controllers. (see Changing Controllers section on next page)
Alarms: Emergency Procedures
Yellow or Red Battery Alarm:
Need to Change Batteries. See
changing batteries section on
next page.
Red Heart Flashing Alarm: This may indicate a Low Flow Hazard. Check
patient--the flow may be too low. If patient is hypovolemic, give volume. If
patient is in right heart failure-- treat per protocol. If the pump has stopped
check connections, batteries and controllers as instructed in the section above.
This guide does not supersede manufacturer instructions. Copy with permission only.
GREEN GREEN GREEN GREEN
GREEN GREEN GREEN GREEN
GREEN GREEN GREEN GREEN GREEN
GREEN GREEN GREEN GREEN GREEN
This guide does not supersede manufacturer instructions. Copy with permission only. SEPTEMBER 2016
Trouble Shooting HeartMate III®
WARNING: At least one power lead must be
connected to a power source AT ALL TIMES.
Do not remove both batteries at the same time or
the pump will stop.
l Obtain two charged batteries from patient’s
accessory bag or battery charger. The charge
level of each gray battery can be assessed
by pressing the battery button on the battery.
(Figures 1 and 2)
l Remove only ONE battery from the clip by
pressing the button on the grey clip to unlock
the battery. (Figure 3)
l Controller will start beeping and flashing yellow
signals and will read POWER DISCONNECT
on the front screen. (Figure 4)
l Replace with new battery by lining up RED
arrows on battery and clip. Gently tug on
battery to ensure connection. If battery is
properly secured, the beeping and yellow
flashing will stop. (Figure 5)
l Slide a new, fully-charged battery (Figure 4)
into the empty battery clip by aligning the
RED arrows. The battery will click into the clip.
Gently tug at battery to ensure connection. If
battery is properly secured, the beeping and
green flashing will stop.
l Repeat previous steps with the second battery
and battery clip.
Figure 1 Figure 2
Figure 5
Figure 3
Changing Batteries
Figure 4
CAUTION—Investigational device. Limited by Federal (or United States) law to investigational use.
GREEN GREEN GREEN GREEN GREEN
GREEN GREEN GREEN GREEN
GREEN GREEN GREEN GREEN
GREEN GREEN GREEN GREEN GREEN
Trouble Shooting HeartMate III®
with Pocket Controllers
l Place the replacement Controller within easy reach,
along with the batteries/battery clips. The spare
Controller is usually found in the patient’s travel case.
l Make sure patient is sitting or lying down since the
pump will momentarily stop during this procedure.
l Attach the battery clips to the
spare controller by lining up
the half moons and gently
pushing together and attach
the batteries to the spare
controller by aligning the
RED arrows.
l On the back of the replacement controller, rotate
down the perc lock so the red tab is fully visible.
Repeat this step on the original controller until the
red tab is fully visible.
l Disconnect the drive-line from the original controller
by pressing down on the red tab and gently pulling
on the metal end. The pump will stop and an alarm
will sound. Note: The alarm will continue until the
original controller is put to sleep. You can silence
the alarm by pressing the silence button. Getting
the replacement controller connected and
pump restarted is the first priority.
l Connect the replacement
Controller by aligning the
BLACK ARROWS on the
driveline and replacement
Controller and gently
pushing the driveline into
the replacement Controller.
The pump should restart, if
not complete the following
steps:
Step 1. Firmly press the Silence Alarm or Test Select
Button to restart the pump.
Step 2. Check the power source to assure that power is
going to the controller.
Step 3. Assure the perc lead is fully inserted into the
socket by gently tugging on the metal end. DO
NOT pull the lead.
l After the pump restarts, rotate up the perc lock on
the new controller so the red tab is fully covered.
If unable to engage perc lock to a fully locked
position, gently push the driveline into the controller
to assure proper connection. Retry to engage perc
lock.
l Disconnect power from the original Controller. The
original Controller will stop alarming once power is
removed.
l Hold down battery symbol for 5 full seconds for
complete shutdown of old controller.
Changing Controllers
Adapted from Sweet, L. and Wolfe, Jr., A. Mechanical Circulatory Devices in Transport
in ASTNA: Patient Transport Principles and Practice, 4th ed., Mosby, 2010 in press.
This guide does not supersede manufacturer instructions. Copy with permission only. SEPTEMBER 2016
CAUTION—Investigational device. Limited by Federal (or United States) law to investigational use.
GREEN GREEN GREEN GREEN
GREEN GREEN GREEN GREEN
GREEN GREEN GREEN GREEN GREEN
GREEN GREEN GREEN GREEN GREEN
This guide does not supersede manufacturer instructions. Copy with permission only. SEPTEMBER 2016
The HeartMate 3 has a modular
cable connection near the exit site of
the driveline (Figure 1). This allows
a damaged driveline to be quickly
replaced (if damage is external).
l When disconnecting a driveline,
NEVER use the modular cable
connection.
l If this section of the driveline requires
replacement, this must be performed
at and by the implanting center.
Patients are not given a back-up
modular cable.
l If the connection is loose, there
will be a yellow/green line at the
connection showing (Figure 2). If the
line is visible, it can be retightened by
turning with the arrow in the locked
direction. It will ratchet and stop
turning once tight.
Trouble Shooting HeartMate III®
with Pocket Controllers
Modular Cable
CAUTION—Investigational device. Limited by Federal (or United States) law to investigational use.
Figure 2
Figure 1
TOTAL ARTIFICIAL HEART TOTAL ARTIFICIAL HEART TOTAL ARTIFICIAL HEART
TOTAL ARTIFICIAL HEART TOTAL ARTIFICIAL HEART TOTAL ARTIFICIAL HEART
TOTAL ARTIFICIAL HEART TOTAL ARTIFICIAL HEART TOTAL ARTIFICIAL HEART TOTAL ARTIFICIAL HEART
TOTAL ARTIFICIAL HEART TOTAL ARTIFICIAL HEART TOTAL ARTIFICIAL HEART TOTAL ARTIFICIAL HEART
EMS Guide
January 2015
This guide is produce by MCSO – The Mechanical Circulatory Support
Organization. It is produced by VAD Coordinators from some of the largest
and most successful VAD implantation hospitals in the US. It has been
vetted by experts on VADS in Air Medical Transport and EMS. It should not
replace the operator manual as the primary source of information.
Reprinted with the permission of Thoratec Corporation
M
C
S
O
ECHANICAL
IRCULATORY
UPPORT
RGANIZATION
Total Artificial Heart
MOST patients have a tag located on the controller around their waist that says what
type of device it is, what institution put it in and a number to call. Most importantly is
the color of the tag – it matches this EMS Field Guide and allows you to quickly locate
the device you are caring for.
JANUARY 2015
Color Coding System
What Is A Total Artificial Heart?
A total artificial heart (TAH) is a device that
replaces the two lower chambers (ventricles) of
the heart. You might benefit from a TAH if both
of your ventricles don’t work due to end-stage
heart failure.
What are the parts of a TAH?
The SYNCARDIA has tubes that, through holes
in the abdomen, run from inside the chest to an
outside power source.
What is the power source?
Shortly after the TAD is implanted, the patient
is switched to the Freedom driver. This is
a mobile “driver” for patients to who are
ambulatory. The patient considered discharge
from the hospital while awaiting a transplant
but ultimately received a heart transplant
while still an inpatient. Higher rates of survival
to transplant have already been proved with
the TAH. Potential benefits for the portable
Freedom driver include increased mobility,
decreased cost, and improved quality of life.
January 2015
Questions and Answers
for Total Artificial Heart
The portability of the Total Artificial Heart (TAH)
enables patients to resume many of their normal
daily activities.
January 2015
Patient Management For TAHs
1. Assess the patients airway and intervene per your protocol.
2. Auscultate heart sounds but you can usually hear them without a stetho
scope. Since this is pulsatile you should hear two sounds if properly
functioning.
3. Assess the device for any alarms.
4. Look on controller usually found around the waist of the patient and to
see what color tag and device it is. The backpack or freedom driver
should have a pink tag on it. It will have the type of device this is and
contact information to the implantation center.
5. Match the color on the device tag to the EMS Guide. The tag on the
backpack or freedom driver’s colored tag should matches the ems guide.
This will tell you how to manage any alarms.
6. Intervene appropriately based on the type of alarm, tag (device) and
EMS Guide.
7. Start Large Bore IV.
8. Assess Vital Signs. REMEMBER THERE IS NO EKG. THE PATIENT IS
ASYSTOLIC.
9. YOU SHOULD BE ABLE TO GET A SYSTOLIC AND DIASTOLIC BLOOD
PRESSURE.
10. Transport to the closest center that can care for a TAH. Look on the PINK
tag to find out this information.
11. Bring all of the patients equipment.
12. Bring the significant other if possible to act as a expert on the device in the
absence of consciousness in the patient.
PINK PINK PINK PINK
PINK PINK PINK PINK PINK
PINK PINK PINK PINK PINK PINK PINK PINK PINK
Total Artificial Heart Freedom™ Driver System
1. Can I do external CPR?
No. Will need to rapidly exchange to the backup driver.
2. Is there a “hand pump” or external backup device to use?
No.
3. Can I give vasopressive IV drugs like epinephrine,
dopamine or dobutimine?
Never give vasopressive drugs, especially epinephrine. These
patients primarily have sysmptomatic hypertension and rarely
have symptoms of hypotension. Most IV vasopressive drugs can
be fatal to a TAH (Total Artificial Heart) patient.
4. Can I speed up the rate of the device?
No. The device has a fixed rate between 120-140-BPM.
5. What is the primary emergency intervention for a TAH (Total
Artificial Heart)?
Nitroglycerin sublingual for symptomatic hypertension.
6. Can the patient be defibrillated or externally paced while
connected to the device?
No. There is no heart.
7. What if the patient is symptomatic and the Freedom Driver
is alarming with a continuous alarm and the red light ?
If the pump has failed or a line is disconnected or kinked,
the patient may pass out within 30 seconds. Even when
alarming, the device should continue to pump. When in doubt,
immediately change out he Freedom™ Driver immediately. Then
quickly check for loose or kinked connections.
8. Does the patient have a pulse with this device?
Yes. The device
produces Pulsatile
flow. The device is
pneumatically driven
and is normally loud.
9. What are acceptable
vital sign
parameters?
The BP will vary.
Normal range 100-130
systolic and 60-90
diastolic.
10. What kind of
Cardiac rhythm
should be
displayed?
Asystole.
This Patient is on an ARTIFICIAL HEART
(not a left ventricular assist device-LVAD)
“Sweet, L. and Wolfe, Jr., A. Mechanical Circulatory
Devices in Transport .ASTNA: Patient Transport
Principles and Practice, 4th ed., Mosby, 2010”
FILTER COVER JANUARY 2015
POWER
ADAPTOR
PLUG
POWER
ADAPTOR
GREEN
RECEPTACLE
POWER
ADAPTOR
POWER
ADAPTOR
GREEN
LIGHT
DRIVE
LINES
PINK PINK PINK PINK
PINK PINK PINK PINK PINK
PINK PINK PINK PINK PINK
This guide does not supersede manufacturer instructions. Copy with permission only. March 2011
PINK PINK PINK PINK
Trouble Shooting Freedom™ Driver System
BEATS PER MINUTE, FILL VOLUME
AND CARDIAC OUTPUT
POWER ADAPTOR
PLUG FILTER COVER
POWER ADAPTOR
GREEN RECEPTACLE
POWER
ADAPTOR
POWER ADAPTOR
GREEN LIGHT
DRIVE LINES
BATTERY
FUEL
GAUGE
BATTERY
CHARGE
BUTTON
BATTERY
RELEASE
BUTTON
RED
LIGHT
VISUAL
ALARM
YELLOW
LIGHT
VISUAL
ALARM
YELLOW
LIGHT
VISUAL
ALARM
“Sweet, L. and Wolfe, Jr., A. Mechanical Circulatory Devices in Transport .ASTNA: Patient Transport Principles and Practice, 4th ed., Mosby, 2010”
This Patient is on an ARTIFICIAL HEART
(not a left ventricular assist device -LVAD)
January 2015
IN THE EVENT OF AN EMERGENCY
Immediately notify VAD coordinator listed on the medical alert bracelet or tag
attached to the console - please identify the device as a total artificial heart.
Freedom™ Driver System
PINK PINK PINK PINK
PINK PINK PINK PINK
PINK PINK PINK PINK PINK
PINK PINK PINK PINK PINK
“Sweet, L. and Wolfe, Jr., A. Mechanical Circulatory Devices in Transport .ASTNA: Patient Transport Principles and Practice, 4th ed., Mosby, 2010”
January 2015
There is no way to mute an Alarm.
HOW TO RESPOND TO FREEDOM™ DRIVER ALARMS
ALARM HEAR SEE MEANING WHAT YOU SHOULD DO
Battery Alarm
Loud
Intermittent
Tone
Yellow
Battery LED
Flashing
One or both of the Onboard
Batteries have less than 35%
remaining charge (only two
green lights display on the
Battery Fuel Gauge).
Replace each low Onboard Battery, one
at a time, with a charged Onboard Battery
or connect to external power (NOTE:
Once the batteries are charged above
35% the Battery Alarm will stop) .
Onboard Battery is incorrectly
installed.
Reinsert Onboard Battery until locked in
place. If Battery Alarm continues, insert a
new Onboard Battery.
One Onboard Battery missing.
Insert charged Onboard Battery into
Freedom™ Driver until locked in place.
Temperature
Alarm
Loud
Intermittent
Tone
Red Alarm
LED
Flashing
The temperature of the Driver
is too hot or too cold.
Remove any objects that are blocking
the Filter Cover and/or Fan and check the
filter.
Move the Freedom Driver to a cooler or
warmer area.
The internal temperature of the
Driver is too hot.
Fault Alarm
Loud
Continuous
Tone
Red Alarm
LED
Solid
Valsalva Maneuver: Strenuous
coughing or laughing,
vomiting, straining during a
bowel movement, or lifting a
heavy weight.
Relax/interrupt Valsalva Maneuver.
Kinked or disconnected drive
lines.
Straighten or connect drive lines.
Driver is connected to External
Power without at least one
correctly inserted Onboard
Battery.
Insert a charged Onboard Battery into the
Freedom™ Driver until locked into place.
One or both of the Onboard
Batteries have less than 30%
remaining charge.
Replace each low Onboard Battery, one
at a time, with a charged Onboard Battery
or connect to external power. (NOTE: the
Fault Alarm will continue and will change
into a Battery Alarm as the Onboard
Batteries recharge. Once the Onboard
Batteries are charged above 35%, the
Battery Alarm will stop.)
Malfunction of the Driver
If the steps above do not stop the Fault
Alarm, switch to Backup Freedom Driver.
Return to implant hospital.
Temperature
Alarm
Loud
Intermittent
Tone
Red
Alarm
LED
Flashing
The internal temperature
of the Driver is too hot.
Remove any objects that are
blocking the Filter Cover
and / or Fan and check filter.
The temperature of the
Onboard Batteries is too
hot or too cold.
Move the Freedom Driver to a
cooler or warmer area.
You must immediately address the issue that caused the Alarm.
PINK PINK PINK PINK
PINK PINK PINK PINK
PINK PINK PINK PINK PINK
PINK PINK PINK PINK PINK
FIGURE 1
FIGURE 2
FIGURE 3
“Sweet, L. and Wolfe, Jr., A. Mechanical Circulatory Devices in Transport .ASTNA: Patient Transport Principles and Practice, 4th ed., Mosby, 2010”
January 2015
Switching from Primary to Backup Freedom™ Driver
Setting up the Backup Freedom™ Driver
1. Remove the drive line caps from the ends of the Drive lines.
2. Insert one charged Onboard Battery. The driver will immediately
start pumping. (Figure 1)
3. Remove the Orange Dummy Battery. (Figure 1)
4. Insert the second charged Onboard Battery. (Figure 2)
5. If possible, connect the backup Driver into a wall power outlet.
6. Your Freedom™ Driver is now ready to connec to the patient.
CAUTION: It is recommended to have TWO people exchange the primary Freedom Driver for
the backup Freedom Driver. Make sure all items and accessories are closely available before
attempting to exchange Drivers.
Continued on next page.
BEATS PER MINUTE, FILL
VOLUME AND CARDIAC
OUTPUT
PINK PINK PINK PINK
PINK PINK PINK PINK
PINK PINK PINK PINK PINK
PINK PINK PINK PINK PINK
1. With the Wire Cutter Tool, cut the Wire Tie under the metal release button of the CPC Connector that
secures the RED TAH-t Cannula to the RED Freedom Drive line. Gently pull to remove the Wire Tie and
discard. DO NOT DISCONNECT THE CANNULA FROM THE DRIVE LINE YET.
2. With the Wire Cutter Tool, cut the Wire Tie under the metal release button of the CPC Connector that
secures the BLUE TAH-t Cannula to the BLUE Freedom Drive line. Gently pull to remove the Wire Tie
and discard. DO NOT DISCONNECT THE CANNULA FROM THE DRIVE LINE YET.
3. Disconnect the RED Cannula from the RED Drive line of the primary Freedom Driver:
• Press and hold down the metal release button. Pull the RED Cannula away from the RED Drive line.
• Immediately insert the RED Cannula into the new RED Drive line from the backup Freedom Drive
Insert until a click is heard and lightly tug on the connection to make sure that it is secure.
4. Simultaneously disconnect the BLUE Cannula from the BLUE Drive line of the primary Freedom Driver:
• Press and hold down the metal release button. Pull the BLUE Cannula away from the BLUE Drive line.
• Immediately insert the BLUE Cannula into the new BLUE Drive line from the backup Freedom Driver.
• Insert until a click is heard and lightly tug on the connection to make sure that it is secure.
5. Slide a Wire Tie under the metal release button of each CPC connector. Create a loose loop in the tie,
taking care not to depress and disconnect the connectors. Cut off the excess length of both Wire Ties.
6. Patient must notify Hospital Contact Person of the switch.
7. The Hospital should notify SynCardia Systems that the Driver has been switched and return the faulty Driver.
January 2015
CAUTION: Before disconnecting the Drive lines of the primary Freedom Driver, you must
have the Drive lines of the backup Freedom Driver within reach. The backup Driver must be
turned on. Perform steps 3 and 4 simultaneously.
Wire Tie
Pull Push In
Press
Switching from Primary to Backup Freedom™ Driver
Continued on from previous page
CPC Connectors
Metal Release
Button with Wire Tie
Blue Cannula
Red Cannula
Blue Drive line
Red Drive line
Medication Administration Cross Check
 Contraindications include:
1) Verification of appropriate Vital Signs. 3) Expiration date.
2) Known patient allergies. 4) Protocol conflict
 If a discrepancy, disagreement, or need for clarification is encountered, it must be resolved prior
to continuing the MACC
 The MACC must be completed prior to the administration of any medication.
 If there is an interruption or change in patient condition of any kind, the process must be reinitiated.
 Never give the contents of a syringe that is not labeled or without visualizing the vial
or ampule from which it was immediately drawn.
Provider 1
(Giving the Medication)
Provider 2
(Remember: R.C.V or R.C.Q. )
Medication Cross
Check
I Agree
Ready
I am going to give:
 Dose
 Medication Name
 Route
 Rate
 Reason
Contraindications?
Volume?
or
Quantity
If none state,
No Contraindications
Otherwise verbally verify
 State the medication
concentration.
 State the volume to be
administered or # of
tablets.
 Show the vial/bottle to
Provider 2.
Agree
Agree
Agree
+
Positive
Visual
RED FLAGS of Lost Situational Awareness
And Errors in Production
Situational Awareness is the ability to identify, process,
and comprehend the critical elements of your team s
actions with regard to achieving your team's goals.
RED FLAGS are signs that you or someone on
your team has lost situational awareness and
a verification is needed.
 Intuition of a bad gut feeling
 Rushing
 Poor Communication
 Disagreement
 Task Saturation
 Trying Something New Under Pressure
 Interruptions
 Ambiguity
 Preoccupation
 Confusion
STOP & VERIFY
Establish a collective awareness by:
 Review the situation out loud (SBAR)
 Situation
 Background
 Assessment
 Recommendation
 Defer to expertise
 Look it up (i.e. protocols, SOP)
 Contact Medical Control
Position 1 (Compressor)
Position on patients right side
1. Initiates compressions (100-120 per min)
2. Rotates to position “2” during analysis and
follows the direction of the AED
Position 2 (AED Operator/Code Manager)
Initial duties
1. Patient assessment and states “Start CPR”
2. Starts metronome
3. Sets up and operates the AED immediately
4. Rotates to position “1” during analysis, prepares for
compressions
ATTACHMENT A
Position 2 (AED Operator/Code Manager)
Duties when positioned at patients head
1. Operate AED, ensure compression resume during charge
2. Inserts an OPA and manages airway, use passive
ventilations (may interpose ventilations with BVM)
3. Rotates to position “1” during analysis, prepares for compressions
Passive ventilation is recommended until adequate resources are available to
provide ventilations without interfering with chest compressions or defibrillation.
Initial Duties
AED Operator positions at head after initial duties
Position 1 (Compressor)
Position on patients right side
1. Initiates compressions (100-120)
2. Counts aloud the final three
compressions “8,9,bag”
3. Rotates to position “3” during analysis
Position 2 (AED Operator/Code Manager)
Position on patients left side
1. Patient assessment and states “Start CPR”
2. Starts metronome
3. Sets up and operates the AED immediately
4. Announces intervals
5. Verbalizes upcoming assignments
6. Gives feedback on CPR
Position 3 (Airway)
Position at patients head
1. Opens airway and Inserts an OPA
2. Assist with AED as needed
3. Assembles BVM and interposes ventilation (1:10)
4. Assess and provides definitive airway, as needed
5. Rotates to position “1” during analysis, prepares for compressions
ATTACHMENT B
Position 1 (Compressor)
Position on patients right side
1. Initiates compressions (100-120)
2. Counts aloud the final three
compressions “8,9,bag”
3. Rotates to position “3" during analysis
Position 2 (AED Operator)
Position on patients left side
1. Patient assessment and states “Start CPR”
2. Starts metronome
3. Sets up and operates the AED immediately
4. Clears the patient for analysis and defibrillation
5. Gives command to resume compressions
Position 3 (Airway)
Position at patients head
1. Opens airway and Inserts an OPA
2. Assists with AED as needed
3. Assembles BVM and interposes ventilation (1:10)
4. Rotates to position “1” during analysis, prepares
for compressions
Position 4 (Code Manager)
Position just outside of triangle
1. Announces interval updates
2. Verbalizes assignments for next rotation
3. Assures quality of CPR and gives feedback
4. Scene management / Family Liaison
ATTACHMENT C
Position 1 (Compressor)
Position on patients right side
1. Initiates compressions (100-120 per min)
2. Rotates to position “2” during analysis and
follows the direction of the AED
The LP15 should be placed in AED mode.
ATTACHMENT D
Position 2 (AED Operator/Code Manager)
Initial duties
1. Patient assessment and states “Start CPR”
2. Starts metronome
3. Sets up and operates the AED
3a. Apply combo pads
3b. Press Analyze
4. Rotates to position “1” during analysis, prepares for compressions
Position 2 (AED Operator/Code Manager)
Duties when positioned at patients head
1. Follows prompt to deliver a shock or resume CPR
2. Inserts an OPA and manages airway, uses passive
ventilations (may interpose ventilations with BVM)
3. Rotates to position “1” during analysis, prepares for compressions
AED Operator positions at head after initial duties
Initial Duties
Position 1 (Compressor)
Position on patients right side
1. Initiates compressions (100-120)
2. Rotates to position “3” when relieved
Position 3 (Airway)
Position at patients head
1. Opens airway and Inserts an OPA
2. Assists with defib pads as needed
3. Assembles BVM and interposes ventilation (1:10)
4. Assess and provides definitive airway, as needed
5. Rotates to position “1” at the 15 second mark
and prepares for compressions
ATTACHMENT E
Position 2 (LP15 Operator ALS Only /Code Manager)
Position at patients left side
1. Patient assessment and states “Start CPR”
2. Starts metronome
3. Attaches combo pads and starts defibrillation
sequence
4. Announces intervals
5. Verbalizes upcoming assignments
6. Gives feedback on CPR
FOR EACH SUBSEQUENT ANALYSIS START THE
DEFIBRILLATION SEQUENCE AT THE 15 SECOND MARK.
DEFIBRILLATON SEQUENCE
1. Start Printing
2. Charge Defibrillator
3. “Stop CPR”
3. Analyze Rhythm
5. Deliver Shock or Dump Charge
6. “Start CPR”
Position 1 (Compressor)
Position on patients right side
1. Initiates compressions (100-120)
2. Rotates to position 3 when relieved
Position 2 (LP15 Operator ALS Only)
Position at patients left side
1. Patient assessment and states “Start CPR”
2. Starts metronome
3. Attaches combo pads and begin defibrillation
sequence
4. Makes ALS treatment decisions
FOR EACH SUBSEQUENT ANALYSIS, START THE
DEFIBRILLATION SEQUENCE AT THE 15 SECOND MARK.
Position 3 (Airway)
Position at patients head
1. Opens airway and Inserts an OPA
2. Assists with defib pads as needed
3. Assembles BVM and interposes ventilation (1:10)
4. Rotates to position 1 during rhythm assessment
and prepares for compressions
Position 4 (Code Manager)
Position just outside of triangle
1. Announces interval updates
2. Verbalizes assignments for next rotation
3. Assures quality of CPR and gives feedback
4. Scene management / Family Liaison
ATTACHMENT F
DEFIBRILLATON SEQUENCE
1. Start Printing
2. Charge Defibrillator
3. “Stop CPR”
3. Analyze Rhythm
5. Deliver Shock or Dump Charge
6. “Start CPR”
Position 1 (Compressor)
Position on patients right side
1. Provides compressions
2. Alternates compressions with
position “2”
3. During off cycle may assist with
other care
Position 2 (Airway)
Position at patients head
1. Opens airway and Inserts an OPA
2. Assembles BVM and interposes ventilation (1:10)
3. Rotates to “On Deck” at 15 second mark
Position 3 (Code Manager)
Position just outside of triangle
1. Announces interval updates
2. Verbalizes assignments for next rotation
3. Assures quality of CPR and gives feedback
4. Scene management / Family Liaison
Position 5 (ALS provider)
Position outside of triangle
1. Intubates as needed
2. Obtains IV/IO access as needed
3. Draws medications requested by Lead Provider
4. Other Care as needed
ATTACHMENT G
DEFIBRILLATON SEQUENCE
1. Start Printing
2. Charge Defibrillator
3. “Stop CPR”
3. Analyze Rhythm
5. Deliver Shock or Dump Charge
6. “Start CPR”
Position 4 (LP15 Operator Lead ALS Provider)
Position at patients left side
1. Patient assessment and states “Start CPR”
2. Starts metronome
3. Attaches pads/begin defibrillation sequence
4. Initiates IV/IO access
5. Makes ALS treatment decisions
6. Administers medications
FOR EACH SUBSEQUENT ANALYSIS STARTS THE
DEFIBRILLATION SEQUENCE AT THE 15 SECOND
MARK.
Additional Provider (when available)
1. Positions “On Deck” to relieve compressor
2. During off cycle may assist with other care
3. “Hovers” in preparation for compressions
Downloading Instructions for the Airtraq
Camera
Step 1:
Open Airtraq software on the station computer. The station computer that has the software
downloaded on it is marked with an P‐Touch Label that says “AED DOWLOAD” on the
computer monitor.
Step 2:
Plug in the Airtraq camera using the included USB cable.
Step 3:
Click on the “DOWNLOAD VIDEOS TO PC”
Step 4:
Highlight the video you want to download.
Step 5:
Clcik the download video button as shown below.
Step 6:
Click the back button to return to the main menu.
Step 7:
Click on “VIDEO GALLERY ON PC”.
Step 8:
Click on “Open” in upper right corner.
Step 9:
Rename the selected video with the medic unit number and incident number (ex. M512
FD170000000). Email the video file to EMSIntubations@pwcgov.org